cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
64640,"reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid",420-070-1,,Org. Perox. D;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H302:0;H312:0;H314:0;H242:0;H400:0;H332:0
64642,"lithium potassium sodium N,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo)]naphthalene-1,3,6-trisulfonato]}-N'-(2-aminoethyl)piperazine",427-850-9,202667-43-4,Skin Sens. 1,Harmonised C&L,0,H317:0
64643,Dibutyldimethoxystannane,213-935-6,1067-55-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,72,H301:40;H331:39;H311:40;H317:19;H341:19;H360:18;H411:32;H372:19;H302:13;H315:13;H319:13;H373:13;H410:1;H400:1;H330:1;H361:1
64651,Tricadmium diarsenide,234-484-1,12006-15-4,Acute Tox. 3;Acute Tox. 2;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,94,H410:94;H400:94;H301:94;H330:56;H350:52;H312:38;H331:38
64652,"(4-aminobenzoato-O)[ethane-1,2-diolato(2-)-O,O'](isooctadecanoato-O)titanium",270-545-9,68443-71-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H335:1
64656,"1,2:5,6-di-O-isopropylidene-α-D-glucofuranose",209-486-0,582-52-5,Not Classified,REACH registration C&L,6,Not classified:6
64657,1-chloropentane,208-846-4,543-59-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H225:0;H332:0;H312:0
64664,5-chloro-N-methyl-2-nitroaniline,609-197-3,35966-84-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
64666,"1,1,1-tributoxypentane",263-367-8,62007-51-6,Not Classified,Notified C&L,3,Not classified:2;H319:1
64668,p-xylene-α-thiol,224-796-6,4498-99-1,,Notified C&L,5,H302:5;H335:4;H315:5;H319:5;H332:5;H312:1
64669,"Diphenylmethylbenzene;tetrakis(2,3,4,5,6-pentafluorophenyl)boranuide",685-485-2,136040-19-2,Acute Tox. 4;STOT SE 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H302:43;H335:40;H410:36;H400:36;H372:35;H312:6;H315:6;H319:6;H332:6;H314:4;H318:1
64673,"Benzene-1,2,4-tricarbonyl trichloride",223-386-4,3867-55-8,Water-react. 1;Skin Corr. 1A,Notified C&L,3,H260:2;H314:3
64675,"6-(3-chloropropylamino)-1,3-dimethylpyrimidine-2,4-dione; hydrochloride",918-399-3,,Not Classified,REACH registration C&L,2,Not classified:2
64677,"2,2'-[methylenebis(phenyleneoxymethylene)]bisoxirane",254-641-8,39817-09-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,40,H319:40;H317:40;H315:40;H411:40
64679,"Tabebuia impetiginosa, ext.",607-027-2,223748-85-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
64683,"Pentane-2,4-dione dioxime",218-472-3,2157-56-4,,Notified C&L,4,H319:4;H315:4;H335:4
64686,fomesafen (ISO);5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide,276-439-9,72178-02-0,Acute Tox. 4,Harmonised C&L,0,H302:0
64687,Decyl laurate,253-087-4,36528-28-6,Not Classified,REACH registration C&L,22,Not classified:22
64691,Di-tert-pentyl peroxide,234-042-8,10508-09-5,Flam. Liq. 3;Org. Perox. E;Skin Irrit. 2;Muta. 2;Aquatic Chronic 2,REACH registration C&L,327,H341:83;H315:326;H411:2;H242:313;H226:122;H225:191;H413:77;H302:39;H319:2;H332:1;H312:1
64692,C8-C16 branched and linear hydrocarbons (full range) – Kerosine,481-670-5,848301-66-6,Flam. Liq. 3;Asp. Tox. 1,REACH registration C&L,7,H304:7;H226:7
64693,Erbium,231-160-1,7440-52-0,Flam. Sol. 1,Notified C&L,103,H228:96;Not classified:5;H260:4;H319:2;H315:2;H335:2
64694,2'-bromopropiophenone,263-531-9,62403-86-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
64699,"4,4'-azo-3-hydroxynaphthalene-1-sulphonate",212-958-9,887-76-3,Eye Dam. 1,REACH registration C&L,131,H318:88;H228:124;H314:125;H317:84;Not classified:2;H319:1;H315:1;H335:1;H302:1
64702,Diethyl(2-methylaminoethyl)amine,203-238-5,104-79-0,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H314:39;H226:39;H318:1
64704,Trisodium bis[2-hydroxy-5-nitro-3-[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo]benzenesulphonato(3-)]cobaltate(3-),289-068-2,85959-73-5,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,88,H319:59;H302:39;H317:39;H411:39;Not classified:29;H412:8
64705,p-aminobenzamide,220-612-3,2835-68-9,Eye Irrit. 2,REACH registration C&L,101,H319:99;H302:44;H315:49;H332:40;H335:7;Not classified:2
64706,"2-Isobutyryl-3,N-diphenylacrylamide",619-636-0,125971-57-5,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,67,H317:67;H411:67
64708,1-methylanthracene,210-224-2,610-48-0,Not Classified,Notified C&L,3,Not classified:3
64716,Cbz-L-tert-Leucin x DCHA,613-119-3,62965-37-1,Not Classified,Notified C&L,6,Not classified:3;H302:4;H412:3;H413:1;H372:2
64718,chrysene,205-923-4,218-01-9,Muta. 2;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H341:0;H350:0;H410:0
64719,Brompheniramine hydrogen maleate,213-562-9,980-71-2,Acute Tox. 4,Notified C&L,43,H302:43;H315:2
64720,Cyclohexylethanol,224-672-1,4442-79-9,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,306,H302:306;H312:306;H315:1;H411:1
64722,"Fatty acids, C14-18 and C16-18-unsatd., iso-Bu esters",284-867-2,84988-78-3,Not Classified,Notified C&L,1,Not classified:1
64725,Methyl 2-[[2-(phenylmethylene)heptylidene]amino]benzoate,271-283-8,68527-78-6,Not Classified,Notified C&L,233,Not classified:233
64729,Chloro(2H5)benzene,221-482-0,3114-55-4,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,9,H411:8;H332:8;H226:8;Not classified:1
64730,Tridodecylamine,203-063-4,102-87-4,Skin Irrit. 2;Eye Irrit. 2;Repr. 1B;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,151,H360:85;H315:151;H411:107;H372:85;H319:151;H335:39
64737,"1,1-dicyanoethyl acetate",232-195-5,7790-01-4,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H310:38;H335:38;H315:38;H331:38;H301:38;H319:38
64742,Diflorasone di(acetate),251-575-1,33564-31-7,Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,41,H351:38;H332:38;H312:39;H319:1;H361:2;H360:1;H315:1;H373:1
64744,2-[(2-hydroxyethyl)octadecylamino]ethyl stearate,257-964-2,52497-24-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4,H318:2;H315:3;Not classified:1;H319:1
64745,"N-(4-methoxyphenyl)benzene-1,4-diamine monohydrochloride",222-652-7,3566-44-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H301:38;H331:38;H311:38;H302:1;H332:1;H312:1
64750,2-chloro-4-fluorobenzoic acid,218-845-0,2252-51-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H318:38;H302:38;H315:46;H335:45;H319:8
64751,"Silicic acid (H4SiO4), tetrakis(2-methoxy-1-methylethyl) ester",606-018-0,18407-95-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,22,H319:22;H302:22
64754,Tris(2-methylaziridin-1-yl)phosphine oxide,200-326-5,57-39-6,Acute Tox. 3;Acute Tox. 2,Notified C&L,40,H301:40;H310:39;H311:1;H330:2;H340:1;H372:1;H361:1
64756,"2,5-dichloro-4-[[2-(dibutylamino)-4-methyl-6-[[2-(4-sulphophenyl)ethyl]amino]-5-pyrimidinyl]azo]benzenesulphonic acid, sodium salt",284-748-5,84962-50-5,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,49,H319:12;H411:41;H318:37
64757,Lead difluoride,231-998-8,7783-46-2,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,108,H302:108;H360:108;H410:108;H400:108;H332:108;H373:108;H340:32;H350:32
64758,Clary Sage Extract,616-984-5,8016-63-5,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,126,H317:87;H315:117;H226:62;H412:84;H304:2;H411:2;H319:2
64760,Sodium 6-[(3-chloro-2-hydroxy-5-nitrophenyl)azo]-5-hydroxynaphthalene-1-sulphonate,233-371-4,10132-98-6,Not Classified,Notified C&L,9,Not classified:9
64762,Mexiletine,250-825-7,31828-71-4,Acute Tox. 4,REACH registration C&L,2,H302:2
64770,7-benzamido-4-hydroxy-3-[[4-[(4-sulphophenyl)azo]phenyl]azo]naphthalene-2-sulphonic acid,246-727-9,25188-42-5,,Notified C&L,87,Not classified:86;H319:1
64771,"Octane-2,3-dione",209-552-9,585-25-1,Flam. Liq. 3,Notified C&L,1374,H226:1374
64773,Isobutamben,202-308-2,94-14-4,Skin Sens. 1,Notified C&L,39,H317:38;H319:1;H315:1
64774,Diethyl ethyl(1-methylbutyl)malonate,200-981-7,76-72-2,Not Classified,REACH registration C&L,5,Not classified:3;H302:2;H319:1;H315:1
64777,"Hydrocarbons, C6-7",295-763-1,92128-66-0,Flam. Liq. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,39,H336:39;H225:39;H411:39;H304:39;H315:13
64779,1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide,424-160-1,139481-22-4,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
64781,"1,1,2,3-tetramethyl-1H-benzo[e]indolium 4-methylbenzenesulfonate",604-261-7,141914-99-0,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,3,H318:2;H301:2;H317:2;H411:2;Not classified:1
64785,Aluminium potassium bis(sulphate),233-141-3,10043-67-1,Not Classified,REACH registration C&L,137,Not classified:134;H319:3
64789,"Opuntia ficus-indica, ext.",290-109-1,90082-21-6,Not Classified,Notified C&L,4,Not classified:2;H413:1;H226:1
64792,"2,2,3-trichloropropionamide",237-084-5,13601-94-0,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H301:38;H315:38;H335:38
64800,"Garlic, ext.",232-371-1,8008-99-9,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1468,H317:1439;H315:1414;H301:1287;H319:1396;H226:1419;H302:131;Not classified:24;H312:2;H412:6;H332:2;H304:3;H335:2
64801,"Glycine, N-[2-[(2-hydroxyethyl)amino]ethyl]-, N-C3-11-acyl derivs., monosodium salts",293-957-0,91671-57-7,Not Classified,Notified C&L,7,Not classified:7
64806,7-hydroxynaphthalene-1-sulphonic acid,205-066-6,132-57-0,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2,H319:1;H315:1;Not classified:1
64810,Ethyl 4-isothiocyanatobenzoate,214-880-0,1205-06-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,44,H302:44;H314:43;H332:44;H312:44;H335:1;H315:1;H319:1
64816,"Fuel oil, residues-straight-run gas oils, high-sulfur;Heavy Fuel oil",270-674-0,68476-32-4,Carc. 1B,Harmonised C&L,0,H350:0
64817,"Phosphoric acid, butyl ester, ammonium salt",258-381-6,53127-03-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
64819,"reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide",434-330-5,,Skin Sens. 1;Carc. 2;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H351:0;H413:0
64822,N'-Benzoyl-4-chloro-N'-(2-methyl-2-propanyl)benzohydrazide,601-173-0,112226-61-6,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,194,H317:194;H411:194
64823,"O,O-dimethyl hydrogen dithiophosphate",212-053-9,756-80-9,Flam. Liq. 3;Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Repr. 2;Aquatic Chronic 3,REACH registration C&L,91,H302:91;H290:91;H412:91;H314:91;H361:91;H226:91;H332:90;H318:1;H330:1
64824,Ethyl 2-methyl-2-(methylthio)propionate,256-483-5,49773-24-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,15,H319:15;H315:15;H335:15
64826,Didodecyl phosphonate,244-325-8,21302-09-0,Not Classified,Notified C&L,28,Not classified:20;H315:8
64830,"(R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate",418-570-8,25383-07-7,Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H361:0;H411:0
64832,(6R-trans)-7-amino-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,239-787-2,15690-38-7,Skin Sens. 1A;Resp. Sens. 1,REACH registration C&L,6,H334:6;H317:6
64834,"Rape oil, polymer with tung oil",606-051-0,185323-46-0,Not Classified,REACH registration C&L,1,Not classified:1
64835,"Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs., ammonium salts",284-902-1,84989-13-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,22,H302:18;H317:10;H315:21;H411:10;H319:10;H318:11;Not classified:1
64836,"5-methyl-1,2-oxazol-4-amine hydrochloride",600-103-6,100499-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
64837,(benzylthio)acetic acid,203-114-0,103-46-8,,Notified C&L,4,H319:4;H315:4;H335:4
64842,"[benzoato(2-)-C2,O1]mercury",227-228-5,5722-59-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H310:38;H300:38;H410:38;H400:38;H330:38;H373:38
64843,Hexamethonium bromide,200-249-7,55-97-0,Not Classified,Notified C&L,7,Not classified:6;H370:1
64846,"1,1,2,3,3,5-hexamethylindan",225-416-1,4834-28-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H302:1;H410:1
64847,Di[(2H3)methyl] sulphate,239-257-0,15199-43-6,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Muta. 2;Carc. 1B,Notified C&L,40,H317:40;H341:40;H314:40;H301:40;H330:40;H350:40;H318:1;Not classified:1
64851,1-chloroanthraquinone,201-421-4,82-44-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:43;H315:42;H335:42;Not classified:4;H412:1
64853,"1,9-diiodononane",246-355-7,24613-65-8,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,38,H301:38;H413:38
64860,"3a,4,5,7a-tetrahydro-7-methyl-5-(tetrahydro-2,5-dioxofuran-3-yl)isobenzofuran-1,3-dione",277-212-7,73003-90-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3
64862,"Amines, (1H-benzotriazol-1-ylmethyl)dicoco alkyl",272-048-2,68650-81-7,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,108,H400:108;H410:108;H317:108;H315:108
64865,"1,3-Dioxolane, 2-(4-chlorophenyl)-",607-307-4,2403-54-5,Aquatic Chronic 3,REACH registration C&L,1,H412:1
64867,2-(pyrrolidinyl)pyrimidin-4-amine,251-699-6,33851-99-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
64870,2-ethylfuran,221-714-0,3208-16-0,Acute Tox. 3;Acute Tox. 2,Notified C&L,1444,H301:1286;H330:1286;H225:158;H302:10;H319:1;H315:1;H335:1
64871,[2-(methacryloyloxy)ethyl]trimethylammonium methyl sulphate,229-995-1,6891-44-7,Not Classified,REACH registration C&L,46,Not classified:8;H315:38
64875,"Bis(1,1,1-trifluoropentane-2,4-dionato-O,O')copper",238-271-4,14324-82-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
64880,"6,6'-di-tert-butyl-4,4'-diethyl-2,2'-methylenediphenol",201-814-0,88-24-4,Aquatic Chronic 4,REACH registration C&L,115,H413:17;Not classified:57;H319:41;H315:41;H335:40;H302:1;H312:1;H332:1
64881,"2-[2-[4-(dimethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate",275-654-5,71598-17-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,90,H302:88;H318:88;H314:86;H410:86;H400:86;Not classified:1;H319:1;H412:1
64885,"Amines, N,N'-bis(3-aminopropyl)-N,N'-bis(C16-18-alkyl and C16-18-alkenyl)methylenedi-",292-548-4,90640-31-6,Not Classified,Notified C&L,441,Not classified:441
64888,"Reaction product of resin acid and rosin acid, 12-Hydroxyoctadecanoic and stearic acid with dipentaerythritol",685-540-0,208126-52-7,Not Classified,REACH registration C&L,3,Not classified:3
64889,5-amino-2-[2-(4-nitro-2-sulphophenyl)vinyl]benzenesulphonic acid,204-346-5,119-72-2,Eye Irrit. 2,Notified C&L,1,H319:1
64892,"Methyl 3-α,7-α-diacetoxy-12-α-hydroxy-5-β-cholan-24-oate",223-151-6,3749-87-9,Not Classified,Notified C&L,3,Not classified:3
64896,reaction mass of C,400-930-0,,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H317:0;H315:0;H411:0
64897,Butyl methyl sulphide,211-034-2,628-29-5,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,46,H319:41;H315:41;H225:46;H335:41
64898,"3-N,N-bis(methoxyethyl)aminoacetanilide",432-530-7,24294-01-7,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
64899,Sucrose hexapalmitate,249-462-7,29130-29-8,Not Classified,Notified C&L,1,Not classified:1
64901,2-butyl-2-ethylpropanediol,204-111-7,115-84-4,Eye Irrit. 2,REACH registration C&L,289,H319:211;Not classified:78
64904,dicyclohexyl phthalate,201-545-9,84-61-7,Skin Sens. 1;Repr. 1B,Harmonised C&L,0,H360:0;H317:0
64909,"Titanate(3-),[[]P,P-bis(2-ethylhexyl) diphosphato(2-)-kO'']bis[[]2-ethylhexyl) diphosphato(2-)-kO'',kO'''][[]2,2-bis[[](2-propen-1-yloxy)methyl]-1-butanolato-kO]-, hydrogen (1:3)",600-435-1,103432-54-8,Eye Irrit. 2,Notified C&L,35,H319:34;H315:2;H335:1;Not classified:1;H302:1
64911,3-(Methylpentylamino)propionic acid hydrochloride,613-046-7,625120-81-2,Not Classified,Notified C&L,3,Not classified:1;H341:1;H317:1;H315:2;H413:1;H319:1;H335:1
64915,"7-Benzothiazolesulfonic acid, 2-[4-[[4-[[3-[[5-(aminocarbonyl)-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl]azo]-4-sulfophenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]phenyl]-6-methyl-, disodium salt",400-640-4,85665-95-8,Not Classified,REACH registration C&L,32,Not classified:32
64918,2-morpholino-2-phenylacetamide,228-696-3,6327-69-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
64921,"Octanal, 7-hydroxy-3,7-dimethyl-, distn. residues, nonvolatile",273-866-2,69102-96-1,Skin Sens. 1;Eye Irrit. 2,Notified C&L,113,H319:113;H317:113
64922,"Benzene, diethenyl-, polymer with 2-methyl-1,3-butadiene, hydrogenated",603-246-2,127883-08-3,Not Classified,Notified C&L,7,Not classified:7
64923,α-[2-(1-pyrrolidinyl)ethyl]-α-(p-tolyl)pyridine-2-methanol,274-792-3,70708-28-0,Not Classified,Notified C&L,1,Not classified:1
64925,3-(4-pyridyl)aniline,254-760-5,40034-44-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
64927,Trimethyl[2-(propionylthio)ethyl]ammonium chloride,274-628-0,70496-34-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
64928,2-butoxyethyl benzoate,226-685-8,5451-76-3,Acute Tox. 4;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,5,H302:2;H411:1;H401:1;H319:3;H315:1
64929,"Siloxanes and Silicones, di-Me, Me 3-(2-oxiranylmethoxy)propyl",620-298-1,68440-71-1,Skin Sens. 1,Notified C&L,6,H317:5;Not classified:1
64931,2-(2-hydroxyethoxy)ethyl palmitate,253-006-2,36381-62-1,Not Classified,Notified C&L,12,Not classified:12
64932,2[2'-Hydroxy-5'-(phenyl)ureylenphenyl]benzothiazole,431-480-3,,,REACH registration C&L,1,Not classified:1
64936,sodium 3-nitrobenzenesulphonate,204-857-3,127-68-4,Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0
64940,"2,4-dichloro-6-phenyl-1,3,5-triazine",216-928-6,1700-02-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:4;H315:4;H335:1
64944,Propyl isothiocyanate,211-035-8,628-30-8,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT SE 3,Notified C&L,46,H302:45;H312:44;H335:41;H314:45;H225:40;H332:45;H226:5;H315:1;H319:1;H318:2;H317:1;H310:1;H410:1;H400:1;H301:1;H330:1
64945,1-(Diphenylmethyl)-3-hydroxyazetidine,606-074-6,18621-17-5,Skin Corr. 1B,Notified C&L,44,H314:39;H319:3;H315:3;H335:2;Not classified:1;H302:1
64946,"Oils, savory, summer",616-987-1,8016-68-0,Skin Irrit. 2,Notified C&L,25,H315:25
64949,2-methylbenzothiazole,204-423-3,120-75-2,,Notified C&L,36,Not classified:34;H319:1;H315:1;H335:1;H302:1
64951,Methoxyacetone,227-549-0,5878-19-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,132,H318:89;H315:89;H226:43;H319:1
64952,"2,5-bis(chloromethyl)-p-xylene",228-575-5,6298-72-2,Not Classified,REACH registration C&L,43,Not classified:1;H315:38;H335:38;H314:4
64953,4-Ethoxybenzyltriphenylphosphonium Bromide,617-299-4,82105-88-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
64956,"2,6-dihydroxyanthraquinone",201-544-3,84-60-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
64958,"Dodecene-1-sulfonic acid, sodium salt (1:1)",608-562-4,30965-85-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,20,H318:20;H315:20
64967,1-[bis(4-fluorophenyl)methyl]piperazine,248-476-0,27469-60-9,Acute Tox. 3;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,48,H317:3;H318:3;H410:3;H411:3;H400:3;H301:48;H319:43;H315:43;H335:42
64969,Dihydroergotamine,208-123-3,511-12-6,Acute Tox. 4,Notified C&L,3,H302:2;H332:2;H312:1
64976,Ethyl 2-methylbut-3-enoate,700-224-5,1647-12-7,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,85,H318:85;H315:85;H226:85
64977,Crill 7,618-421-9,9005-66-7,Not Classified,Notified C&L,36,Not classified:36
64981,CERIUM CHLORIDE HEPTAHYDRATE,606-073-0,18618-55-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H319:54;H315:54;H335:54
64986,"2-Pentanone, 3-hydroxy-",608-623-5,3142-66-3,Not Classified,Notified C&L,88,Not classified:88
64989,"2',4'-dimethylacetophenone",201-935-9,89-74-7,Not Classified,Notified C&L,89,Not classified:88;H319:1;H315:1;H335:1
64990,"2-isopropyl-2,3-dimethylbutyronitrile",259-882-2,55897-64-8,Acute Tox. 4;Skin Sens. 1,Notified C&L,11,H302:11;H317:10;H319:1;H315:1;H312:1
64992,3-chloropropyl(diethyl)amine,203-235-9,104-77-8,Not Classified,Notified C&L,3,Not classified:2;H318:1;H314:1;H226:1
64994,Dimethyl terephthalate,204-411-8,120-61-6,Not Classified,REACH registration C&L,534,Not classified:415;H317:69;H412:34;H319:16;H335:2
65003,4-[(4-nitrophenyl)azo]aniline,211-984-8,730-40-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:42;H317:53;H315:42;H335:42;Not classified:2;H334:1
65004,3-(trimethoxysilyl)propylamine,237-511-5,13822-56-5,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,1008,H318:369;H315:402;H319:581;H314:511;Not classified:23;H226:16;H360:5;H335:3;H413:1
65006,"1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, sodium salt, dihydrate",612-173-5,6155-57-3,Not Classified,Notified C&L,15,Not classified:15
65009,"2,6-dimethoxybenzonitrile",241-000-2,16932-49-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:2;H332:2;H312:2
65010,2-(2H-benzotriazol-2-yl)-4-tert-butylphenol,221-574-0,3147-76-0,Not Classified,REACH registration C&L,2,Not classified:1;H319:1;H315:1
65013,Propatylnitrate,220-866-5,2921-92-8,Expl. 1.1;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,2,H201:2;H317:2;H412:2
65014,"Tallow, sulfated, sodium salt",232-494-0,8052-50-4,Not Classified,Notified C&L,5,Not classified:5
65019,α-D-glucose pentaacetate,210-073-2,604-68-2,Skin Sens. 1A,REACH registration C&L,3,H317:1;H302:1;Not classified:1
65027,"(R)-α-aminocyclohexa-1,4-diene-1-acetic acid",247-999-1,26774-88-9,Not Classified,REACH registration C&L,3,Not classified:3
65028,Bromomethyl 4-methoxyphenyl ketone,220-118-8,2632-13-5,Skin Corr. 1B;STOT SE 3,Notified C&L,48,H314:46;H335:40;H319:2;H302:4;H317:1;H315:2;H318:2;H312:1;H290:1;H332:1
65032,5-amino-2-anilinobenzenesulphonic acid,202-058-4,91-30-5,Skin Sens. 1,REACH registration C&L,44,H317:41;H302:40;Not classified:2;H332:1;H312:1
65034,"Fatty acids, C16-22",268-103-5,68002-88-0,Not Classified,REACH registration C&L,92,Not classified:92
65039,"2,5-dimethylfuran",210-914-3,625-86-5,Not Classified,Notified C&L,141,Not classified:90;H302:51;H225:51;H317:8;H335:8;H315:8;H319:9;H332:4;H312:4
65040,Hexane-1-sulphonyl chloride,238-558-4,14532-24-2,Skin Corr. 1B,Notified C&L,39,H314:39;H302:1;H332:1;H312:1
65041,"Calcium, acetate hydrogenated tallow fatty acids complexes",269-613-0,68307-87-9,Not Classified,Notified C&L,2,Not classified:2
65044,"5,12-dihydro-2,9-dimethylquino[2,3-b]acridine-7,14-dione",213-561-3,980-26-7,Not Classified,REACH registration C&L,900,Not classified:814;H412:84;H318:1;H315:1;H319:1
65045,4-(isopropyl)cyclohexyl propionate,264-165-2,63449-95-6,Aquatic Chronic 2,REACH registration C&L,89,H411:11;Not classified:78
65047,Enzymatic Digest of Casein (Bovine) and Meat Peptic Digest,927-350-5,,Not Classified,Notified C&L,1,Not classified:1
65048,3'-chloropropiophenone,252-242-3,34841-35-5,Not Classified,REACH registration C&L,10,Not classified:7;H319:3;H315:3;H335:3
65050,(4-methoxybiphenyl-3-yl)hydrazine hydrochloride,924-885-6,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H319:1;H315:1;H335:1
65052,1-methyl-4-(1-methylvinyl)-7-oxabicyclo[4.1.0]heptane,214-805-1,1195-92-2,Not Classified,Notified C&L,113,Not classified:97;H317:14;H315:16;H335:14;H319:2
65055,4-(6-acryloyloxyhexyloxy)benzoic acid (4-(trans-4-propylcyclohexyl)phenyl ester),425-880-7,,Skin Sens. 1B,REACH registration C&L,2,H317:2
65057,1-anthrylamine,210-225-8,610-49-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
65058,3-(4-chlorophenyl) glutarate,252-477-1,35271-74-0,,Notified C&L,9,H319:8;H315:8;H335:8;H302:1
65059,"Benzenamine, 3-bromo-N,N-dimethyl-",605-393-8,16518-62-0,,Notified C&L,4,H302:4;H312:4;H315:4;H319:4;H332:4
65062,Europium,231-161-7,7440-53-1,Pyr. Sol. 1,Notified C&L,47,H250:39;H228:6;H260:5;Not classified:2
65064,Furan-3-methanol,224-570-7,4412-91-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H226:40;H335:39
65073,"hexaconazole (ISO);(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol",413-050-7,79983-71-4,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H317:0;H411:0
65074,2-(Naphthalene-2'-sulphonylamino)-benzoic acid,601-471-0,117309-52-1,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,34,H318:34;H411:34
65076,Bromoacetyl bromide,209-923-5,598-21-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,68,H302:6;H312:6;H318:13;H314:68;H332:6;H341:1;H290:1
65081,nickel matte,273-749-6,69012-50-6,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H317:0;H410:0;H400:0;H372:0;H350:0
65083,"Distillates (petroleum), hydrotreated middle, intermediate boiling;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",270-092-7,68410-96-8,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
65084,Cyclopropylbenzene,212-839-1,873-49-4,Flam. Liq. 3,Notified C&L,38,H226:38
65085,"(R)-(+)-1,2-Epoxyhexane",600-614-4,104898-06-8,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H335:38;H315:38;H225:38;H319:38
65089,Diammonium pentachlororuthenate,268-715-2,68133-88-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,42,H335:42;H315:42;H331:38;H301:38;H311:38;H319:42
65090,Phenethyl butyrate,203-119-8,103-52-6,Not Classified,REACH registration C&L,1538,Not classified:1538
65092,"4,4'-diamino[1,1'-bianthracene]-9,9',10,10'-tetraone",223-754-4,4051-63-2,Aquatic Chronic 4,Notified C&L,664,H413:473;Not classified:191
65093,Dichlorodimethylgermane,216-216-5,1529-48-2,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,43,H314:43;H226:43;H318:1
65095,4-hydroxy-3-methylacetophenone,212-880-5,876-02-8,,Notified C&L,6,H319:6;H315:6;H335:5
65098,"fosthietan (ISO);diethyl 1,3-dithietan-2-ylidenephosphoramidate",244-437-7,21548-32-3,Acute Tox. 2;Acute Tox. 1,Harmonised C&L,0,H300:0;H310:0
65100,"p-[5-(4-methyl-1-piperazinyl)[2,5'-bi-1H-benzimidazol]-2'-yl]phenol trihydrochloride",245-690-6,23491-45-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H319:45;H302:40;H315:45
65101,Tetrahydro-2-isobutyl-4-methyl-2H-pyran,236-770-1,13477-62-8,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,172,H315:172;H412:172;H226:161
65103,Aluminium sodium tetrahydroxide,235-487-0,12251-53-5,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,43,H318:43;H314:43;H290:43
65105,4-(octadecylamino)-4-oxoisocrotonic acid,221-361-2,3077-27-8,Not Classified,REACH registration C&L,83,Not classified:83;H319:45;H315:45
65109,"Fatty acids, C12-20 and C12-20-unsatd., calcium salts",292-784-8,90990-22-0,Not Classified,Notified C&L,6,Not classified:6
65111,Dammar,232-528-4,9000-16-2,Not Classified,Notified C&L,10,Not classified:10
65116,Quinazolin-4(1H)-one,207-735-8,491-36-1,Acute Tox. 4,REACH registration C&L,53,H302:53;H319:52;H315:52;H335:51
65117,Astrazon Red BBL,611-137-6,54392-43-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H312:38;H335:38;H315:38;H319:38
65119,Zinc Concentrate,934-649-4,,Repr. 1A;STOT RE 2;Aquatic Chronic 3,Notified C&L,2,H360:2;H412:1;H373:1;H350:1;H411:1
65121,Molybdenum diselenide,235-027-9,12058-18-3,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 1,Notified C&L,212,H410:212;H331:212;H400:212;H301:212;H373:212
65123,Stachyose,207-427-3,470-55-3,Not Classified,Notified C&L,1,Not classified:1
65127,"1H-Pyrazole-3-carboxylic acid, 4,4'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)imino(6-chloro-1,3,5-triazine-4,2-diyl)imino(6-sulfo-3,1-phenylene)azo]]bis[1-(2-chlorophenyl)-4,5-dihydro-5-oxo-, sodium salt",289-000-1,85959-10-0,Not Classified,Notified C&L,2,Not classified:2
65129,"Oleic acid, cobalt salt",238-709-4,14666-94-5,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,3,H317:2;H412:2;H411:1
65131,"Fatty-acids, C16-C18 & C18 unsatd., dimerized",615-494-9,71808-39-4,Not Classified,REACH registration C&L,4,Not classified:4
65134,"4,5-Dihydro-5-methyl-3,4-diphenyl-5-isoxazolol",443-400-4,,Skin Sens. 1,REACH registration C&L,1,H317:1
65137,"Naphthenic acids, zinc salts",234-409-2,12001-85-3,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,862,H319:505;H317:6;H411:30;H226:446;H410:269;H315:297;Not classified:105;H400:91;H304:26;H335:26;H350:4;H412:3;H318:1
65143,"1-(2,6,6-trimethyl-3-cyclohexen-1-yl)pent-1-en-3-one",232-074-7,7784-98-7,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,138,H317:94;H411:138;H319:49;H315:67
65148,"(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",616-684-4,79350-37-1,Skin Sens. 1,Notified C&L,56,H317:55;H335:13;H315:13;H334:15;H319:13;Not classified:1
65150,2-cyclohexylpropanal,412-270-0,2109-22-0,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
65154,"3-ethyl-5,5-dimethyloxazolidine-2,4-dione",208-297-0,520-77-4,Eye Irrit. 2,Notified C&L,38,H319:38
65158,"1,2-diiodoethane",210-859-5,624-73-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
65160,C.I. Solvent Yellow 82,602-487-0,12227-67-7,Not Classified,Notified C&L,95,Not classified:92;H400:3;H410:3
65162,"(R)-(4-oxido-10-oxo-7-palmitoyl-3,5,9-trioxa-4-phosphapentacosyl)trimethylammonium 4-oxide",200-567-6,63-89-8,Not Classified,Notified C&L,1,Not classified:1
65163,Sodium deuteroxide,237-825-2,14014-06-3,Skin Corr. 1B,Notified C&L,82,H314:46;Not classified:36;H318:1
65164,"Benzenepropanoic acid, β-amino-3-fluoro-",601-475-2,117391-51-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
65165,(triphenylphosphoranylidene)acetonitrile,240-689-7,16640-68-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40;H331:1;H301:1;H311:1
65166,"Isopropyl 2,4-dichlorophenoxyacetate",202-305-6,94-11-1,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H400:40;H302:44;H317:40;H410:40;H319:1
65168,(S)-3-phenylpiperidine,261-713-2,59349-71-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
65171,"2,2-diethoxyethyl(diethyl)amine",222-801-6,3616-57-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
65172,Dipentylamine,218-108-3,2050-92-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Aquatic Acute 1,Notified C&L,66,H314:40;H331:39;H400:39;H301:40;H311:66;H302:26;H335:26;H315:26;H319:26;H226:27;H318:1
65176,"2,3,5,6-tetrafluorotoluene",226-028-5,5230-78-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H312:38;H335:38;H315:38;H332:38;H319:38;H226:38
65179,"Ethanaminium, N-[4-[[4-(diethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, molybdatephosphate",272-334-7,68814-00-6,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H400:2;H319:2;H302:2;H410:2
65180,"naphtha (petroleum), hydrodesulphurized heavy;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]",265-185-4,64742-82-1,Asp. Tox. 1;Muta. 1B;Carc. 1B;STOT RE 1,Harmonised C&L,0,H372:0;H350:0;H304:0;H340:0
65181,Hex-3-yn-1-ol,213-685-8,1002-28-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H319:56;H315:56;H335:55
65183,"Sodium 1,4-bis(1,3-dimethylbutyl) sulphonatosuccinate",219-147-9,2373-38-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,508,H318:56;H302:471;H315:398;H319:426;H226:92;Not classified:26
65188,Diammonium 1-icosyl 2-sulphonatosuccinate,304-096-8,94236-98-3,Not Classified,Notified C&L,1,Not classified:1
65190,4-aminobenzenethiol,214-763-4,1193-02-8,Skin Corr. 1B,Notified C&L,47,H314:47;H302:7;H318:2
65191,Butyl 3-mercaptopropionate,240-343-5,16215-21-7,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 3;Aquatic Acute 1,REACH registration C&L,486,H302:448;H317:448;H331:1;H400:448;H319:39;H410:447;H315:38;H335:38
65193,"1,1,2,2-tetramethylcyclopropane",223-937-9,4127-47-3,Flam. Liq. 2;Acute Tox. 3,Notified C&L,43,H301:38;H225:39;H304:4;H224:4
65194,"ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate",427-490-2,158585-86-5,Aquatic Chronic 3,Harmonised C&L,0,H412:0
65196,"8-(1H-indol-1-yl)-2,6-dimethyloct-7-en-2-ol",271-284-3,68527-79-7,Not Classified,Notified C&L,112,Not classified:112
65197,"Diisooctyl 4,4'-[(dioctylstannylene)bis(oxy)]bis[4-oxoisocrotonate]",251-576-7,33568-99-9,Not Classified,Notified C&L,6,Not classified:5;H361:1;H412:1;H373:1
65198,N-methylanthranilic acid,204-343-9,119-68-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
65199,Calcite,603-785-3,13397-26-7,Not Classified,Notified C&L,34,Not classified:34
65208,"[hydroxyacetato(2-)-O1,O2](isooctadecanoato-O)[4-(1-methyl-1-phenylethyl)phenolato]titanium",270-546-4,68443-72-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H335:1
65214,Tri-m-tolyl phosphate,209-241-8,563-04-2,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,73,H302:71;H411:71;H312:71;H400:33;H300:1;H330:1;H310:1;Not classified:1
65220,"Fatty acids, C12-18 and C12-18-iso",273-294-3,68955-97-5,Not Classified,Notified C&L,1,Not classified:1
65221,"3-(4'-bromo[1,1'-biphenyl]-4-yl)-1,2,3,4-tetrahydro-1-naphthol",260-038-0,56181-82-9,Acute Tox. 4,Notified C&L,90,H312:89;H410:1
65222,Sodium 4-(2-hydroxyethyl)piperazin-1-ylethanesulphonate,278-169-7,75277-39-3,Not Classified,REACH registration C&L,50,Not classified:48;H319:2;H315:2;H335:2
65234,1-chloro-4-[[(2-chloroethyl)sulphonyl]methyl]benzene,275-567-2,71501-39-8,Acute Tox. 3,Notified C&L,38,H301:38
65237,2-hydroxy-4-(methylthio)butyronitrile,241-756-3,17773-41-0,Acute Tox. 2;Eye Irrit. 2;Acute Tox. 2;Aquatic Chronic 2,REACH registration C&L,3,H300:3;H401:3;H411:3;H330:3;H319:3
65242,"2,3-dichlorobutane",231-486-4,7581-97-7,Flam. Liq. 2;Acute Tox. 4;Skin Sens. 1,Notified C&L,46,H302:38;H317:38;H225:46;H319:3;H315:3;H335:3
65244,"Tetrasodium [2-[2-[4-[[3-hydroxy-4-[(2-hydroxy-5-sulphophenyl)azo]phenyl]azoxy]-2-sulphophenyl]vinyl]-5-[[4-[(4-sulphophenyl)azo]-2,5-xylyl]azoxy]benzenesulphonato(6-)]cuprate(4-)",274-548-6,70304-36-8,Eye Irrit. 2,Notified C&L,29,H319:24;Not classified:5
65245,(Z)-N-[2-(2-hydroxyethoxy)ethyl]-9-octadecenamide,243-818-5,20429-33-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,19,H319:19;H315:19;H411:6;H412:13
65246,"Nitric acid, manganese salt",236-196-1,13224-08-3,Ox. Liq. 2;Ox. Sol. 2;Skin Corr. 1C;Eye Irrit. 2,Notified C&L,1,H272:1;H319:1;H302:1;H315:1
65248,o-(hydroxymethyl)benzamide,251-692-8,33832-98-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
65249,"α,α'-ethylenedinitrilodi-o-cresol",202-376-3,94-93-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
65253,"2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4-[2-[4-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-2-sulfophenyl]ethenyl]-3-sulfophenyl]azo]-4-hydroxy-, compd. with 2,2',2''-nitrilotris[ethanol] (1:5)",278-220-3,75476-99-2,Not Classified,Notified C&L,2,Not classified:2
65254,2-(chloromethyl)-4-methylquinazoline,476-280-7,,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H302:4;H317:4;H318:4;H341:4;H410:4;H400:4
65256,Disodium fumarate,241-087-7,17013-01-3,Not Classified,Notified C&L,137,Not classified:94;H319:43;H315:43;H335:43
65260,"1,4,7-trimethyl-1,4,7-triazonane",619-228-2,96556-05-7,Skin Corr. 1;Eye Dam. 1,REACH registration C&L,82,H318:16;H314:82;H302:5;H412:1
65261,2-hydroxy-3-methylvaleric acid,207-671-0,488-15-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
65262,tetrachloro-p-benzoquinone,204-274-4,118-75-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H319:0;H410:0;H315:0
65263,"2,2,2-trifluoroethanol",200-913-6,75-89-8,Flam. Liq. 3;Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;Repr. 1B;STOT RE 2,REACH registration C&L,276,H318:262;H360:175;H331:227;H301:262;H226:275;H373:213;H312:96;H335:49;H315:90;H332:35;H302:13;H311:12;Not classified:3;H361:4;H319:1
65266,"3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate",413-910-1,95718-78-8,Flam. Liq. 3;Org. Perox. C;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H242:0;H400:0;H226:0
65270,(R)-Glycidyl Trityl Ether,613-772-4,65291-30-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
65273,"1H-Pyrazole-1-ethanol, 4,5-diamino-, sulfate (1:1)",605-017-2,155601-30-2,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,90,H318:90;H317:90;H411:90
65278,"2,3,5,6-tetramethyl-1,4-dioxane-2,5-diol",245-457-9,23147-57-1,Flam. Liq. 2;Skin Irrit. 2,Notified C&L,91,H315:88;H225:88;Not classified:3
65282,"sodium α-(3-bromo-5-methyl-4-oxo-2,5-cyclohexadienylidene)-α-(3-bromo-5-methyl-4-hydroxyphenyl)toluenesulphonate",263-655-3,62625-30-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H319:45;H315:45;H335:44;Not classified:9
65284,"3,7-Nonadien-2-ol, 4,8-dimethyl-, 2-acetate",618-746-6,91418-25-6,Not Classified,Notified C&L,88,Not classified:88
65286,"Disodium 4-[[2,4-dihydroxy-5-[(2-hydroxy-4-nitrophenyl)azo]-3-[(4-nitrophenyl)azo]phenyl]azo]-5-hydroxynaphthalene-2,7-disulphonate",300-391-0,93939-99-2,,Notified C&L,42,Not classified:42
65288,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane, reaction products with N'-(3-aminopropyl)-N,N-dimethyl-1,3-propanediamine",605-562-6,169797-09-5,Not Classified,Notified C&L,9,Not classified:9
65290,phenylmercury nitrate,200-242-9,55-68-5,Acute Tox. 3;Skin Corr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H314:0;H410:0;H400:0;H301:0;H372:0
65295,C.I. Acid Yellow 79,602-097-0,12220-70-1,Aquatic Chronic 3,Notified C&L,3,H412:2;Not classified:1
65297,1-acetyl-3-methylpiperidine,224-983-2,4593-16-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
65298,"Ethanol, 2-(ethenylthio)-",608-554-0,3090-56-0,Skin Sens. 1;Eye Dam. 1,REACH registration C&L,123,H318:85;H317:85;H301:38;H319:38;H331:38;H311:38
65302,"α-(chloromethyl)-2,4-dichlorobenzyl alcohol",237-206-7,13692-14-3,Eye Irrit. 2,Notified C&L,38,H319:38
65309,Triphenylsulphonium hexafluoroarsenate(1-),261-009-5,57900-42-2,,Notified C&L,4,H301:4;H410:4;H331:4;H373:4
65313,"Sodium N-(2,6-dimethoxy-4-pyrimidinyl)sulphanilamidate",213-859-3,1037-50-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H302:41;H317:40;H312:40;H335:39;H315:40;H319:40;H332:40;H334:3;Not classified:1
65316,"Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]",270-758-7,68477-76-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
65317,"Resin acids and Rosin acids, compds. with diethanolamine",270-091-1,68410-74-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
65321,chromium dihydroxy nitrate solution,601-792-6,12158-48-4,Skin Corr. 1A,Notified C&L,1,H314:1
65326,"3,4-dihydroxybenzaldehyde",205-377-7,139-85-5,Not Classified,Notified C&L,136,Not classified:88;H319:48;H315:47;H335:47
65327,"Albumins, blood serum",232-936-2,9048-46-8,Acute Tox. 4,Notified C&L,88,H302:82;Not classified:6
65335,Trisodium [2-[[α-[(3-amino-2-hydroxy-5-sulphophenyl)azo]benzyl]azo]-4-sulphobenzoato(5-)]cuprate(3-),278-757-3,77743-24-9,Not Classified,Notified C&L,10,Not classified:10
65336,Not known,601-482-0,117527-71-6,Skin Irrit. 2,Notified C&L,18,H315:18
65341,4'-Bromo-3'-fluoroacetanilide,609-068-1,351-30-4,,Notified C&L,5,H319:5;H315:5;H335:5
65344,Bis[bis(2-hydroxyethyl)ammonium] sulphate,243-651-8,20261-60-3,Not Classified,Notified C&L,11,Not classified:7;H319:3;H302:4;H315:3;H373:1
65345,Benzoic anhydride,202-291-1,93-97-0,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,83,H319:8;H315:46;H318:38;H335:43;Not classified:37
65346,"N,N'-bis(3-aminopropyl)propane-1,3-diamine",225-007-8,4605-14-5,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,128,H318:123;H302:85;H314:128;H311:85
65353,(3-chloropyridin-2-yl)hydrazine,474-260-2,,Acute Tox. 3;Acute Tox. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H410:3;H400:3;H301:3;H372:3;H330:3
65355,"1,3,5-tribenzylhexahydro-1,3,5-triazine",219-831-7,2547-66-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
65357,Ammonium diisopropylnaphthalenesulphonate,270-360-3,68425-60-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,94,H319:63;H315:63;Not classified:31
65364,N-[3-(triethoxysilyl)propyl]ethylenediamine,225-806-1,5089-72-5,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,48,H318:46;H317:46;H315:47;H411:28;H314:1;H319:2;H335:1
65365,"(3aR,8aS,8bS)-1,3-Dibenzyl-2-oxodecahydrothieno[1',2':1,2]thieno[3,4-d]imidazol-5-ium bromide",700-349-5,33719-11-8,Aquatic Chronic 3,REACH registration C&L,1,H412:1
65368,1-ethyl-1-methyl-3-phenylpropyl acetate,276-282-6,72007-81-9,Not Classified,Notified C&L,88,Not classified:88
65369,Chlorprothixene,204-032-8,113-59-7,Acute Tox. 3,REACH registration C&L,5,H301:5
65370,Apovincamine,225-491-0,4880-92-6,,Notified C&L,1,H302:1
65372,Tetramethylammonium sulphate (2:1),238-043-4,14190-16-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
65373,Ricinine,208-359-7,524-40-3,Acute Tox. 3,Notified C&L,38,H301:38
65381,"L-Asparagine, hydrate (1:1)",611-593-6,5794-13-8,Not Classified,Notified C&L,6,Not classified:6
65384,"2,2-bis(allyloxymethyl)butan-1-ol",211-661-1,682-09-7,Not Classified,REACH registration C&L,557,Not classified:65;H319:492;H315:492;H335:491
65387,"3,3,6,6-tetramethoxy-2,7-dioxa-3,6-disilaoctane",242-285-6,18406-41-2,Skin Irrit. 2;Acute Tox. 1;Muta. 2;Aquatic Chronic 3,REACH registration C&L,94,H330:59;H315:15;H341:1;H412:1;H301:22;H302:14;H372:14;H319:14;H300:13
65389,"Hydrocarbons, C",305-975-9,95371-08-7,Carc. 1B,Harmonised C&L,0,H350:0
65398,Isopentyl phenethyl ether,259-943-3,56011-02-0,Aquatic Chronic 2,REACH registration C&L,1614,H411:1337;Not classified:277
65402,3-bromopropyl phenyl ether,209-623-4,588-63-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,20,H319:19;H315:19;Not classified:1;H302:1;H335:1
65407,4-tert-butylphenol-formaldehyde copolymer,472-160-3,25085-50-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H400:1;H410:1;H319:2;H315:2;H335:2
65409,"N,N'-[iminobis(ethyleneiminoethylene)]dioleamide",267-077-2,67785-94-8,Eye Irrit. 2,Notified C&L,2,H319:1;Not classified:1
65412,Acetonyltriphenylphosphonium chloride,214-974-1,1235-21-8,,Notified C&L,5,H319:5;H315:5;H335:4
65416,Hexadecyl dihydrogen phosphate,222-581-1,3539-43-3,Eye Dam. 1,REACH registration C&L,70,H318:61;H315:58;Not classified:6;H319:3
65419,Acetyl fluoride,209-188-0,557-99-3,Skin Corr. 1B,Notified C&L,38,H314:38
65422,"3-methoxypregna-3,5-diene-21,17α-carbolactone",244-047-7,20802-57-7,Not Classified,REACH registration C&L,2,Not classified:2
65423,(Trimethylsilyl)octyl Phosphonic acid,643-079-2,959418-49-6,Skin Corr. 1B,Notified C&L,36,H314:36;H318:14
65425,Ethyl stearate,203-887-4,111-61-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,137,H319:136;H315:136;H335:53;Not classified:1
65430,"1,1'-(1,3,3-trimethylprop-1-ene-1,3-diyl)dibenzene",228-396-2,6258-73-7,Not Classified,Notified C&L,13,Not classified:12;H319:1;H411:1;H335:1
65431,17 alpha-Cyanomethyl-17 beta-hydroxy-5(10)-estren-3-one,613-855-5,65928-65-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
65435,"2,6-dimethylhept-3-ene",220-362-5,2738-18-3,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,1,H225:1;H304:1
65437,"1,2,5,6-Di-O-isopropylidene-alpha-D-allofuranose",607-832-9,2595-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
65438,2-[(1-oxooctadecyl)amino]ethyl stearate,238-310-5,14351-40-7,Not Classified,Notified C&L,1,Not classified:1
65440,(4-methoxyphenyl)glycolonitrile,251-614-2,33646-40-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
65442,"5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole",601-281-8,113775-47-6,Skin Sens. 1;Repr. 1A;STOT RE 2,Notified C&L,1,H360:1;H317:1;H373:1
65444,1-cyclohexylnaphthalene,221-247-2,3042-69-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1;H332:1
65445,"Fatty acids, tall-oil, triesters with sorbitan, ethoxylated",612-387-9,61790-88-3,Not Classified,Notified C&L,59,Not classified:59
65446,Titanium(4+) ethanolate,221-410-8,3087-36-3,Flam. Liq. 3;Eye Irrit. 2,REACH registration C&L,230,H319:227;H226:224;H315:125;H335:117;H228:4;Not classified:4;H302:1
65449,Bisomer SiGMA,810-701-0,69861-02-5,Eye Irrit. 2,Notified C&L,2,H319:2
65450,"trans-4-Propyl-(trans,trans-4'-propyl-1,1'-bicyclohexyl)methoxy-cyclohexan",918-035-3,,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
65451,Phosphorus pentafluoride,231-602-3,7647-19-0,Press. Gas (Liq.);Skin Corr. 1A;Acute Tox. 1,Notified C&L,142,H330:142;H314:142;H280:116
65452,"N,N,2-triethylhexanamide",274-259-5,70024-54-3,Acute Tox. 4,Notified C&L,35,H302:35
65455,"1H-Pyrrolo [2,3D] Pyrimidine Benzoic",682-744-1,137281-39-1,Acute Tox. 3;Carc. 2;Repr. 1A,Notified C&L,3,H301:2;H360:2;H351:2;H319:1;H315:1
65458,Chlorotriethylgermane,213-614-0,994-28-5,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,43,H319:39;H302:38;H332:38;H312:38;H314:4;H315:1
65459,"2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine",428-200-7,103577-66-8,Aquatic Chronic 3,Harmonised C&L,0,H412:0
65464,"Poly(oxy-1,2-ethanediyl), α-[bis(1-methylpropyl)phenyl]-ω-hydroxy-",611-072-3,53964-94-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,69,H318:69;H302:69
65465,"Hydrocarbons, C11-C13, isoalkanes, <2% aromatics",920-901-0,246538-78-3,Asp. Tox. 1,REACH registration C&L,480,H304:480
65467,"(5-ethyl-1,3-dioxan-5-yl)methyl acrylate",266-380-7,66492-51-1,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,840,H317:651;H315:659;H411:635;Not classified:181;H319:5;H335:1;H334:1
65475,"1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-C8-18 acyl derivs., hydroxides, inner salts",308-107-7,97862-59-4,Eye Dam. 1,Notified C&L,81,H318:72;H412:13;H319:9
65481,"Ethyl 2-ethyl-3,6,6-trimethylcyclohexenecarboxylate",305-029-5,94333-50-3,Not Classified,Notified C&L,88,Not classified:88
65484,"Fatty acids, Dipteryx",293-053-6,91051-04-6,Acute Tox. 3;Skin Sens. 1A,Notified C&L,1,H301:1;H317:1
65487,Sulfafurazole,204-858-9,127-69-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:42;H315:42;H335:41;H361:1;H302:1
65488,"L-Ascorbic acid, 2-(dihydrogen phosphate), magnesium salt (2:3)",601-239-9,113170-55-1,Not Classified,Notified C&L,89,Not classified:89
65489,Dichloro(3-chloropropyl)methylsilane,232-136-3,7787-93-1,Acute Tox. 2;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,70,H300:3;H318:4;H314:70;H226:40;H301:26;H311:26;H302:1;H335:1;H290:1
65494,Cortodoxone,205-805-2,152-58-9,,Notified C&L,2,H361:1;H351:1;H341:1;H302:1
65505,"3-ethyl-4,5-dihydro-2-methylthiazolium iodide",259-279-4,54654-71-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
65508,"3-aminopropyldiethylamine;N,N-diethyl-1,3-diaminopropane",203-236-4,104-78-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0,H302:0;H317:0;H312:0;H314:0;H226:0
65511,"2,3,4,6-tetrahydroxybenzocyclohepten-5-one",209-324-9,569-77-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
65512,Chlorotriethylsilane,213-615-6,994-30-9,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,93,H318:39;H302:2;H314:88;H226:88;H301:44;Not classified:4;H290:1;H225:1;H335:1
65515,"3,5-bis(benzyloxy)-α-chlorotoluene",216-927-0,1699-59-8,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H314:38;H335:38
65516,"1-(2,2-diethoxyethyl)piperidine",222-802-1,3616-58-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
65518,(+-)-2-(P-METHOXYPHENOXY)PROPIONIC ACID,604-052-0,13794-15-5,Not Classified,Notified C&L,129,Not classified:89;H319:40;H315:40;H335:40
65520,"Benzenamine, 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, N-Me derivatives, benzoates",271-941-4,68647-14-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,4,H318:2;H315:3;H335:3;H319:1;Not classified:1
65521,Sodium [6-amino-5-[(2-hydroxy-4-nitrophenyl)azo]naphthalene-1-sulphonato(3-)]hydroxychromate(1-),233-577-4,10241-21-1,Not Classified,Notified C&L,11,Not classified:10;H315:1
65523,N-tert-butyl-5-methylisoxazolium perchlorate,234-048-0,10513-45-8,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H272:39;H319:38;H315:38;H335:38
65525,Adenine hydrochloride,220-867-0,2922-28-3,Acute Tox. 4,Notified C&L,45,H302:44;H319:1;H315:1
65529,"[(3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5(or 6)-yl)oxy]acetaldehyde",304-309-4,94248-38-1,Not Classified,Notified C&L,36,Not classified:36
65530,1-naphthaldehyde,200-633-4,66-77-3,Acute Tox. 4,Notified C&L,127,H302:124;H312:57;H335:67;H315:69;H319:67;H332:55;Not classified:2;H301:1
65531,"(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride",415-110-8,54417-53-7,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
65533,Dydrogesterone,205-806-8,152-62-5,STOT RE 1;Aquatic Chronic 1,Notified C&L,44,H372:44;H410:42;H411:2
65535,7-acetamido-4-hydroxy-3-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2-sulphonic acid,269-197-0,68189-39-9,Not Classified,REACH registration C&L,15,Not classified:15
65537,2-(4-aminoanilino)-5-nitrobenzenesulphonic acid,202-057-9,91-29-2,Not Classified,REACH registration C&L,44,Not classified:43;H318:1;H315:1
65538,"Bone, ash",270-423-5,68439-86-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:39;H315:39;Not classified:1
65539,"Ethyl acrylate, polymer with methyl methacrylate, 2-hydroxyethyl methacrylate, allyl methacrylate and itaconic acid",919-577-3,,Not Classified,Notified C&L,36,Not classified:36
65542,"2,6-dichloro-4-mesylaniline",279-599-8,80866-96-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:2;H312:2;H335:2;H315:2;H319:2;H332:2
65549,Cyclohexyl trimethoxysilane,605-828-1,17865-54-2,Skin Corr. 1B,Notified C&L,58,H314:38;H412:14;H335:15;H315:16;H319:16;H226:14;Not classified:4
65554,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane, dodecanoate 2-propenoate",614-255-6,68071-07-8,Eye Irrit. 2,Notified C&L,98,H319:71;Not classified:26;H317:1
65556,Bis(2-hydroxyethyl)ammonium hydrogen sulphate,261-663-1,59219-56-6,Not Classified,Notified C&L,8,Not classified:7;H319:1;H302:1;H315:1
65560,"Caper, Capparis spinosa, ext.",289-646-4,89958-23-6,Not Classified,Notified C&L,1,Not classified:1
65561,1-ethyl-1-methylmorpholinium bromide,418-250-8,65756-41-4,Muta. 2,Harmonised C&L,0,H341:0
65562,Dimethylbis[2-[(1-oxohexadecyl)oxy]ethyl]ammonium chloride,306-361-3,97158-31-1,Aquatic Chronic 3,REACH registration C&L,2,H412:2
65565,1-(dipropylamino)propan-2-ol,253-007-8,36388-09-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
65566,"Glycerides, C8-18 and C18-unsatd. mono- and di-, acetates",293-170-2,91052-13-0,Not Classified,REACH registration C&L,15,Not classified:11;H412:4
65569,Iridium,231-095-9,7439-88-5,Not Classified,REACH registration C&L,201,Not classified:67;H413:83;H319:49;H228:44;H335:6;H315:2;H251:1
65572,"1,1-dichloroethane",200-863-5,75-34-3,Flam. Liq. 2;Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0;H335:0;H225:0;H319:0
65573,"5-prop-1-enyl-1,3-benzodioxole",204-410-2,120-58-1,Acute Tox. 4;Muta. 2;Carc. 1B,Notified C&L,314,H341:272;H302:314;H350:272;H315:39
65575,Chloro-1-ethyl isopropyl carbonate,424-590-8,,Flam. Liq. 3;Skin Sens. 1B,REACH registration C&L,2,H317:1;H226:1;Not classified:1
65577,"2,6-dibromonaphthalene-1,5-diol",201-543-8,84-59-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H335:38
65578,"ethane-1,2-bis(aminium) methylphosphonate",483-300-8,99580-93-5,Aquatic Chronic 3,REACH registration C&L,1,H412:1
65580,"2,2,4-trimethylhexamethylene-1,6-di-isocyanate",241-001-8,16938-22-0,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H335:0;H315:0;H331:0;H334:0;H319:0
65582,"dichlofluanid (ISO);N-[(dichlorofluoromethyl)thio]-N′,N′-dimethyl-N-phenylsulfamide",214-118-7,1085-98-9,Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H400:0;H319:0;H317:0;H332:0
65586,β-D-glucose pentaacetate,210-074-8,604-69-3,Not Classified,REACH registration C&L,32,Not classified:32
65589,Propylphosphonic acid,225-121-8,4672-38-2,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,45,H318:3;H314:45;H290:2
65590,"N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide",407-430-1,3741-80-8,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
65591,"Crambe maritima, ext.",296-898-9,93165-14-1,Not Classified,Notified C&L,1,Not classified:1
65592,3-butyltetrahydro-5-methyl-2H-pyran-4-yl acetate,253-863-2,38285-49-3,,Notified C&L,1580,H412:1342;Not classified:238
65598,Clofedanol hydrochloride,208-124-9,511-13-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H400:38;H302:39;H410:38
65599,Molybdenum oxide,235-026-3,12058-07-0,Not Classified,Notified C&L,1,Not classified:1
65600,"2'-(4'-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bis-1H-benzimidazole trihydrochloride trihydrate",245-691-1,23491-52-3,Acute Tox. 4;Skin Irrit. 2;STOT SE 3;Muta. 2,Notified C&L,42,H341:39;H302:42;H315:41;H335:42;H318:2;H314:1
65601,Suxibuzone,248-477-6,27470-51-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:39;H332:38;H312:38;H361:1
65602,"1,4-Naphthalenedione, 2-cyclohexyl-",609-049-8,34987-31-0,,Notified C&L,1,H302:1;H332:1;H312:1
65603,"5-chloro-2-(2,4-dichlorophenoxy)aniline",260-480-4,56966-52-0,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,85,H400:2;H410:85
65604,"3,5-diiodosalicylaldehyde",220-117-2,2631-77-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
65605,"2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol",410-760-9,157661-93-3,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H317:0;H315:0
65606,"ethyl hydrogen sulfate, nickel(II) salt",275-897-7,71720-48-4,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H317:0;H341:0;H360:0;H410:0;H400:0;H372:0;H334:0;H350:0
65607,"Oleic acid, compound with 2-(2-aminoethoxy)ethanol (1:1)",301-765-6,94042-97-4,,Notified C&L,2,H319:1;Not classified:1
65609,Methyl tri-O-acetyl-1-bromo-1-deoxy-α-D-glucopyranuronate,244-203-4,21085-72-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
65610,"5-acetyl-1,3-phenylene bis(dimethylcarbamate)",279-804-0,81732-48-1,,Notified C&L,2,H302:1;Not classified:1
65613,Tetrapotassium peroxydiphosphorate,239-665-9,15593-49-4,Ox. Sol. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,38,H318:38;H314:38;H331:38;H301:38;H311:38;H272:38
65616,(S)-5-Methoxy-2-propionamidotetralin,607-376-0,244239-67-6,Flam. Sol. 1;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,2,H228:2;H315:2;H411:2;H301:2;H336:2;H319:2
65619,"2,4-dichlorobenzoyl chloride",201-936-4,89-75-8,Skin Corr. 1B,REACH registration C&L,84,H314:84;H335:38;H318:2;H290:1
65620,"Octane-1,8-diylbis[chlorodimethylsilane]",225-804-0,5089-28-1,,Notified C&L,1,H314:1;H315:1
65622,"N,O-Dibenzoyltyrosine",619-271-7,97485-13-7,Not Classified,Notified C&L,1,Not classified:1
65623,Di-tert-butyl 2-butynedioate,266-135-4,66086-33-7,Skin Corr. 1B;STOT SE 3,Notified C&L,38,H314:38;H335:38
65624,Decaglyceryl monooleate,618-437-6,9007-48-1,Not Classified,Notified C&L,71,Not classified:51;H319:20;H315:20
65626,Hexadecyl lactate,252-478-7,35274-05-6,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,69,H400:2;H410:2;Not classified:67
65627,"Sodium 1-amino-9,10-dihydro-9,10-dioxo-4-[(2,2,4-trimethylcyclohexyl)amino]anthracene-2-sulphonate",276-123-0,71873-46-6,Aquatic Chronic 3,REACH registration C&L,41,H412:4;Not classified:37
65630,nickel dithiocyanate,237-205-1,13689-92-4,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H317:0;H341:0;H360:0;H410:0;H400:0;H372:0;H334:0;H350:0
65632,2-(methylamino)hydroquinone hydrobromide,250-947-0,32190-96-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
65637,Gadolinium,231-162-2,7440-54-2,Flam. Sol. 1,REACH registration C&L,58,H228:10;H261:41;Not classified:7;H260:5
65638,tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate,434-840-8,225786-91-4,Aquatic Chronic 2,Harmonised C&L,0,H411:0
65644,Cyheptamide,230-570-8,7199-29-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
65645,"Flavonoids, lignan-type, Silybum marianum",288-672-3,85865-73-2,Not Classified,Notified C&L,1,Not classified:1
65646,Diallyl trisulphide,218-107-8,2050-87-5,Acute Tox. 4,Notified C&L,1589,H302:1549;H301:40
65647,2-hydroxytrimethylenediaminetetra(acetic acid),221-575-6,3148-72-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:44;H335:43;H312:1
65649,"β-D-Galactopyranoside, 6-chloro-1H-indol-3-yl",604-065-1,138182-21-5,Not Classified,Notified C&L,1,Not classified:1
65653,"2-Naphthalenesulfonic acid, 7-(benzoylamino)-4-hydroxy- 3-[[4-[(4-sulfophenyl)azo]phenyl]azo]-, compd. with 2,2',2''-nitrilotris[ethanol] (1:2)",616-259-3,75768-93-3,Not Classified,Notified C&L,31,Not classified:31
65654,"Distillates (petroleum), light distillate hydrotreating process, low-boiling;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",270-093-2,68410-97-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
65655,"Manganese ores, reduced",273-748-0,69012-49-3,Eye Irrit. 2;Repr. 2,REACH registration C&L,7,H319:7;H361:6
65656,Tetrakis(2-methoxyethyl) orthosilicate,218-470-2,2157-45-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,60,H319:38;H315:38;H361:22
65659,"2,4,6,8,10,12,14-Hexadecaheptaenedial, 2,6,11,15-tetramethyl-, (2E,4E,6E,8E,10E,12E,14E)-",610-516-3,502-70-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,1,H302:1;H317:1
65660,"1,1'-phenyliminodipropan-2-ol",221-360-7,3077-13-2,Eye Irrit. 2,Notified C&L,153,H319:74;H318:55;Not classified:24;H315:20
65662,p-methoxybenzyl acetate,203-185-8,104-21-2,Skin Sens. 1B,REACH registration C&L,1682,H317:30;Not classified:1328;H319:296;H315:327;H302:1;H335:1;H318:1
65664,"Fatty acids, C14-18 and C16-22-unsatd., calcium salts",292-785-3,90990-23-1,Not Classified,Notified C&L,6,Not classified:6
65668,"3,5-dimethyl-1H-pyrazole-1-methanol",286-553-0,85264-33-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,44,H319:44;H412:38;H315:44;H335:43
65669,trinickel bis(arsenate);nickel(II) arsenate,236-771-7,13477-70-8,Skin Sens. 1;Carc. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H400:0;H372:0;H350:0
65671,tert-butyl methyl ether;MTBE;2-methoxy-2-methylpropane,216-653-1,1634-04-4,Flam. Liq. 2;Skin Irrit. 2,Harmonised C&L,0,H315:0;H225:0
65673,1H-indazole-3-carboxylic acid,224-794-5,4498-67-3,Not Classified,REACH registration C&L,6,Not classified:1;H319:5;H315:4;H335:3;H302:1
65674,4-methylquinoline,207-734-2,491-35-0,Not Classified,Notified C&L,277,Not classified:234;H319:43;H315:43;H335:38;H341:4
65677,Disilver sulphide,244-438-2,21548-73-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:48;H315:46;H335:48;H317:2;H314:2;H400:3;Not classified:2;H410:1
65681,"Bis(5-oxo-L-prolinato-N1,O2)magnesium",263-365-7,62003-27-4,Not Classified,Notified C&L,3,Not classified:3
65682,"Reaction mass of 3a, 4, 5, 6, 7, 7a-hexahydro-1H-4, 7-methanoinden-5-yl butyrate and 3a, 4, 5, 6, 7, 7a-hexahydro-1H-4, 7-methanoinden-6-yl butyrate",441-420-8,,Aquatic Chronic 2,REACH registration C&L,1289,H411:1288;H400:1;H410:1
65683,"5-(N,N-diethylaminosulphonyl)-2-methoxybenzenediazonium chloride",248-543-4,27580-14-9,Unst. Expl.,REACH registration C&L,39,H200:1;H302:38;H351:38;H332:38;H312:38
65684,Pentyl nitrate,213-684-2,1002-16-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H226:1
65685,1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptane,207-428-9,470-67-7,Flam. Liq. 3,Notified C&L,1720,H226:1720;H317:24;H304:24;H315:24;H411:24
65693,Sodium 4-chloro-3-nitrobenzenesulphonate,241-680-0,17691-19-9,Not Classified,REACH registration C&L,40,Not classified:2;H319:38;H315:38;H335:38
65695,(+)-S-Trityl-L-cysteine,608-157-2,2799-07-7,Acute Tox. 4,Notified C&L,47,H302:47;Not classified:2
65697,Chalk,603-784-8,13397-25-6,Not Classified,Notified C&L,31,Not classified:31
65698,N-methyl-N-cyanomethylmorpholiniummethylsulfate,429-340-1,,Acute Tox. 4;Eye Dam. 1,Harmonised C&L,0,H318:0;H302:0
65703,"2,5-dimethyl-1H-pyrrole",210-913-8,625-84-3,Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,1561,H317:3;H310:3;H335:41;H300:3;H412:3;H315:42;H331:41;H319:42;H301:1558;H226:1558;H311:38
65706,"Trisodium hydrogen [2-[[α-[[3-[[4-chloro-6-[ethyl[3-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulphophenyl]azo]benzyl]azo]-4-sulphobenzoato(6-)]cuprate(4-)",281-889-4,84057-71-6,Aquatic Chronic 3,REACH registration C&L,34,H412:21;H335:19;H315:19;Not classified:32;H334:19;H320:19
65707,"Sodium α-(3,5-dibromo-4-oxo-2,5-cyclohexadienylidene)-α-(3,5-dibromo-4-hydroxyphenyl)toluenesulphonate",263-653-2,62625-28-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
65708,Heptyl valerate,226-686-3,5451-80-9,Not Classified,Notified C&L,1,Not classified:1
65709,"Quaternary ammonium compounds, benzyl-C14-18-alkyldimethyl, chlorides",269-916-8,68390-98-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,26,H318:26;H400:26;H302:26;H315:24;H314:2
65710,3-[2-(dimethylamino)ethyl]-1H-indol-4-ol,208-296-5,520-53-6,Acute Tox. 4,Notified C&L,39,H302:39;H317:1
65711,Massoia Lactone,610-624-0,51154-96-2,Skin Irrit. 2;Skin Sens. 1,Notified C&L,114,H317:114;H315:114;H319:25
65712,Phenyl o-aminobenzenesulphonate,269-381-0,68227-69-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
65716,2-ethoxyethylamine,203-801-5,110-76-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,27,H302:6;H314:26;H225:26;H312:5;H318:20;Not classified:1
65718,1-bromo-4-propylbenzene,454-790-0,,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H410:1;H315:1
65721,"Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and 4,4'-(1-methylethylidene)bis[phenol]",611-169-0,54579-44-1,Not Classified,Notified C&L,8,Not classified:5;H317:3
65722,"Amines, polyethylenepoly-, distn. residues",294-726-7,91745-55-0,Not Classified,Notified C&L,1,Not classified:1
65724,3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide,411-520-6,112195-27-4,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H317:0;H411:0
65725,"3-(3,4-dihydroxyphenyl)-DL-alanine",200-566-0,63-84-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:43;H315:43;H335:42;H302:8;H373:3
65727,"3-Hepten-2-one, 6-methyl-, (3E)-",606-660-1,20859-10-3,Not Classified,Notified C&L,88,Not classified:88
65731,Risocaine,202-306-1,94-12-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
65732,Ethyl propyl ether,211-036-3,628-32-0,,Notified C&L,48,Not classified:47;H336:1;H225:1
65736,Chloromethyl methyl sulphide,219-148-4,2373-51-5,Flam. Liq. 2,Notified C&L,54,H225:54;H335:15;H319:6;H315:6
65737,Acetoacetamide,227-774-4,5977-14-0,Not Classified,REACH registration C&L,95,Not classified:95
65739,"Phosphoric acid, C8-10-branched and linear alkyl esters, compds. with diethanolamine",306-944-2,97467-95-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,28,H318:28;H314:28
65740,5-amino-2-(p-aminoanilino)benzenesulphonic acid,204-344-4,119-70-0,Not Classified,REACH registration C&L,140,Not classified:138;H319:1;H315:1;H335:1;H302:1;H312:1;H318:1;H314:1;H332:1
65741,Ethyl 3-bromopropionate,208-724-0,539-74-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H341:1
65746,Copals,232-527-9,9000-14-0,Eye Irrit. 2;STOT SE 3,Notified C&L,34,H319:32;H335:32;Not classified:2
65748,(±)-octan-2-ol,223-938-4,4128-31-8,Not Classified,Notified C&L,4,Not classified:3;H411:1;H226:1
65749,Dichloroethylmethylsilane,224-860-3,4525-44-4,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,57,H314:57;H225:57;H318:2
65751,Dibutyl peroxydicarbonate,240-344-0,16215-49-9,Org. Perox. D;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H400:2;H317:2;H410:2;H242:6;H304:1;H226:1;H315:4
65752,"2,4-Dibromo-6-fluoroaniline",604-235-5,141474-37-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H302:44;H312:44;H335:44;H315:44;H319:44;H332:44
65753,Methyl methylthiomethyl sulphoxide,251-577-2,33577-16-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
65758,"1,3-Benzenediamine, coupled with diazotized m-phenylenediamine, acetates",282-617-7,84281-74-3,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,102,H318:93;H400:92;H410:92;H319:5;H335:85;H315:88;H314:3;H411:4;H412:3;Not classified:1;H334:1
65762,Manganese sulphide,242-599-3,18820-29-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,206,H319:176;H317:138;H315:176;H411:133;H335:38;Not classified:25;H302:5
65770,"1,1,2-trifluoroethane",207-066-1,430-66-0,Not Classified,Notified C&L,1,Not classified:1
65771,"4-[(2,4-dimethylphenyl)azo]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one",229-043-5,6407-78-9,Not Classified,REACH registration C&L,3,Not classified:3
65773,"2-Ethylhexyl dihydrogen phosphate, compound with N,N,N-triethylamine (1:2)",929-048-9,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,83,H318:83;H302:83;H315:83;H335:83
65774,Zinc phthalate,220-730-5,2880-85-5,Not Classified,Notified C&L,3,Not classified:3
65776,"Hexamethylene diisocyanate, oligomers, reaction products with Bis-(Trimethoxysilylpropyl)amine",918-105-3,,Skin Sens. 1B,REACH registration C&L,2,H317:2
65777,5-aminoisophthalic acid,202-748-5,99-31-0,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,59,H319:57;H302:19;H315:49;H335:48;H317:2
65783,"Sulfonamides, C10-21-alkane, chloro",286-678-0,85338-06-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,35,H319:34;H315:34;H335:34;Not classified:1
65784,Methyl pentafluoropropionate,206-828-0,378-75-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H225:44;H335:43
65785,Tris(2-methoxyphenyl) phosphate,209-240-2,563-03-1,STOT SE 1;Aquatic Chronic 2,Notified C&L,1,H370:1;H411:1
65796,3-ethoxycarbonylanilinium methanesulphonate,212-956-8,886-86-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
65800,"3-methoxyoestra-1,3,5(10)-trien-17-β-ol",213-858-8,1035-77-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
65801,Benzyltrimethylammonium iodide,224-861-9,4525-46-6,,Notified C&L,4,H319:4;H302:4;H315:4;H335:4
65803,reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate,406-910-8,124649-82-7,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
65804,"Disodium 6-[[2,6-dihydroxy-3-[(2-hydroxy-3-nitro-5-sulphonatophenyl)azo]phenyl]azo]-4-hydroxy-3-[(4-nitrophenyl)azo]naphthalene-2-sulphonate",300-392-6,93940-00-2,Not Classified,Notified C&L,3,Not classified:3
65805,"2,5-Cyclohexadien-1-one, 2,6-bis(1,1-dimethylethyl)-4-(methoxymethylene)-",606-532-5,20357-48-6,Not Classified,Notified C&L,1,Not classified:1
65807,"N,N'-ethylenedi-o-toluidine",202-375-8,94-92-8,,Notified C&L,4,H302:4;H312:4;H335:4;H315:4;H319:4
65812,"2-[(2-methyl-1-oxoallyl)oxy]ethyl 1,3-dihydro-1,3-dioxoisobenzofuran-5-carboxylate",274-547-0,70293-55-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,2,H319:2;H302:2;H317:2;H315:2
65814,3-(2-thienyl)alanine,205-378-2,139-86-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
65817,1-iodononane,224-286-3,4282-42-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
65818,Manganese molybdenum tetraoxide,237-823-1,14013-15-1,Repr. 1B,Notified C&L,71,H360:38;Not classified:33
65819,"Viola odorata, ext.",290-427-0,90147-36-7,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1425,H302:1287;H411:1287;Not classified:123;H317:14;H412:11;H361:10;H319:10;H373:10;H400:3
65825,"3,4-dihydroxy-5-nitrobenzaldehyde",441-810-8,116313-85-0,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H318:0;H302:0;H317:0
65826,(±)-α-[[(tert-butyl)amino]methyl]-7-ethyl-2-benzofuranmethanol hydrochloride,262-216-3,60398-91-6,Acute Tox. 4,Notified C&L,38,H302:38
65828,Tetrachlorohydroquinone,201-779-1,87-87-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H318:38;H302:39;H319:1;H315:1
65830,hexachlorobenzene,204-273-9,118-74-1,Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H372:0;H400:0;H350:0;H410:0
65834,"Sodium hydrogen 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2-methylphenolate) S,S-dioxide",263-654-8,62625-29-0,Not Classified,Notified C&L,1,Not classified:1
65836,"Chloro-1,1,1-trifluoroethane",200-912-0,75-88-7,Press. Gas (Liq.),Notified C&L,114,H280:114;H059:22
65837,"Amines, C16-18-alkyldimethyl",269-915-2,68390-97-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,113,H400:113;H302:113;H314:113;H410:87;H318:45
65839,"Kerosine (petroleum), hydrodesulfurized;Kerosine - unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-184-9,64742-81-0,Asp. Tox. 1,Harmonised C&L,0,H304:0
65844,"Benzamide, 2,6-dimethoxy-N-(3-(1-ethyl-1-methylpropyl)-5-isoxazolyl)-",617-354-2,82558-50-7,Aquatic Chronic 4,Notified C&L,194,H413:194
65845,Pyroxylin,618-392-2,9004-70-0,Flam. Sol. 1,Notified C&L,991,H228:447;H201:366;H225:178;H413:84;Not classified:1
65849,Paramethasone 21-acetate,216-486-4,1597-82-6,Repr. 1A,Notified C&L,1,H360:1
65850,"2-chloro-2',6'-dimethylacetanilide",214-460-7,1131-01-7,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,56,H319:55;H302:9;H315:47;H335:46
65851,"Tetrahydro-1,3,5-triazin-2(1H)-one",230-406-5,7098-14-8,Not Classified,Notified C&L,6,Not classified:6
65852,"(1α,3β,5Z,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1,3,24-triol",601-218-4,112965-21-6,Acute Tox. 2;Acute Tox. 3;Acute Tox. 2;STOT RE 1,Notified C&L,4,H300:3;H330:2;H372:2;H311:2;H319:1;H315:1;H310:2;H335:1;H362:1
65853,Palladium(II) bromide,236-588-2,13444-94-5,,Notified C&L,8,H319:8;H315:8;H335:7
65855,(2-hydroxyethyl)ammonium sulphamate,259-430-4,55011-64-8,Not Classified,Notified C&L,34,Not classified:34
65856,"N,N-dimethyl-1,3-diaminopropane, reaction product with epichlorhydrin and 3-chloropropane-1,2-diol",928-716-7,,Not Classified,Notified C&L,1,Not classified:1
65858,4-Nitro-1-naphthol,611-992-5,605-62-9,,Notified C&L,6,H319:6;H302:5;H315:6;H335:5
65860,1-Heptyn-3-ol,616-022-4,7383-19-9,Flam. Liq. 3;Acute Tox. 4,Notified C&L,42,H302:42;H226:42
65861,1-chloro-4-[[(2-chloroethyl)thio]methyl]benzene,275-566-7,71501-38-7,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
65877,2;2 ;6;6 -TETRAMETHYL-PIPERIDINE DERIVATIVE,603-360-2,129757-67-1,Aquatic Chronic 4,Notified C&L,290,H413:280;Not classified:10
65878,"Gases (petroleum), catalytic cracker, C1-5-rich;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]",270-757-1,68477-75-8,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
65882,trans-hex-2-ene,223-752-3,4050-45-7,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H304:47;H335:60;H315:60;H225:73;H319:60
65886,2-bromopropan-1-ol,209-921-4,598-18-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H226:1;H335:1
65888,"(1E,Z)-2,6-dimethylhepta-1,5-dienyl 2-methylpropanoate",479-370-4,942594-24-3,Skin Sens. 1,Notified C&L,25,H317:25
65889,Triisotridecyl phosphite,278-758-9,77745-66-5,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,127,H317:123;H413:29;H319:2;H315:2;Not classified:2
65891,"Speiss, lead, nickel-contg.",308-765-5,98246-91-4,Skin Irrit. 2;Skin Sens. 1;Resp. Sens. 1;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H317:1;H360:1;H410:1;H400:1;H316:1;H372:1;H334:1;H350:1
65893,"Mercaptoacetic acid, sodium salt",253-166-3,36722-22-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 1,Notified C&L,1,H317:1;H314:1;H410:1;H331:1;H301:1;H311:1
65894,Hex-2-yne,212-117-6,764-35-2,Flam. Liq. 2,Notified C&L,44,H225:44;H304:5;H335:4;H315:5;H319:5;Not classified:1
65896,Iodobis(triphenylphosphino)copper,240-276-1,16109-82-3,,Notified C&L,34,Not classified:33;H413:1
65900,"Tetrasodium 3-[[1-hydroxy-6-[[[[4-[(8-hydroxy-3,6-disulphonato-1-naphthyl)azo]-2-methoxy-5-methylphenyl]amino]carbonyl]amino]-3-sulphonato-2-naphthyl]azo]-p-anisate",276-124-6,71873-47-7,Not Classified,Notified C&L,8,Not classified:8
65901,"DISODIUM ETHYLENEDIAMINE-N,N'-DIACETATE",609-507-7,38011-25-5,Not Classified,Notified C&L,47,Not classified:32;H319:13;H302:15
65902,"Stigmasta-5,22-dien-3-β-ol",201-482-7,83-48-7,,Notified C&L,2,H302:1;H312:1;H335:1;H315:1;H319:1;H332:1;Not classified:1
65903,"Fatty acids, C9-13-neo-, cobalt salts",273-293-8,68955-83-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3;Carc. 2,Notified C&L,40,H302:40;H317:40;H335:40;H315:40;H351:40;H334:40;H319:40
65908,Pent-3-enenitrile,225-060-7,4635-87-4,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 3;Acute Tox. 2,REACH registration C&L,40,H300:1;H311:39;H226:40;H330:2;H335:38;H318:38;H315:39;H331:38;H301:38;H302:1;H319:1
65909,"3,5-dimethylhex-3-en-2-ol",614-095-7,676532-41-5,Flam. Liq. 3,REACH registration C&L,2,H226:2
65910,(3-chloropropyl)triethoxysilane,225-805-6,5089-70-3,Not Classified,REACH registration C&L,100,Not classified:24;H226:52;H412:23;H319:17;H315:17;H335:16;H227:1;H320:1
65912,Quillaja Saponin,613-951-7,66594-14-7,Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1
65913,Embramine hydrochloride,237-757-3,13977-28-1,Acute Tox. 1;Skin Sens. 1,Notified C&L,1,H300:1;H317:1
65915,Dosulepin,204-031-2,113-53-1,Acute Tox. 4;Repr. 2;Lact.,Notified C&L,38,H302:38;H362:38;H361:38
65916,"Fatty acids, essential, Et esters",293-054-1,91051-05-7,Not Classified,REACH registration C&L,39,Not classified:39
65921,"N,N-dimethyl-4-(m-tolylazo)aniline",200-243-4,55-80-1,Acute Tox. 4,Notified C&L,1,H302:1
65922,"(3α,16α)-eburnamenin-14(15H)-one",225-490-5,4880-88-0,STOT RE 2;STOT RE 2;STOT RE 2,Notified C&L,1,H373:1
65924,"4-hydroxy-3,5-dimethylbenzaldehyde",218-774-5,2233-18-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50,H319:50;H315:50;H335:48
65925,"Amines, N-tallow alkyltrimethylenedi-, ethoxylated",500-149-6,61790-85-0,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,664,H302:593;H318:594;H314:480;H410:481;H400:459;H315:179;H411:80;H319:41;H413:31;Not classified:1
65929,Dichlorododecylmethylsilane,242-286-1,18407-07-3,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,25,H318:2;H314:25;H225:23;H335:23;H290:1
65930,"1-(allyloxy)-2,2-bis[(allyloxy)methyl]butane",211-660-6,682-08-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,620,H319:619;H315:619;H335:619;Not classified:1
65933,Amezinium metilsulfate,250-248-0,30578-37-1,Acute Tox. 4,Notified C&L,43,H302:43
65936,"Hydrocarbons, C",305-974-3,95371-07-6,Carc. 1B,Harmonised C&L,0,H350:0
65943,4-iodo-2-nitrotoluene,255-279-3,41252-97-5,,Notified C&L,6,H319:6;H315:6;H335:5
65945,Fthalide Standard,608-088-8,27355-22-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,90,H400:90;H410:90
65948,"2,3,4,9-tetrahydro-2-methyl-1H-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridyl maleate",288-065-3,85650-57-3,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,16,H302:16;H317:16;H312:16;H334:16;H332:16
65949,4-amino-N-methylbenzylamine,253-747-1,38020-69-8,Acute Tox. 4;Skin Corr. 1C,Notified C&L,45,H302:43;H314:43;H319:2;H315:2;H335:2
65952,2-hydroxyethyl stearate,203-886-9,111-60-4,Not Classified,Notified C&L,313,Not classified:274;H319:39;H315:1;H335:1
65953,Tripropyltin acetate,221-879-9,3267-78-5,,Notified C&L,4,H410:4;H331:4;H400:4;H301:4;H311:4
65954,2-hydroxypropyl myristate,222-580-6,3539-38-6,Not Classified,Notified C&L,1,Not classified:1
65956,"(2R,4S)-2-({2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl}carbamoyl)-1-methyl-4-propylpyrrolidin-1-ium hydrate chloride",615-424-7,7179-49-9,Skin Sens. 1;Resp. Sens. 1,Notified C&L,6,H334:4;H317:4;H319:2;H315:2;H335:2;Not classified:1
65960,Carbon tetrabromide,209-189-6,558-13-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,122,H318:116;H302:122;H315:121;H335:61;H319:5;Not classified:2;H312:1;H332:1;H370:1;H372:1
65963,"1,2,3,6-tetrahydromethyl-3,6-methanophthalic anhydride",246-644-8,25134-21-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Resp. Sens. 1,REACH registration C&L,280,H302:280;H317:213;H318:48;H315:120;H331:33;H334:279;H314:160;H335:74;H319:74;H332:5
65964,"2',(2')'-bis(salicyloyl)dodecanedi(ohydrazide)",264-042-3,63245-38-5,Not Classified,Notified C&L,3,Not classified:3
65966,N-(2-aminoethyl)-N'-[2-(1-piperazinyl)ethyl]ethylenediamine,250-556-5,31295-49-5,,Notified C&L,34,Not classified:33;H314:1
65970,"Silicic acid, lithium salt",235-730-0,12627-14-4,Eye Dam. 1;STOT SE 3,REACH registration C&L,141,H318:83;H335:84;H319:55;H320:1;Not classified:3;H315:5
65971,"3,7-dimethyloctanal",227-810-9,5988-91-0,Aquatic Chronic 2,REACH registration C&L,1575,H411:16;Not classified:1521;H319:38;H315:38
65979,"5-[(4-anilino-5-sulpho-1-naphthyl)azo]-4-hydroxynaphthalene-2,7-disulphonic acid, ammonium sodium salt",280-128-3,83006-78-4,Not Classified,Notified C&L,2,Not classified:2
65980,"Ethylene oxide, propylene oxide copolymer, tall oil fatty acid ester",614-134-8,67784-86-5,Aquatic Chronic 3,Notified C&L,22,H412:21;Not classified:1
65983,di(benzothiazol-2-yl) disulphide,204-424-9,120-78-5,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0
65986,Phenylacetohydrazide,213-328-6,937-39-3,Acute Tox. 3,Notified C&L,42,H301:41;H319:4;H315:4;H335:3;H331:1;H311:1
65987,"1,4-anhydro-D-glucitol",248-391-9,27299-12-3,Acute Tox. 3;Eye Irrit. 2,Notified C&L,39,H301:38;H319:38;Not classified:1
65988,(trifluorovinyl)benzene,207-180-1,447-14-3,Flam. Liq. 3,Notified C&L,1,H226:1
65992,Titanium tetrapropanolate,221-411-3,3087-37-4,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,110,H318:4;H315:44;H336:4;H226:52;H332:2;H319:106;H335:38
65994,"2-chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane",219-380-6,2428-06-0,Skin Corr. 1B,Notified C&L,38,H314:38
65996,3-ethylrhodanine,231-603-9,7648-01-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:39;H302:44;H315:39;H335:39
66010,3-methylpyrocatechol,207-672-6,488-17-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:45;H335:44;H302:6;H312:6;H332:5;H317:1;H318:1
66012,"Trisodium 4-[[2,6-dihydroxy-3-[(4-nitrophenyl)azo]-5-[(4-sulphonato-1-naphthyl)azo]phenyl]azo]-5-hydroxynaphthalene-2,7-disulphonate",279-681-3,81064-47-3,Not Classified,Notified C&L,2,Not classified:2
66013,Barium tartrate,227-615-9,5908-81-6,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,43,H302:43;H332:43
66015,2-ethylhexyl octanoate,264-098-9,63321-70-0,Not Classified,Notified C&L,32,Not classified:32
66017,"Tetrasodium [2-[2-[4-[[2,6-dihydroxy-3-[(2-hydroxy-5-sulphophenyl)azo]phenyl]azo]-2-sulphophenyl]vinyl]-5-[[4-[(4-sulphophenyl)azo]phenyl]azo]benzenesulphonato(6-)]cuprate(4-)",273-456-3,68966-90-5,Not Classified,Notified C&L,15,Not classified:15
66019,"imazalil (ISO);1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole",252-615-0,35554-44-0,Acute Tox. 3;Eye Dam. 1;Acute Tox. 4;Carc. 2;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H410:0;H301:0;H351:0;H332:0
66021,p-fluorotoluene-α-thiol,240-031-9,15894-04-9,,Notified C&L,7,H302:6;H312:5;H335:5;H315:6;H319:6;H332:6;Not classified:1
66022,Chromium trifluoride,232-137-9,7788-97-8,Acute Tox. 3;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,92,H317:19;H318:60;H314:92;H411:18;H400:18;H301:45;H302:45;H312:45;H332:45;H372:25
66023,"Hydrogen 5-chloro-2-[2-[[5-phenyl-3-(3-sulphonatobutyl)-3H-benzoxazol-2-ylidene]methyl]but-1-enyl]-3-(3-sulphonatopropyl)benzoxazolium, compound with triethylamine (1:1)",263-942-3,63148-90-3,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
66026,"Quaternary ammonium compounds, (C16-18 and C18-unsatd. alkyl)tris(hydroxyethyl), acetates (salts)",293-560-2,91080-64-7,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H302:2;H314:1;H410:2;H400:2;H311:1;H318:1;H315:1
66027,"1-[bis[4-(diethylamino)phenyl]methyl]naphthalene-2,7-disulphonic acid",269-848-9,68345-20-0,Not Classified,REACH registration C&L,11,Not classified:10;H319:1;H317:1
66028,"3,4,5-trimethoxybenzaldehyde",201-701-6,86-81-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H302:3;H315:3;Not classified:1
66032,"Acetamide, N-[4-[[(5,6-dimethoxy-4-pyrimidinyl)amino]sulfonyl]phenyl]-",610-509-5,5018-54-2,Not Classified,Notified C&L,1,Not classified:1
66033,C.I. Acid Blue 140,601-950-4,12219-21-5,Not Classified,Notified C&L,1,Not classified:1
66035,"Bis[[1,4a-dimethyl-7-(1-methylethyl)tetradecahydrophenanthryl]methyl] phthalate",253-008-3,36388-36-0,Not Classified,Notified C&L,11,Not classified:11
66037,2-ethylhexyl methyl terephthalate,264-249-9,63468-13-3,,Notified C&L,3,Not classified:1;H319:2;H315:2;H335:2;H302:1
66042,"4,4'-Methylenediphenyl diisocyanate, oligomers, reaction products with 2-ethylhexan-1-ol and 2-hexyloxyethanol",500-519-7,161074-84-6,Skin Sens. 1;Resp. Sens. 1,Notified C&L,25,H334:25;H317:25;Not classified:25
66045,2-ethylhexyl bis(2-hydroxyethyl) phosphate,274-794-4,70710-10-0,Not Classified,Notified C&L,1,Not classified:1
66047,"4,6-dichloropyrimidine methyl sulphide",228-577-6,6299-25-8,Met. Corr. 1;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 2;Aquatic Chronic 2,Notified C&L,136,H302:89;H317:89;H290:89;H318:90;H315:90;H411:89;H330:89;H314:43;H335:39;H332:3;H312:3;H319:1
66049,"Benzenamine, N-phenyl-, reaction products with 2,4,4-trimethylpentene",270-128-1,68411-46-1,Aquatic Chronic 3,REACH registration C&L,904,H412:666;Not classified:210;H411:23;H319:6;H400:5;H373:3
66051,"4,5-dichloro-3,6-dioxocyclohexa-1,4-diene-1,2-dicarbonitrile",201-542-2,84-58-2,Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,67,H301:67;H319:8;H317:8;H318:4;H332:2;H312:2;H331:2;H311:3;Not classified:1;H413:1;H314:1
66053,Purine,204-421-2,120-73-0,Not Classified,Notified C&L,1,Not classified:1
66054,"Osyris tenuifolia, ext.",294-831-8,91770-46-6,Not Classified,Notified C&L,2,Not classified:2
66056,cyclobutanecarbaldehyde,608-426-4,2987-17-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42,H319:41;H302:40;H225:1;H315:2;H335:2;H226:1
66057,2-methylhexan-3-one,230-940-9,7379-12-6,Flam. Liq. 3,Notified C&L,40,H226:40;H319:1
66060,(3S)-3-(Aminomethyl)-5-methylhexanoic acid,604-639-1,148553-50-8,Eye Dam. 1;Repr. 2;STOT RE 2,Notified C&L,192,H318:151;H361:188;H373:97;H362:10;H319:1;H315:1;H335:1;Not classified:2;H302:1;H332:1;H312:1;H336:1
66061,"1,2-Dibromocyclopent-1-ene",616-222-1,75415-78-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H302:1;H312:1;H335:1;H315:1;H319:1
66065,"N,N'-ethylenebis(3,4,5,6-tetrabromophthalimide)",251-118-6,32588-76-4,Not Classified,REACH registration C&L,98,Not classified:98
66068,3-(phosphonooxy)-N-(o-tolyl)naphthalene-2-carboxamide,248-542-9,27580-13-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
66072,Zirconium tetra(2-ethylhexanoate),218-776-6,2233-42-3,,Notified C&L,4,H361:4
66074,"N-[5-(diethylamino)-2-[(3,5-dinitro-2-thienyl)azo]phenyl]acetamide",261-540-2,58979-46-7,Skin Sens. 1,Notified C&L,25,H317:24;Not classified:1
66075,Ethyl oleate,203-889-5,111-62-6,Not Classified,Notified C&L,139,Not classified:138;H319:1;H315:1;H335:1
66081,"1,1'-[[(2-chlorophenyl)methylene]bis[(2,5-dimethyl-4,1-phenylene)azo]]bis(2-naphthol)",229-753-5,6706-75-8,Not Classified,Notified C&L,36,Not classified:36
66082,"p-nitrophenyl dihydrogen phosphate, compound with 2-amino-2-(hydroxymethyl)propane-1,3-diol (1:2)",269-198-6,68189-42-4,Not Classified,Notified C&L,1,Not classified:1
66085,"1,2,3,4-tetrahydro-2,2,4-trimethylquinoline",224-791-9,4497-58-9,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,2,H302:2;H412:2
66094,"2,2'-(naphthalene-1,4-diyl)bis(benzoxazole)",225-803-5,5089-22-5,Not Classified,REACH registration C&L,68,Not classified:28;H413:40
66095,"Chicory, ext.",272-045-6,68650-43-1,Not Classified,Notified C&L,172,Not classified:171;H226:1
66096,"Vetiverol, acetate",263-597-9,62563-80-8,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,181,H317:142;H411:142;H315:38;H319:1;Not classified:1
66100,"Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated;Baseoil - unspecified;[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C",295-300-3,91995-39-0,Carc. 1B,Harmonised C&L,0,H350:0
66101,Biperiden hydrochloride,214-976-2,1235-82-1,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,134,H228:84;H332:84;H302:134;H412:85;H319:39;H341:9;H317:9;H410:9;H312:1;H335:1;H315:1;H226:1
66102,"5-(bromoacetyl)-1,3-phenylene bis(dimethylcarbamate)",279-805-6,81732-49-2,Not Classified,Notified C&L,1,Not classified:1
66106,LICOMONT ER 165,443-030-3,,Not Classified,Notified C&L,31,Not classified:31
66109,"Decanol, branched and linear",291-169-1,90342-32-8,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1,H319:1;H412:1
66117,"lindane (ISO);γ-HCH or γ-BHC;γ-1,2,3,4,5,6-hexachlorocyclohexane",200-401-2,58-89-9,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4;Lact.;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H312:0;H410:0;H400:0;H301:0;H362:0;H332:0;H373:0
66119,2-[(2-methoxy-4-nitrophenyl)amino]ethanol,266-138-0,66095-81-6,Acute Tox. 4,Notified C&L,6,H302:6
66121,Titanium(4+) 2-methylpropan-2-olate,221-412-9,3087-39-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,82,H319:82;H315:76;H226:82;H335:50;H336:6;H332:6
66123,1H-indazol-7-amine,244-391-8,21443-96-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:40;H302:46;H315:40;H335:40;H332:1;H412:1
66124,Tetrasodium hexacyanoferrate,237-081-9,13601-19-9,Not Classified,REACH registration C&L,274,Not classified:215;H302:38;H312:38;H412:38;H310:21;H300:21;H410:21;H400:21;H330:21
66125,alpha-Bromo-2-chlorophenylacetic Acid,608-337-0,29270-30-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H318:1;H314:1;H290:1
66126,Hexadecanol,249-583-5,29354-98-1,Not Classified,Notified C&L,55,Not classified:55
66127,2-(2-methoxyethoxy)ethyl methacrylate,256-190-2,45103-58-0,Eye Irrit. 2,REACH registration C&L,55,H319:55;H317:53;H315:53;H335:51;H302:13;H311:13
66130,"Hydrogen [6R-[6α,7β(R*)]]-4-carbamoyl-1-[[2-carboxylato-8-oxo-7-(phenylsulphonatoacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridinium, monosodium salt",257-692-4,52152-93-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:47;H317:50;H315:48;H335:48;H334:10
66132,Benzocaine,202-303-5,94-09-7,Skin Sens. 1;STOT SE 1;STOT SE 1,REACH registration C&L,201,H317:161;Not classified:39;H319:18;H315:15;H335:10;H332:3;H312:3;H411:3;H302:1;H413:1;H370:1
66134,4-nitro-DL-phenylalanine,220-868-6,2922-40-9,Acute Tox. 3,Notified C&L,39,H301:39
66136,Phenoxybenzamine hydrochloride,200-569-7,63-92-3,Acute Tox. 4;Carc. 2,Notified C&L,40,H302:40;H351:40
66147,S-allyl acrylo-1-sulphinothioate,208-727-7,539-86-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
66149,"Isooctadecanoic acid, compound with 2,2'-iminodiethanol (1:1)",300-113-8,93920-28-6,Not Classified,Notified C&L,1,Not classified:1
66151,"(±)-1-(tert-butylamino)-3-[(3,4-dihydro-2H-1-benzothiopyran-8-yl)oxy]propan-2-ol hydrochloride",251-578-8,33580-30-2,Acute Tox. 4;Repr. 2;Lact.;Aquatic Chronic 2,Notified C&L,1,H302:1;H362:1;H411:1;H361:1
66156,3-(1H-pyrrol-1-ylmethyl)pyridine,279-598-2,80866-95-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
66157,Acenocoumarol,205-807-3,152-72-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H302:45;H335:38;H315:38;H319:38;H361:38;H360:5;H332:1;H312:1
66161,Pin-2-en-4-one,214-807-2,1196-01-6,Not Classified,Notified C&L,90,Not classified:89;H302:1;H312:1
66169,"2-Naphthalenesulfonic acid, 6-hydroxy-, monosodium salt, polymer with disodium sulfite, formaldehyde and methylphenol",615-881-2,73003-46-0,Aquatic Chronic 3,Notified C&L,33,Not classified:33;H412:33
66171,4-(Methoxycarbonyl)benzeneboronic acid,619-459-9,99768-12-4,,Notified C&L,13,H319:12;H315:12;H335:11;H302:3;H332:2;H312:2
66174,"Nonylphenol, branched, ethoxylated, phosphated",614-460-0,68412-53-3,Met. Corr. 1;Skin Irrit. 2;Eye Dam. 1,Notified C&L,655,H318:649;H315:591;H290:450;H412:84;H314:59;H411:22;Not classified:5;H319:1
66178,3-butoxypropylamine,240-566-8,16499-88-0,Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,103,H318:12;H301:23;H314:70;Not classified:33;H302:8
66180,"reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea",406-530-2,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
66183,"4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;C.I. Basic Red 9",209-321-2,569-61-9,Carc. 1B,Harmonised C&L,0,H350:0
66184,"Monarda fistulosa, ext.",308-354-0,97952-61-9,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,14,H318:14;H317:14;H315:14
66187,"Disodium 3,3'-[sulphonylbis[p-phenyleneazo(5-imino-3-methyl-1H-pyrazole-4,1-diyl)]]bis(benzenesulphonate)",275-148-4,71033-19-7,Aquatic Chronic 3,REACH registration C&L,127,H412:36;H336:83;H226:83;Not classified:8
66188,Heptyl 4-hydroxybenzoate,214-115-0,1085-12-7,,Notified C&L,5,H319:5;H315:5;H335:4
66189,Dibenzylamine,203-117-7,103-49-1,Acute Tox. 4;Skin Corr. 1C;Aquatic Chronic 1,REACH registration C&L,142,H302:140;H314:79;H410:7;H318:1;H319:62;H315:62;H412:40;H335:11;Not classified:1;H301:1
66191,"Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",270-094-8,68410-98-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
66192,2-bromo-4-chloroaniline,212-837-0,873-38-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:40;H315:40;H335:39;H302:6;H332:6;H311:5;H373:4;H312:2;H301:1;H331:1
66193,Young Living Manuka Essential Oil,607-036-1,223749-44-8,Skin Sens. 1,Notified C&L,3,H317:3;H412:1
66195,"3-[(2,2-Dimethyl-1,2-azasilolidin-1-yl)(dimethyl)silyl]-1-propanamine",470-090-8,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H302:1;H317:1;H312:1;H318:1;H315:1
66198,2-chloroethyl ethyl ether,211-037-9,628-34-2,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3,Notified C&L,44,H301:39;H225:44;H331:39;H335:4;H315:5;H319:5;H332:5
66199,"[4R-(4α,4aα,6β)]-4,4a,5,6,7,8-hexahydro-4,4a-dimethyl-6-(1-methylvinyl)naphthalen-2(3H)-one",225-124-4,4674-50-4,Not Classified,Notified C&L,192,Not classified:191;H319:1;H315:1
66200,"Proteinase, Agkistrodon serine",232-933-6,9046-56-4,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H334:38;H319:38;H315:38;H335:38
66203,3-methylbut-1-yne,209-925-6,598-23-2,Flam. Liq. 1,Notified C&L,40,H224:39;H319:1;H315:1;H335:1;H242:1
66213,1-iodo-3-nitrobenzene,211-427-9,645-00-1,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:43;H312:44;H335:43;H228:40;H315:45;H319:45;H332:44
66214,N-(4-{[3-(dimethylamino)propyl]sulfamoyl}phenyl)-2-[(2-methoxy-4-nitrophenyl)diazenyl]-3-oxobutanamide,700-222-4,1065519-44-9,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,1,H400:1;H319:1;H410:1
66218,p-ethoxyphenyl isothiocyanate,222-410-0,3460-49-9,,Notified C&L,7,H302:5;H314:6;H332:5;H312:5;H301:2;H331:2;H311:2
66221,"Fleabane, Erigeron canadensis, ext.",285-528-1,85116-76-3,Not Classified,Notified C&L,186,Not classified:184;H226:2;H317:1;H304:1;H410:1;H400:1;H319:1
66224,5-ethyl-m-cresol,211-818-4,698-71-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,127,H302:127;H335:127;H318:127;H315:127;H400:127
66230,2-iodo-6-methylpyridin-3-ol,245-376-9,23003-30-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
66231,Silver bromide,232-076-8,7785-23-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,8,H400:4;H410:5;Not classified:3
66235,"1,3-dihydro-1,3-dioxo-2H-isoindole-2-hexanoic acid",224-675-8,4443-26-9,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,40,H319:39;H302:38;H317:38;Not classified:1;H315:1;H303:1;H335:1
66236,4-(2-hydroxypropyl)morpholine,218-298-8,2109-66-2,Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,52,H300:39;H318:39;H315:44;H335:39;Not classified:8;H319:5
66239,5-aminobarbituric acid,204-277-0,118-78-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
66243,Sulfamoxole,211-982-7,729-99-7,Skin Sens. 1,Notified C&L,38,H317:38
66245,Iron,231-096-4,7439-89-6,Not Classified,REACH registration C&L,5447,Not classified:3983;H228:819;H251:1123;H302:90;H410:89;H315:90;H400:95;H319:167;H335:76;H373:47;H372:2;H370:2;H371:3;H250:1
66246,2-aminopropane;isopropylamine,200-860-9,75-31-0,Flam. Liq. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H315:0;H335:0;H224:0
66251,"Poly(oxy-1,2-ethanediyl), a-hydro-[?]-hydroxy-, phosphate",618-579-9,9056-42-2,,Notified C&L,1,H318:1;H315:1
66252,"Slimes and Sludges, copper electrolytic",266-972-5,67711-95-9,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,14,H317:14;H318:14;H341:14;H360:14;H315:12;H410:14;H400:12;H301:14;H372:14;H334:14;H350:14;H332:14;H314:2
66253,Tetraallyl orthosilicate,213-930-9,1067-43-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
66256,"4,4'-methylenebis[3-hydroxy-2-naphthoic] acid, compound with (E)-3-[2-(1,4,5,6-tetrahydro-1-methylpyrimidin-2-yl)vinyl]phenol (1:1)",272-332-6,68813-55-8,Not Classified,Notified C&L,2,Not classified:2
66259,Tetratetracontane,230-407-0,7098-22-8,Not Classified,Notified C&L,5,Not classified:5
66262,"Residues, precious metal refining cementation",310-051-3,102110-50-9,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Resp. Sens. 1;STOT SE 3;Muta. 2;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,7,H317:7;H335:7;H318:7;H341:7;H360:7;H314:7;H410:7;H331:7;H400:7;H301:7;H372:7;H334:7;H350:7
66264,"N,N'-diacetylhydrazine",221-576-1,3148-73-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H302:40;H312:40;H335:43;H315:44;H319:44;H332:40
66265,Thulium(3+) perchlorate,237-827-3,14014-10-9,,Notified C&L,4,H272:4;H319:4;H315:4;H335:4
66266,"1,1-dimethyl-2-phenylethyl isobutyrate",261-715-3,59354-71-1,Not Classified,Notified C&L,136,Not classified:136
66268,DL-arginine,230-571-3,7200-25-1,Eye Irrit. 2,Notified C&L,44,H319:41;Not classified:3;H315:1;H335:1
66270,2-chloroheptane,213-683-7,1001-89-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H226:39;H335:38
66271,"Tris(2,4,4-trimethylpentyl)aluminium",240-345-6,16216-31-2,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,Notified C&L,17,H250:17;H260:17;H314:17
66273,"Fatty acids, C10-16",268-105-6,68002-90-4,Not Classified,Notified C&L,26,Not classified:25;H318:1
66276,Tetrabutylthioperoxydicarbamic acid,216-652-6,1634-02-2,Not Classified,REACH registration C&L,7,Not classified:6;H317:1
66277,4-(4-methoxyphenyl)butan-2-one,203-184-2,104-20-1,Not Classified,REACH registration C&L,1569,Not classified:1566;H302:2;H332:2;H312:2;H317:1;H412:1
66278,2-ethyloctan-1-ol,243-898-1,20592-10-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
66279,"Tributyl benzene-1,2,4-tricarboxylate",217-038-0,1726-23-4,Not Classified,Notified C&L,1,Not classified:1
66281,"2-bromo-1-(2,4-dichlorophenyl)ethan-1-one",220-116-7,2631-72-3,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H318:39;H301:38;H315:38;H335:38;H314:2;H290:1
66282,Isoquinoline,204-341-8,119-65-3,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Carc. 1B;Aquatic Chronic 3,REACH registration C&L,1687,H302:1655;H413:2;H315:1567;H350:43;H311:1649;H319:1567;H412:40;Not classified:34;H310:6;H341:1;H410:1
66287,"Gases (petroleum), catalytic cracker;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",270-756-6,68477-74-7,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
66292,"2-[[6-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]-1-hydroxy-3-sulpho-2-naphthyl]azo]naphthalene-1,5-disulphonic acid, sodium salt",280-744-2,83763-57-9,Skin Sens. 1B;Resp. Sens. 1B,REACH registration C&L,46,H334:46;H317:46
66294,"Trisodium 2-(-hydrogen arsonatophenylazo)-1,8-dihydroxynaphthalene-3,6-disulphonate",208-285-5,520-10-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 1,Notified C&L,1,H301:1;H410:1;H331:1;H311:1
66299,"2,4-dimethyl-1H-pyrrole",210-912-2,625-82-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:41;H302:1;H312:1;H332:1
66303,Iron vanadium tetraoxide,237-758-9,13977-56-5,Aquatic Chronic 2,REACH registration C&L,2,H411:2
66309,"2,9,11,13,15,22,24,26,27,28- decaazatricyclo[21.3.1.1^(10,14)]octacosa- 1(27),10,12,14(28),23,25-hexaene-12,25-diamine, N,N'-bis(1,1,3,3-tetramethylbutyl)-2,9,15,22-tetrakis(2,2,6,6-tetramethyl-4-piperidinyl)-",401-300-8,,Not Classified,Notified C&L,87,Not classified:87
66312,"Quino [2,3-b]acridine-7-14-dione,5,12-dihydro-3,10-dimethyl-",605-208-0,16043-40-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,19,H319:19;H315:19;H335:19
66314,"4,6-Diamino-2-cyclopropylamino-pyrimidine-5-carbonitrile",601-192-4,112636-83-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:39;H332:39;H411:1
66318,Osmium trichloride,236-587-7,13444-93-4,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,46,H318:40;H314:46;H331:42;H301:42;H311:42;H302:4;H332:4;H312:4
66319,"4-oxo-4H-pyran-2,6-dicarboxylic acid",202-749-0,99-32-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:38;H315:38;H335:38;Not classified:2
66320,"3,3-dimethylhexane",209-243-9,563-16-6,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H304:0;H315:0;H410:0;H400:0;H336:0;H225:0
66321,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with cyclohex-1,2-ylenediamine",500-268-3,87041-44-9,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,138,H302:49;H317:52;H411:49;H400:3;H319:3;Not classified:86;H318:2;H315:2;H314:1
66322,Imipramine hydrochloride,204-030-7,113-52-0,Acute Tox. 4,Notified C&L,91,H302:91;H341:1;H410:1;H319:1;H315:1;H335:1
66324,"1,2,3,4-tetrahydronaphthalene",204-340-2,119-64-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H315:0;H411:0
66327,Desonide,211-351-6,638-94-8,Acute Tox. 4;Acute Tox. 4;STOT RE 1,Notified C&L,46,H372:25;H302:41;H312:41;H332:17;Not classified:1;H319:2;H315:2;H361:3;H335:1;H351:1
66328,"3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoic acid",616-069-0,7423-55-4,Not Classified,Notified C&L,495,Not classified:441;H319:54;H315:54;H335:53
66330,"2',4'-dinitroacetanilide",210-227-9,610-53-7,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,39,H302:8;H412:8;Not classified:31
66332,"Rape oil, hydrogenated",283-532-8,84681-71-0,Not Classified,Notified C&L,72,Not classified:72
66335,Gallium,231-163-8,7440-55-3,Met. Corr. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,337,H302:21;H412:21;H290:89;H314:222;H413:19;Not classified:9;H315:9;H318:2;H319:3;H335:3
66337,"1,4,7,10,13-pentaoxacyclopentadecane-2-methanol",278-222-4,75507-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
66340,1-iodoheptane,224-285-8,4282-40-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H315:43;H335:42;H302:1;H332:1;H312:1
66342,"1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidine-4-yl octadecanoate",433-060-5,,Not Classified,REACH registration C&L,84,Not classified:84
66343,Tilidine,243-774-7,20380-58-9,,Notified C&L,1,H302:1
66345,γ-oxo-α-phenylbenzenebutyronitrile,228-440-0,6268-00-4,Aquatic Acute 1,Notified C&L,38,H400:38
66347,L-homocysteine,227-891-0,6027-13-0,Acute Tox. 4,Notified C&L,40,H302:39;Not classified:1
66348,"Amines, coco alkyl, 4-dodecylbenzenesulfonates",294-722-5,91745-51-6,Not Classified,Notified C&L,1,Not classified:1
66349,Benzaldehyde phenylhydrazone,209-625-5,588-64-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
66350,"α,α'-propylenedinitrilodi-o-cresol",202-374-2,94-91-7,Acute Tox. 4;Skin Sens. 1;Repr. 1B;Aquatic Chronic 3,REACH registration C&L,1083,H360:540;H302:1006;H317:1042;H412:604;H411:421;H319:542;H226:397;H315:145;H335:39;Not classified:1
66353,Tris(4-nitrophenyl) phosphate,223-389-0,3871-20-3,Acute Tox. 3,Notified C&L,40,H301:38;H370:1;H411:1;H319:1;H315:1
66358,"1,2,3,4,5,6-hexachloro-7-methoxynaphthalene",216-135-5,1506-15-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H301:38;H331:38;H311:38
66361,"(2S, 3S)-3-Amino-2-hydroxy-hexanoic acid cyclopropylamide hydrochloride",619-041-6,944716-73-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
66364,N-(benzyloxycarbonyl)-O-benzyl-L-serine,244-049-8,20806-43-3,Not Classified,Notified C&L,1,Not classified:1
66365,Trichloroacetaldehyde,200-911-5,75-87-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,51,H301:5;H319:50;H315:50;H335:44;H302:46;H330:5;H373:3;H312:1;H318:1;H314:1;H340:1;H370:1;H361:1;H351:1
66367,1-(chloroacetyl)-2-methylpiperidine,224-985-3,4593-18-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H315:38;H335:38
66370,Dexamethasone 21-pivalate,217-659-7,1926-94-9,,Notified C&L,2,H302:1;H332:1;H312:1;H373:1;H361:1;H317:1
66371,β-pilocarpine hydrochloride,249-338-2,28958-85-2,,Notified C&L,1,H301:1
66376,4-benzylresorcinol,218-922-9,2284-30-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
66378,"6,7-dimethyl-2,4-pteridine-2,4-diamine",215-844-7,1425-63-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H315:38;H335:38
66380,"4-methyl-2-pentyl-1,3-dioxolane",216-489-0,1599-49-1,Not Classified,Notified C&L,1401,Not classified:1287;H319:114;H315:114
66382,Poly[oxy(methylsilylene)],618-393-8,9004-73-3,Not Classified,Notified C&L,36,Not classified:36
66385,"(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-Ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",611-907-1,59865-13-3,Acute Tox. 4;Carc. 1B;Repr. 1B,Notified C&L,340,H360:330;H302:340;H350:337;H372:36;H351:3;H362:5;H412:2;H361:4;H373:1
66387,Calcium bis(4-O-(β-D-galactosyl)-]Dgluconate) - calcium bromide (1:1),251-616-3,33659-28-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
66389,N-acetyl-L-isoleucine,221-364-9,3077-46-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
66393,(bromomethyl)triphenylphosphonium bromide,213-857-2,1034-49-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
66394,"Molasses, yeast fermn. distn. residues",302-644-0,94114-07-5,Not Classified,Notified C&L,1,Not classified:1
66397,"1,6-Hexanediol, homopolymer",608-061-0,27236-13-1,Not Classified,Notified C&L,25,Not classified:25
66398,"9(or 10)-(sulphooxy)octadecanoic acid, sodium salt",269-770-5,68331-91-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,73,H319:56;H315:73;H318:17
66399,Altretamine,211-428-4,645-05-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H302:41;H315:41;H335:41;H341:2;Not classified:1;H361:2
66408,Undecyl glucoside,308-766-0,98283-67-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,2,H318:2;H315:2
66410,N-ethyldiethanolamine,205-379-8,139-87-7,Eye Dam. 1,Notified C&L,155,H318:83;H319:39;H315:38;H335:38;Not classified:33
66414,"Carboxypeptidase, serine",232-934-1,9046-67-7,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,42,H334:42;H319:40;H315:40;H335:40
66417,"2-Propenoic acid, ammonium salt (1:1), polymer with 2-propenamide",607-863-8,26100-47-0,Not Classified,Notified C&L,125,Not classified:125
66419,"disodium {}{5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}}cuprate(2-);CI Direct Brown 95",240-221-1,16071-86-6,Carc. 1B,Harmonised C&L,0,H350:0
66422,"2-methylhexa-1,5-diene",223-751-8,4049-81-4,Flam. Liq. 2,Notified C&L,1,H225:1
66426,pentachlorophenol,201-778-6,87-86-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H335:0;H315:0;H410:0;H400:0;H301:0;H351:0;H311:0;H330:0;H319:0
66428,Cyanogen bromide,208-051-2,506-68-3,Met. Corr. 1;Acute Tox. 1;Acute Tox. 1;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,70,H310:70;H290:1;H300:70;H318:1;H314:61;H410:63;H400:66;H330:70;H411:1;H351:1
66429,"Distillates (petroleum), hydrodesulfurized middle;Gasoil - unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-183-3,64742-80-9,Carc. 1B,Harmonised C&L,0,H350:0
66431,Disodium 6-acetamido-4-hydroxy-3-[[4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2-sulphonate,243-653-9,20262-58-2,Skin Sens. 1;Resp. Sens. 1B,Notified C&L,76,H334:74;H317:42;H319:10;H335:9;H318:2;Not classified:1
66434,"Gases (petroleum), gas oil hydrodesulfurization effluent;Refinery gas;[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]",295-398-8,92045-16-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
66436,3-chloropropyne,210-856-9,624-65-7,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,290,H335:242;H412:242;H314:290;H301:286;H225:290;H330:242;H318:85;H331:44;H311:44;H304:4;H336:4;H361:4;H373:4
66437,Ammonium chromate,232-138-4,7788-98-9,Ox. Sol. 2;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H317:89;H314:38;H410:89;H400:89;H272:38;H334:38;H350:89
66440,Phenyl acrylate,213-329-1,937-41-7,,Notified C&L,5,H319:5;H315:5;H411:4;H335:4
66441,"CELLULOSE, HEXADECYL 2-HYDROXYETHYL ETHER",617-075-6,80455-45-4,Not Classified,Notified C&L,127,Not classified:107;H319:20
66444,"(Benzyloxycarbonyl)methyl 4-(1-Butyl-5-cyano-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-benzoate",442-520-4,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,39,H319:39;H317:39;H413:39
66449,Ethyl 2-bromopropionate,208-609-5,535-11-5,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,63,H302:6;H335:8;H315:9;H319:4;H226:63;H314:44;H318:5;H301:5;H332:2;H225:1
66450,"Dibenzo[a,j]-1,4,7,10,13,16-hexaoxacyclooctadeca-2,11-diene",238-041-3,14187-32-7,Eye Irrit. 2,Notified C&L,61,H319:61;H315:20;H335:20
66451,"3,4-diethoxyphenethylamine",262-752-8,61381-04-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,4,H319:3;H315:3;H335:3;Not classified:1;H302:1
66454,butyl 3-[3-(methylamino)-4-nitrophenyl]prop-2-enoate,617-844-6,863886-03-7,Flam. Sol. 2;Self-heat. 2;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;STOT SE 3,Notified C&L,1,H317:1;H335:1;H228:1;H315:1;H301:1;H252:1
66458,"2,5-dimethyl-1,3,4-thiadiazole",248-473-4,27464-82-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
66460,"S-(2-Chlorobenzyl) N,N-diethylthiocarbamate",609-008-4,34622-58-7,Acute Tox. 4;Acute Tox. 3,Notified C&L,38,H302:38;H331:38
66461,Choline iodide,241-754-2,17773-10-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
66465,"4-Piperidinone, 2,6-diethyl-2,3,6-trimethyl-1-(1-phenylethoxy)-",440-550-2,244021-01-0,Skin Sens. 1B;Aquatic Chronic 4,Notified C&L,85,H317:85;H413:85;H227:2
66466,α-chlorodeoxybenzoin,207-181-7,447-31-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43,H318:39;H314:43
66467,"Psychotria ipecacuanha, ext.",296-224-3,92347-35-8,Flam. Liq. 3,Notified C&L,2,H226:1;H302:1;H225:1;H332:1
66468,"1,1,3,3-tetramethylbutylperoxypivalate",424-980-8,22288-41-1,Flam. Liq. 2;Org. Perox. D;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H315:0;H411:0;H242:0;H225:0
66471,Potassium 3-(phenylsulphonyl)benzenesulphonate,264-097-3,63316-43-8,Not Classified,Notified C&L,7,Not classified:7
66473,"Disodium 7,7'-iminobis[4-hydroxy-3-(phenylazo)naphthalene-2-sulphonate]",225-669-8,5001-72-9,Not Classified,Notified C&L,5,Not classified:5
66474,Cyclopropanecarbonyl chloride,223-684-4,4023-34-1,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1B;Carc. 1B,REACH registration C&L,286,H314:286;H331:10;H301:204;H350:10;H226:253;H335:43;H318:26
66476,2-[2-(4-nonylphenoxy)ethoxy]ethanol,243-816-4,20427-84-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H315:1;H412:1
66484,N-DL-alanyl-2-naphthylamine hydrochloride,277-736-6,74144-49-3,Carc. 2,Notified C&L,39,H351:38;H350:1
66485,"Poly(oxy-1,2-ethanediyl), α-(1-oxo-2-butenyl)-ω-(tributylphenoxy)-",619-433-7,99456-65-2,Not Classified,Notified C&L,44,Not classified:44
66486,Dipotassium peroxide,241-089-8,17014-71-0,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H272:1;H319:1;H315:1
66487,2-sec-butylphenol,201-933-8,89-72-5,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,309,H318:142;H302:272;H314:272;H312:181;H411:133;H332:181;Not classified:4;H311:4;H335:1
66492,"6-(cyclohexylamino)-3-methyl-3H-dibenz[f,ij]isoquinoline-2,7-dione",244-320-0,21295-57-8,Not Classified,Notified C&L,86,Not classified:86
66493,"1,5-Naphthalenedisulfonic acid, 2-[2-[6-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3-sulfo-2-naphthalenyl]diazenyl]-, sodium salt (1:?)",606-767-3,214425-86-2,Not Classified,Notified C&L,2,Not classified:2
66494,"Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane",271-555-6,68585-32-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,120,H317:93;H335:47;H315:81;H334:93;H319:80;H302:34;H312:34;H413:34;H332:34;Not classified:26;H318:14;H301:14
66497,IMINOFLUMIZOLINE,474-470-4,,Acute Tox. 3,Notified C&L,1,H301:1
66503,dichlorodioctylstannane;dichlorodioctyl stannane,222-583-2,3542-36-7,Acute Tox. 2;STOT RE 1;Aquatic Chronic 3;Repr. 1B,Harmonised C&L,0,H372:0;H330:0;H360:0;H412:0
66507,"6-(2,2-Difluoro-2-phenylethoxy)-hexylammonium Hydrogen Fumarate.",618-761-8,915132-93-3,Eye Dam. 1,Notified C&L,1,H318:1
66508,2-AMINO-5-METHYLTIAZOLE,615-902-5,7305-71-7,Acute Tox. 4;Aquatic Acute 1,Notified C&L,51,H400:47;H302:49;H410:7;H373:7;H319:1;H315:1;H335:1;H332:1;H312:1
66511,"2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetic acid",607-487-4,25021-08-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:1;H335:1
66512,Sodium (Z)-N-methyl-N-(1-oxo-9-octadecenyl)aminoacetate,238-312-6,14351-62-3,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,12,H318:9;H400:9;H315:9;Not classified:3
66515,(S)-α-(trifluoromethyl)benzyl alcohol,206-430-7,340-06-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
66519,"(R)-p-mentha-1,8-diene;d-limonene",227-813-5,5989-27-5,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H315:0;H400:0;H226:0
66520,"Octadecanoic acid, reaction products with diethylenetriamine and urea, acetates",284-698-4,84962-05-0,Not Classified,REACH registration C&L,48,Not classified:47;H319:1;H315:1
66523,5-bromosalicylaldehyde,217-167-2,1761-61-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46
66525,"Disodium 4-amino-3-[[4'-[(1-hydroxy-4-sulphonato-2-naphthyl)azo][1,1'-biphenyl]-4-yl]azo]naphthalene-1-sulphonate",219-381-1,2429-70-1,,Notified C&L,4,H319:4
66526,3-([3-Cholamidopropyl]dimethylammonio)-2-hydroxy-1-propanesulfonate,617-338-5,82473-24-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:47;H315:47;H335:47;H302:2;H332:2;H312:2
66528,"Acetic acid, 2-[4-(1,1-dimethylethyl)cyclohexylidene]-",604-014-3,13733-51-2,,Notified C&L,1,H319:1;H315:1;H335:1
66529,"Fatty acids, C16-22, esters with neopentyl glycol",292-935-8,91031-34-4,Not Classified,Notified C&L,6,Not classified:6
66532,"1,1'-(1,3-butadiyne-1,4-diyl)bisbenzene",212-953-1,886-66-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
66535,"trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole maleate",288-064-8,85650-56-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,60,H335:42;H315:42;H400:57;H301:59;H319:42;H410:20;H331:16;H370:17;H372:17;H361:18;H413:1;H330:1;H332:1
66538,"Fatty acids, C16-18, C16-18-alkyl esters",306-797-4,97404-33-6,Not Classified,REACH registration C&L,101,Not classified:101
66539,5-methoxy-1H-indole-3-ethylamine monohydrochloride,200-637-6,66-83-1,Acute Tox. 4,Notified C&L,43,H302:43
66544,Methyl [[(methoxycarbonyl)amino](methylthio)methylene]carbamate,252-240-2,34840-23-8,Acute Tox. 4,Notified C&L,77,H302:40;Not classified:37
66550,"Benzo[1,2-b:4,5-b']difuran-2,6-dione, 3-(4-butoxyphenyl)-7-phenyl-",604-827-3,152165-67-8,Not Classified,Notified C&L,8,Not classified:8
66551,4-tert-butyl-2-ethoxybenzoic acid,616-720-9,796875-53-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
66552,"Starch, carboxymethyl ether, sodium salt",618-597-7,9063-38-1,Not Classified,Notified C&L,63,Not classified:63
66560,1-dodecylpyridinium chloride,203-232-2,104-74-5,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,7,H302:2;H317:3;H312:5;H315:6;H410:3;H400:3;H301:6;H319:6;Not classified:2;H318:1;H314:1
66561,"Fatty acids, essential, Me esters",293-055-7,91051-06-8,Not Classified,Notified C&L,1,Not classified:1
66567,2-ethylhexan-1-ol,203-234-3,104-76-7,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,3812,H319:3776;H315:3420;H332:2775;H335:2770;H412:123;H312:68;Not classified:27;H318:31;H317:11;H336:14;H302:2;H226:1;H413:1;H411:1
66572,"Tetradecanoic acid, octyldodecyl ester",617-493-9,83826-43-1,Not Classified,Notified C&L,1,Not classified:1
66575,"(2E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine",618-706-8,91161-71-6,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,91,H400:91;H410:91
66576,Lanthanum oxide,215-200-5,1312-81-8,Not Classified,REACH registration C&L,622,Not classified:306;H319:317;H315:230;H335:230;H400:83;H410:83
66582,"Benzenamine, dodecyl-, branched",270-129-7,68411-48-3,,Notified C&L,3,Not classified:1;H302:2;H301:1
66584,"Pandanus odoratissimus, ext.",294-832-3,91770-47-7,,Notified C&L,1,Not classified:1
66588,"Acetic acid, sodium salt, trihydrate",612-115-9,6131-90-4,Not Classified,Notified C&L,293,Not classified:289;H319:4;H315:3;H335:2
66591,4-chloro-α-methylbenzylamine,228-576-0,6299-02-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,41,H318:39;H314:41;H302:1
66592,"Cycloocta-1,3-diene",216-929-1,1700-10-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,44,H319:40;H315:44;H304:44;H226:44;H335:4
66600,Bromophenylmercury,214-760-8,1192-89-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H310:38;H300:38;H410:38;H400:38;H330:38;H373:38;Not classified:3
66605,"[1aS-(1aα,4aβ,8aR*)]-1,1a,4,4a,5,6,7,8-octahydro-2,4a,8,8-tetramethylcyclopropa[d]naphthalene",207-426-8,470-40-6,Not Classified,Notified C&L,75,Not classified:37;H304:38;H400:1;H410:1
66608,3-mercaptopropiononitrile,213-682-1,1001-58-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H302:40;H312:40;H335:40;H315:40;H319:40;H332:40;H227:2;H334:2
66611,"β,β'-dihydroxypiperazine-1,4-dipropanesulphonic acid",269-199-1,68189-43-5,Not Classified,Notified C&L,3,Not classified:2;H319:1;H315:1;H335:1
66613,"(1S-cis)-3,7,7-trimethylbicyclo[4.1.0]hept-2-ene",224-792-4,4497-92-1,Flam. Liq. 3,Notified C&L,40,H226:40;H317:1;H315:1;H304:1
66619,"Amines, C10-14-branched and linear alkyl, bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-) (1:1)",284-628-2,84961-40-0,Acute Tox. 4;Aquatic Chronic 4,REACH registration C&L,397,H302:394;H413:120;H411:16;Not classified:3
66627,"Cannabis sativa, ext.",289-644-3,89958-21-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,5,H317:4;H304:4;H315:4;H411:3;H319:4;H226:4;Not classified:1;H410:1;H400:1
66635,Cobalt bis[citrato(3-)]di-μ-oxodioxodimolybdate(2-),297-988-0,93776-58-0,Not Classified,Notified C&L,1,Not classified:1
66639,Methyl (methylsulphinyl)acetate,257-691-9,52147-67-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
66640,Oxazepam,210-076-9,604-75-1,Carc. 2,Notified C&L,43,H351:41;H361:2;H336:2;H362:1
66642,1-Formyl-4-piperidinecarboxylic Acid,617-539-8,84163-42-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;H335:1;Not classified:1
66643,3-phenyl-L-alanine,200-568-1,63-91-2,Not Classified,REACH registration C&L,259,Not classified:202;H319:57;H314:4;H335:5;H315:1
66648,"azimsulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea",601-676-5,120162-55-2,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
66652,Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid,204-422-8,120-74-1,Skin Corr. 1B,Notified C&L,44,H314:43;H319:1;H315:1
66656,"2,3-dihydro-6-(2-hydroxy-2-methyl-1-oxopropyl)-1,1,3-trimethyl-3-[4-(2-hydroxy-2-methyl-1-oxopropyl)phenyl]-1H-indene; 2,3-dihydro-5-(2-hydroxy-2-methyl-1-oxopropyl)-1,1,3-trimethyl-3-[4-(2-hydroxy-2-methyl-1-oxopropyl)phenyl]-1H-indene",605-336-7,163702-01-0,Not Classified,Notified C&L,122,Not classified:88;H361:33;H413:1
66664,Ethyl valerate,208-726-1,539-82-2,Flam. Liq. 3,REACH registration C&L,1653,H226:1653
66667,L-arginine monothiazolidine-4-carboxylate,260-857-3,57631-15-9,Not Classified,Notified C&L,1,Not classified:1
66668,[4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl]4-(diaminomethylideneamino)benzoate; hydrochloride,921-983-0,,Not Classified,REACH registration C&L,2,Not classified:2
66674,Almitrine,248-475-5,27469-53-0,Not Classified,Notified C&L,1,Not classified:1
66684,Carazolol,260-945-1,57775-29-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:38;H315:39;H335:38;H301:1
66686,Salicylohydroxamic acid,201-934-3,89-73-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,133,H312:127;H335:132;H315:133;H351:127;H319:133;H332:127;H341:6
66689,Fluoroacetone,207-064-0,430-51-3,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,40,H300:40;H330:40;H225:40;H310:40
66693,"(3aR,4S,5R,6aS)-(-)-Hexahydro-5-hydroxy-4-(hydroxymethyl)-2H-cyclopenta[b]furan-2-one",608-721-8,32233-40-2,Eye Dam. 1,REACH registration C&L,4,H318:3;H302:1;H332:1;H312:1
66694,Bentone 38,234-406-6,12001-31-9,Not Classified,Notified C&L,46,Not classified:46
66697,"1,3,5-triazine-2,4,6(1H,3H,5H)-trione, zinc salt",246-279-4,24468-28-8,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,3,H400:3;H411:2;H410:1
66704,Xylose,200-400-7,58-86-6,Not Classified,REACH registration C&L,204,Not classified:204
66705,"Alcohols, C12-14, ethoxylated, sulfates, magnesium salts (1 - 2.5 mol EO)",605-198-8,160104-51-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,83,H318:83;H315:83;H412:83
66706,malachite green hydrochloride,209-322-8,569-64-2,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H302:0;H318:0;H410:0;H400:0;H361:0
66707,"Disodium 3-[[4-amino-9,10-dihydro-9,10-dioxo-3-[sulphonato-4-(1,1,3,3-tetramethylbutyl)phenoxy]-1-anthryl]amino]-2,4,6-trimethylbenzenesulphonate",276-516-7,72243-90-4,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2177,H319:2172;H412:2172;Not classified:5
66710,"Oxidase, glycerol phosphate",232-932-0,9046-28-0,Resp. Sens. 1,Notified C&L,5,H334:5
66711,"Alkenes, C>8",270-095-3,68411-00-7,Not Classified,REACH registration C&L,505,Not classified:63;H319:441;H413:442;H304:1;H412:1;H315:1;H336:1;H226:1
66712,Dibenzyl ether,203-118-2,103-50-4,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2185,H400:1430;H317:1406;H410:1429;H319:481;H411:313;H315:39;H335:39;Not classified:3
66713,"(2,2-diethoxyethyl)dimethylamine",222-800-0,3616-56-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,49,H319:48;H315:48;H226:48;H335:46
66716,Hexahydro-2H-azepine-2-thione,230-572-9,7203-96-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H302:1;H332:1;H312:1
66717,Terbium(3+) perchlorate,237-826-8,14014-09-6,,Notified C&L,4,H272:4;H319:4;H315:4;H335:4
66721,p-amino-DL-phenylalanine hydrate,220-869-1,2922-41-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
66722,"Lithium 1-amino-9,10-dihydro-9,10-dioxo-4-[(2,4,6-trimethylphenyl)amino]anthracene-2-sulphonate",277-037-6,72927-96-9,Aquatic Chronic 2,Notified C&L,31,H411:31
66724,"Isooctadecanoic acid, compound with 2-aminoethanol (1:1)",300-114-3,93920-29-7,Not Classified,Notified C&L,13,Not classified:13
66727,"Estra-1,3,5(10),16-tetraene-3,17-diol diacetate",243-899-7,20592-42-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,17,H302:16;H312:16;H351:16;H361:16;H332:16;H360:1;H350:1;H372:1
66729,1-hydroxyisoquinoline,207-732-1,491-30-5,,Notified C&L,7,H319:7;H315:7;H335:7
66731,"Fatty acids, sunflower-oil, sodium salts",270-425-6,68439-98-5,Eye Irrit. 2,Notified C&L,1,H319:1
66735,(1-methyl-3-piperidyl)methanol,231-488-5,7583-53-1,,Notified C&L,6,H319:6;H315:6;H335:6
66736,"N,N-bis(2-hydroxyethyl)octanamide",221-362-8,3077-30-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
66738,"N,N,4-trimethylpiperazine-1-ethylamine",203-183-7,104-19-8,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,350,H312:29;H412:242;H318:141;H314:311;H301:4;H302:346;H311:282;H315:39;H335:38;H317:89;H373:25;H411:8
66740,2-isopropylpyridine,211-426-3,644-98-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1375,H302:1375;H332:1375;H312:1375;H226:89;H335:1;H315:1;H319:1
66742,6-aminonicotinic acid,221-630-4,3167-49-5,,Notified C&L,7,H319:7;H315:7;H335:6
66744,N-(4-chlorophenyl)-2-nitroaniline,245-377-4,23008-56-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
66746,Diisopropyl sulphide,210-911-7,625-80-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:44;H315:44;H225:51;H335:43
66752,Dicerium trisulphide,234-603-7,12014-93-6,Not Classified,REACH registration C&L,149,Not classified:144;H319:5;H315:5;H335:5;H261:5
66753,"(2R,3R,4S,5S,6R,7R,9R,11S,12R,13S,14S)-6-{[(2S,3R,4S,6R) -4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy} -14-ethyl-12,13-dihydroxy-4-{[(2R,4S,5S,6S)-5-hydroxy -4-methoxy-4,6-dimethyloxan-2-yl]oxy}-7 -methoxy-3,5,7,9,11,13-hexamethyl -1-oxacyclotetradecane-2,10-dione",617-200-4,81103-11-9,Acute Tox. 4,Notified C&L,211,H302:210;H373:6;H412:3;H362:1;H361:4;H334:1;H317:1;H341:2;H319:1;H315:1;H335:1;H400:2;H410:2
66757,"Methyl 5-amino-1H-1,2,4-triazole-3-carboxylate",222-869-7,3641-14-3,Skin Sens. 1,Notified C&L,39,H317:39;H302:1;H335:1;H315:1;H319:1
66764,Medroxyprogesterone,208-298-6,520-85-4,Repr. 2,Notified C&L,41,H361:39;H360:2;H351:1
66765,"3-(2,2-dimethyl-3-hydroxypropyl)toluene;(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol",403-140-4,103694-68-4,Aquatic Chronic 3,Harmonised C&L,0,H412:0
66766,3-methyl-2-furoic acid,224-571-2,4412-96-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45;H302:1;H312:1;H332:1
66768,"2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-",610-392-0,479-41-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H335:1
66771,"7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt",606-766-8,214362-06-8,Eye Dam. 1,Notified C&L,1,H318:1
66774,Propane-2-thiol,200-861-4,75-33-2,Flam. Liq. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1477,H400:35;H410:36;H317:29;H225:1453;H319:1437;H302:1300;H331:1286;H315:149;H335:71;Not classified:2
66775,"R-1-chloro-2,3-epoxypropane",424-280-2,51594-55-9,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Carc. 1B,Harmonised C&L,0,H317:0;H314:0;H331:0;H301:0;H311:0;H350:0;H226:0
66776,Sodium hydrogen 2-[1-(2-hydroxy-5-sulphonatophenyl)-3-phenyl-5-formazano]benzoate,263-651-1,62625-22-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H319:43;H315:43;H335:4;Not classified:2
66780,"(2,2-dimethyl-1,3-dioxolan-4-yl)methyl methacrylate",230-408-6,7098-80-8,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,41,H318:38;H315:39;H226:38;H335:39;H319:3;H412:1
66785,2-hydroxyethyl formate,211-038-4,628-35-3,Not Classified,Notified C&L,79,Not classified:52;H319:24;H302:26;H315:22;H318:3;H301:1;H227:1
66786,"5-bromo-6-methylpyridine-2,3-diamine",261-714-8,59352-90-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H302:39;H315:39;H335:38;H319:1
66788,"Sodium bis[2-(3-chlorophenyl)-2,4-dihydro-4-[[2-hydroxy-5-mesylphenyl]azo]-5-methyl-3H-pyrazol-3-onato(2-)]chromate(1-)",257-014-7,51147-75-2,Aquatic Chronic 2,Notified C&L,320,H411:280;H400:23;H317:23;H410:23;Not classified:17
66789,4-(triethoxysilyl)butyronitrile,213-931-4,1067-47-6,,Notified C&L,4,H319:4;H315:4
66791,"2,5-dichloro-4-(3-methyl-5-oxo-2-pyrazolin-1-yl)benzenesulphonic acid",201-541-7,84-57-1,Eye Irrit. 2,Notified C&L,2,H319:2
66792,Propionyl bromide,209-924-0,598-22-1,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,REACH registration C&L,44,H302:3;H314:44;H317:3;H226:44;H318:2
66794,N-benzylidene-o-toluidine,227-546-4,5877-55-4,Acute Tox. 4,Notified C&L,38,H302:38
66796,"Fatty acids, tallow, sodium salts",232-491-4,8052-48-0,Not Classified,Notified C&L,186,Not classified:129;H319:44;H315:44;H335:44;H317:13
66803,3-hydroxy-3-carbethoxy-1-azabicyclo[2.2.2]octane,925-046-7,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H315:2;H335:2
66805,"Soybean oil, polymer with isophthalic acid and pentaerythritol",613-890-6,66071-86-1,Not Classified,Notified C&L,68,Not classified:68
66809,Phthalaldehydic acid,204-342-3,119-67-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H335:46
66813,"1,3,5-trichlorotrinitrobenzene",220-115-1,2631-68-7,Expl. 1.1;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,40,H319:2;H201:2;H315:2;H318:38;H334:38;H302:38;H317:38
66815,"Sorbitan, dihexadecanoate",275-722-4,71617-69-1,Not Classified,Notified C&L,11,Not classified:11
66817,"2-(3-chloropropyl)-2-methyl-1,3-dioxolane",227-776-5,5978-08-5,Not Classified,Notified C&L,1,Not classified:1
66818,1-methyl-1-(4-methylcyclohex-3-enyl)ethyl isobutyrate,231-878-5,7774-65-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1399,H319:1296;H315:1296;Not classified:103;H411:10
66819,Ammonium magnesium orthophosphate,232-075-2,7785-21-9,Not Classified,REACH registration C&L,17,Not classified:12;H319:5;H315:5;H335:5
66820,(dichloromethylene)dimethylammonium chloride,251-695-4,33842-02-3,Skin Corr. 1B;STOT SE 3,Notified C&L,43,H314:43;H335:38;H318:1;H290:1
66821,1-dibutylaminopropan-2-ol,218-297-2,2109-64-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38;H315:38
66823,5-Methoxy-2-tetralone,457-080-9,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1,H302:1;H317:1;H315:1;H411:1
66824,"Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]",270-755-0,68477-73-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
66826,"2-hydroxy-α,α,4-trimethylcyclohexanemethanol",255-953-7,42822-86-6,Flam. Liq. 3;Eye Dam. 1,Notified C&L,1399,H318:1290;H226:1353;H317:56;H412:54;Not classified:36;H319:18;H315:3;H335:2
66828,2-Iodobenzaldehyde,607-898-9,26260-02-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
66833,6-(2-hydroxyphenyl)pyridazin-3(2H)-one,263-598-4,62567-42-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H315:38;H335:38
66835,"Benzene, (trans-4-ethylcyclohexyl)-",600-108-3,100558-60-9,Not Classified,Notified C&L,1,Not classified:1
66836,"5,7-dihydroxy-6-methoxy-2-(4-methoxyphenyl)-4-benzopyrone",208-286-0,520-12-7,,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
66837,"Ditetradecyl 3,3'-thiobispropionate",240-613-2,16545-54-3,Not Classified,Notified C&L,1,Not classified:1
66839,DEMNUM,441-060-1,,Not Classified,Notified C&L,1,Not classified:1
66845,"ethion (ISO);O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);diethion",209-242-3,563-12-2,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H301:0;H410:0;H312:0
66848,"Hydrocarbons, ethylene-manuf.-by-product distn. residues",272-951-1,68921-67-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Muta. 1B;Carc. 1A;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,705,H304:385;H315:385;H411:385;H340:385;H350:385;H372:129;H319:129;H226:193;H302:192;H410:192;H373:320;H361:288;H332:160;H312:160;H225:192;Not classified:16;H336:96
66851,"L-Proline, N-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-",616-271-9,75847-73-3,Skin Sens. 1;Repr. 2,Notified C&L,38,H361:38;H317:38
66853,"Hydrocarbons, C12-18",300-239-3,93924-45-9,Asp. Tox. 1,Notified C&L,89,H304:89
66858,"2,4-dinitrophenetole",210-228-4,610-54-8,Acute Tox. 4,Notified C&L,38,H302:38
66860,"Disodium 4-[[2,4-dihydroxy-3-[(2-hydroxy-4-nitrophenyl)azo]-5-[(4-nitrophenyl)azo]phenyl]azo]-5-hydroxynaphthalene-2,7-disulphonate",300-390-5,93939-98-1,Not Classified,Notified C&L,14,Not classified:14
66864,Urs-12-en-3β-ol,211-352-1,638-95-9,Acute Tox. 4,Notified C&L,1,H302:1
66867,Germanium,231-164-3,7440-56-4,Repr. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,297,H400:14;H361:14;H411:14;H373:14;Not classified:238;H228:41;H302:3;H312:3;H335:3;H315:5;H319:5;H332:3
66870,"(2,4-dichlorophenyl)oxirane",237-207-2,13692-15-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3;Muta. 2,Notified C&L,1,H302:1;H317:1;H312:1;H335:1;H341:1;H315:1;H332:1;H319:1;H226:1
66872,"Benzenamine, 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, N-Me derivatives, tungstatephosphates",269-771-0,68332-68-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,3,H318:2;H315:2;H335:2;Not classified:1;H412:1
66874,Ethyl cis-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate hydrochloride,243-775-2,20380-60-3,Not Classified,Notified C&L,1,Not classified:1
66875,propan-2-amine; 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one,925-146-0,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H335:2;H410:2;H315:2;H400:2;H319:2
66877,"Thiophene-2,5-dicarboxylic acid",224-284-2,4282-31-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
66879,"α,α-dicyclopropylbenzyl alcohol",227-156-4,5689-19-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
66880,5-ethylpyridine-2-ethanol,226-024-3,5223-06-3,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,20,H318:7;H312:19;H335:13;H319:13;H311:1;H315:2
66885,"2-Butenedioic acid (Z)-, mono-C16-18-alkyl esters",273-500-1,68987-59-7,Not Classified,Notified C&L,24,Not classified:23;H317:1
66886,Isobutyl oleate,233-022-6,10024-47-2,Not Classified,Notified C&L,234,Not classified:211;H319:23;H315:22;H335:22
66890,"Diisopropylnaphthalenesulphonic acid, compound with cyclohexylamine (1:1)",270-361-9,68425-61-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:40;H315:40
66892,Trichloromethanesulphonyl chloride,219-830-1,2547-61-7,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:39;H314:39;H335:38;H290:1
66896,"Fatty acids, C16-18 and C18-unsatd., Me esters, sulfurized",269-913-1,68390-93-2,Not Classified,Notified C&L,74,Not classified:62;H411:12
66897,"Gas oils (petroleum), hydrodesulfurized;Gasoil - unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",265-182-8,64742-79-6,Carc. 1B,Harmonised C&L,0,H350:0
66904,Hexamethylbenzene,201-777-0,87-85-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:3;H312:3
66905,N-dodecylacrylamide,216-136-0,1506-53-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
66907,2-chloropropene,209-187-5,557-98-2,Flam. Liq. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,102,H302:55;H312:55;H335:97;H315:56;H224:102;H319:99;H332:55;H301:3;H341:1;H351:1
66910,"Alcohols, C10-18, ethoxylated",500-267-8,85422-93-1,Eye Dam. 1,Notified C&L,189,H318:104;H302:96;H315:96;Not classified:2
66911,"1,1-dimethoxyhexane",216-488-5,1599-47-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H226:43;H335:43
66915,p-methoxyphenyl isothiocyanate,218-921-3,2284-20-0,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Notified C&L,46,H334:40;H314:46;H317:39;H302:5;H332:5;H312:4;H318:1
66921,Butyldimethylchlorosilane,600-021-0,1000-50-6,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,45,H314:45;H225:40;H226:5;H335:1
66929,2-[[(4-chlorophenyl)methyl]thio]ethanol,275-568-8,71501-40-1,Acute Tox. 4,Notified C&L,42,H302:38;H319:4;H315:4
66937,Pentadecylbenzene,218-352-0,2131-18-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
66942,Mucobromic acid,207-670-5,488-11-9,Skin Corr. 1B,Notified C&L,45,H314:45;H318:2
66944,(Z)-pent-3-en-1-ol,212-119-7,764-38-5,Acute Tox. 4;STOT SE 3,Notified C&L,1288,H332:1286;H335:1286;H226:1;H225:1
66947,4-[2-(dimethylamino)ethyl]phenol hydrochloride,227-892-6,6027-23-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
66948,"Dipotassium 3,3'-sulphonylbis(benzenesulphonate)",264-096-8,63316-33-6,Not Classified,Notified C&L,1,Not classified:1
66950,Ethyldimethyl[2-[(2-methyl-1-oxoallyl)oxy]ethyl]ammonium ethyl sulphate,236-195-6,13223-03-5,Not Classified,REACH registration C&L,87,Not classified:2;H317:85
66952,"Octadecanoic acid, C16-20-branched alkyl esters",286-283-3,85203-92-5,Not Classified,REACH registration C&L,6,Not classified:6
66955,"Amines, coco alkyl, hydrochlorides",294-723-0,91745-52-7,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;STOT RE 2;STOT RE 2;Aquatic Acute 1,Notified C&L,22,H302:21;H318:21;H314:21;H400:21;H373:21;Not classified:1
66956,"1,2-epoxy-3-(propenyloxy)propane",216-530-2,1607-23-4,Not Classified,Notified C&L,5,Not classified:5
66958,"Hexanedioic acid, polymer with 2,2-dimethyl-1,3-propanediol and 1,6-hexanediol",607-651-5,25214-14-6,Not Classified,Notified C&L,5,Not classified:5
66960,"2,6-dichloro-N-phenylaniline",239-349-0,15307-93-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,45,H400:42;H319:44;H410:42;H315:44;H335:1;H302:1
66967,Oxyphenonium bromide,200-010-7,50-10-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
66968,2-propynal,210-857-4,624-67-9,Flam. Liq. 3,Notified C&L,7,H226:6;H317:1;H335:1;H318:1;H315:1;H225:1
66969,Disilver thiosulphate,245-458-4,23149-52-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
66971,"2,5-dichloropyridine",240-278-2,16110-09-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45;H302:6;H311:4
66972,"N-ethyl-N',N'-dimethyl-N-phenylethylenediamine",248-611-3,27692-91-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,11,H319:2;H302:11;H315:11;H335:2
66975,p-methoxyphenethylamine,200-245-5,55-81-2,Skin Corr. 1B,REACH registration C&L,44,H314:44;H301:1;H332:1;H318:1
66978,Dibutyldichlorogermane,224-986-9,4593-81-1,,Notified C&L,5,H301:5;H314:5
66980,Calcium molybdenum zinc oxide,611-883-2,59786-91-3,Not Classified,Notified C&L,9,Not classified:9
66983,Methaqualone hydrochloride,206-431-2,340-56-7,Acute Tox. 3,Notified C&L,39,H301:39
66985,Pyrrolidin-1-amine monohydrochloride,264-040-2,63234-71-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
66988,"Amides, C8-12, N-(hydroxyethyl)",292-495-7,90622-90-5,Not Classified,Notified C&L,71,Not classified:71
66992,Chlorodimethoxymethylsilane,213-613-5,994-07-0,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,22,H314:22;H225:22
66995,"4,4'-methylenebis(cyclohexylamine)",217-168-8,1761-71-3,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 1;Aquatic Chronic 3,Notified C&L,1302,H302:1251;H317:1180;H412:501;H314:1272;H330:503;H335:260;H411:617;H373:402;H318:198;Not classified:29;H301:16;H410:14;H361:7;H332:1;H319:1;H315:1;H371:2;H312:1
66996,Methoxydiphenylphosphine,223-683-9,4020-99-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:39
66997,copper dihydroxide;copper(II) hydroxide,243-815-9,20427-59-2,Acute Tox. 4;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H318:0;H410:0;H400:0;H330:0
67001,"cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole maleate",288-063-2,85650-55-1,Acute Tox. 3;Acute Tox. 2;Repr. 2;Aquatic Chronic 1,Notified C&L,1,H301:1;H361:1;H410:1;H330:1
67003,Calcium bis(4-O-(β-D-galactosyl)-D-gluconate),225-668-2,5001-51-4,Not Classified,Notified C&L,1,Not classified:1
67007,"cycloheximide (ISO);4-{}{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}}piperidine-2,6-dione",200-636-0,66-81-9,Acute Tox. 2;Muta. 2;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0,H300:0;H341:0;H360:0;H411:0
67010,"3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate",261-665-2,59219-71-5,Not Classified,REACH registration C&L,143,Not classified:143
67011,3-chloromethyl-1-methylpiperidinium chloride,266-381-2,66496-82-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
67012,"2',5'-dimethoxycinnamic acid",234-114-9,10538-51-9,,Notified C&L,5,H319:5;H315:5;H335:4
67015,"2,3-dimethyl-5-nitro-1H-indole",244-321-6,21296-94-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H302:38;H315:38;H335:38
67016,"N,N,N'-tris(2-aminoethyl)ethylenediamine",250-554-4,31295-46-2,,Notified C&L,33,Not classified:33
67020,"Gases (petroleum), gas oil hydrodesulfurization purge;Refinery gas;[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",295-399-3,92045-17-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
67021,Perlite,603-442-8,130885-09-5,Not Classified,Notified C&L,1,Not classified:1
67023,"6-chloro-5-(chloroacetyl)-1,3-dihydro-2H-indol-2-one",601-518-5,118307-04-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3
67024,"2,3-epoxybutane",221-877-8,3266-23-7,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2;Carc. 2,REACH registration C&L,134,H312:86;H335:122;H341:1;H315:133;H225:134;H351:84;H319:133;H302:2;H332:2
67027,"Phenol, 2,5-difluoro-",608-045-3,2713-31-7,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H302:47;H312:47;H335:42;H228:47;H315:43;H319:43;H332:43;H314:4
67030,Sulfabenzamide,204-859-4,127-71-9,Eye Irrit. 2,Notified C&L,4,H319:3;H335:3;Not classified:1
67037,"2-Propenoic acid, 2-methyl-, C9-18-alkyl esters, polymers with Me methacrylate",600-491-7,103818-89-9,Not Classified,Notified C&L,6,Not classified:6
67040,"Imidazolium compounds, 1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-dihydro-2-norcoco alkyl, hydroxides, sodium salts",272-043-5,68650-39-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,682,H319:534;H315:486;H318:98;Not classified:50
67042,"N,N-dimethyloleyl N-oxide",238-311-0,14351-50-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,442,H318:442;H400:442;H302:442;H315:442
67043,Disodium 4-(octadecylamino)-4-oxo-2-sulphonatobutyrate,238-479-5,14481-60-8,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,507,H319:490;H411:446;H318:17;H315:15;H360:1
67045,"9,10-secoergosta-5(Z),7(E),10(19)-trien-3β-ol",208-127-5,511-28-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2;STOT RE 1,Notified C&L,38,H372:38;H301:38;H311:38;H330:38
67049,"Fatty acids, C16-18, esters with propylene glycol",292-936-3,91031-35-5,Not Classified,Notified C&L,69,Not classified:69
67052,"19-norpregn-5(10)-en-20-yn-17-OL,3,3-dimethoxy-7-methyl-,(7alpha,17alpha)-",600-638-5,105186-33-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,2,H302:2;H332:2;H312:2;H361:2;H351:1
67058,3-bromo-p-anisaldehyde,252-241-8,34841-06-0,,Notified C&L,5,H319:4;H315:4;H335:4;H302:1;H332:1;H312:1
67063,1H-imidazole-1-propylamine,225-730-9,5036-48-6,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Repr. 1B,REACH registration C&L,232,H318:133;H302:192;H314:232;H360:40;H412:57
67065,"3,5,5-trimethylhexanoyl chloride",253-168-4,36727-29-4,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Acute Tox. 1;Aquatic Chronic 3,REACH registration C&L,128,H302:126;H317:42;H290:126;H412:125;H314:127;H330:126;H318:84;H332:2;H301:1
67067,3-Amino-1-butanol,619-543-5,2867-59-6,Skin Corr. 1B,Notified C&L,40,H314:39;H319:1;H315:1;H226:1
67068,"4''-(trans-4-Butylcyclohexyl)-2'-fluor-4-propyl-1,1':4',1''- terphenyl",618-757-6,915021-67-9,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
67070,"1-Heptanol, 2-propyl- , 7EO",605-233-7,160875-66-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,650,H318:511;H302:351;Not classified:108;H315:72;H319:31;H202:3;H412:1
67071,2-ethylhexylamine,203-233-8,104-75-6,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,2959,H302:2958;H318:757;H314:2959;H330:2718;H226:2894;H312:2151;H412:517;H311:690;H331:156;H335:20;H411:20;H301:1
67073,6-Hydroxy-1-indanone,613-084-4,62803-47-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,42,H319:42;H302:41;H317:40;H315:42;H335:1;H332:1
67076,Violet HO-1063-0115R (notification presscake),459-570-8,,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,37,H317:37;H413:37
67081,"pendimethalin (ISO);N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine",254-938-2,40487-42-1,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0
67082,"2,4-dibromo-1-{[(2-methoxypropan-2-yl)oxy]methyl}benzene",929-928-2,1201913-61-2,,,0,No data
67083,Stigmast-5-en-3-β-ol,201-480-6,83-46-5,Not Classified,Notified C&L,99,Not classified:98;H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
67084,morfamquat dichloride,225-062-8,4636-83-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0;H335:0;H315:0;H319:0
67085,"Naphtho[1,2-d]thiazolium, 2-[3-[5,6-dichloro-1-ethyl-1,3-dihydro-3-(3-sulfobutyl)-2H-benzimidazol-2-ylidene]-1-propenyl]-1-(3-sulfopropyl)-, hydroxide, inner salt, compd. with N,N-diethylethanamine (1:1)",263-944-4,63148-94-7,Not Classified,Notified C&L,1,Not classified:1
67086,"Fatty acids, fish-oil",293-056-2,91051-07-9,Not Classified,Notified C&L,1,Not classified:1
67090,"2-[[(4-methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium hydrogen sulphate",281-422-4,83949-62-6,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,7,H318:7;H302:5;H411:5;H301:2;H410:2;H400:2
67091,Betamethasone,206-825-4,378-44-9,Repr. 1B;STOT RE 2,REACH registration C&L,85,H360:83;H373:48;H372:35;H330:35;H410:35;H361:1;H302:1;H332:1;H312:1
67097,Dimethyl 5-aminoisophthalate,202-743-8,99-27-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,76,H319:43;H315:43;H335:42;Not classified:33
67100,"flupyrsulfuron-methyl-sodium (ISO);methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt",604-441-5,144740-54-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
67102,Barium nitrate,233-020-5,10022-31-8,Ox. Sol. 2;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,367,H272:224;H301:50;H319:99;H332:362;H302:312;Not classified:6;H312:1
67104,Dicopper pyrophosphate,239-250-2,15191-80-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,5,H318:2;H315:2;H335:2;H302:1;H332:2;H312:1;Not classified:1;H400:1;H319:1;H411:1
67105,5-nitrosalicylic acid,202-548-8,96-97-9,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,63,H319:55;H315:55;H335:45;Not classified:7;H302:1
67107,"2-(1,3-dioxan-2-yl)ethyltriphenylphosphonium bromide",274-189-5,69891-92-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
67109,"Fatty acids, C6-12, triesters with trimethylolpropane",273-299-0,68956-08-1,Not Classified,Notified C&L,42,Not classified:42
67114,"Hexasodium 2,2'-[p-phenylenebis[vinylene(3-sulphonato-p-phenylene)]]bis[naphtho[1,2-d]triazole-6,8-disulphonate]",275-146-3,71033-16-4,Not Classified,Notified C&L,4,Not classified:4
67116,"Amides, tallow, N,N'-[[(2-hydroxyethyl)imino]di-2,1-ethanediyl]bis-, ethoxylated",614-487-8,68439-67-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,31,H318:31;H400:31;H410:31;H315:31
67119,Diphenyl sulphone,204-853-1,127-63-9,Acute Tox. 4,REACH registration C&L,163,H302:129;H315:113;H319:42;H335:41;Not classified:33;H332:1
67126,3-chloroperbenzoic acid,213-322-3,937-14-4,Ox. Sol. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,55,H271:7;H317:8;H335:11;H315:12;H319:12;H302:6;H318:38;H314:42;H410:1;H242:11;H400:1;H226:36;H312:1;H332:1;H240:3;Not classified:1
67132,2-[[(2-amino-5-chlorophenyl)phenylmethylene]amino]ethanol,218-296-7,2109-45-7,Not Classified,REACH registration C&L,2,Not classified:2
67134,Menthol,201-939-0,89-78-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2042,H319:1703;H315:1988;H318:48;H335:48;Not classified:7;H302:3
67135,3-(trifluoromethyl)benzylamine,220-367-2,2740-83-2,Acute Tox. 4;Skin Corr. 1B,Notified C&L,49,H302:39;H314:49;H319:1;H335:1;H318:1
67136,Isopropyl 2-[(aminomethoxyphosphinothioyl)oxy]benzoate,246-192-1,24353-61-5,Acute Tox. 2;Acute Tox. 3,Notified C&L,38,H300:38;H311:38
67137,"5-amino-1H-1,2,4-triazole-3-carboxylic acid",222-868-1,3641-13-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,7,H319:7;H315:7;H335:6
67138,"Petrolatum (petroleum), alumina-treated;[A complex combination of hydrocarbons obtained when petrolatum is treated with Al",285-098-5,85029-74-9,Carc. 1B,Harmonised C&L,0,H350:0
67139,4-chloro-3-nitrobenzyl alcohol,245-374-8,22996-18-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67140,Sodium ethylenesulphonate,221-242-5,3039-83-6,Not Classified,REACH registration C&L,46,Not classified:23;H412:14;H319:9;H315:9
67141,"Tetrahydrogen [μ-[[4,4'-[(3,3'-dihydroxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-hydroxynaphthalene-2,7-disulphonato]](8-)]]dicuprate(4-), compound with 2,2',2''-nitrilotriethanol (1:4)",279-807-7,81737-17-9,Not Classified,Notified C&L,1,Not classified:1
67142,5-[2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide,926-076-3,,Acute Tox. 4,REACH registration C&L,2,H302:2
67147,"5,7,12,14-tetrahydro-7,14-dioxo-quino[2,3-b]acridine-2,9-disulfonyl dichloride",610-420-1,483965-67-9,Skin Corr. 1B,REACH registration C&L,35,H314:34;Not classified:1
67148,CYCLOMER-P (ACA)250,448-280-7,,Not Classified,Notified C&L,1,Not classified:1
67152,(E)-non-2-en-1-ol,250-662-1,31502-14-4,Not Classified,Notified C&L,89,Not classified:89
67153,3-hydroxyiminoindolin-2-one,210-132-2,607-28-3,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,121,H302:83;H411:83;H319:38;H317:38
67154,"ethyl [(1-chloro-10-oxo-10H-dibenzo[b,e]thiopyran-4-yl)oxy]acetate",600-066-6,1003315-69-2,Not Classified,Notified C&L,1,Not classified:1
67155,"2-Oxepanone, polymer with 1,6-hexanediol",609-271-5,36609-29-7,Not Classified,REACH registration C&L,1,Not classified:1
67157,Dichloro(phenyl)phosphine,211-425-8,644-97-3,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,149,H302:86;H314:147;H290:86;H318:84;H301:46;H335:55;Not classified:4
67165,4-methylthiazole-2(3H)-thione,227-152-2,5685-06-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
67167,Potassium nonafluorobis(trifluoromethyl)cyclohexanesulphonate,268-998-2,68156-01-4,Not Classified,Notified C&L,5,Not classified:5
67171,"α,α-dimethylphenethyl propionate",267-072-5,67785-77-7,Not Classified,Notified C&L,88,Not classified:88
67173,Ethyl p-anisoylacetate,220-733-1,2881-83-6,Not Classified,Notified C&L,13,Not classified:12;H319:1;H315:1;H335:1
67175,"Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, acetate (1:1)",611-510-3,57359-12-3,Not Classified,Notified C&L,83,Not classified:83
67176,Undec-10-ynoic acid,220-471-8,2777-65-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
67180,Tris(diethylamino)phosphine,218-920-8,2283-11-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H226:44;H335:43
67181,2-tert-pentylcyclohexyl acetate,267-500-0,67874-72-0,Aquatic Chronic 2,REACH registration C&L,1650,H411:1612;Not classified:38;H319:36;H315:1
67182,[2-[(chloroformyl)oxy]ethyl]triphenylphosphonium chloride,262-582-4,61083-59-8,Skin Corr. 1B;STOT SE 3,Notified C&L,38,H314:38;H335:38
67183,"Disodium 1,3,4-thiadiazole-2,5-dithiolate",259-886-4,55906-42-8,Aquatic Chronic 3,REACH registration C&L,38,H412:2;Not classified:36
67186,"Glycerides, montan-wax",270-679-8,68476-38-0,Not Classified,Notified C&L,165,Not classified:165
67187,"N,N-diethyl-1,1-dimethylsilylamine",237-202-5,13686-66-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H225:42;H335:42
67188,Isopropyl 3-amino-4-methylbenzoate,244-393-9,21447-47-2,Eye Irrit. 2,Notified C&L,1,H319:1
67190,"5-(benzoylamino)-4-hydroxy-3-[[1-sulpho-6-[[2-(sulphooxy)ethyl]sulphonyl]-2-naphthyl]azo]naphthalene-2,7-disulphonic acid, sodium salt",287-842-4,85586-40-9,Not Classified,REACH registration C&L,87,Not classified:86;H318:1;H317:1;H412:1
67191,"2,2',6,6'-tetra-tert-butyl-4,4'-methylenediphenol",204-279-1,118-82-1,Not Classified,REACH registration C&L,724,Not classified:524;H411:71;H413:65;H319:61;H315:61;H335:60;H312:4
67192,4-heptylphenol,217-862-0,1987-50-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,451,H302:446;H410:446;H315:446;H400:446;H319:446;H314:5;H318:1
67194,"bentazone (ISO);3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide",246-585-8,25057-89-0,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H319:0;H302:0;H317:0;H412:0
67196,Bromotriphenylethylene,216-531-8,1607-57-4,,Notified C&L,5,H361:5
67200,"3-[1,1'-biphenyl]-4-yl-3,4-dihydronaphthalen-1(2H)-one",260-033-3,56181-65-8,Acute Tox. 4,Notified C&L,1,H302:1
67201,"3,4',5,7-tetrahydroxyflavone",208-287-6,520-18-3,Acute Tox. 3;Muta. 2,Notified C&L,46,H301:40;H341:41;H302:2;H319:3;H315:3;H335:3;Not classified:1
67206,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [[3-(dimethylamino)propyl]amino]sulfonyl derivs.",270-096-9,68411-04-1,Aquatic Chronic 3,REACH registration C&L,93,H412:85;Not classified:8
67207,Tetradecyl methacrylate,219-835-9,2549-53-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,700,H319:690;H317:495;H315:690;H335:196;Not classified:10
67209,Dodecylethyldimethylammonium hydroxide,242-862-2,19184-59-9,Skin Corr. 1B,Notified C&L,38,H314:38
67211,Bis(2-methyl-2-propanyl)phosphinous chloride,604-003-3,13716-10-4,Skin Corr. 1B,Notified C&L,47,H314:47;H318:4;H290:1;H227:1
67215,Oct-7-en-1-ol,236-122-8,13175-44-5,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,34,H318:34;H314:34
67216,4-(dimethylamino)salicylic acid,245-398-9,23050-91-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67217,"[1,1'-bicyclopentyl]-2-one",225-495-2,4884-24-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,90,H319:90;H315:90;H335:90
67219,"Imidodicarbonic acid, C,C'-bis(1,1-dimethylethyl) ester",921-192-0,51779-32-9,,Notified C&L,4,H319:4;H315:4;H335:4
67220,4-[(2-chloro-6-methylphenyl)azo]-3-hydroxy-2-naphthoic acid,276-286-8,72011-13-3,Not Classified,Notified C&L,33,Not classified:33
67221,Cadmium molybdenum tetroxide,237-752-6,13972-68-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H302:42;H312:42;H410:42;H400:42;H332:42
67224,"Passionflower, Passiflora edulis, ext.",294-833-9,91770-48-8,Flam. Liq. 3,Notified C&L,95,H226:80;Not classified:15
67226,o-tolyl isocyanate,210-389-0,614-68-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,104,H302:79;H312:40;H335:104;H315:45;H334:104;H319:45;H332:40;H318:58;H314:59;H330:63;H331:1
67229,perfluorooctanoic acid,206-397-9,335-67-1,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;Carc. 2;Lact.;STOT RE 1;Repr. 1B,Harmonised C&L,0,H302:0;H318:0;H360:0;H362:0;H351:0;H372:0;H332:0
67230,Copper bromide,232-131-6,7787-70-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,186,H302:94;H318:87;H410:91;H315:152;H400:91;H319:98;H335:98;H372:1
67234,sec-butyllithium,209-927-7,598-30-1,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,73,H250:73;H260:73;H314:73;H304:4;H410:4;H224:4;H400:4;H336:4;H252:4
67236,(2-methoxy-5-nitrobenzyl)dimethylsulphonium bromide,264-876-8,64415-08-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67237,"7-methoxy-3,7-dimethyloctan-1-ol",253-908-6,38376-28-2,Not Classified,Notified C&L,5,Not classified:5
67246,"(E)-3,7-dimethyl-2,6-octadienyl 2-methylcrotonate",232-078-9,7785-33-3,Not Classified,Notified C&L,295,Not classified:294;H411:1
67254,Biphenyl-4-ol,202-179-2,92-69-3,Skin Corr. 1B;Aquatic Chronic 2,REACH registration C&L,118,H315:116;H411:113;H319:15;H335:13
67257,"1,3,5-Triazine, 2,4,6-tris(2,4,6-tribromophenoxy)-",607-784-9,25713-60-4,Not Classified,Notified C&L,31,Not classified:31
67259,flonicamid (ISO);N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide,605-127-0,158062-67-0,Acute Tox. 4,Harmonised C&L,0,H302:0
67260,"1-benzoxepin-3,5(2H,4H)-dione",263-595-8,62557-53-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
67265,"Distillates (petroleum), heat-soaked steam-cracked naphtha, C",295-302-4,91995-41-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
67267,"1,2-dichloro-3-(chloromethyl)benzene",221-947-8,3290-01-5,Skin Corr. 1B,Notified C&L,40,H314:40;H318:1;H335:1
67269,"N,N-bis[3-(dimethylamino)propyl]-N',N'-dimethylpropane-1,3-diamine",251-459-0,33329-35-0,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,99,H318:71;H314:95;H312:95;H412:4;H302:22;H332:24;Not classified:4
67275,"4-(α,α,α-trifluoro-m-tolyl)piperidin-4-ol",218-840-3,2249-28-7,,Notified C&L,4,H319:4;H315:4;H335:4
67277,"2,2'-[(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[4-nonylphenol]",268-048-7,67990-27-6,Not Classified,REACH registration C&L,22,Not classified:22
67280,"1,3-Dioxan-2-one",423-980-5,,Not Classified,REACH registration C&L,1,Not classified:1
67284,12-oxahexadecan-16-olide,229-755-6,6707-60-4,Aquatic Chronic 3,REACH registration C&L,1558,H412:14;Not classified:1544
67287,Ammonium 2-(sulphonatooxy)ethyl methacrylate,258-668-6,53621-34-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
67288,"Fatty acids, vegetable-oil, iso-Bu esters",305-970-1,95371-03-2,Not Classified,Notified C&L,1,Not classified:1
67289,5-bromoindole-3-carbaldehyde,212-884-7,877-03-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
67290,magnesium phosphide;trimagnesium diphosphide,235-023-7,12057-74-8,Water-react. 1;Acute Tox. 2;Acute Tox. 3;Acute Tox. 1;Aquatic Acute 1,Harmonised C&L,0,H260:0;H300:0;H400:0;H311:0;H330:0
67294,"Residues (petroleum), atmospheric;Heavy Fuel oil;[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C",269-777-3,68333-22-2,Carc. 1B,Harmonised C&L,0,H350:0
67298,"5-chloro-2,3-difluoropyridine",410-090-7,89402-43-7,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H226:0;H412:0
67300,"2,3,4,5-Tetrafluorobenzoic Acid",601-673-9,1201-31-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46
67302,"Amines, N-tallow alkyltrimethylenedi-, hydrochlorides",294-729-3,91745-58-3,Acute Tox. 4;Skin Corr. 1A,Notified C&L,5,H302:5;H314:5
67304,Ethyl p-toluate,202-301-4,94-08-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
67305,Mitobronitol,207-676-8,488-41-5,Acute Tox. 4;Carc. 1B,Notified C&L,38,H302:38;H350:38
67308,Metaboric acid,236-659-8,13460-50-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67310,"1,3-diethyl-2-fluorobenzene",283-349-3,84604-67-1,Acute Tox. 4,Notified C&L,38,H302:38
67316,Ruthenium tribromide,237-829-4,14014-88-1,,Notified C&L,4,H314:4
67320,1-pentynylbenzene,224-211-4,4250-81-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:38
67325,"2,3-Dimethyl-4-nitropyridine N-Oxide",609-469-1,37699-43-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45;H302:4;H341:5;H351:1
67326,Propyl lactate,210-464-8,616-09-1,Not Classified,Notified C&L,60,Not classified:55;H318:4;H226:1
67327,"1,2,3,6-tetrahydro-1-methyl-4-phenylpyridine",248-939-7,28289-54-5,Acute Tox. 3;STOT SE 1,Notified C&L,39,H370:38;H301:39;H331:1;H371:1;H351:1;H311:1;H361:1
67330,Hydrochlorothiazide,200-403-3,58-93-5,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,177,H334:67;H302:124;H317:66;H372:38;H361:14;H362:6;H351:16;H341:8;Not classified:3;H335:2;H315:3;H319:7;H373:8;H360:4;H340:4;H336:1;H332:2
67331,"Phosphoric acid, sodium salt",231-558-5,7632-05-5,Not Classified,Notified C&L,172,Not classified:153;H315:19
67335,Isobutyl butyrate,208-729-8,539-90-2,Flam. Liq. 3,Notified C&L,1506,H226:1506;H412:38
67336,Sodium trinitrobenzenesulphonate,226-441-0,5400-70-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,39,H334:38;H317:38;H201:1;H332:1;H302:1;H312:1
67337,"Ethanol, 2-amino-, reaction products with ammonia, by-products from",272-729-4,68910-05-4,Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 3;Resp. Sens. 1;STOT SE 3;Repr. 1B;Lact.;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,141,H317:86;H335:86;H318:86;H360:86;H314:86;H410:86;H331:86;H400:86;H362:85;H334:86;Not classified:55
67340,"Ammonia, propoxylated",500-261-5,75790-79-3,Eye Dam. 1,Notified C&L,65,H318:55;H319:10;H302:9
67341,Methyl 4(or 1)-isopropyl-1(or 4)-methylbicyclo[2.2.2]oct-5-ene-2-carboxylate,273-453-7,68966-86-9,Aquatic Chronic 2,REACH registration C&L,1425,H411:1313;H319:1300;Not classified:111;H315:1
67342,N-benzyloxycarbonyl-L-alanine,214-532-8,1142-20-7,Not Classified,Notified C&L,5,Not classified:2;H319:3;H315:3;H335:3;H302:1;H332:1
67343,Strontium 4-[(4-chloro-5-methyl-2-sulphonatophenyl)azo]-3-hydroxy-2-naphthoate (1:1),267-291-6,67828-72-2,Not Classified,REACH registration C&L,115,Not classified:115
67344,"Sodium 1-amino-4-bromo-9,10-dioxoanthracene-2-sulphonate",228-391-5,6258-06-6,Not Classified,Notified C&L,166,Not classified:125;H319:40;H315:39;H335:39;H317:1
67346,N-(3-chloro-o-tolyl)-3-oxobutyramide,243-539-9,20139-54-2,Acute Tox. 4,Notified C&L,38,H302:38
67347,"1,1-bis(octyloxy)octane",271-288-5,68527-82-2,Not Classified,Notified C&L,89,Not classified:89
67349,methyl 3-sulphamoyl-2-thenoate,402-050-2,,Skin Sens. 1,Harmonised C&L,0,H317:0
67350,"N-(4-amino-9,10-dihydro-3-methoxy-9,10-dioxo-1-anthryl)-4-methylbenzenesulphonamide",201-369-2,81-68-5,STOT RE 2;Aquatic Chronic 2,REACH registration C&L,48,H411:38;H373:7;Not classified:9;H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
67354,Aminopropyl(methylsiloxane)-dimethylsiloxane copolymer,619-426-9,99363-37-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,41,H319:39;H302:22;H315:40;Not classified:1
67355,N-[4-[[2-[4-[(butylsulphonyl)amino]phenoxy]-1-oxotetradecyl]amino]-5-chloro-2-hydroxyphenyl]benzamide,264-324-6,63573-38-6,Not Classified,Notified C&L,1,Not classified:1
67356,"2,6-diamino-5-(β-D-glucopyranosyloxy)-(1H)-pyrimidin-4-one",205-809-4,152-93-2,Acute Tox. 4,Notified C&L,1,H302:1
67358,L-octan-2-ol,227-777-0,5978-70-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:39;H335:40;Not classified:1;H411:1
67359,"5-ethylidene-8,9,10-trinorborn-2-ene",240-347-7,16219-75-3,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,848,H317:38;H304:78;H315:352;H411:262;H226:357;H332:713;H373:64;H335:210;H319:276;H360:45;H302:23;H331:10;H370:1;H361:1
67364,Methyldiphenylphosphine,216-065-5,1486-28-8,,Notified C&L,6,H319:6;H302:5;H315:6;H335:1
67366,N-phenyl-o-phenylenediamine,208-606-9,534-85-0,Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,79,H302:77;H315:79;H332:73;H319:8;H335:6;H312:2;Not classified:1
67368,2-(1-naphthyl)acetamide,201-704-2,86-86-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,57,H318:44;H302:56;H412:4;H361:2;H312:1
67369,"α,α,α-trifluoro-2-toluonitrile",207-184-3,447-60-9,Acute Tox. 4,Notified C&L,46,H302:44;H312:6;H315:7;H319:7;H332:6;H331:1;H301:2;H311:2;H335:2;H330:1;H412:1
67371,"O,O-tert-butyl isopropyl monoperoxycarbonate",219-143-7,2372-21-6,Org. Perox. C;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,44,H317:6;H304:2;H315:6;H410:6;H242:6;H400:6;H318:38;H241:38;H226:38
67372,"7-acetamido-4-hydroxy-3-[[6-sulpho-8-[[2-(sulphooxy)ethyl]sulphonyl]-2-naphthyl]azo]naphthalene-2-sulphonic acid, sodium salt",288-979-2,85958-91-4,Not Classified,Notified C&L,1,Not classified:1
67373,"7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl acetate",606-198-0,19011-80-4,Repr. 2;Lact.,REACH registration C&L,1,H361:1;H362:1
67374,"Gas oils (petroleum), hydrodesulfurized heavy vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-189-6,64742-86-5,Carc. 1B,Harmonised C&L,0,H350:0
67375,"3-phenyl-1'-(phenylmethyl)[3,4'-bipiperidine]-2,6-dione monohydrochloride",227-072-8,5633-14-7,Acute Tox. 4,Notified C&L,38,H302:38
67378,Disodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)][1-[[2-hydroxy-4(or5)-nitrophenyl]azo]-2-naphtholato(2-)]chromate(2-),288-978-7,85958-90-3,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,35,H319:23;H411:23;Not classified:11;H315:6;H335:1
67379,"Phenol, 2,4,6-tris[(dimethylamino)methyl]-, polymer with [(2-methylphenoxy)methyl]oxirane",614-448-5,68403-88-3,Not Classified,Notified C&L,9,Not classified:9
67380,"(1R,2S,10R,11S,15S)-2,15-dimethyl-4-(morpholin-4-yl)-13-(pyrrolidin-1-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,14-diol",601-595-5,119302-20-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:1;H332:1;H312:1;H400:1;H301:1;H317:1;H410:1
67384,"Tricyclo[3.3.1.13,7]dec-1-ylmethylamine",241-752-1,17768-41-1,Skin Corr. 1B,Notified C&L,40,H314:39;H319:1;H315:1
67388,Isononyl alcohol,248-471-3,27458-94-2,Eye Dam. 1,Notified C&L,527,H318:289;H315:431;H412:154;H319:142;H411:33;Not classified:1;H401:1;H303:1
67390,Lithium metaphosphate,237-361-0,13762-75-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H315:38;H335:38
67398,"1,2-dihydroxybenzene; pyrocatechol",204-427-5,120-80-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;Carc. 1B,Harmonised C&L,0,H341:0;H315:0;H301:0;H350:0;H311:0;H319:0
67399,"3,4-bis(benzyloxy)phenethylamine hydrochloride",216-924-4,1699-56-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H302:38;H335:38;H318:38;H315:38;H410:38;H400:38
67400,"4-(1H-1,2,4-triazol-1-yl)phenol",269-845-2,68337-15-5,,Notified C&L,5,H319:5;H315:5;H335:5
67402,"1,1-dimethoxytrimethylamine",225-063-3,4637-24-5,Flam. Liq. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,197,H318:131;H317:132;H225:197;H332:151;H302:43;H335:50;H315:67;H319:66
67405,"3,5-DIFLUOROPHENOL",608-047-4,2713-34-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,48,H302:46;H312:46;H335:43;H315:44;H319:44;H332:42;H314:4;H228:4
67409,"Sulfuric acid, mono-C10-16-alkyl esters, sodium salts",271-557-7,68585-47-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,878,H318:491;H315:856;H319:240;H302:218;H335:164;H412:116;H228:103;H332:89;Not classified:21;H314:1
67410,Potassium toluene-4-sulphonate,240-273-5,16106-44-8,Not Classified,Notified C&L,41,Not classified:41
67411,"1-(2,5-DICHLORO-4-SULFOPHENYL)-5-PYRAZOLONE-3-CARBOXYLIC ACID",615-778-2,7253-04-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67417,Ethyl o-toluenesulphonate,261-666-8,59222-96-7,,Notified C&L,2,Not classified:1;H319:1;H302:1;H315:1;H335:1
67418,"Hexanedioic acid, ester with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol",277-217-4,73018-30-1,Not Classified,Notified C&L,1,Not classified:1
67419,"fenchlorphos (ISO);O,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate",206-082-6,299-84-3,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H410:0;H312:0
67421,"1,3-diiodo-5,5-dimethylimidazolidine-2,4-dione",606-981-7,2232-12-4,Ox. Sol. 2;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,42,H272:40;H400:38;H314:42;H302:2;H317:2;H411:2;H311:2;H318:1
67425,"2,2-dichlorobutane",224-283-7,4279-22-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H226:39;H335:38
67428,4-(1-hydroxy-2-(methylamino)ethyl)phenol,202-300-9,94-07-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H315:42;H335:42;H317:1
67429,Zinc hydroxide,243-814-3,20427-58-1,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,204,H400:129;H411:46;H319:62;H315:62;H410:74;Not classified:11
67433,1-phenyl-3-(2-pyridyl)thiourea,212-951-0,886-60-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H302:38;H315:39;H335:39;H319:1
67435,1-(4-chlorobutoxy)-4-methylbenzene,275-893-5,71720-44-0,Acute Tox. 4,Notified C&L,38,H302:38
67441,Bicyclo[2.2.1]hept-2-yltrichlorosilane,242-121-3,18245-29-9,Eye Irrit. 2,Notified C&L,38,H319:38
67442,"Silver(1+) 2,6,6-trimethylbicyclo[3.1.1]heptanethiolate",269-857-8,68365-86-6,Flam. Sol. 2,Notified C&L,1,H228:1
67444,Bis[(aminooxy)acetic] acid hydrochloride,220-862-3,2921-14-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39;H302:1
67445,Diethyl (6-chloro-9H-carbazol-2-yl)methylmalonate,275-262-4,71208-55-4,Not Classified,REACH registration C&L,4,Not classified:4
67448,3-(3-thienyl)acrylic acid,214-800-4,1195-52-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
67452,Iron(2+) sulphate,240-616-9,16547-58-3,Not Classified,Notified C&L,3,Not classified:3
67454,2-ethylhexyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate,263-471-3,62256-00-2,Not Classified,REACH registration C&L,17,Not classified:4;H317:13;H319:1;H315:1
67456,Decylbenzene,203-230-1,104-72-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
67457,3-hydroxyanthranilic acid,208-962-5,548-93-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,40,H302:39;H312:39;H335:39;H315:40;H351:39;H319:40;H332:38
67458,"1,1-difluoroethylene",200-867-7,75-38-7,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,282,H220:182;H280:183;Not classified:99;H350:40;H340:40;H224:1
67459,C.I. Disperse Yellow 71,602-355-2,12223-92-6,Not Classified,Notified C&L,1,Not classified:1
67460,"[1S-(1α,4α,4aα,6α,8aβ)]-decahydro-4-isopropyl-1,6-dimethylnaphthalene, didehydro derivative",249-580-9,29350-73-0,Asp. Tox. 1,Notified C&L,1375,H304:1287;Not classified:88
67462,Ethyl benzoylacetate,202-295-3,94-02-0,Not Classified,Notified C&L,135,Not classified:133;H319:2;H315:2;H335:2
67464,3-(chloromethyl)-1-azabicyclo[2.2.2]octane hydrochloride,289-128-8,86014-80-4,Acute Tox. 3;Acute Tox. 3,REACH registration C&L,3,H301:2;H331:2;H319:1;H315:1;H335:1
67466,5-hexyldihydro-5-methylfuran-2(3H)-one,230-291-1,7011-83-8,Skin Irrit. 2,REACH registration C&L,285,H315:12;Not classified:273
67468,"4,6,9-trimethyl-3,5,8,10-tetraoxadodecane",266-979-3,67715-79-1,Not Classified,Notified C&L,89,Not classified:89
67476,3-iodotoluene,210-918-5,625-95-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H315:49;H335:48;H302:1;H312:1;H332:1;H227:1
67477,"1,1'-Biphenyl]-4-carboxylic acid,(3aR,4S,5R,6aS)-hexahydro-4-(hydroxymethyl)- 2-oxo-2H-cyclopenta[b]furan-5-yl ester",608-667-5,31752-99-5,Not Classified,REACH registration C&L,3,Not classified:3
67478,"2-Naphthalenol, 1-[[2-methyl-4-[(2-methylphenyl)azo]phenyl]azo]-, ar-styrenated",286-282-8,85203-90-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,10,H400:6;H410:6;Not classified:4
67480,Ethyl 3-ethoxypropionate,212-112-9,763-69-9,Flam. Liq. 3,REACH registration C&L,1530,H226:1274;H412:581;Not classified:234;H319:127;H410:14;H225:3;H413:1
67481,"2-(2,2,3-trimethylcyclopent-3-en-1-yl)prop-2-enal",604-146-1,139539-68-7,Not Classified,REACH registration C&L,2,Not classified:2
67482,"Trisodium 3-[(2-chloro-4-nitrophenyl)azo]-5-[[2,4-dihydroxy-5-[[4-[(4-nitro-2-sulphonatophenyl)amino]phenyl]azo]phenyl]azo]-4-hydroxynaphthalene-2,7-disulphonate",286-796-2,85391-42-0,Not Classified,Notified C&L,38,Not classified:38
67485,"trifloxystrobin (ISO);(E,E)-α-methoxyimino-{}{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester",604-237-6,141517-21-7,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0
67488,Molybdenum trichloride,236-775-9,13478-18-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H315:38;H335:38;H314:4
67490,Gold,231-165-9,7440-57-5,Not Classified,REACH registration C&L,486,Not classified:483;H319:2;H315:1;H335:2;H351:1
67495,"Lithium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-)",268-272-5,68039-65-6,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,2,H317:2;H410:2;H411:2
67501,4-iodo-m-xylene,224-141-4,4214-28-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
67505,"Pyridinium, 4-[2-(4-formylphenyl)ethenyl]-1-methyl-, methyl sulfate (1:1)",616-086-3,74401-04-0,Not Classified,Notified C&L,1,Not classified:1
67509,"[2,2'-[1,2-phenylenebis(nitrilomethylidyne)]-bis(phenolato)]-N,N',O,O'-nickel(II)",400-870-5,14406-71-4,Not Classified,REACH registration C&L,2050,Not classified:2050
67514,N-(2-hydroxyethyl)stearamide,203-883-2,111-57-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,148,H318:138;H315:128;H412:21;H411:105;Not classified:10
67515,Methyl 1-benzyl-4-oxopiperidine-3-carboxylate hydrochloride,223-522-2,3939-01-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
67517,"1,1-dibromoethane",209-184-9,557-91-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H315:1;H331:1;H301:1;H311:1;H319:1
67518,"3,7-diaminophenothiazin-5-ium perchlorate",246-647-4,25137-58-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67519,(2S)-2-(benzyloxy)propanal,617-235-5,81445-44-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
67520,N-(2-chloroethyl)-N-ethylaniline,245-082-0,22564-43-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,4,H319:4;H302:4;H315:4;H412:4
67524,"(5α,6α)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-yl (1S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulphonate",281-527-5,83968-47-2,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Lact.,Notified C&L,1,H318:1;H362:1;H302:1;H317:1
67528,1-methyl-4-quinolone,201-485-3,83-54-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
67531,Aluminium copper dioxide,235-483-9,12250-93-0,Not Classified,Notified C&L,31,Not classified:31
67541,Benzaldehyde azine,209-627-6,588-68-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
67542,Di(succinimido) carbonate,277-730-3,74124-79-1,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;STOT RE 2,REACH registration C&L,110,H319:110;H302:14;H317:7;H373:7;H315:103;H335:100;H301:39;Not classified:2;H332:1
67548,3-chloro-6-phenylpyridazine,243-772-6,20375-65-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40;H302:1;H312:1;H332:1
67549,Iron boride,234-489-9,12006-84-7,Not Classified,Notified C&L,5,Not classified:5
67551,Ethyl 5-bromovalerate,238-705-2,14660-52-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H335:42
67554,5-acetylsalicylamide,254-830-5,40187-51-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45,H319:45;H302:45;H315:45;H335:44;H312:38;H332:38
67556,"Carbamic acid, [5-(tetrahydro-3,6-dioxo-2H-1,2-oxazin-2-yl)pentyl]-, benzyl ester",619-055-2,94622-86-3,,Notified C&L,1,H319:1
67557,Magnesium phosphonate(1:1),238-277-7,14332-25-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,12,H319:6;H302:6;H315:6;H335:6;Not classified:6
67561,"4-(2-pyridylazo)-1,3-bis(sodiooxy)benzene",258-131-6,52722-53-9,,Notified C&L,4,H319:4;H315:4;H335:4
67563,5-nitroisoquinoline,210-133-8,607-32-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
67565,6-chloro-9-[[3-[(2-chloroethyl)amino]propyl]amino]-2-methoxyacridine dihydrochloride,241-129-4,17070-45-0,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1;Carc. 1B,Notified C&L,38,H300:38;H330:38;H350:38;H310:38
67567,(dimethylamino)trimethylstannane,213-610-9,993-50-0,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H310:38;H300:38;H410:38;H400:38;H225:38;H330:38
67571,"3-[(2,6-dichlorophenyl)methylene]carbazamidine monoacetate",245-534-7,23256-50-0,Acute Tox. 3,Notified C&L,45,H301:45;H361:1
67573,Bis(4-methylbenzyl) oxalate,406-470-7,,Not Classified,Notified C&L,1,Not classified:1
67575,"[R-(R*,S*)]-3,7-dihydro-7-[2-[(2-hydroxy-1-methyl-2-phenylethyl)amino]ethyl]-1,3-dimethyl-1H-purine-2,6-dione monohydrochloride",221-243-0,3039-97-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1
67578,.alpha.-Cyclodextrin-2-hydroxypropylether,619-816-9,128446-33-3,Not Classified,REACH registration C&L,3,Not classified:2;H319:1
67579,"Gases (petroleum), refinery;Refinery gas;[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]",272-338-9,68814-67-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
67584,Sulphanilamide,200-563-4,63-74-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,243,H319:13;H315:13;H335:11;Not classified:230;H302:3;H332:2;H371:1
67586,Potassium hydrogen tartrate,212-769-1,868-14-4,Not Classified,REACH registration C&L,162,Not classified:162
67588,8-[(dimethylamino)methyl]-7-methoxy-3-methyl-2-phenyl-4-benzopyrone hydrochloride,220-366-7,2740-04-7,Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1
67592,"3,3-dimethylpiperidine",214-767-6,1193-12-0,,Notified C&L,5,H314:5;H226:5
67594,"tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate",413-210-6,192662-33-2,Aquatic Chronic 2,Harmonised C&L,0,H411:0
67601,Cyanogen iodide,208-053-3,506-78-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H335:1;H315:1;H331:1;H301:1;H311:1;H319:1
67603,Tetraamminepalladium(2+) dihydroxide,270-241-6,68413-68-3,Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,85,H302:85;H317:85;H410:85;H400:85;H319:2;H318:83;H373:83
67607,Manganese hydrogen cyclohexanebutyrate,252-610-3,35542-88-2,Eye Irrit. 2,Notified C&L,39,H319:39
67608,Hexane-3-thiol,216-650-5,1633-90-5,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H312:1;H335:1;H315:1;H332:1;H319:1;H226:1
67609,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chlorinated",273-501-7,68987-63-3,Not Classified,REACH registration C&L,140,Not classified:140
67612,"7H-furo[3,2-g][1]benzopyran-7-one",200-639-7,66-97-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H302:41;H315:43;H335:42
67616,"[N,N-bis[2-[bis(carboxymethyl)amino]ethyl]glycinato(5-)]cuprate(3-)",234-281-8,11065-66-0,Not Classified,Notified C&L,1,Not classified:1
67617,tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate,425-420-5,98737-29-2,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
67622,"5,5-dibutyldihydrofuran-2(3H)-one",231-875-9,7774-47-2,Not Classified,Notified C&L,88,Not classified:88
67624,"Residues, copper-iron-lead-nickel matte, sulfuric acid-insol.",310-050-8,102110-49-6,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H317:2;H318:2;H341:2;H360:2;H401:2;H315:2;H410:2;H400:2;H301:2;H372:2;H334:2;H350:2;H332:2
67627,"2,6-dibromo-4-nitrophenol",202-744-3,99-28-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H302:40;H312:40;H335:44;H315:45;H319:45;H332:40;H301:1;H331:1;H311:1
67631,2-nitro-p-anisidine;4-methoxy-2-nitroaniline,202-547-2,96-96-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H310:0;H412:0;H300:0;H330:0;H373:0
67634,"(2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol",606-239-2,19130-96-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
67636,"Ethanol, 2-(2-butoxyethoxy)-, phosphate, potassium salt",271-945-6,68647-25-6,,Notified C&L,46,H319:39;H315:46;H335:14;H318:7
67640,"Acetic acid ethenyl ester, polymer with ethenol, cyclic acetal with butanal",614-691-7,68648-78-2,Not Classified,Notified C&L,147,Not classified:147
67641,"β-Cyclodextrin, 2-hydroxypropyl ethers",603-269-8,128446-35-5,Not Classified,Notified C&L,50,Not classified:50
67644,manganese dioxide,215-202-6,1313-13-9,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H332:0
67645,"2,4,6-tribromophenol",204-278-6,118-79-6,Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,180,H400:170;H319:176;H317:170;H302:9;H410:6;H335:6;H315:6;H411:7;H312:2;H301:5;H332:2;H371:1;H373:1;H361:1;Not classified:1
67652,"L-Valinamide, N2-[[(1-carboxy-2-phenylethyl)amino]carbonyl]-L-arginyl-N-[4-[(aminoiminomethyl)amino]-1-formylbutyl]-, dihydrochloride",609-466-5,37682-72-7,Not Classified,Notified C&L,2,Not classified:2
67655,"calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate",400-480-5,36669-85-9,Aquatic Chronic 3,Harmonised C&L,0,H412:0
67657,"2,3,4,5,6-pentabromotoluene",201-774-4,87-83-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38;H400:1;H410:1
67660,"Sulfonic acids, shale-oil, sodium salts",297-668-0,93686-18-1,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1,H319:1;H317:1;H412:1
67663,(Z)-(carboxymethyl)dimethyl-3-[(1-oxo-9-octadecenyl)amino]propylammonium hydroxide,246-584-2,25054-76-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H319:40;H315:42;H400:21;H302:2;H410:2;H318:3;H411:1;H412:1
67664,2-ethyl-2-hydroxybutyric acid,222-867-6,3639-21-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67668,"5-(trans-4-(trans-4-Butyltetrahydropyran-2-yl)-cyclohexyl]di fluormethoxy-1,2,3-trifluorbenzen",615-061-4,700863-40-7,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
67669,"3-[1,1'-biphenyl]-4-yl-1,2,3,4-tetrahydro-1-naphthol",260-034-9,56181-66-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:2;H312:2;H335:2;H315:2;H319:2;H332:2
67672,"2,4'-dichloroacetophenone",213-323-9,937-20-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:39;H315:44;H335:43;H318:5;H317:5
67677,2-mercaptopyridin-3-ol,245-375-3,23003-22-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
67678,"4-(5-chloro-2-pyridylazo)benzene-1,3-diamine",251-334-0,33006-91-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
67682,"2,2,4-trimethyl-1,3-dioxolane",214-766-0,1193-11-9,Not Classified,Notified C&L,134,Not classified:90;H318:38;H302:38;H315:44;H226:44;H319:6;H335:5
67685,2-nitro-1-naphthol,210-131-7,607-24-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67688,1-(2-Butoxypropoxy)propan-2-ol,246-011-6,24083-03-2,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H312:0
67689,Tribenzylphosphine,231-608-6,7650-89-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
67690,[No public or meaningful name is available],930-944-7,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H335:1;H318:1;H315:1;H411:1;H319:1
67692,"3-methylbuta-1,2-diene",209-926-1,598-25-4,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H304:44;H335:43;H315:44;H225:44;H319:44
67697,"Citric acid, iron(3+) sodium salt",257-620-1,52031-09-1,Not Classified,Notified C&L,2,Not classified:2
67698,CITRUS AURANTIFOLIA (LIME) OIL,616-919-0,8008-26-2,Flam. Liq. 3,Notified C&L,152,H226:148;H317:89;H304:87;H410:86;H315:89;H400:43;Not classified:2;H411:3;H319:2
67703,Methyl (Z)-octadec-6-enoate,220-470-2,2777-58-4,Not Classified,Notified C&L,1,Not classified:1
67705,Methylprednisolone 21-acetate,200-171-3,53-36-1,Repr. 2;STOT RE 2,REACH registration C&L,77,H361:45;H373:34;H360:31;H341:1;H302:1;H372:1
67707,long chain alkyl thio carbamide metal complex,457-320-2,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,4,H317:4;H315:4;H412:4
67708,"Poly(oxy-1,2-ethanediyl), α-methyl-ω-hydroxy-",618-394-3,9004-74-4,Not Classified,Notified C&L,248,Not classified:247;H302:1;H312:1;H335:1;H336:1;H372:1;H319:1
67711,2(or 3)-methylbutyl acetate,282-263-3,84145-37-9,Flam. Liq. 3,Harmonised C&L,0,H226:0
67712,α-phenylpiperidine-2-acetic acid,243-020-7,19395-41-6,Acute Tox. 4,REACH registration C&L,50,H302:10;H319:41;H315:2;H335:1;H341:1
67714,Octyl 2-pyridyl ether,274-542-3,70289-27-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H319:38;H315:38;H413:38;H335:38
67715,Clebopride,259-885-9,55905-53-8,Acute Tox. 4,Notified C&L,38,H302:38
67716,4-bromophenetole,209-629-7,588-96-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,35,H319:35;H315:35;H335:35
67722,"(1,4'-Bipiperidine)-4'-carboxamide, 1'-(3-(p-fluorobenzoyl)propyl)-",606-172-9,1893-33-0,Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,3,H301:2;H411:1;H302:1;H312:1;H335:1;H315:1;H332:1
67728,4'-(trifluoromethyl)-4-biphenylcarbaldehyde,618-368-1,90035-34-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4,H400:2;H302:2;H410:2;H319:2;H315:2;H335:2
67730,C.I. Acid Yellow 110,602-101-0,12220-74-5,Not Classified,Notified C&L,1,Not classified:1
67731,Hesperidin,208-288-1,520-26-3,Not Classified,REACH registration C&L,42,Not classified:42
67737,3-(bromomethyl)thiophene,252-247-0,34846-44-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:2;H315:2;H335:2;H302:2;H314:2;H411:2
67738,"Disodium 2,5-dichloro-4-[4-[[5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-2-sulphonatophenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",225-800-9,5089-16-7,Not Classified,Notified C&L,3,Not classified:3
67742,Tributyltetradecylphosphonium chloride,279-808-2,81741-28-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,79,H302:79;H314:79;H410:41;H400:40;H330:41;H318:15
67744,"1-bromo-4,5-difluoro-2-nitrobenzene",608-704-5,321-17-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
67748,"(1S,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene",232-077-3,7785-26-4,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,677,H302:203;H317:592;H304:546;H315:373;H410:591;H400:590;H226:644;H312:58;H332:58;H335:44;H319:52;Not classified:35;H411:7
67751,5-amino-1-naphthol,201-486-9,83-55-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H319:54;H315:54;H335:52
67756,Trapidil,239-434-2,15421-84-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67760,"2-(bromomethyl)-2-(hydroxymethyl)propane-1,3-diol",242-863-8,19184-65-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
67761,Ergocristine,208-120-7,511-08-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,40,H301:39;H331:39;H311:39;H302:1;H332:1
67762,"Phosphonium, (3-methyl-4-oxo-2-butenyl)triphenyl-, chloride",609-124-5,3541-81-9,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,REACH registration C&L,1,H334:1;H319:1;H302:1;H317:1
67764,"Methyl hydrogen (endo-endo)-bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate",225-494-7,4883-79-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,15,H319:15;H315:15;H335:15
67770,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, (dimethylamino)methyl derivs.",270-097-4,68411-05-2,Not Classified,Notified C&L,126,Not classified:126
67773,"3,5-dihydroxybenzamide",221-571-4,3147-62-4,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,43,H319:43;H302:38;H317:38;H315:5;H335:4
67774,"2,5-diethyltetrahydrofuran",255-274-6,41239-48-9,Flam. Liq. 2,Notified C&L,112,H225:112
67776,"Patchouli, ext., acetylated",294-834-4,91770-49-9,Asp. Tox. 1;Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H315:1;H304:1;H411:1
67780,4-bromo-3-thenoic acid,240-739-8,16694-17-0,,Notified C&L,2,H302:2;H335:2;H315:2;H319:2;H332:1
67783,"2,3,4,6-tetrachlorophenol",200-402-8,58-90-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H315:0;H400:0;H301:0;H319:0
67784,"Naphthalenesulfonic acid, bis(1-methylethyl)-, Me derivs.",619-460-4,99811-86-6,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H302:1;H314:1;H335:1
67786,Pentadecafluorooctyl fluoride,206-396-3,335-66-0,Skin Corr. 1B,Notified C&L,1,H314:1
67790,"2,3-Dichlorobenzenesulfonyl Chloride",617-331-7,82417-45-6,Flam. Sol. 2;Skin Corr. 1B,Notified C&L,48,H228:40;H314:48;H318:1;H290:1;H302:1;H332:1;H312:1
67791,Fentin chloride,211-358-4,639-58-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,168,H410:168;H331:168;H400:168;H301:168;H311:168;H318:38;H315:39;H319:1;H361:1
67792,"A mixture of: propan-2-one-O,O'-(methoxymethylsilandiyl)dioxime; propan-2-one-O-(dimethoxymethylsilyl)oxime; propan-2-one-O,O',O''-(methylsilantriyl)trioxime",460-110-3,,Not Classified,REACH registration C&L,2,Not classified:2
67793,2-bromoindan-1-ol,226-442-6,5400-80-6,,Notified C&L,6,H319:6;H315:6;H335:5
67802,8-(β-D-glucopyranosyloxy)-7-hydroxy-6-methoxy-2H-1-benzopyran-2-one,208-355-5,524-30-1,Not Classified,Notified C&L,1,Not classified:1
67805,"Distillates (petroleum), dewaxed light paraffinic, hydrotreated;Baseoil - unspecified;[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C",295-301-9,91995-40-3,Carc. 1B,Harmonised C&L,0,H350:0
67806,"2-[7-(diethylamino)-2-oxo-2H-1-benzopyran-3-yl]-1,3-dimethyl-1H-benzimidazolium methyl sulphate",252-770-4,35869-60-4,Eye Irrit. 2,Notified C&L,10,H319:5;H318:4;H317:3;Not classified:1;H315:1
67810,"2,2'-[cyclohexylidenebis[(2-methyl-4,1-phenylene)azo]]bis[4-cyclohexylphenol]",229-754-0,6706-82-7,Not Classified,Notified C&L,92,Not classified:92
67814,"(1R,3S)-2,2-Dimethyl-3-(2-oxopropyl)cyclopropanecarboxylic acid",615-083-4,70223-33-5,Skin Corr. 1C;Aquatic Chronic 2,REACH registration C&L,1,H314:1;H411:1
67818,"Naphtha (petroleum), heavy coker;Kerosine - unspecified;[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C",269-778-9,68333-23-3,Asp. Tox. 1,Harmonised C&L,0,H304:0
67820,"azocyclotin (ISO);1-(tricyclohexylstannyl)-1H-1,2,4-triazole",255-209-1,41083-11-8,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H335:0;H318:0;H315:0;H410:0;H400:0;H301:0;H330:0
67824,3-chloro-4-nitrophenol,207-730-0,491-11-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
67828,1-amino-1-deoxy-D-glucitol,207-677-3,488-43-7,Eye Irrit. 2,REACH registration C&L,4,H319:4;H315:2
67831,6-(2-Ethyl-6-methyl-phenylamino)-4-hydroxy-naphthalene-2-sulfonic acid,920-927-2,,Eye Dam. 1,Notified C&L,31,H318:31
67832,"Naphtha (petroleum), light catalytic reformed, arom.-free;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",270-993-5,68513-03-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
67847,"Fatty acids, tall-oil, barium salts",272-497-4,68855-79-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,597,H302:596;H332:596;H413:2;Not classified:1
67848,zineb (ISO);zinc ethylenebis(dithiocarbamate) (polymeric),235-180-1,12122-67-7,Skin Sens. 1;STOT SE 3,Harmonised C&L,0,H317:0;H335:0
67849,C.I. Acid Blue 182,601-956-7,12219-26-0,Not Classified,Notified C&L,37,Not classified:37
67850,7-(trifluoromethyl)quinoline-4-thiol,264-875-2,64415-07-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67854,"Fatty acids, C8-21 and C8-21-unsatd., esters with propylene glycol",307-329-1,97593-26-5,Not Classified,Notified C&L,22,Not classified:22
67856,Disodium C-dodecyl sulphonatosuccinate,248-030-5,26838-05-1,Eye Dam. 1,Notified C&L,63,H318:62;H302:23;H315:4;H319:1
67857,"Phenol, 4-(trans-4-ethylcyclohexyl)-",618-236-3,89100-78-7,Not Classified,Notified C&L,2,Not classified:1;H317:1;H413:1
67860,"L-threo-a-D-galacto-Octopyranoside, methyl-7-chloro-6,7,8-trideoxy-3,4-O-(1-methylethyliden)-6-[[[(2S,4R)-1-methyl-4-propyl-2-pirrolidinyl]carbonyl]amino]-1-thio-, monohydrochloride",602-998-9,124547-63-3,Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H319:1;H317:1;H410:1;H332:1
67861,"(1α,2β,4β,5α,7β)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02.4]nonan-7-ol hydrochloride",288-237-8,85700-55-6,Repr. 2,Notified C&L,13,H361:10;H300:3;H330:3;H310:2;H335:1;H315:1;H319:1
67862,"2,6-dimethoxypyrimidin-4-amine",221-946-2,3289-50-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,102,H319:102;H315:102;H335:101
67864,1-chloro-3-(1-naphthyloxy)propan-2-ol,243-538-3,20133-93-1,Acute Tox. 4;Repr. 1A;Lact.,Notified C&L,3,H360:3;H302:3;H362:3
67866,"Amino acids, wheat, reaction products with cocoyl chloride, sodium salts",616-824-4,800392-66-9,Eye Dam. 1,REACH registration C&L,2,H318:2
67868,Tris(3-chlorophenyl)phosphine,249-970-9,29949-85-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,42,H302:38;H413:38;H335:42;H315:42;H319:42;H301:4
67869,"ferrocene, (4-chlorobutyl)-",604-247-0,141719-29-1,Acute Tox. 4;Repr. 1B,REACH registration C&L,2,H360:2;H302:2
67872,2-(4-chlorophenyl)-2-methylpropionic acid,228-392-0,6258-30-6,,Notified C&L,4,H319:4;H315:4;H335:4
67873,3-(acetylthio)-2-methylpropionic acid,251-458-5,33325-40-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
67874,Bis(4-chlorophenyl) disulphide,214-531-2,1142-19-4,,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
67883,"methyl cis-1-{[(2,5-dimethylphenyl)acetyl]amino}-4-methoxycyclohexanecarboxylate",606-524-1,203313-47-7,Not Classified,Notified C&L,1,Not classified:1
67886,p-(benzyloxy)benzoic acid,216-066-0,1486-51-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,46,H319:46;H302:39;H315:7;H335:6
67887,"Benzaldehyde, reaction products with N,N-diethylbenzenamine and N,N-dimethylbenzenamine, oxidized, acetates",281-492-6,83968-15-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,95,H400:86;H302:95;H410:95;H318:12;H361:12
67888,o-(trifluoromethyl)benzaldehyde,207-185-9,447-61-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H335:47;H302:4;H226:1
67890,Sodium butanolate,219-144-2,2372-45-4,Flam. Liq. 3;Skin Corr. 1B,REACH registration C&L,87,H314:87;H226:87;H318:83
67894,9H-fluoren-9-amine hydrochloride,227-778-6,5978-75-6,,Notified C&L,6,H319:5;H315:5;H335:5;H302:1
67898,1-naphthylacetic acid,201-705-8,86-87-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,80,H302:76;H412:46;H318:54;H335:49;H315:50;H319:16;H361:6;H411:4;Not classified:1;H312:1;H332:1
67899,Ethyl 4-oxovalerate,208-728-2,539-88-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1712,H319:104;H315:104;Not classified:1608;H335:1
67904,Produkt 1771,419-440-3,,Not Classified,Notified C&L,100,Not classified:100
67914,2-methoxy-2-methylbutane;tert-amyl methyl ether,213-611-4,994-05-8,Flam. Liq. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H336:0;H302:0;H225:0
67916,sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate,417-550-6,168151-92-6,Skin Sens. 1,Harmonised C&L,0,H317:0
67917,"2,3-dihydro-5-methylfuran",216-067-6,1487-15-6,Flam. Liq. 2,Notified C&L,38,H225:38
67923,"1,4-diphenylbuta-1,3-diene",212-952-6,886-65-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
67924,4-methoxy-α-toluenethiol,228-393-6,6258-60-2,,Notified C&L,5,H319:4;H302:4;H315:4;H335:4;H334:1;H317:1
67925,potassium titanium oxide (K2Ti6O13),432-240-0,12056-51-8,Carc. 2,Harmonised C&L,0,H351:0
67926,5-Amino-2-ethoxypyridin,610-768-4,52025-34-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H302:2;H335:3;H315:3;H319:3;H332:2;H312:1
67927,"11β,17,21-trihydroxy-6α-methylpregna-1,4-diene-3,20-dione 21-(hydrogen succinate)",220-863-9,2921-57-5,Repr. 1B;STOT RE 2,REACH registration C&L,53,H360:35;H373:35;H302:16;H312:16;H361:18;H351:1
67928,"1,2-Diamino-4,5-difluorobenzene",616-301-0,76179-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:40;H302:1;H312:1;H332:1
67930,"Aurio(1+) 2,6,6-trimethylbicyclo[3.1.1]heptanethiolate",269-858-3,68365-87-7,Flam. Sol. 1,REACH registration C&L,2,H228:2
67931,N-Methyl-2-(4-nitrophenoxy)-N-[2-(4-nitrophenyl)ethyl]ethanamine,601-352-3,115287-37-1,Acute Tox. 4;Skin Sens. 1,Notified C&L,30,H302:30;H317:29;H360:1;H373:1
67932,Tetrasodium pyrophosphate,231-767-1,7722-88-5,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,1545,H318:733;H302:739;H319:717;Not classified:95;H315:254;H335:224;H317:10;H301:5;H312:1
67936,Sodium D-pantothenate,212-768-6,867-81-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;Not classified:1
67940,"2-Ethyl-1,6-dioxaspiro[4,4]nonane",609-549-6,38401-84-2,Not Classified,Notified C&L,121,Not classified:83;H319:38;H302:38;H315:38;H335:38
67941,Pentyl 2-methylvalerate,228-570-8,6297-48-9,Not Classified,Notified C&L,1,Not classified:1
67942,"(±)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinoline",216-923-9,1699-51-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,40,H301:40;H331:39;H311:39;H330:1;H335:1;H315:1;H319:1
67947,3-methyl-2-[3-(3-methyl-3H-benzoxazol-2-ylidene)prop-1-enyl]benzoxazolium iodide,237-987-4,14134-79-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67951,Acetaldehyde--ammonia,200-868-2,75-39-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
67953,"3,4-Difluorophenol",608-046-9,2713-33-9,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,44,H228:44;H314:42;H302:43;H312:43;H335:2;H315:2;H319:2;H332:1
67954,"Sulfuric acid, mono-C10-16-alkyl esters, compds. with diethanolamine",271-556-1,68585-44-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,441,H319:441;H315:441
67955,"Petroleum Destillat, steam-cracked, polymers with light steam- cracked, Petroleum Naphtha",614-450-6,68410-16-2,Not Classified,Notified C&L,82,Not classified:81;H413:1
67957,"1,2-Benzenedicarboxylic acid, mixed cetyl and stearyl esters",270-487-4,68442-70-6,Not Classified,Notified C&L,41,Not classified:41
67958,Trimethyl Orthopropionate,607-445-5,24823-81-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,42,H319:42;H315:42;H225:42
67959,"1,1'-dimethyl-2,2'-oxydiethyl dibenzoate",202-296-9,94-03-1,Not Classified,Notified C&L,1,Not classified:1
67964,Bromomethyl 3-methoxyphenyl ketone,225-666-1,5000-65-7,Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:39;H314:46;H335:40;H318:1;H290:1;H302:1
67965,"2,4,6-trichlorophenyl acetoacetate",261-667-3,59225-85-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
67966,"Heparitin, sulfate",232-939-9,9050-30-0,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Notified C&L,1,H302:1;H317:1;H332:1
67969,Glucosamine hydrochloride,200-638-1,66-84-2,Not Classified,Notified C&L,60,Not classified:58;H319:1;H315:1;H335:1;H302:1
67976,2-[N-methyl-N-(5-nitro-2-pyridyl)amino]ethanol,247-359-1,25948-15-6,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H302:38;H317:38
67979,Acipimox,256-928-3,51037-30-0,Eye Irrit. 2,Notified C&L,71,H319:41;Not classified:30
67982,"1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)",418-330-2,162241-33-0,Expl. 1.1;Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H302:0;H317:0;H318:0;H410:0;H400:0;H201:0;H373:0
67984,"[3R-(3α,3aβ,6α,7β,8aα)]-hexahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5(4H)-one",237-450-4,13794-73-5,Skin Irrit. 2,Notified C&L,113,H315:103;Not classified:10
67985,1-chloro-4-isothiocyanatobenzene,218-358-3,2131-55-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,46,H317:40;H335:42;H315:42;H331:42;H301:41;H311:41;H334:41;H319:42;H302:4;H314:4;H332:4;H312:4
67989,"1,3-Propanediol, 1,3-bis(4-methylbenzenesulfonate)",611-186-3,5469-66-9,Not Classified,Notified C&L,1,Not classified:1
67993,2'-methylacetanilide,204-414-4,120-66-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,542,H319:453;H302:542;H315:453;H335:452;H318:38
67995,3-hydroxy-2-(3-hydroxy-2-quinolyl)-1H-inden-1-one,241-753-7,17772-51-9,Skin Sens. 1B,REACH registration C&L,179,H317:178;H413:13;Not classified:1
67996,"1,1'-binaphthyl",210-070-6,604-53-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H302:38;H413:38
68003,"Diethyl (6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)methylmalonate",275-261-9,71208-54-3,Not Classified,REACH registration C&L,4,Not classified:4
68009,(S)-β-amino-1H-imidazole-4-propanol dihydrochloride,216-482-2,1596-64-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:41
68017,Trimagnesium dinitride,235-022-1,12057-71-5,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,212,H319:212;H228:174;H315:212;H335:212;H260:38
68019,"benalaxyl (ISO);methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate",275-728-7,71626-11-4,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
68020,"Onion, ext.",232-498-2,8054-39-5,Flam. Liq. 3,Notified C&L,151,H226:90;Not classified:35;H315:26
68021,"3,5-dibromosalicylic acid",221-570-9,3147-55-5,,Notified C&L,6,H319:6;H315:6;H335:5
68024,N-chloroacetyl-L-tryptophan,265-029-5,64709-57-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
68031,But-2-yn-1-ol,212-113-4,764-01-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H315:49;H226:49;H335:48;H302:1;H312:1
68033,Retrorsine,610-403-9,480-54-6,Acute Tox. 2,Notified C&L,40,H300:40;H330:2;H311:2
68034,3-Amino-1-(2-chlorophenyl)-1-phenylpropan-1-ol,609-081-2,35173-30-9,Not Classified,REACH registration C&L,2,Not classified:2
68038,N-(3-acetyl-4-hydroxyphenyl)butyramide,254-831-0,40188-45-2,Not Classified,REACH registration C&L,51,Not classified:6;H315:43;H319:4;H335:4;H410:2;H302:1;H360:1;H400:1;H362:1;H350:1;H373:1
68040,Hafnium,231-166-4,7440-58-6,Pyr. Sol. 1,REACH registration C&L,235,H250:179;Not classified:18;H228:16;H413:19;H251:5;H302:2;H314:2;H332:2;H312:2;H319:1;H335:1;H373:1
68046,nickel hydrogen phosphate,238-278-2,14332-34-4,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H317:0;H410:0;H400:0;H372:0;H334:0;H350:0
68053,Trityl tetrafluoroborate,206-433-3,341-02-6,Skin Corr. 1B,Notified C&L,45,H314:45;H318:2;H302:2;H332:1;H312:1
68055,Bicyclo[4.4.0]decan-1-one,225-410-9,4832-16-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
68057,"COCO AMINE, MALEIC ANHYDRIDE ESTER",927-944-4,,Not Classified,Notified C&L,8,Not classified:8
68058,"N1,N1-bis(2-chloroethyl)-N4-(6-chloro-2-methoxyacridin-9-yl)pentane-1,4-diamine dihydrochloride",224-140-9,4213-45-0,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1;Repr. 2,Notified C&L,38,H317:38;H331:38;H301:38;H334:38;H361:38
68059,"N,N-dimethylpyridin-4-amine",214-353-5,1122-58-3,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 1;STOT SE 1;Aquatic Chronic 2,REACH registration C&L,622,H310:457;H318:261;H315:414;H331:291;H411:278;H301:616;H370:192;H335:197;H319:254;H314:167;H311:59;Not classified:6;H412:1;H361:1
68071,"tert-butyl (1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate",609-213-9,361440-67-7,Not Classified,Notified C&L,85,Not classified:85
68073,"4-acetamidobenzoic acid, compound with 1-(dimethylamino)propan-2-ol (1:1)",263-361-5,61990-51-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,6,H319:6;H315:6;H335:6
68074,"Hydrogen [4-[4-(diethylamino)-5'-hydroxy-2',4'-disulphonatobenzhydrylidene]cyclohexa-2,5-dien-1-ylidene]diethylammonium, monosodium salt",243-654-4,20262-76-4,Not Classified,REACH registration C&L,2090,Not classified:2089;H319:1;H315:1;H335:1
68077,2-bromododecanoic acid,203-882-7,111-56-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
68079,"Borate(5-), bis[μ-oxotetraoxodiborato(4-)]-, sodium tetrahydrogen, trihydrate, (T-4)-",603-131-7,12631-71-9,Repr. 2,Notified C&L,16,H361:16
68082,"(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione hydrate",605-591-4,17086-28-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,147,H319:57;H315:57;H335:57;H302:63;H360:51;H362:14;H317:20;H312:3;H332:3;H361:2
68083,Diethyl (chloromethyl)phosphonate,221-632-5,3167-63-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39;H227:1
68085,2-bromopropene,209-185-4,557-93-7,Flam. Liq. 2,REACH registration C&L,78,H225:78;H319:75;H315:75;H335:74
68090,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-hydroxy-, C11-14-isoalkyl ethers, C13-rich, sodium salts",616-613-7,78330-30-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,501,H319:501;H315:501
68092,6-methyl-4-phenylchroman-2-one,609-846-0,40546-94-9,Skin Sens. 1,REACH registration C&L,5,H317:5;H412:1
68098,Guanosine 5'-(disodium dihydrogen triphosphate),259-940-7,56001-37-7,Not Classified,Notified C&L,3,Not classified:2;H319:1;H315:1;H335:1
68099,"(E)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine citrate (1:1)",227-154-3,5685-86-9,Acute Tox. 4,REACH registration C&L,40,H302:2;H301:38;H319:38;H331:38;H311:38
68100,Ethyl cis-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate,243-773-1,20380-56-7,,Notified C&L,1,H302:1
68102,"1-[[5-(4-nitrophenyl)furfurylidene]amino]imidazolidine-2,4-dione, sodium salt",238-706-8,14663-23-1,Muta. 2;Carc. 2;Repr. 2;STOT RE 2,Notified C&L,7,H341:6;H361:6;H351:6;H373:6;Not classified:1
68105,"D-pentose and D-glucose, oligomeric, C8 and C10 alkyl glycosides",483-960-7,,Eye Dam. 1,Notified C&L,1,H318:1
68108,3-[(6-aminotrimethylhexyl)amino]propiononitrile,300-511-1,93941-62-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,9,H302:9;H314:9;H317:9
68111,2-[[(3-Methyl-4-nitro-pyridin-2-yl)methyl]sulfanyl]-1H-benzoimidazole,604-848-8,152402-98-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H302:1;H332:1;H312:1
68114,Diphenylpropylphosphine,231-607-0,7650-84-2,Acute Tox. 4,Notified C&L,43,H302:43;H319:5;H315:5
68116,2-piperidinoethanol,221-244-6,3040-44-6,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;STOT SE 3,REACH registration C&L,145,H302:145;H335:54;H318:87;H290:2;H314:91;H317:2;H312:85;H412:2;H319:53;H315:53;H311:4;H301:2;H227:1
68119,"Tetrasodium 3,3'-[[6-[(2-hydroxyethyl)amino]-1,3,5-triazine-2,4-diyl]bis[imino(2-methyl-4,1-phenylene)azo]]bisnaphthalene-1,5-disulphonate",256-851-5,50925-42-3,Not Classified,REACH registration C&L,50,Not classified:35;H290:13;H334:2;H317:2
68120,Sodium (6R-trans)-3-(acetoxymethyl)-8-oxo-7-[(4-pyridylthio)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,246-194-2,24356-60-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,41,H317:41;H335:40;H315:40;H334:41;H319:40
68123,Trimethylphenoxysilane,216-211-8,1529-17-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H226:40;H335:39
68124,"Fatty acids, coco, esters with cottonseed-oil fatty acids, polyglycerol and soya fatty acids",614-133-2,67784-82-1,Not Classified,Notified C&L,1,Not classified:1
68125,"1,2,4-trichlorobenzene",204-428-0,120-82-1,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H410:0;H315:0
68131,Ethyl 2-pyridylacetate,220-365-1,2739-98-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
68132,Potassium tetrahydroborate,237-360-5,13762-51-1,Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Repr. 1B,REACH registration C&L,145,H318:8;H301:145;H360:8;H314:145;H260:79;H311:137;H331:4;H261:4;Not classified:2;H330:1
68133,L-methionine,200-562-9,63-68-3,Not Classified,REACH registration C&L,204,Not classified:201;H341:1;H302:1;H319:1;H315:1;H335:1
68141,Cyanogen chloride,208-052-8,506-77-4,Press. Gas (Comp.);Acute Tox. 1;Acute Tox. 1;Eye Irrit. 2;Acute Tox. 1;Aquatic Acute 1,REACH registration C&L,255,H310:128;H300:128;H314:202;H400:101;H330:254;H319:16;H280:127;H318:89;H315:1;H332:1;H335:1
68143,Ethyl methoxyacetate,223-521-7,3938-96-3,Flam. Liq. 3,Notified C&L,43,H226:43
68145,Bis(triethoxysilylpropyl)amine,236-818-1,13497-18-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,106,H319:65;H315:65;H314:39;H318:1;H411:1;Not classified:1
68153,"Fatty acids, lanolin, Bu esters",293-058-3,91051-09-1,Not Classified,Notified C&L,1,Not classified:1
68155,"1-[3-(2,4,6-trimethoxybenzoyl)propyl]pyrrolidinium chloride",252-611-9,35543-24-9,Acute Tox. 4,Notified C&L,53,H302:53;H311:1;H312:1;H335:1;H315:1;H319:1;H332:1
68156,(E)-but-2-ene,210-855-3,624-64-6,Press. Gas;Flam. Gas 1,Harmonised C&L,0,H220:0;Not classified:0
68159,"Glass, oxide, calcium magnesium potassium sodium phosphosilicate",305-415-3,94551-67-4,Not Classified,Notified C&L,3,Not classified:3
68162,"4'-amino-2',5'-dimethoxybenzanilide",228-441-6,6268-05-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
68163,"Benzenamine, 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, N-Me derivatives, molybdatesilicates",271-946-1,68647-35-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,31,H400:2;H410:2;Not classified:26;H318:2;H315:2;H335:2;H319:1;H317:1
68166,"Acetic acid ethenyl ester, polymer with chloroethane and ethenol",607-539-6,25086-48-0,Not Classified,Notified C&L,163,Not classified:81;H319:82;H315:82;H335:82
68168,crufomate (ISO);4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate,206-083-1,299-86-5,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H410:0;H312:0
68171,Oxandrolone,200-172-9,53-39-4,Acute Tox. 4;Acute Tox. 4;Repr. 1B,Notified C&L,58,H360:55;H332:56;H312:56;H351:17;H302:1;H335:1;H315:2;H319:2;H361:2;Not classified:1
68172,Chlorotrimethylgermane,216-214-4,1529-47-1,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,43,H314:43;H225:43;H318:1
68177,2-bromo-6-chloro-4-nitroaniline,202-745-9,99-29-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:38;H301:4;H311:4;H330:4;H373:4;H302:1
68182,"Ethyl 5-[5-acetamido-2-methoxy-4-[(5-nitrothiazol-2-yl)azo]phenyl]-9-oxo-2,8,10-trioxa-5-azadodecanoate",277-340-3,73275-65-7,Not Classified,Notified C&L,1,Not classified:1
68183,p-(methylsulphonyl)benzoic acid,223-756-5,4052-30-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,45,H319:45;H302:39;H315:7;H335:7;H312:1;H332:1
68185,"Poly(oxy-1,2-ethanediyl), .alpha.-(9Z)-9-octadecenyl-.omega.-hydroxy-, phosphate, potassium salt",611-794-9,59112-71-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H318:8;H315:8
68189,Dropropizine,241-683-7,17692-31-8,Acute Tox. 4,Notified C&L,43,H302:43
68190,Manganese selenide,215-203-1,1313-22-0,,Notified C&L,4,H410:4;H331:4;H400:4;H301:4;H373:4
68194,"4-bromo-α,α,α-trifluorotoluene",206-943-6,402-43-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:48;H315:48;H226:49;H335:47
68202,"methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate",407-550-4,69184-17-4,Aquatic Chronic 2,Harmonised C&L,0,H411:0
68204,Hexabromobenzene,201-773-9,87-82-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 4,Notified C&L,43,H302:38;H312:38;H335:42;H413:38;H315:43;H319:43;H332:38
68205,2-(trifluoromethyl)phenylacetic acid,221-240-4,3038-48-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46
68208,5-(benzyloxy)-2-nitrotoluene,244-988-3,22424-58-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H318:38;H400:38;H315:38;H335:38
68209,Diisopropanolammonium p-toluenesulphonate,603-351-3,129678-02-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
68215,"Distillates (coal tar), heavy oils, pyrene fraction;Heavy Anthracene Oil Redistillate;[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 °C to 400 °C (662 °F to 752 °F). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.]",295-304-5,91995-42-5,Carc. 1B,Harmonised C&L,0,H350:0
68224,1-chloro-4-(4-chlorophenyl)butan-2-ol,918-013-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H302:2;H332:2;H312:2
68229,trans-4-(4-chlorophenyl)cyclohexanecarboxylic acid,406-380-8,,STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H373:1
68232,"N,N',N''-tris(methoxymethyl)-N,N',N''-tris[(octadecyloxy)methyl]-1,3,5-triazine-2,4,6-triamine",268-346-7,68072-52-6,Not Classified,Notified C&L,1,Not classified:1
68233,"5,6-dichloro-1,3-diethyl-2-methyl-1H-benzimidazolium iodide",246-190-0,24351-12-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
68235,"12'-hydroxy-5'α-isobutyl-2'-isopropylergotaman-3',6',18-trione",208-121-2,511-09-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2;Lact.,REACH registration C&L,40,H302:1;H312:1;H362:1;H361:40;H332:1
68237,"N,N'-[ethane-1,2-diylbis(iminoethane-1,2-diyl)]distearamide",258-666-5,53620-54-5,Not Classified,Notified C&L,1,Not classified:1
68238,"Fatty acids, C8-18 and C18-unsatd., C12-18-alkyl esters",292-786-9,90990-24-2,Not Classified,Notified C&L,7,Not classified:7
68239,Ethylammonium chloride,209-182-8,557-66-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H315:49;H335:48
68241,4-(diethylamino)but-2-ynyl cyclohexylphenylglycolate hydrochloride,216-139-7,1508-65-2,Acute Tox. 4,Notified C&L,53,H302:53;H317:8;H335:10;H411:9;H319:8;H332:1;H312:1;H318:1;H315:1
68244,"Phosphoric acid, isooctyl ester, potassium salt",271-944-0,68647-19-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,613,H318:524;H315:595;H319:71;H412:35;Not classified:18
68245,Isononylphenol,234-284-4,11066-49-2,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,68,H302:68;H318:55;H314:68;H410:68;H400:55;H361:68;Not classified:13
68246,Ethyl bromophenylacetate,220-735-2,2882-19-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43,H318:39;H314:43
68247,"9-Octadecenoic acid (Z)-, monoester with 1,2,3-propanetriol ester with boric acid (H3BO3)",264-092-6,63310-16-7,Not Classified,REACH registration C&L,16,Not classified:16
68248,"N1-Ethyl-4-nitro-1,2-phenylenediamine",613-972-1,66668-41-5,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,31,H319:31;H302:31;H317:31
68251,"Bis(2-ethylhexyl) hydrogen phosphate, compound with tert-dodecylamine (1:1)",268-996-1,68155-99-7,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,9,H319:9;H315:9;H411:9
68253,2-[(2-Hydroxyethyl)(methyl)amino]-1-phenyl-1-propanone,618-508-1,902267-47-4,Not Classified,REACH registration C&L,1,Not classified:1
68258,Methyl 2-bromotetradecanoate,240-687-6,16631-25-7,Skin Irrit. 2;Aquatic Chronic 1,Notified C&L,1,H410:1;H315:1
68260,"2,4'-methylenedianiline",214-900-8,1208-52-2,Acute Tox. 3;Skin Sens. 1;Muta. 2;Carc. 1B;STOT SE 1;STOT RE 2;Aquatic Chronic 2,Notified C&L,40,H317:26;H341:26;H411:26;H370:26;H301:25;H350:26;H373:26;Not classified:14
68262,"1-(1,3-benzodioxol-5-yl)propan-1-one",248-937-6,28281-49-4,Not Classified,REACH registration C&L,39,Not classified:1;H302:38;H411:38
68263,METHYL 4-(DECYLOXY)BENZOATE,613-033-6,62443-10-1,Aquatic Chronic 4,Notified C&L,38,H413:38
68266,Cyclohexyldiphenylphosphine oxide,237-204-6,13689-20-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
68268,Dichromium trisulphide,234-638-8,12018-22-3,Not Classified,Notified C&L,29,Not classified:25;H302:4;H317:4;H332:4
68272,"Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides",269-919-4,68391-01-5,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,870,H400:700;H302:835;H314:781;H312:155;H318:243;H315:75;H410:185;H311:32;H226:9;H301:10;Not classified:5;H330:1;H319:1
68273,N-cyclohexyl-N-methyl-o-nitrobenzylamine,279-522-8,80638-08-0,,Notified C&L,1,H302:1
68275,Methyl-beta-cyclodextrin A.I.,603-270-3,128446-36-6,Not Classified,Notified C&L,124,Not classified:68;H319:56;H332:56
68277,"Formaldehyde, oligomeric reaction products with 4,4'-isopropylidenediphenol and diethylenetriamine",500-263-6,77138-45-5,Skin Corr. 1B;Skin Sens. 1;STOT SE 3;Repr. 2,REACH registration C&L,10,H361:1;H314:1;H317:1;H335:1;Not classified:9
68280,1-(4-ammonio-2-methylpyrimidin-5-yl)-3-(2-hydroxyethyl)-2-methylpyridinium dibromide,208-604-8,534-64-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H302:38;H332:38;H312:38
68285,5-(dimethylamino)naphthalene-1-sulphonyl fluoride,252-071-4,34523-28-9,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1;H290:1
68286,"2-Propenenitrile, reaction products with ethylenediamine, hydrogenated",272-727-3,68909-99-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 2;Skin Corr. 1A;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1B;Aquatic Chronic 3,REACH registration C&L,84,H302:84;H317:84;H310:84;H412:84;H318:84;H314:84;H332:84;H311:1;H334:84;H226:84
68287,"1,4-diamino-2,3-dihydroanthraquinone",201-367-1,81-63-0,Acute Tox. 4;Skin Sens. 1,Notified C&L,1,H302:1;H317:1
68293,Trisodium trihydrogen [nitrilotris(methylene)]trisphosphonate,231-520-8,7611-50-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
68295,p-anisidinium chloride,243-657-0,20265-97-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,40,H302:38;H317:39;H312:38;H335:39;H315:40;H334:39;H319:40;H331:2;H410:1;H400:1;H301:2;H370:1;H311:2;H372:1
68300,4-phenylazo-1-naphthylamine,205-018-4,131-22-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,52,H319:52;H315:52
68301,"3',5'-di-tert-butyl-2-(ethoxymethoxy)-5-methylbiphenyl",917-383-3,,Not Classified,Notified C&L,1,Not classified:1
68302,N-[3-(dimethylamino)propyl]stearamide,231-609-1,7651-02-7,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,284,H318:149;H400:88;H411:33;H314:111;H315:110;H410:62;H319:25;H302:14;Not classified:4;H301:1
68304,2-benzylheptanol,296-229-0,92368-90-6,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,285,H315:24;H411:247;H319:38;H413:38
68305,"Storax (balsam), Levant",295-229-8,91845-54-4,Skin Sens. 1,Notified C&L,76,H317:76
68307,"N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine",219-145-8,2372-82-9,Acute Tox. 3;Skin Corr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,750,H314:715;H410:667;H400:671;H301:710;H373:668;H318:480;H311:38;H319:35;H317:35;H315:35;H411:35;H302:5
68308,Dimethylcadmium,208-055-4,506-82-1,Flam. Liq. 2;Pyr. Liq. 1;Water-react. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H250:38;H302:38;H312:38;H314:38;H410:38;H400:38;H225:38;H332:38;H261:38
68309,2-(4-Hydroxy-phenoxy)-propionic acid,614-094-1,67648-61-7,Eye Dam. 1,Notified C&L,128,H318:89;H319:39;H315:39;H335:39
68310,(E)-oct-2-enal,219-833-8,2548-87-0,Not Classified,Notified C&L,162,Not classified:113;H319:43;H315:48;H335:41;H317:4;H302:2;H412:1
68312,"Naphtha (petroleum), light steam-cracked;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C",265-187-5,64742-83-2,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
68313,"Benzenesulfonic acid, 2-amino-5-[2-(4-sulfophenyl)diazenyl]-, sodium salt (1:?)",616-750-2,79873-36-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
68314,"2,4,6-triphenylpyrylium tetrafluoroborate",207-186-4,448-61-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H302:43;H312:39;H335:43;H315:43;H319:43;H332:39
68320,"2,3,4,5,6,7,8,9,10,11,12,13-dodecahydro-1H-cyclopenta[12]annulen-1-one",604-824-7,15210-25-0,Not Classified,REACH registration C&L,2,Not classified:2
68323,"Potassium 1,2-naphthoquinone-4-sulphonate",227-611-7,5908-27-0,Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:1
68327,"[2-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium chloride",275-144-2,71033-12-0,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,3,H319:2;H302:2;H411:2;Not classified:1
68328,2-phenylbut-3-yn-2-ol,204-855-2,127-66-2,Acute Tox. 4,Notified C&L,89,H302:89;H319:22;H315:22
68331,Trichloro(1-chloroethyl)silane,232-133-7,7787-82-8,,Notified C&L,1,H314:1;H225:1
68332,But-3-en-2-ol,209-929-8,598-32-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H335:40;H315:40;H225:45;H319:40;H332:39;H310:5;H318:4;H411:4;H301:5;H302:1;H312:1
68343,Ethyl cyclohexanecarboxylate,221-945-7,3289-28-9,Not Classified,Notified C&L,90,Not classified:89;H319:1;H315:1;H227:1;H335:1
68351,"Glycerides, rape-oil mono-, di- and tri-, hydrogenated",294-661-4,91744-94-4,Not Classified,REACH registration C&L,1,Not classified:1
68353,"disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate",421-880-6,201792-73-6,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0
68355,biphenyl-4-ylamine;xenylamine;4-aminobiphenyl,202-177-1,92-67-1,Acute Tox. 4;Carc. 1A,Harmonised C&L,0,H302:0;H350:0
68356,4-hydroxyphenylacetonitrile,238-046-0,14191-95-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,46,H302:46;H332:41;H312:41;H319:8;H315:8;H335:7
68357,2-phenoxyethyl propionate,245-692-7,23495-12-7,Not Classified,Notified C&L,1552,Not classified:1552
68369,behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride,423-420-1,136920-10-0,Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H318:0;H400:0;H317:0;H410:0
68371,"Thiocyanic acid, (1,3,8,10-tetrahydro-1,3,8,10-tetraoxoanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-2,9-diyl)di-3,1-phenylene ester, reaction products with sodium sulfide (Na2(Sx))",271-559-8,68585-53-5,Not Classified,REACH registration C&L,38,Not classified:38
68373,Triallyl borate,216-897-9,1693-71-6,,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H226:1
68380,"cyfluthrin (ISO);α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;beta-cyfluthrin",269-855-7,68359-37-5,,,0,H300:0;H330:0;H410:0;H400:0
68383,Isooctadecane,276-354-7,72123-30-9,Not Classified,Notified C&L,2,Not classified:2
68384,"Sodium 3,3'-(9,10-dioxoanthracene-1,4-diyldiimino)bis(2,4,6-trimethylbenzenesulphonate)",224-748-4,4474-24-2,Aquatic Chronic 4,REACH registration C&L,360,H413:22;H412:230;Not classified:67;H319:80;H302:39
68390,"1,3-Diazaspiro(4.4)non-1-en-4-one, 2-butyl-3-((2'-(1H- tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-",604-078-2,138402-11-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,103,H319:58;H315:59;H335:58;H360:25;H372:15;H361:19;H362:20;H412:17;H373:5;H334:1;H317:1;H413:3;Not classified:1
68391,"Fatty acids, C14-26, aluminum salts",306-792-7,97404-28-9,Not Classified,Notified C&L,149,Not classified:149
68394,Disodium C-hexadecyl sulphonatosuccinate,248-031-0,26838-10-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,22,H318:22;H302:22
68395,Tripotassium hexacyanoiridate,244-044-0,20792-41-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
68396,"1,1-dichloroethylene;vinylidene chloride",200-864-0,75-35-4,Flam. Liq. 1;Acute Tox. 4;Carc. 2,Harmonised C&L,0,H351:0;H332:0;H224:0
68398,1-deoxy-1-formamido-D-glucitol,618-251-5,89182-60-5,Not Classified,Notified C&L,1,Not classified:1
68399,trans-4-(4-propylcyclohexyl)phenyl trans-4-pentylcyclohexanecarboxylate,280-292-6,83242-82-4,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
68401,"Extracts (petroleum), light naphtha solvent",265-100-0,64741-99-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Muta. 1B;Carc. 1A;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,132,H304:72;H315:72;H411:72;H340:72;H350:72;H226:36;H373:60;H302:36;H410:36;H372:24;H319:24;H361:54;H312:30;H336:18;H332:30;H225:36;Not classified:3
68402,DL-norleucine,210-462-7,616-06-8,Not Classified,Notified C&L,3,Not classified:3
68403,Sodium 2-oxobutyrate,217-937-8,2013-26-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
68405,[2-(methacryloyloxy)ethyl]trimethylammonium chloride,225-733-5,5039-78-1,Not Classified,REACH registration C&L,216,Not classified:22;H319:193;H317:190;H315:34;H335:37;H302:1;H318:1
68415,"3,5-dibromopyridine",210-916-4,625-92-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:50;H315:50;H335:49;H302:8;H312:8;H332:8
68416,Sodium butyl 9(or 10)-(sulphonatooxy)octadecanoate,255-950-0,42808-36-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,445,H319:445;H315:445
68417,"Disodium 5-(benzoylamino)-3-[(2,5-dimethylphenyl)azo]-4-hydroxynaphthalene-2,7-disulphonate",279-682-9,81064-48-4,Not Classified,Notified C&L,1,Not classified:1
68418,"(±)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine",288-060-6,85650-52-8,Acute Tox. 4;STOT SE 3,Notified C&L,58,H336:38;H302:58;H373:16;H411:19;H361:17;H312:1;H362:1;H351:2;H332:1
68421,Ethylaluminium dichloride,209-248-6,563-43-9,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1A,REACH registration C&L,256,H250:168;H260:126;H314:164;H225:130;H318:116;H261:38;H304:4;H411:4;H336:4;H252:4;H361:4;H373:4
68422,Diosmin,208-289-7,520-27-4,Not Classified,REACH registration C&L,96,Not classified:87;H341:9
68423,Apoatropine hydrochloride,227-779-1,5978-81-4,,Notified C&L,1,H302:1
68425,"Fatty acids, C14-18 and C16-22 unsatd.",268-101-4,68002-87-9,Not Classified,Notified C&L,1,Not classified:1
68430,"2-methyl-4,6-bis(trichloromethyl)-1,3,5-triazine",213-440-5,949-42-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:40;H302:38;H315:40;H335:38;Not classified:7
68432,N-benzylbenzamide,216-063-4,1485-70-7,Not Classified,Notified C&L,1,Not classified:1
68434,[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]methanol,601-797-3,121660-11-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
68440,Amodimethicone,614-604-2,68554-54-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,111,H319:110;H315:104;H400:36;H410:36;Not classified:1
68441,2-Amino-4-chloro-6-methoxypyrimidine,611-506-1,5734-64-5,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H315:1;H335:1
68444,Ethyl 4-[(2-amino-4-chlorophenyl)amino]piperidine-1-carboxylate,258-775-8,53786-45-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
68445,Tetraammonium hexacyanoferrate,238-476-9,14481-29-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:38;H332:38;H312:38;H412:4;Not classified:1
68452,1-(p-toluenesulphonyl)imidazole,218-771-9,2232-08-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
68453,"Fatty acids, castor-oil, hydrogenated, magnesium salts",294-298-1,91697-37-9,Not Classified,Notified C&L,1,Not classified:1
68456,"Ethanone, 2-chloro-1-(3-chloro-4-hydroxyphenyl)-",620-219-0,39066-18-7,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,1,H319:1;H302:1
68458,Morphine N-oxide,211-355-8,639-46-3,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1,Notified C&L,41,H317:40;H360:38;H331:39;H301:40;H334:40;H361:2;H330:1;H362:1;H302:1
68461,"N,N'-dimethyldithiooxamide",204-425-4,120-79-6,Acute Tox. 4,Notified C&L,38,H302:38
68462,"Sucrose, propoxylated",500-029-3,9049-71-2,Not Classified,REACH registration C&L,162,Not classified:162
68465,"3,4-bis(benzyloxy)benzyl alcohol",216-926-5,1699-58-7,Aquatic Acute 1,Notified C&L,38,H400:38
68467,Methyl 4-pyridyl ketone,214-350-9,1122-54-9,Not Classified,Notified C&L,136,Not classified:88;H319:47;H315:48;H335:45;H302:5;H312:4;H332:3
68468,Pyridoxamine dihydrochloride,208-357-6,524-36-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H315:42;H335:41;H302:1
68469,Bis(hexafluoroisopropyl)itaconate,619-351-1,98452-82-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
68471,Bicyclo[2.2.1]heptanebis(methylamine),260-280-7,56602-77-8,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,72,H318:21;H302:49;H314:50;H412:8;Not classified:22
68474,3-(m-methoxyphenyl)propionic acid,234-049-6,10516-71-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
68479,"[1R-(1α,3aβ,4α,7β)]-1,2,3,3a,4,5,6,7-octahydro-7-isopropenyl-1,4-dimethylazulene",245-084-1,22567-17-5,Not Classified,Notified C&L,10,Not classified:10
68483,"Residual oils (petroleum,) solvent-refined;Baseoil - unspecified;[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C",265-101-6,64742-01-4,Carc. 1B,Harmonised C&L,0,H350:0
68486,"3β,21-dihydroxy-2'-methyl-16β-5'H-pregn-5-eno[17,16-d]oxazol-20-one 21-acetate",289-006-4,85959-16-6,STOT RE 2,REACH registration C&L,2,H373:2
68488,Propyl oleate,203-885-3,111-59-1,Not Classified,Notified C&L,7,Not classified:7
68489,Ethylstyrene,248-846-1,28106-30-1,,Notified C&L,228,Not classified:85;H319:107;H315:107;H411:105;H335:106;H318:38;H302:38
68490,"Magnesium, EDTA cobalt copper iron manganese zinc complexes",607-234-8,234446-82-3,Not Classified,REACH registration C&L,84,Not classified:84
68491,"2,6-dichloro-3-nitropyridine",240-151-1,16013-85-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H317:44;H315:44;H335:43;H302:2;H312:2;H341:1;H334:1;H332:2
68493,1-phenylpentan-3-one,244-045-6,20795-51-1,Acute Tox. 4,Notified C&L,38,H302:38
68494,Hexyl pivalate,226-602-5,5434-57-1,Not Classified,Notified C&L,88,Not classified:88
68500,5-chlorosalicylanilide,225-065-4,4638-48-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
68504,5-chlorobenzotriazole,202-378-4,94-97-3,Acute Tox. 4,Notified C&L,136,H302:129;Not classified:6;H335:1
68506,5-(4-Hydroxymethyl-phenoxymethyl)-3-isopropyloxazolidin-2-one,926-787-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
68507,Isopropalin,251-690-7,33820-53-0,Flam. Liq. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H400:38;H410:38;H226:41
68508,"Acetic acid, reaction products with isoprene",277-219-5,73018-39-0,Not Classified,Notified C&L,88,Not classified:88
68513,"Hexamethylenetetramine, compound with 1-chloro-2,3-epoxypropane",243-770-5,20368-76-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1;H312:1
68514,"magnesium salts, fatty acids, C",448-690-6,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
68515,"1,2,3,4-tetramethylbenzene",207-673-1,488-23-3,,Notified C&L,96,H319:93;H315:93;H335:93;Not classified:3
68516,"Horse chestnut, Aesculus hippocastanum, ext.",232-497-7,8053-39-2,Not Classified,Notified C&L,126,Not classified:115;H302:8;H332:8;H335:8;H226:2;H319:2;H411:1
68518,2-[(5-nitro-2-pyridyl)amino]ethanol,247-358-6,25948-12-3,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38;H317:38
68520,ephedrine,206-080-5,299-42-3,Acute Tox. 4,Harmonised C&L,0,H302:0
68521,p-(dimethylamino)cinnamic acid,216-299-8,1552-96-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:43
68523,Methyl 1H-pyrrole-1-carboxylate,224-281-6,4277-63-8,Flam. Liq. 3;Acute Tox. 4,Notified C&L,38,H302:38;H226:38
68528,1-benzoylpiperidine-4-carboxylic acid,226-099-2,5274-99-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
68532,"Benzenamine, oxidized",235-850-3,13007-86-8,Not Classified,REACH registration C&L,154,Not classified:154
68535,α-dimethylamino-o-cresol,204-413-9,120-65-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Muta. 1B;Repr. 1B;STOT SE 1;STOT RE 1,Notified C&L,1,H302:1;H312:1;H318:1;H360:1;H314:1;H340:1;H370:1;H372:1;H332:1
68537,1-phenylheptan-1-one,216-802-0,1671-75-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:38
68538,dimethyl(dipropyl)azanium;bromide,610-854-1,52509-52-1,Not Classified,REACH registration C&L,2,Not classified:2
68541,N-ethyl-4-nitroaniline,222-927-1,3665-80-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H312:38;H335:38;H315:38;H319:38;H332:38
68543,1-(methylsulphinyl)decane,221-368-0,3079-28-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H335:1
68547,2-chloro-4-dimethylaminobenzaldehyde,215-840-5,1424-66-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:1
68548,(4-tert-butylphenyl)acetonitrile,221-944-1,3288-99-1,Not Classified,Notified C&L,1376,Not classified:1374;H302:1;H312:1;H335:1;H315:2;H319:2;H332:1;H331:1;H301:1;H311:1
68550,"4-AMINO-3,3-DIMETHYLBUTYLTRIMETHOXYSILANE",605-117-6,157923-74-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,6,H318:6;H302:6;H317:6;H315:6
68551,red phosphorus;white phosphorus,231-768-7,7723-14-0,,,0,H228:0;H412:0
68552,"2,4,6,8-tetramethyl-2,4,6,8-tetrakis(3,3,3-trifluoropropyl)cyclotetrasiloxane",207-060-9,429-67-4,Not Classified,Notified C&L,34,Not classified:29;H319:4;H315:4;H335:2;H302:3;H413:1;H312:3;H410:2;H400:2;H332:2
68554,2-(p-chlorophenylthio)ethanol,236-657-7,13457-98-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H302:38;H312:38;H335:38;H315:38;H319:38;H332:38
68555,"2-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt",430-740-3,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
68558,Diyttrium trioxalate,212-767-0,867-68-5,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1,Notified C&L,5,H318:4;H302:5;H312:5
68559,1-(1-naphthylmethyl)quinolinium chloride,406-220-7,65322-65-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Muta. 2;Carc. 2;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0;H318:0;H341:0;H315:0;H351:0
68560,"(±)-cis-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2,4-dihydro-2-sec-butyl-3H-1,2,4-triazol-3-one",283-347-2,84604-65-9,,Notified C&L,2,H302:2
68561,"Poly(oxy-1,2-ethanediyl), α,α'-(2,2-dimethyl-1,3-propanediyl)bis[ω-[(1-oxo-2-propen-1-yl)oxy]-",617-545-0,84170-28-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,19,H319:19;H315:19
68562,Daminozide,216-485-9,1596-84-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,5,H319:4;H315:4;Not classified:1
68565,Thiophene-2-methanethiol,228-394-1,6258-63-5,Acute Tox. 4,Notified C&L,1374,H302:1374
68566,"chlorpyrifos (ISO);O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate",220-864-4,2921-88-2,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H301:0;H410:0
68571,N-1-naphthyl-3-oxobutyramide,201-702-1,86-83-9,Eye Irrit. 2,Notified C&L,38,H319:38
68572,Dichloro(2-chloroethyl)methylsilane,232-134-2,7787-85-1,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,39,H314:39;H226:39
68573,"Cashew, nutshell liquid, reaction products with resorcinol and other dihydric phenols",917-405-1,,Not Classified,Notified C&L,1,Not classified:1
68578,pentyl propionate,210-852-7,624-54-4,Flam. Liq. 3,Harmonised C&L,0,H226:0
68582,"3,5,7-trihydroxy-2-phenyl-4-benzopyrone",208-960-4,548-83-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:43;H315:43;H335:43;H302:2
68583,"methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate",429-890-2,144550-06-1,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
68585,4-pyrrolidin-1-ylbutyronitrile,252-612-4,35543-25-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H302:42;H312:41;H335:40;H315:41;H319:41;H332:41
68586,"Iron, [μ-[[3,3'-methylenebis[(4,6-dihydroxy-3,1-phenylene)azo]bis[2(or 4)-hydroxy-5-nitrobenzenesulfonato]](6-)]]di-, sodium hydrogen",286-018-1,85186-33-0,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,88,H319:86;H412:86;Not classified:2
68587,"Trisodium 7-[(5-chloro-2,6-difluoropyrimidin-4-yl)amino]-2-[4-[(hexahydro-2,4,6-trioxopyrimidin-5-yl)azo]-3-sulphonatophenyl]-2H-naphtho[1,2-d]triazole-5,9-disulphonate",273-336-0,68957-39-1,Skin Sens. 1,Notified C&L,31,H317:31
68588,"BENZOGUANAMINE FORMALDEHYDE RESIN, BUTYLATED",614-206-9,68002-26-6,Aquatic Chronic 2,Notified C&L,269,H411:265;H413:4
68589,"4,5-dimethyl-o-phenylenediamine",221-635-1,3171-45-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:41;H302:5;H311:4;H332:5;H312:1
68594,"Boric acid, compd. with 2,2'-iminobis[ethanol]",270-366-6,68425-66-1,Not Classified,Notified C&L,6,Not classified:4;H319:2;H315:2;H335:2
68598,Chlorotriphenylsilane,200-989-0,76-86-8,Skin Corr. 1B;STOT SE 3,Notified C&L,48,H314:48;H335:39;H318:3;H290:1
68600,2-chloro-1-iodo-4-nitrobenzene,255-278-8,41252-96-4,Acute Tox. 4,Notified C&L,44,H302:44;H312:6;H335:6;H315:6;H319:6;H332:6
68604,Iodoacetyl chloride,253-748-7,38020-81-4,,Notified C&L,4,H314:4
68605,"Aloe vera, ext.",287-390-8,85507-69-3,Not Classified,Notified C&L,409,Not classified:368;H319:41;H315:41;H335:41
68607,"ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)",400-110-2,109125-51-1,Self-react. C;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H242:0
68609,N-(tert-butoxycarbonyl)glycine,224-864-5,4530-20-5,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,93,H318:55;H302:47;Not classified:38;H301:1;H303:1
68611,Undecan-1-ol,203-970-5,112-42-5,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1988,H400:1584;H319:1805;H411:478;H315:424;H317:46;H331:25;H335:47;H410:25;Not classified:3
68618,Trilithium arsenate,236-773-8,13478-14-3,,Notified C&L,4,H410:4;H331:4;H400:4;H301:4;H350:4
68630,"3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine",421-150-7,143860-04-2,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H400:0;H360:0;H314:0;H410:0
68634,"2,5-dibromoaniline",222-865-5,3638-73-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:44;H317:39;H312:40;H335:43;H315:44;H319:44;H332:44;H311:5;H301:1;H331:1;H373:1
68636,"3-α,6-α-dihydroxy-5-β-cholan-24-oic acid",201-483-2,83-49-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,94,H319:94;H315:94;H335:94
68638,"Sodium α-(3,5-dibromo-2-methyl-4-oxo-2,5-cyclohexadienylidene)-α-(3,5-dibromo-4-hydroxyphenyl)toluenesulphonate",263-657-4,62625-32-5,Not Classified,Notified C&L,2,Not classified:2
68643,"Glass, oxide, calcium magnesium sodium phosphosilicate",305-416-9,94551-68-5,Not Classified,Notified C&L,3,Not classified:3
68646,Ethyl pivalate,223-520-1,3938-95-2,Flam. Liq. 2,Notified C&L,47,H225:46;Not classified:1;H411:1;H302:1;H413:1;H412:1;H335:1;H315:1
68650,"Alcohols, C9-11, ethoxylated (2,5-4EO)",931-012-2,,Eye Dam. 1,Notified C&L,3,H318:3;H319:3
68652,"Benzamide, N,N',N''-(9,10-dihydro-9,10-dioxo-1,4,5-anthracenetriyl)tris-",610-157-2,4392-71-6,Not Classified,Notified C&L,1,Not classified:1
68653,Laurocapram,261-668-9,59227-89-3,,Notified C&L,1,H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
68655,Diethyl peroxydicarbonate,238-707-3,14666-78-5,Flam. Liq. 3;Org. Perox. D;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,8,H319:8;H315:8;H226:8;H242:8
68656,"Trisodium 5-[[4-chloro-6-(morpholino)-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methyl-2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",277-033-4,72927-92-5,Not Classified,Notified C&L,31,Not classified:31
68657,Titanium(III) chloride tetrahydrofuran complex (1:3),605-895-7,18039-90-2,Flam. Sol. 1;Skin Corr. 1B,Notified C&L,73,H228:73;H314:73
68658,1-(methylsulphonyl)acetone,225-665-6,5000-46-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
68659,"reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)",444-290-0,508202-43-5,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H317:0;H412:0
68661,1-(tert-Butoxycarbonyl)-4-hydroxypiperidine,600-916-6,109384-19-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
68665,(±)-nerolidyl acetate,259-941-2,56001-43-5,Not Classified,Notified C&L,233,Not classified:233
68668,"3,5-diethyl 1H-pyrazole-3,5-dicarboxylate",609-467-0,37687-24-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
68670,"2,4-dinitrophenylhydrazinium(1+) chloride",259-888-5,55907-61-4,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H228:1;H315:1
68673,8-nitroquinoline,210-135-9,607-35-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,44,H302:40;H312:40;H335:43;H315:44;H351:43;H319:44;H332:40;H341:4
68674,Boldine--chloroform,207-509-9,476-70-0,Acute Tox. 4,Notified C&L,41,H302:41;H319:2;H315:2;H335:2;H332:1
68675,"4',5-dihydroxy-7-methoxyflavone",220-980-5,2957-21-3,Acute Tox. 4,Notified C&L,38,H302:38
68676,"2,3-dichlorobenzaldehyde",228-711-3,6334-18-5,Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,96,H317:8;H401:8;H315:10;H411:8;H320:8;H314:53;H412:34;H335:34;H318:2;H319:2;Not classified:2
68678,Zinc phosphonate,238-279-8,14332-59-3,,Notified C&L,10,Not classified:7;H302:3;H314:3;H411:3
68679,Sodium decanoate,213-688-4,1002-62-6,Not Classified,Notified C&L,2,Not classified:2
68681,Dichromium trioxalate,250-317-5,30737-19-0,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,6,H302:6;H317:6;H412:6
68688,Pyridine-2-acetonitrile,220-364-6,2739-97-1,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48,H310:43;H335:46;H315:47;H301:43;H319:47;H302:4;H312:4;H332:4;H300:1;H330:1;H331:1;H311:1
68691,tris(2-chloroethyl)phosphate,204-118-5,115-96-8,Acute Tox. 4;Carc. 2;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0,H360:0;H302:0;H411:0;H351:0
68697,"(3β,6α,12β)-3,12-dihydroxydammar-24-ene-6,20-diylbis[β-D-glucopyranoside]",244-989-9,22427-39-0,Acute Tox. 4,Notified C&L,42,H302:41;Not classified:1
68700,"1-Hexadecanol, phosphate",272-336-8,68814-13-1,,Notified C&L,61,H314:40;Not classified:18;H319:3
68701,"Chromium chloride, basic",256-852-0,50925-66-1,Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,6,H317:3;H318:6;H314:3;H411:3;H400:3;H302:3;H315:3;H312:3
68702,1-(bromomethyl)cyclohexene,253-619-5,37677-17-1,Aquatic Chronic 2,Notified C&L,1,H411:1
68703,glycerol trinitrate;nitroglycerine;[>40 % phlegmatiser],200-240-8,55-63-0,,,0,H310:0;H300:0;H411:0;H330:0;H201:0;H373:0
68704,Butyltris(dodecylthio)stannane,239-739-0,15666-28-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,24,H302:19;H317:19;H312:19;H315:19;H410:19;H400:19;Not classified:5
68706,4'-Methyl-2-biphenylcarbonitrile,601-326-1,114772-53-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,76,H302:76;H332:71;H312:71;H372:5;H411:5;H361:5
68708,1-bromo-4-fluoronaphthalene,206-434-9,341-41-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:43
68709,"Hydrocarbons, C9-C12, n-alkanes, isoalkanes, cyclics, aromatics (2-25%)",919-446-0,,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3;STOT SE 3;STOT RE 1;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,27,H304:27;H411:27;H336:27;H372:24;H226:27
68712,"2,3-dihydrophthalazine-1,4-dione dihydrazone monomethanesulphonate",274-013-7,69467-96-5,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H302:1;H312:1;H412:1
68713,4-phenylazobenzoyl chloride,203-188-4,104-24-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:39;H314:39;H290:1
68714,"p-chloro-α,α-dimethylbenzyl alcohol",217-865-7,1989-25-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
68716,Phenyl benzoate,202-293-2,93-99-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,Notified C&L,135,H302:125;H317:87;H315:116
68717,Oxacyclododecan-2-one,217-034-9,1725-03-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
68722,Alizapride,261-710-6,59338-93-1,,Notified C&L,1,H302:1;H332:1;H312:1
68723,(trans(trans))-4'-vinyl-4-(4-methylphenyl)bicyclohexyl,439-730-3,,STOT RE 2,REACH registration C&L,1,H373:1
68725,3-Sulfanyl-1-hexanol,922-990-1,,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
68727,Mercury diiodide,231-873-8,7774-29-0,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,82,H310:82;H300:82;H410:81;H400:81;H330:82;H373:82;Not classified:1;H362:1;H314:1
68729,"2,6-dichloro-4-nitroaniline",202-746-4,99-30-9,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,142,H310:131;H300:131;H411:131;H330:131;H373:131;H319:7;H315:7;H335:6;Not classified:4;H400:1
68734,"Tamarind seed gum, carboxymethyl ether",271-943-5,68647-15-4,Not Classified,Notified C&L,32,Not classified:32
68736,3-nitro-p-toluic acid,202-549-3,96-98-0,Not Classified,REACH registration C&L,78,Not classified:33;H302:39;H319:7;H315:7;H335:6
68738,"Ethanol, 2-(2-butoxyethoxy)-, phosphate",272-335-2,68814-09-5,Skin Corr. 1B,Notified C&L,1,H314:1
68740,Aluminum chloride hydroxide sulfate,254-400-7,39290-78-3,Met. Corr. 1;Eye Irrit. 2,REACH registration C&L,169,H319:82;H290:140;H318:85;H315:21;H314:1;Not classified:2
68745,4-Bromo-2-fluorobenzaldehyde,611-583-1,57848-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H315:49;H335:48
68748,D-tagatose,201-772-3,87-81-0,Not Classified,Notified C&L,10,Not classified:10
68750,Ethyl 3-methoxy-4-oxopiperidine-1-carboxylate,281-138-0,83863-72-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
68752,Trichloro[4-(chloromethyl)phenyl]silane,237-203-0,13688-90-9,Skin Corr. 1B,Notified C&L,42,H314:42
68753,Antimony sodium tartrate,252-070-9,34521-09-0,Not Classified,Notified C&L,7,Not classified:5;H302:2;H315:1;H411:2;H319:1;H332:2
68760,"Siloxanes and silicones, 3-[(2-aminoethyl)amino]propyl Me, di-Me, reaction products with acetic anhydride",603-271-9,128446-37-7,Not Classified,Notified C&L,38,Not classified:37;H315:1
68763,molybdenum trioxide,215-204-7,1313-27-5,Eye Irrit. 2;STOT SE 3;Carc. 2,Harmonised C&L,0,H319:0;H351:0;H335:0
68766,Semicarbazide hydrochloride,209-247-0,563-41-7,Not Classified,REACH registration C&L,95,Not classified:4;H318:4;H301:91;H361:13;H373:13;H319:45;H315:45;H335:5;H311:3;H331:1;H351:2;H314:1
68771,"N,N'-(2-chloro-1,4-phenylene)bis[4-[(4-chloro-2-nitrophenyl)azo]-3-hydroxynaphthalene-2-carboxamide]",252-772-5,35869-64-8,Not Classified,REACH registration C&L,102,Not classified:102
68776,2-(2-methoxyethoxy)-2-methylpropane,266-463-8,66728-50-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H226:38;H335:38
68778,2-chloro-1-[(4-fluorophenyl)methyl]-1H-benzimidazole,284-624-0,84946-20-3,Not Classified,REACH registration C&L,2,Not classified:2
68780,"Octa-1,3,7-triene",213-686-3,1002-35-3,Flam. Liq. 2,Notified C&L,1,H225:1
68781,4-chloroanilinium chloride,243-656-5,20265-96-7,,Notified C&L,11,H317:10;H410:10;H331:10;H400:10;H301:10;H311:10;H350:10;H300:1;H330:1;H310:1
68783,"Oils, vegetable, residues",273-570-3,68989-98-0,Not Classified,Notified C&L,23,Not classified:23
68785,Vinyl alcohol,209-183-3,557-75-5,Not Classified,Notified C&L,653,Not classified:545;H301:107;H225:20;H319:1;H351:1;H335:1;H224:1
68786,Vinyl chloroacetate,219-834-3,2549-51-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;STOT SE 3;Muta. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,56,H302:50;H317:1;H335:1;H318:3;H341:1;H315:1;H410:1;H400:2;H351:1;H226:56;H314:55;H301:4;H311:4;H330:5;H310:1;H300:2
68792,"3,7-dinitro-1,3,5,7-tetraazabicyclo[3.3.1]nonane",213-441-0,949-56-4,Expl. 1.1,Notified C&L,1,H201:1
68796,Sodium tetradecenesulphonate,234-283-9,11066-21-0,Not Classified,Notified C&L,7,Not classified:5;H318:2;H302:1;H314:2;H317:1;H312:1;H412:1
68799,4-chloro-4'-isopropylbutyrophenone,274-544-4,70289-38-2,Acute Tox. 4,Notified C&L,38,H302:38
68800,Androsterone,200-173-4,53-41-8,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,133,H334:129;H319:130;H315:130;H335:129;Not classified:3;H331:1;H301:1;H311:1
68803,Iron stearate,225-889-4,5136-76-5,Not Classified,Notified C&L,7,Not classified:7
68805,"17-hydroxy-3-methoxyestra-2,5(10)-diene-17-carbonitrile",241-083-5,17006-17-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
68806,"Cuprate(3-), [2-[[[[3-[[4-[[2-[(2-chloroethyl)sulfonyl]ethyl]amino]-6-fluoro-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulfophenyl]azo]phenylmethyl]azo]-4-sulfobenzoato(5-)]-, trihydrogen",620-141-7,85745-52-4,Eye Irrit. 2,Notified C&L,1,H319:1
68809,Sodium 4-(2-methylprop-2-en-1-yl)benzenesulphonate,214-901-3,1208-67-9,Not Classified,REACH registration C&L,12,Not classified:10;H319:2;H315:1;H335:2
68810,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-hydroxy-, C6-12-alkyl ethers, sodium salts",605-106-6,157707-85-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
68811,6-methyl-5-nitrouracil,240-688-1,16632-21-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H318:39;H302:39;H315:40;H335:39;H319:1
68817,"2,4-dichloro-5-methylbenzene-1-sulphonyl chloride",248-938-1,28286-86-4,,Notified C&L,4,H314:4
68819,"2-(2,4,5,7-tetrabromo-3,6-dihydroxyxanthen-9-yl)benzoic acid, aluminium salt",240-569-4,16508-80-8,Not Classified,Notified C&L,48,Not classified:48
68823,"Ethanol, 2,2'-[[6,13-dichloro-3,10-bis[[2-(sulfooxy)ethyl]amino]triphenodioxazinediyl]bis(sulfonyl)]bis-, 1,1'-bis(hydrogen sulfate), potassium sodium salt (1:?:?)",600-877-5,108692-09-7,Not Classified,Notified C&L,41,Not classified:41
68825,"1,2-difluorobenzene",206-680-7,367-11-3,Flam. Liq. 2,Notified C&L,166,H225:164;H314:27;H332:5;H319:5;Not classified:2;H302:1;H312:1;H226:1;H315:1;H335:1
68835,"Amides, C14-18, N-(hydroxyethyl)",269-918-9,68391-00-4,Eye Dam. 1,Notified C&L,23,H318:23
68838,"2,5-Dimethyl-3-furoyl Chloride",610-594-9,50990-93-7,Skin Corr. 1B,Notified C&L,44,H314:43;H318:1;H290:1;H319:1;H315:1;H335:1
68839,"1,4-dihydroxyanthraquinone",201-368-7,81-64-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2144,H400:76;H410:76;H319:2066;H315:2064;H335:2064;Not classified:7;H317:3;H341:1
68841,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with 2,4'-diisocyanatodiphenylmethane and [(methylethylene)bis(oxy)]dipropanol",500-262-0,75880-28-3,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,85,H335:85;H315:85;H351:85;H334:85;H319:85;H332:85;H373:85;H317:2
68844,1-(4-nitrophenyl)piperazine,228-443-7,6269-89-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H302:45;H312:45;H335:45;H315:46;H319:46;H332:45
68848,"2-[7-isopropyl-5-methylbicyclo[2.2.2]oct-5-en-2-yl]-1,3-dioxolane",301-916-6,94087-23-7,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,389,H315:389;H411:389
68849,"metribuzin (ISO);4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one",244-209-7,21087-64-9,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H410:0
68850,Tris(dimethylamino)phosphine,216-534-4,1608-26-0,Flam. Liq. 3,Notified C&L,48,H226:48;H350:5;H302:2;H312:2;H315:3;H332:2;H319:3;H340:2;H335:2;H351:1
68853,"3-Hexenoic acid, methyl ester, (3Z)-",604-104-2,13894-62-7,Not Classified,Notified C&L,88,Not classified:88
68854,Disodium tetrabromophthalate,246-890-6,25357-79-3,Not Classified,Notified C&L,22,Not classified:17;H319:5;H315:5;H335:5
68856,"Dimethyl pyridine-3,5-dicarboxylate",224-981-1,4591-55-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
68858,"2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt",442-230-8,321679-52-1,Eye Dam. 1,Harmonised C&L,0,H318:0
68859,4-chloroanthranil acid,201-938-5,89-77-0,STOT SE 3,REACH registration C&L,53,H319:53;H315:53;H335:52;H302:4
68860,di-n-pentyl phthalate,205-017-9,131-18-0,Aquatic Acute 1;Repr. 1B,Harmonised C&L,0,H400:0;H360:0
68862,"bifenthrin (ISO);(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate",617-373-6,82657-04-3,Acute Tox. 2;Skin Sens. 1B;Acute Tox. 3;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H300:0;H410:0;H331:0;H400:0;H351:0;H372:0
68863,"(5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one",614-276-0,6809-52-5,Not Classified,REACH registration C&L,1,Not classified:1
68864,[2H4]tetrahydro[2H4]furan,216-898-4,1693-74-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;Carc. 2,Notified C&L,52,H319:48;H315:39;H225:49;H351:39;H318:4;H335:14;H224:3;Not classified:1;H302:1;H371:1;H372:1
68868,"[(4,6-dimethylpyrimidin-2-yl)thio]acetic acid",259-790-2,55749-30-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H318:38;H315:40;H335:40;H302:2;H312:1;H319:2;H332:1
68870,4-(chloromethyl)benzoyl chloride,212-881-0,876-08-4,Skin Corr. 1B;STOT SE 3,Notified C&L,79,H314:73;H335:39;H302:6;H290:7;H318:1;H227:1
68871,(Z)-hex-3-enyl hexanoate,250-661-6,31501-11-8,Not Classified,Notified C&L,212,Not classified:169;H319:42;H315:42;H335:42;H413:1
68874,N-(2-carboxyethyl)-N-dodecyl-β-alanine,241-127-3,17066-08-9,Eye Irrit. 2,Notified C&L,31,H319:31
68875,6-hydroxy-4-methyl-2-benzopyrone,219-146-3,2373-31-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
68877,"2-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol",221-573-5,3147-75-9,Not Classified,REACH registration C&L,714,Not classified:317;H412:154;H413:77;H319:110;H315:110;H335:109;H410:57;H312:2;H317:1
68878,2-methyl-3-(methylthio)pyrazine,220-736-8,2882-20-4,Not Classified,Notified C&L,1559,Not classified:1521;H319:38;H315:38;H335:38
68880,Tris(2-hydroxyethyl)ammonium mercaptoacetate,236-190-9,13220-80-9,Not Classified,Notified C&L,1,Not classified:1
68883,"Siloxanes and Silicones, di-Me, hydroxy-terminated, reaction products with chlorotrimethylsilane, hydrochloric acid, iso-Pr alc. and sodium silicate",614-496-7,68440-70-0,Not Classified,Notified C&L,89,Not classified:64;H411:16;H413:9
68887,tosylchloramide sodium,204-854-7,127-65-1,Acute Tox. 4;Skin Corr. 1B;Resp. Sens. 1,Harmonised C&L,0,H334:0;H302:0;H314:0
68888,"N,α-dimethylphenethylamine",231-559-0,7632-10-2,Acute Tox. 3;STOT SE 3;Carc. 2;Repr. 2,REACH registration C&L,2,H301:2;H336:2;H351:2;H361:2
68892,Chlorothiazide,200-404-9,58-94-6,Skin Sens. 1;Resp. Sens. 1,Notified C&L,327,H334:327;H317:326;H302:1
68898,Triethylammonium 4-(4-(3-(4-dimethylaminophenyl)prop-2-enylidene)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzenesulfonate,403-560-8,109940-17-2,Aquatic Chronic 2,Notified C&L,1,H411:1
68899,Dichromium zinc tetraoxide,234-637-2,12018-19-8,Ox. Sol. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,90,H272:83;H400:88;H410:88;H350:5;H317:5;Not classified:2
68901,"3,3-dimethyl-8,9-dinorbornan-2-one",214-804-6,1195-79-5,Not Classified,REACH registration C&L,312,Not classified:270;H226:42
68902,"4-[(4-isothiocyanatophenyl)azo]-N,N-dimethylaniline",231-521-3,7612-98-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,43,H334:38;H317:38;H302:4;H335:4;H315:5;H319:5;H332:4
68903,7-methylisoquinoline,258-913-7,54004-38-5,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A,Notified C&L,1,H319:1;H302:1;H315:1;H311:1
68907,6-O-α-D-glucopyranosyl-D-glucitol,208-605-3,534-73-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
68911,"Sulfuric acid, mono-C10-16-alkyl esters, compds. with isopropanolamine",272-728-9,68910-01-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H318:8;H315:8
68912,"2,5-diiodothiophene",210-915-9,625-88-7,,Notified C&L,6,H319:6;H315:6;H335:5
68913,"[1,1'-bicyclohexyl]-4-one",202-178-7,92-68-2,Eye Dam. 1,Notified C&L,38,H318:38
68915,(S)-2-chloropropionic acid,411-150-5,29617-66-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A,Harmonised C&L,0,H302:0;H314:0;H312:0
68916,"Ethanol, 2-amino-, reaction products with cyclohexane and peroxidized N-butyl-2,2,6,6-tetramethyl-4-piperidinamine-2,4,6-trichloro-1,3,5-triazine reaction products",606-250-2,191743-75-6,,Notified C&L,1,Not classified:1
68919,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, (1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl derivs.",270-099-5,68411-06-3,Not Classified,REACH registration C&L,260,Not classified:260
68922,2-hydroxychalcone,211-422-1,644-78-0,,Notified C&L,6,H319:6;H315:6;H335:5
68924,1-cyclohexylpiperazine,241-750-0,17766-28-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H315:40;H335:39;H302:1;H332:1;H312:1;H318:1;H314:1
68927,Di-sec-butylphenol,250-550-2,31291-60-8,Not Classified,REACH registration C&L,85,Not classified:1;H318:68;H302:68;H314:84
68936,Etocrilene,226-029-0,5232-99-5,Not Classified,REACH registration C&L,187,Not classified:147;H335:38;H410:38;H315:40;H400:38;H319:40;H302:2;H312:2;H332:2
68939,Ethyl 7-chloro-2-oxoheptanoate,278-992-1,78834-75-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H319:1;H332:1
68940,Bromoacetone,209-928-2,598-31-2,Flam. Liq. 3,Notified C&L,4,H226:4;H335:1;H315:1;H330:1;H319:1
68944,Barium dipropionate,227-612-2,5908-77-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1
68946,"Naphtha (petroleum), full-range coker;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C",270-991-4,68513-02-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H304:0;H340:0
68947,endothion (ISO);S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate,220-472-3,2778-04-3,Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0,H301:0;H311:0
68950,3-(3-fluoro-4-methoxyphenyl)propionic acid,274-186-9,69888-90-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
68951,"(S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol",248-032-6,26839-75-8,Acute Tox. 4;Carc. 2;Repr. 1B;Lact.,Notified C&L,1,H360:1;H302:1;H362:1;H351:1
68953,"p-fluoro-α,α,α-trichlorotoluene",206-942-0,402-42-6,,Notified C&L,4,H302:4;H314:4;H312:4
68955,N-benzylacrylamide,603-701-5,13304-62-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H318:38;H302:43;H315:42;H335:42;H319:4
68956,"2,2'-[(1-methylethylidene)bis[4,1-phenyleneoxy[1-(butoxymethyl)ethylene]oxymethylene]]bisoxirane",275-143-7,71033-08-4,Skin Sens. 1,Notified C&L,517,H317:516;H319:18;H315:26;H332:1
68961,acetyl chloride,200-865-6,75-36-5,Flam. Liq. 2;Skin Corr. 1B,Harmonised C&L,0,H314:0;H225:0
68963,"4,6-dichloro-2-methylthio-5-phenylpyrimidine",264-877-3,64415-11-8,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H314:38;H335:38
68964,"Amides, C14-18, N-(2-hydroxypropyl)",272-495-3,68855-61-8,Eye Irrit. 2,Notified C&L,442,H319:442
68965,2-bromohexanoic acid,210-461-1,616-05-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,57,H302:51;H312:39;H318:50;H314:56;H332:39;H371:11;H319:1;H315:1;H335:1;H290:1
68971,"Hydrocarbons, C10-C13, aromatics,",922-153-0,,Asp. Tox. 1;Aquatic Chronic 2,REACH registration C&L,103,H304:103;H411:94;H226:9;H412:9
68974,"2,2,2-trifluoroethylhydrazine",225-734-0,5042-30-8,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H228:38;H332:40;H302:40;H312:40;H335:1;H315:1;H319:1;H226:1
68977,Methoxymethylpyrazine,264-168-9,63450-30-6,Not Classified,Notified C&L,89,Not classified:89
68984,"Hexanedioic acid, polymer with 2,2-dimethyl-1,3-propanediol, isodecyl ester",619-205-7,96294-08-5,Not Classified,Notified C&L,1,Not classified:1
68989,"4,4'-methylenebis(2,6-dimethylphenyl cyanate)",405-790-4,101657-77-6,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
68992,"Carbamic acid, [3-(triethoxysilyl)propyl]-, 2-hydroxyethyl ester",608-819-0,33002-30-1,Not Classified,Notified C&L,25,Not classified:25
68995,"Hydrocarbons, C",305-971-7,95371-04-3,Carc. 1B,Harmonised C&L,0,H350:0
68996,"(8α)-12'-hydroxy-5'α-isobutyl-2'-isopropylergotaman-3',6',18-trione",208-122-8,511-10-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2;Lact.,Notified C&L,1,H302:1;H312:1;H362:1;H361:1;H332:1
69002,"D-Xylopyranose, oligomeric, 2-octyldodecyl xylosides",464-320-6,423772-95-6,Not Classified,Notified C&L,1,Not classified:1
69006,Cyclooct-4-en-1-ol,224-280-0,4277-34-3,Not Classified,REACH registration C&L,2,Not classified:2
69011,Helium,231-168-5,7440-59-7,Press. Gas (Comp.),Notified C&L,566,H280:398;H281:172;Not classified:2
69015,"Hydrocarbons, C",305-972-2,95371-05-4,Carc. 1B,Harmonised C&L,0,H350:0
69016,"Commiphora mukul, ext.",296-895-2,93165-11-8,STOT SE 3,Notified C&L,2,H335:1;Not classified:1
69021,Terbutryn,212-950-5,886-50-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,459,H400:445;H302:286;H410:358;H317:142;H413:55;H319:39;H332:33;Not classified:5
69024,Cyclohexanecarboxamide,214-351-4,1122-56-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
69026,Tris[oxalato(2-)]digadolinium,212-766-5,867-64-1,Not Classified,REACH registration C&L,4,Not classified:4
69029,Methyltrivinylsilane,242-120-8,18244-95-6,,Notified C&L,4,H225:4
69031,6-p-toluidinonaphthalene-2-sulphonic acid,231-769-2,7724-15-4,Skin Irrit. 2,Notified C&L,38,H315:38
69033,4-fluoro-3-phenoxybenzaldehyde,269-856-2,68359-57-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H319:38;H302:40;H332:1;H312:1
69036,p-chlorotoluene-α-thiol,228-395-7,6258-66-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H302:6;H331:7;H301:1;H311:1
69037,2-chloro-3-pyridylamine,228-572-9,6298-19-7,Not Classified,REACH registration C&L,51,Not classified:7;H319:44;H315:44;H335:43;H312:4;H302:1
69041,"Extracts (petroleum), light naphthenic distillate solvent",265-102-1,64742-03-6,Carc. 1B,Harmonised C&L,0,H350:0
69043,Aluminum oxide,618-619-5,90669-62-8,STOT SE 3;STOT SE 3,Notified C&L,1,H335:1
69045,"1-methyldiazolidine-2,4-dione",210-460-6,616-04-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,90,H319:90;H315:90;H335:90
69046,m-phenylene dibenzoate,202-294-8,94-01-9,Not Classified,Notified C&L,11,Not classified:11
69051,"Alkenes, C14-20 α-",272-494-8,68855-60-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,469,H319:441;H315:441;H304:23;Not classified:5
69052,"1,1-difluoroethane",200-866-1,75-37-6,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,598,H220:567;H280:449;H350:40;H340:40;H224:25;Not classified:5;H336:6;H370:5
69053,Oxo(propan-2-olato)aluminium,270-365-0,68425-65-0,Not Classified,Notified C&L,21,Not classified:20;H319:1
69054,"2-Propenamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methyl-",618-539-0,90357-53-2,,Notified C&L,1,H319:1;H315:1;H335:1
69056,N-(2-hydroxyethyl)oleamide,203-884-8,111-58-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,190,H318:62;H315:183;H411:4;H319:39;H335:39
69058,2-tert-Butyl-5-(4-tert-butylbenzylthio)-4-chloro-pyridazine-3(2H)-one,619-218-8,96489-71-3,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,197,H400:197;H301:197;H410:197;H331:197
69059,4-[(5-chloro-4-methyl-2-sulphophenyl)azo]-3-hydroxy-2-naphthoic acid,240-150-6,16013-44-8,Not Classified,Notified C&L,5,Not classified:5
69060,5-nitro-2-n-propylaminopyridine,247-357-0,25948-11-2,,Notified C&L,4,H319:4;H302:4;H315:4;H335:4
69064,"Hydrocarbons, C3-4-rich, petroleum distillate;Petroleum gas;[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]",270-990-9,68512-91-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
69067,"2-ethylhexane-1,3-diol;octylene glycol;ethoexadiol",202-377-9,94-96-2,Eye Dam. 1,Harmonised C&L,0,H318:0
69068,2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl methacrylate,244-279-9,21217-75-4,Skin Irrit. 2,Notified C&L,1,H315:1
69070,DL-xylose,255-277-2,41247-05-6,Not Classified,Notified C&L,1,Not classified:1
69073,"Tricyclo[3.3.1.13,7]dec-1,3-diyldi(acetic acid)",241-751-6,17768-28-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
69079,Dicarbonylbis(triphenylphosphine)nickel,235-851-9,13007-90-4,Skin Sens. 1;Carc. 1B,Notified C&L,42,H350:38;H317:38;H301:4;H311:4;H330:4
69082,Molybdenum carbide,234-569-3,12011-97-1,Not Classified,Notified C&L,1,Not classified:1
69088,"(3S)-4,4,4-Trifluorobutane-1,3-diol",603-900-7,135154-88-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
69093,"1,3,5-TRIAZINE-2,4,6-TRIAMINE, POLYMER WITH FORMALDEHYDE, BUTYLATED",614-205-3,68002-25-5,Aquatic Chronic 4,Notified C&L,594,H413:324;H226:134;H411:71;H312:89;H350:38;H302:38;H317:38;Not classified:27
69094,N-hydroxyphthalimide,208-358-1,524-38-9,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,49,H319:49;H315:49;H335:46
69098,4-hydroxy-m-toluic acid,207-890-1,499-76-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44,H318:38;H302:38;H315:44;H335:43;H319:6
69099,Barium dimetaphosphate,237-362-6,13762-83-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,48,H302:48;H332:48
69100,Benzylammonium chloride,221-943-6,3287-99-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,46,H318:40;H302:44;H315:46;H335:45;H319:6
69103,"Pyridine-2,6-diyldimethanol",214-803-0,1195-59-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,49,H318:47;H315:49;H335:47;H319:2
69104,"Poly(oxy-1,2-ethanediyl), a-hydro-w-[(1-oxo-2-propenyl)oxy]-, ether with 1,6-Hexanediol (2:1) (3EO)",617-544-5,84170-27-4,Not Classified,Notified C&L,145,Not classified:108;H319:37;H317:36;H335:22;H315:14
69107,(1-chloroethyl)trimethylsilane,232-135-8,7787-87-3,Flam. Liq. 2,Notified C&L,38,H225:38
69112,"Fatty acids, C18-unsatd, dimers, oligomeric reaction products with tall-oil fatty acids and ethanol, 2-amino-, reaction products with ammonia, by-products from",922-318-7,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Repr. 1B;Aquatic Chronic 3,Notified C&L,1,H317:1;H412:1;H360:1;H315:1;H319:1
69113,α-tocopheryl acetate,200-405-4,58-95-7,Aquatic Chronic 4,Notified C&L,253,H413:155;Not classified:98
69117,1-naphthyl isocyanate,201-703-7,86-84-0,Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,REACH registration C&L,81,H335:80;H318:34;H315:78;H334:80;H332:75;H302:39;H312:39;H319:44;H331:6;H314:2;H301:2;H311:1
69120,ethyl 4-[(3-ethoxy-3-oxopropyl)(methyl)amino]butanoate,600-917-1,109386-70-1,Not Classified,REACH registration C&L,1,Not classified:1
69123,Ethylenediamine dihydrobromide,210-853-2,624-59-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
69125,"Amides, C18-unsatd., dimers, N-[2-(2-oxo-1-imidazolidinyl)ethyl]",600-276-8,1021354-77-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
69127,Sodium bis[N-[7-hydroxy-8-[[2-hydroxy-5-[(methylamino)sulphonyl]phenyl]azo]-1-naphthyl]acetamidato(2-)]chromate(1-),273-454-2,68966-87-0,Not Classified,REACH registration C&L,3,Not classified:3
69129,Dimethoxydimethylsilane,214-189-4,1112-39-6,Flam. Liq. 2,REACH registration C&L,307,H225:292;H319:127;H361:91;H335:26;H300:22;H315:32;H302:9;Not classified:7;H360:2;H370:2;H372:2;H317:1
69135,"2,5-dimethylhexa-2,4-diene",212-115-5,764-13-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H226:44;H335:43
69137,"2'-hydroxy-4',6'-dimethylacetophenone",240-274-0,16108-50-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38
69140,Ammonium bromide,235-183-8,12124-97-9,Eye Irrit. 2,REACH registration C&L,637,H319:634;H315:74;H335:70;Not classified:3;H412:1
69141,Glycerides,265-027-4,64706-27-0,Not Classified,Notified C&L,6,Not classified:6
69142,Treosulfan,206-081-0,299-75-2,Carc. 1A;STOT SE 2,Notified C&L,1,H350:1;H371:1
69145,3-nitrocarbazole,221-367-5,3077-85-8,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38,H301:38;H319:38
69148,5-nitroquinoline,210-134-3,607-34-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,40,H302:40;H351:40;H332:40;H312:40
69153,"1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-, ethyl ester",616-734-5,79794-75-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,86,H319:58;H315:58;H335:58;H400:16;H360:10;H410:17;H361:12;H362:10;H351:10;Not classified:2;H302:1
69154,cadmiumhexafluorosilicate(2-);cadmium fluorosilica,241-084-0,17010-21-8,Acute Tox. 3;Acute Tox. 3;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H331:0;H400:0;H301:0;H351:0;H373:0
69157,Isooctadecan-1-ol,248-470-8,27458-93-1,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1691,H315:19;H412:19;Not classified:1513;H319:159
69159,1H-indole-7-carboxylic acid,216-801-5,1670-83-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
69160,Bis(4-bromophenyl)glycolic acid,250-318-0,30738-49-9,Acute Tox. 4,Notified C&L,38,H302:38
69163,methyl N-{[dimethoxy(methyl)silyl]methyl}carbamate,457-690-5,23432-65-7,Flam. Liq. 2;Repr. 1B;STOT SE 2,REACH registration C&L,6,H360:4;H225:2;H371:2;Not classified:2;H332:2
69165,Carbinoxamine hydrogen maleate,222-498-0,3505-38-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,84,H301:82;H319:81;H315:81;H335:81;H302:2;H332:2;H312:2
69167,PEG 120 Methyl Glucose Dioleate,617-932-4,86893-19-8,Aquatic Chronic 4,Notified C&L,220,H413:167;Not classified:40;H317:13
69168,(Bromomethylphenyl-4')-2 benzonitrile,601-327-7,114772-54-2,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,40,H317:40;H411:2;H400:38;H410:38
69170,N-(2-thioxo-4-oxothiazolidine)acetic acid,227-220-1,5718-83-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
69173,"L-Histidine, hydrochloride, hydrate (1:1:1)",611-821-4,5934-29-2,Eye Irrit. 2,REACH registration C&L,7,H319:2;Not classified:5;H315:1
69175,Orphenadrine hydrochloride,206-435-4,341-69-5,Acute Tox. 3,Notified C&L,41,H301:40;H302:1
69177,Reactive Blue 221,618-318-9,89933-65-3,Aquatic Chronic 3,Notified C&L,3,H412:3
69178,2-butoxyethyl (+)-2-(4-chloro-2-methylphenoxy)propionate,307-443-1,97659-39-7,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H400:2;H302:2;H317:2;H410:2
69185,4-(2-bromoethyl)phenol,237-989-5,14140-15-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
69188,"Dipotassium 2,2'-[oxybis(2,1-ethanediyloxy)]bisacetate",303-629-1,94201-43-1,Not Classified,REACH registration C&L,2,Not classified:2
69189,4'-aminoazobenzene-4-sulphonic acid,203-187-9,104-23-4,Acute Tox. 4,REACH registration C&L,148,H302:141;H319:100;H317:95;H315:100;H412:83;H335:4;Not classified:3
69200,"Lithium bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)",281-420-3,83949-60-4,Not Classified,REACH registration C&L,2,Not classified:2
69201,N-phenyl-p-anisidine,214-902-9,1208-86-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
69203,(2H10)-o-xylene,259-942-8,56004-61-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,45,H315:45;H332:45;H226:45;H312:45
69206,"Reaction products of alcohols, C8-22, distn. residues and sulfuric acid, sodium salt",921-986-7,,Not Classified,Notified C&L,36,Not classified:36
69207,"(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one",616-385-9,76801-85-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,72,H319:69;H315:2;H335:2;H334:2;H317:2;H302:1;H413:1
69209,"Trisodium [N,N-bis[2-[bis(carboxymethyl)amino]ethyl]glycinato(5-)]manganate(3-)",234-282-3,11065-74-0,Not Classified,Notified C&L,4,Not classified:4
69212,"Fatty acids, C16-18, esters with ethylene glycol",292-932-1,91031-31-1,Not Classified,REACH registration C&L,245,Not classified:244;H319:1;H302:1
69214,8-aminooctanoic acid,213-687-9,1002-57-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H315:3;H335:2;H252:1;H228:1
69218,Dipotassium titanium oxide dioxalate,238-475-3,14481-26-6,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,7,H318:2;H302:7;H312:7
69220,"3-Pyridinemethanesulfonic acid, 5-[2-[5-[[4-chloro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]diazenyl]-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-, sodium salt (1:3)",618-317-3,89923-43-3,Not Classified,Notified C&L,14,Not classified:14
69222,"cis-3,4-dichlorocyclobutene",220-981-0,2957-95-1,Flam. Liq. 3,Notified C&L,38,H226:38
69228,"cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride",426-020-3,51229-78-8,Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H302:0;H317:0;H228:0;H315:0;H411:0;H361:0
69240,Bis(2-chloroethyl) vinylphosphonate,204-119-0,115-98-0,Acute Tox. 4,Notified C&L,39,H302:39;H319:1;H335:1
69241,"Lactic acid, compound with 5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine (1:1)",245-533-1,23256-42-0,Not Classified,Notified C&L,3,Not classified:2;H302:1;H332:1;H312:1
69242,3-chlorophenylacetonitrile,216-213-9,1529-41-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,45,H301:41;H331:44;H311:45;H335:5;H300:4;H315:6;H319:6
69243,4-ethylacetophenone,213-326-5,937-30-4,Not Classified,Notified C&L,1,Not classified:1
69247,"1-(4-chlorophenyl)imidazolidine-2,4-dione",608-754-8,32549-33-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:2;H312:2;H335:2;H315:2;H319:2;H332:2
69253,"Phosphonic acid, α-(C12-18-alkylamino)-C12-18-alkyl derivs.",306-942-1,97467-93-1,Skin Irrit. 2,Notified C&L,24,H315:13;Not classified:11
69255,p-(1-phenylethyl)phenol,217-864-1,1988-89-2,Eye Irrit. 2,Notified C&L,39,H319:39
69260,(S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone,604-844-6,152305-23-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:41;H302:40;H315:41;H335:40;H317:3
69261,"Fatty acids, C16-18 and C18-unsatd., branched and linear",273-295-9,68955-98-6,Not Classified,REACH registration C&L,593,Not classified:573;H319:20
69264,"1,4-dibromonaphthalene",201-484-8,83-53-4,STOT SE 3,REACH registration C&L,10,H335:9;H319:8;H315:8
69269,Decyldimethyloctylammonium chloride,251-035-5,32426-11-2,Not Classified,Notified C&L,35,Not classified:23;H400:11;H302:11;H314:11;H319:1
69271,"1,1,1,3,3-Pentafluorbutan",609-856-5,406-58-6,Flam. Liq. 2,Notified C&L,188,H225:188
69272,mepanipyrim;4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine,600-951-7,110235-47-7,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H351:0
69275,"Gases (petroleum), catalytic reformed naphtha stripper overheads;Refinery gas;[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",270-759-2,68477-77-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
69276,Cyclohexyl isovalerate,231-874-3,7774-44-9,Flam. Liq. 3,Notified C&L,1374,H226:1286;Not classified:88
69281,"Flue dust, zinc-refining",273-760-6,69012-63-1,Skin Irrit. 2;Eye Dam. 1;Muta. 2;Carc. 1A;Repr. 1A;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,27,H412:27;H318:26;H341:27;H360:27;H315:26;H350:27;H373:26
69286,4-chloro-3-nitro-5-sulphamoylbenzoic acid,245-310-9,22892-96-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,44,H319:44;H315:44;H335:44
69287,Tantalum pentabutanolate,256-962-9,51094-78-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H226:39;H335:40
69289,Disodium disulphate,237-625-5,13870-29-6,Not Classified,Notified C&L,4,Not classified:4
69291,"7-ethyl-1,4-dimethylazulene",208-449-6,529-05-5,Aquatic Chronic 4,Notified C&L,50,H413:38;H412:10;Not classified:2
69293,Trimetozine,211-236-0,635-41-6,Acute Tox. 4,Notified C&L,38,H302:38
69300,Vinyl chloroformate,225-874-2,5130-24-5,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,38,H314:38;H331:38;H301:38;H225:38;H311:38
69301,2-bromo-3-(trifluoromethyl)aniline,261-261-6,58458-10-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H315:3;H335:3;H302:1;H312:1;H332:1
69305,"2,3,4,5-Tetramethylcyclopent-2-enone",611-148-6,54458-61-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
69310,Zirconium tetrafluoride,232-018-1,7783-64-4,Skin Corr. 1B,Notified C&L,64,H314:64;H301:4;H330:4;H302:1;H312:1;H318:1;H332:1
69311,Sodium C-tetradecyl 2-sulphosuccinate,276-214-5,71963-19-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,5,H318:3;H315:4;Not classified:1;H319:1
69312,Dimethyl(octyl)amine,230-939-3,7378-99-6,Acute Tox. 3;Skin Corr. 1B;Aquatic Acute 1,REACH registration C&L,131,H400:72;H301:86;H314:93;H317:2;H318:77;H360:2;H410:2;H330:2;H315:38;H335:39;H302:45;Not classified:2;H411:1
69315,"[S(R*,R*)]-2-amino-1-phenylpropane-1,3-diol",248-867-6,28143-91-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:44
69317,"2-[8-isopropyl-6-methylbicyclo[2.2.2]oct-5-en-2-yl]-1,3-dioxolane",272-669-9,68901-32-6,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1178,H315:922;H411:946;Not classified:232
69319,"1,4-Benzenedicarboxylic acid, polymer with 1,2-ethanediol, 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bis[ethanol] and 1,1'-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bis[2-propanol]",604-640-7,148556-68-7,Not Classified,Notified C&L,2049,Not classified:2049
69321,"(1S,2S)-(-)-1,2-Diaminocyclohexane D-tartrate",614-051-7,67333-70-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40,H302:40;H332:39;H312:39;H319:2;H315:2;H335:2
69323,4-chloro-α-propylbenzyl alcohol,237-592-7,13856-86-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H315:38;H335:38
69326,"Bicyclo[2.2.1]hept-5-ene-2,3-dimethanol",201-601-2,85-39-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
69331,"2,5-difluorobenzoic acid",221-060-6,2991-28-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46
69335,2-hydroxy-5-methylbenzophenone,216-002-1,1470-57-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
69339,Disodium 6-amino-5-[(4-amino-2-sulphonatophenyl)azo]-4-hydroxynaphthalene-2-sulphonate,228-821-1,6360-04-9,Not Classified,REACH registration C&L,35,Not classified:35
69343,trans-4-methylcyclohexanol,231-790-7,7731-29-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H302:40;H312:39;H335:39;H315:40;H319:39;H332:41;H336:1
69345,"Amides, from diethylenetriamine and stearic acid",295-957-6,92201-27-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,14,H319:9;H315:10;Not classified:4;H318:1
69346,2-bromo-5-nitrotoluene,230-481-4,7149-70-4,Acute Tox. 4,Notified C&L,46,H302:45;H312:6;H335:5;H315:6;H319:6;H332:2;H301:1;H331:1;H311:1;H411:1
69347,"trans-5-hydroxy-α,α,4-trimethylcyclohex-3-ene-1-methanol",255-780-7,42370-41-2,Eye Irrit. 2,Notified C&L,38,H319:38
69349,"Propane-1,2,3-triyl tris[(9Z,12Z)-octadeca-9,12-dienoate]",208-666-6,537-40-6,Not Classified,Notified C&L,1,Not classified:1
69350,"1,1-dimethoxypropane",225-258-3,4744-10-9,Flam. Liq. 2,Notified C&L,2,H225:2
69353,"2,2'-[(octadecylimino)bis(ethane-2,1-diyloxy)]diethanol",607-973-6,26635-92-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,215,H318:188;H400:183;H410:206;H315:195;H302:70;H317:11;H312:11;H314:11;H319:8;Not classified:5;H411:2;H335:1
69354,Cytosine,200-749-5,71-30-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58,H319:50;H315:50;H335:49;Not classified:8
69355,"Hydrogen bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)",227-022-5,5601-29-6,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,169,H319:12;H317:13;H412:17;Not classified:151
69356,"Imidazolium compounds, 4,5-dihydro-1-(hydroxyethyl)-1(or 3)-(2-hydroxy-3-sulfopropyl)-2-norcoco alkyl, hydroxides, monosodium salts",271-705-0,68604-73-9,Not Classified,Notified C&L,5,Not classified:5
69360,2-(piperazin-1-yl)pyrimidine,244-135-5,20980-22-7,Skin Corr. 1,REACH registration C&L,60,H314:15;H319:43;H315:45;H335:42;H302:4;H312:1;H318:3;H332:1
69361,Potassium methyl sulphate,209-231-3,562-54-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1A,Notified C&L,1,H302:1;H335:1;H315:1;H350:1;H319:1
69365,N2-{4-[(3-Fluorbenzyl)oxy]benzyl}-L-alaninamid,603-772-2,133865-89-1,Acute Tox. 4;Eye Irrit. 2;Repr. 2,REACH registration C&L,41,H319:3;H302:3;H361:3;H318:38;H301:38;H400:38
69366,4-aminotoluene-3-sulphonic acid,201-831-3,88-44-8,Not Classified,REACH registration C&L,175,Not classified:121;H314:43;H319:11;H315:9
69369,Cadmium wolframate,232-226-2,7790-85-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H302:39;H312:39;H410:39;H400:39;H332:39
69371,"p-tert-butylphenyl 1-(2,3-epoxy)propyl ether",221-453-2,3101-60-8,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,903,H317:875;H411:251;H319:838;H314:466;H315:886;H412:81;H304:16;Not classified:7;H341:1
69372,"Dehydrogenase, lactate",232-617-8,9001-60-9,Not Classified,Notified C&L,3,Not classified:2;H334:1
69375,"10,10-dimethyl-2,6-bis(methylene)bicyclo[7.2.0]undecan-5-ol",253-859-0,38284-26-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1286,H319:1286;H315:1286;H335:1286
69378,1-(3-Methyl-2-benzofuranyl)-ethanone,429-100-6,23911-56-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1327,H400:1325;H302:1327;H410:1327
69379,Nitroterephthalic acid,210-217-4,610-29-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
69382,(R)-piperidine-2-carboxylic acid,217-024-4,1723-00-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
69385,"Fatty acids, C14-22 and C16-22 unsatd.",268-099-5,68002-85-7,Not Classified,Notified C&L,12,Not classified:11;H315:1
69387,"Fatty acids, C14-18 and C12-20-unsatd.",307-931-4,97808-15-6,Skin Irrit. 2,Notified C&L,28,H315:28
69389,1-phenylcyclohexane-1-carboxylic acid,214-495-8,1135-67-7,,Notified C&L,5,H319:5;H315:5;H335:4
69390,2-bromopyrimidine,224-993-7,4595-60-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46
69392,Nonan-4-olide,203-219-1,104-61-0,Not Classified,REACH registration C&L,1722,Not classified:1716;H319:6;H335:4;H315:3
69394,"Glycerides, C16-18 mono- and di-",286-490-9,85251-77-0,Not Classified,REACH registration C&L,225,Not classified:223;H412:2
69397,"1,1'-[ethane-1,2-diylbis(thio)]bisbenzene",210-723-5,622-20-8,Acute Tox. 4,REACH registration C&L,45,H302:3;H319:41;H315:41;H413:38;Not classified:2;H335:2
69399,Sodium naphthalene-1-acetate,200-504-2,61-31-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,4,H319:3;H302:4;H318:1;H412:1;H413:1
69402,Methyl hex-2-ynoate,242-690-8,18937-79-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
69404,"2-benzyl-5,6-dihydro-4,4,6-trimethyl-4H-1,3-oxazine",248-119-9,26939-22-0,Acute Tox. 4,Notified C&L,38,H302:38
69406,Chlorotriphenylplumbane,214-572-6,1153-06-6,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H302:38;H360:38;H410:38;H400:38;H332:38;H373:38
69407,Iron titanium pseudobrookite,603-450-1,1310-39-0,Not Classified,REACH registration C&L,2,Not classified:2
69409,"3,4,5-trimethoxycinnamic acid",201-999-8,90-50-6,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,8,H319:8;H317:3;H315:5;H335:4
69410,"reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1)",412-940-2,148878-18-6,Skin Sens. 1,Harmonised C&L,0,H317:0
69412,Neodymium(3+) octanoate,279-133-3,79321-04-3,Skin Irrit. 2,Notified C&L,1,H315:1
69417,"Cyclohexanol, (4-ethylbicyclo.(.2.2.1.).hept-2-yl)-",618-809-8,92046-48-5,Skin Sens. 1,Notified C&L,154,H317:106;H315:38;H411:48;H400:10
69418,"1,3-dimethyl-1,1,3,3-tetravinyldisiloxane",240-187-8,16045-78-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H226:38;H335:38
69423,"Disodium [[[[3-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-sulphophenyl]amino]sulphonyl]sulphamoyl-29H,31H-phthalocyaninesulphonato(4-)-N29,N30,N31,N32]cuprate(2-)",273-465-2,68967-01-1,Not Classified,Notified C&L,31,Not classified:29;H319:1;H317:2;H315:1;H335:1
69426,"Silicic acid (H4SiO4), tetraethyl ester, reaction products with dibutylbis[(1-oxododecyl)oxy]stannane",274-840-3,70750-24-2,Not Classified,Notified C&L,26,Not classified:26
69427,5-[(4-amino-1-naphthyl)azo]-2-anilinobenzenesulphonic acid,259-124-0,54363-79-0,Not Classified,REACH registration C&L,3,Not classified:3
69428,Pyrazinecarbonyl chloride,243-367-4,19847-10-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H318:39;H314:44
69429,"Sorbitan monooleate, ethoxylated",500-019-9,9005-65-6,Not Classified,Notified C&L,2075,Not classified:2055;H319:13;H315:13;H302:5;H312:7;H332:5;H412:7;H335:1
69431,"Sal, ext.",294-848-0,91770-61-5,Not Classified,Notified C&L,1,Not classified:1
69434,2-(Dicyclohexylphosphino)-2'-(dimethylamino)biphenyl,606-749-5,213697-53-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,81,H319:80;H315:80;H335:79;H413:1;H302:1
69435,Bis(3-cyclopentadienyl)dichlorozirconium,215-066-8,1291-32-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,117,H319:95;H315:95;H335:95;H318:18;H411:16;H302:5;H314:6;H332:5;H312:5;H290:1
69447,2-ethylnaphthalene,213-360-0,939-27-5,Aquatic Chronic 2,Notified C&L,24,H411:21;Not classified:3
69449,4-trans-propenylveratrole,228-958-7,6379-72-2,Skin Sens. 1B,REACH registration C&L,61,H317:61
69450,4-methylthiosemicarbazide,229-563-2,6610-29-3,Acute Tox. 2,Notified C&L,45,H300:45;H311:2;H411:1
69453,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [[3-(dimethylamino)propyl]amino]sulfonyl derivs., acetates",291-010-6,90295-19-5,Aquatic Chronic 3,REACH registration C&L,129,H412:96;Not classified:33;H318:1;H314:1
69454,7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate,219-207-4,2386-87-0,Skin Sens. 1B,REACH registration C&L,769,H317:758;H412:236;H373:22;Not classified:11;H319:8;H315:7;H335:3;H341:2;H302:1
69456,"Sodium [3-[[3-[(3-amino-4-nitrophenyl)azo]-2,4-dihydroxyphenyl]azo]-4-hydroxybenzenesulphonato(3-)]cuprate(1-)",235-862-9,13011-68-2,Eye Irrit. 2,Notified C&L,75,H319:42;Not classified:31;H315:2;H412:1
69459,"Metazachlor (ISO);2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide",266-583-0,67129-08-2,Skin Sens. 1B;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0;H351:0
69468,"chloro-N,N-dimethylformiminium chloride",425-970-6,3724-43-4,Acute Tox. 4;Skin Corr. 1A;Repr. 1B,Harmonised C&L,0,H360:0;H302:0;H314:0
69472,"Starch, polymer with 2-propenoic acid, graft, sodium salt",611-963-7,60323-79-7,,Notified C&L,65,Not classified:65
69473,Ytterbium triiodide,237-474-5,13813-44-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
69475,"9,13b-Dihydro-1H-dibenz(c,f)imidazo(1,5a)azepin-3-amin",616-785-3,80012-43-7,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,2,H302:2;H411:2
69481,"Hexabromo-1,1'-biphenyl",252-994-2,36355-01-8,,Notified C&L,1,H302:1;H332:1;H312:1
69482,"N,N'-diethylbut-2-ynylenediamine",203-948-5,112-22-1,Acute Tox. 4,Notified C&L,38,H302:38
69488,Dexamphetamine sulphate,200-111-6,51-63-8,Acute Tox. 2,Notified C&L,45,H300:44;H317:1;H334:1;H330:2;H361:1;H311:2;H301:1;H331:1
69492,"mecarbam (ISO);N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate",219-993-9,2595-54-2,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H301:0;H410:0;H311:0
69493,"Ethene, chloro-, homopolymer",618-338-8,9002-86-2,Not Classified,Notified C&L,349,Not classified:269;H319:79;H315:78;H335:78;H400:1;H362:1;H410:1;H412:1
69494,(2Z)-2-phenylhex-2-enenitrile,482-160-5,130786-09-3,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,28,H302:28;H317:28;H411:28;H332:4
69495,Dilithium glutarate,608-319-2,29126-51-0,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,2,H319:2;H302:2
69499,3-[ethyl[3-methyl-4-[(6-nitrobenzothiazol-2-yl)azo]phenyl]amino]propiononitrile,240-639-4,16586-42-8,Not Classified,Notified C&L,43,Not classified:43
69500,"2,4,6-trichloropyrimidine",223-183-0,3764-01-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,60,H302:40;H312:40;H335:44;H315:44;H319:44;H332:40;H300:10;H330:10;H314:16;H310:10;H317:2
69502,Methyl methanesulphonate,200-625-0,66-27-3,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 1B;Carc. 2;Repr. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,221,H317:175;H315:217;H411:175;H340:176;H301:220;H351:175;H319:217;H373:175;H361:176;H335:42;H350:43;H302:1;H341:2
69503,1-methylcyclopentanol,215-963-4,1462-03-9,Flam. Sol. 1;Acute Tox. 4;Eye Dam. 1,Notified C&L,47,H318:39;H228:45;H302:39;H319:6;H315:6;H335:6;H226:1
69510,1-(2-chloro-5-nitrophenyl)ethan-1-one,245-421-2,23082-50-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:1;H341:1
69512,1-[(1-methylethyl)amino]anthraquinone,248-425-2,27354-18-3,Not Classified,Notified C&L,1,Not classified:1
69513,"alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride",435-650-8,,Acute Tox. 4;Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H314:0;H410:0
69520,"2,2'-[(1-methylethylidene)bis(cyclohexane-4,1-diyloxymethylene)]bisoxirane",236-502-3,13410-58-7,Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,145,H317:145;H411:85;H319:55;H315:60;H412:55
69529,N2-[(tert-butoxy)carbonyl]-L-asparagine,231-405-2,7536-55-2,Not Classified,Notified C&L,3,Not classified:2;H319:1;H315:1;H335:1
69531,3-methoxypivalic acid,264-749-7,64241-78-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H335:1
69536,C.I. Acid Orange 139,616-394-8,76822-87-2,Not Classified,Notified C&L,1,Not classified:1
69537,"1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine hydrate hydrochloride",603-075-3,125494-59-9,Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Repr. 2;STOT RE 1,Notified C&L,44,H317:42;H301:43;H372:42;H334:42;H319:42;H361:42;H302:1;H332:1;H312:1
69538,"Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]",270-804-6,68478-24-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
69539,"Tail gas (petroleum), catalytic cracker refractionation absorber;Refinery gas;[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]",270-805-1,68478-25-1,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
69540,N-(benzyl)-6-methylpyridin-2-amine,274-716-9,70644-47-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
69544,N-isopropyl-tert-butylamine,231-370-3,7515-80-2,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,42,H314:42;H226:38;H225:4
69546,"m-Phenylenebis(methylamine), oligomeric reaction products with 1,6-bis(2,3-epoxypropoxy) hexane, reaction products with 2,3-epoxypropyl neodecanoate",500-597-2,161278-08-6,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 3,Notified C&L,18,H302:18;H317:18;H412:18;H314:18;H331:18
69548,Dimethyl(3-sulphonatopropyl)tetradecylammonium,239-003-9,14933-09-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:45;H335:44;H302:1;H412:1;H318:1;Not classified:1
69550,"3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-ar-carboxylic acid",276-331-1,72088-94-9,Eye Irrit. 2,Notified C&L,3,H319:2;H317:1
69551,(1-chloroethyl) cyclohexyl carbonate,619-434-2,99464-83-2,Skin Sens. 1;Muta. 2,Notified C&L,5,H341:4;H317:4;H314:1;Not classified:1
69554,"Oils, vegetable, hydrogenated, interesterified",307-350-6,97593-45-8,Not Classified,Notified C&L,6,Not classified:6
69556,isopropyl (diaminophosphoryl) carbamate,620-216-4,298692-41-8,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H302:1;H410:1
69558,"L-Leucine, N-[(2S,3R)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl]-, hydrochloride (1:1)",613-790-2,65391-42-6,Not Classified,Notified C&L,3,Not classified:2;H319:1;H315:1;H335:1
69559,2-Cyanopyrimidine,604-202-5,14080-23-0,Acute Tox. 3;Skin Sens. 1,Notified C&L,136,H301:130;H317:130;H319:5;H315:5;H335:4;Not classified:1;H302:3;H312:3;H332:3
69561,"N,N-bis(2-aminoethyl)ethylenediamine",223-857-4,4097-89-6,Acute Tox. 3;Acute Tox. 2;Skin Corr. 1B;Eye Dam. 1;STOT SE 1,Notified C&L,539,H310:503;H318:457;H314:504;H301:502;H370:442;Not classified:33;H311:3;H302:2
69568,"Methyl 3-α,7-α-diacetoxy-12-oxo-5-β-cholan-24-oate",249-070-6,28535-81-1,Acute Tox. 4,Notified C&L,2,H302:1;Not classified:1
69570,Cadmium bis(4-cyclohexylbutyrate),259-767-7,55700-14-6,,Notified C&L,5,H302:5;H312:5;H410:5;H400:5;H332:4
69572,2-[(p-nitrophenyl)azo]acetoacetanilide,216-754-0,1657-16-5,Not Classified,Notified C&L,71,Not classified:71
69573,4-(3-methyl-5-oxo-2-pyrazolin-1-yl)benzenesulphonic acid,201-901-3,89-36-1,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,88,H317:7;H413:4;H314:42;Not classified:38;H412:3;H319:1;H315:1;H335:1;H318:1
69574,2-[(E)-(2-methoxy-5-nitrophenyl)diazenyl]-N-(2-methoxyphenyl)-3-oxobutanamide,617-143-5,80675-49-6,Not Classified,REACH registration C&L,85,Not classified:2;H413:83
69575,Dibismuth tritelluride,215-135-2,1304-82-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,213,H302:213;H312:213;H335:213;H315:213;H319:213;H332:213
69579,4-Fluoro-3-methylanisole,607-225-9,2338-54-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
69582,"2,3-dimethoxyphenol",225-922-2,5150-42-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:43
69594,2-phenylpropionaldehyde-dimethyl acetal,202-022-8,90-87-9,Acute Tox. 4,REACH registration C&L,1624,H302:1624;H319:38;H315:38;H335:38
69596,"Ethanone, 2-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-",604-982-7,15485-65-1,Not Classified,Notified C&L,1,Not classified:1
69597,"Sulfuric acid, mono-C12-18-alkyl esters, ammonium salts",292-211-1,90583-13-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,32,H318:30;H315:31;H319:2;H302:1;H228:1;Not classified:1;H332:1
69599,Lutetium triiodide,237-475-0,13813-45-1,,Notified C&L,5,H319:4;H315:4;H335:4;Not classified:1
69600,"N,N-diethyl-4-nitrosoaniline",204-379-5,120-22-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,44,H301:43;H331:39;H311:43;H228:5;H330:4;H373:4;Not classified:1
69605,3-methylbenzothiazole-2(3H)-thione,218-852-9,2254-94-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
69609,"Benzaldehyde, 3-(1,1-dimethylethyl)-",607-191-5,23039-28-3,Acute Tox. 3;Aquatic Chronic 1,Notified C&L,2,H302:1;H410:1;H319:1;H315:1;H335:1
69610,o-tolyl chloroformate,242-993-5,19358-42-0,Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 2,Notified C&L,1,H310:1;H300:1;H318:1;H314:1;H330:1
69614,2-Bromobenzaldoxime,608-951-9,34158-72-0,,Notified C&L,5,H319:5;H315:5;H335:4
69617,Propham,204-542-0,122-42-9,Acute Tox. 4,Notified C&L,48,H302:48;H411:1
69619,"reaction mass of: 2,2-dimethoxyethanal [(this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate;water(Including free water and water in hydrated 2,2-dimethoxyethanal)]",421-890-0,,Skin Sens. 1,Harmonised C&L,0,H317:0
69621,Disodium 2-ethylhexyl phosphate,239-535-1,15505-13-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,34,H319:33;H315:33;Not classified:1
69627,(S)-alpha-hydroxy-benzeneacetic acid compd. With (R)-N-methyl-gamma-(2-methylphenoxy)benzenepropanamine (1:1),617-437-3,83113-55-7,Acute Tox. 3;Eye Dam. 1;Acute Tox. 2;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H318:4;H410:4;H400:4;H301:4;H336:4;H330:4;H373:4
69633,"N,N'-(iminodiethylene)bispalmitamide monoacetate",299-939-9,93918-59-3,,Notified C&L,9,H318:9;H412:9
69640,"Fatty acids, C16-18, reaction products with diethylenetriamine",288-312-5,85711-52-0,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,37,H319:25;H315:25;Not classified:12
69641,"p-mentha-1(7),2-diene",209-081-9,555-10-2,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,317,H304:316;H226:317;H302:2;H335:1;H315:1;H334:1;H319:1
69642,"2-methylol-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yloxy",604-763-6,150980-90-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
69645,(1S)-1-(napghthalen-1-yl)ethan-1-amine,600-536-0,10420-89-0,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,131,H318:84;H301:88;H314:88;H411:83;H319:42;H315:43;H335:41;H311:5;H331:1;H302:1;H317:1;H312:1
69650,Man-made vitreous (silicate) fibres,608-250-8,287922-11-6,Not Classified,Notified C&L,25,Not classified:23;H315:2
69651,"Dihydrogen [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)",258-272-3,52953-39-6,Not Classified,REACH registration C&L,10,Not classified:2;H412:8
69654,5-Methylpyrazine-2-carboxylic acid [2-(4-sulfamoylphenyl)ethyl]amide,924-293-8,,Acute Tox. 4;Muta. 2;Repr. 2;Aquatic Chronic 4,REACH registration C&L,2,H341:2;H302:2;H413:2;H361:2
69657,"(1R,2S,5S)-2-(methoxycarbonyl)-6,6-dimethyl-3-azoniabicyclo[3.1.0]hexane chloride",611-400-5,565456-77-1,Skin Sens. 1,Notified C&L,12,H317:11;H319:1;H335:1;Not classified:1
69658,"Rue, ext.",284-531-5,84929-47-5,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1389,H317:1353;H411:1352;H319:31;H412:27;Not classified:10;H226:1
69659,"[2R*(4R*,8R*)]-(±)-3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl nicotinate",257-501-4,51898-34-1,Not Classified,Notified C&L,4,Not classified:4
69660,sodium chromate,231-889-5,7775-11-3,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;Muta. 1B;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H317:0;H312:0;H360:0;H314:0;H410:0;H340:0;H334:0;H301:0;H400:0;H372:0;H330:0;H350:0
69661,Ethyl 4-methoxyphenylacetate,237-903-6,14062-18-1,Flam. Liq. 3,Notified C&L,1,H226:1
69663,5-bromopyrimidine,224-992-1,4595-59-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,85,H319:84;H315:50;H335:47;H302:1
69665,"3,5,6-tri-O-.benzyl-1,2-O-isopropylidene-α-D-glucofuranose",258-868-3,53928-30-6,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 3;Carc. 1B;Aquatic Chronic 3,REACH registration C&L,4,H302:2;H412:2;H331:2;H350:2;H319:2;Not classified:2
69670,(4-fluorophenyl)acetone,207-284-7,459-03-0,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H317:1;H315:1;H335:1
69671,"2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutyramide]",226-939-8,5567-15-7,Not Classified,REACH registration C&L,947,Not classified:942;H412:2;H302:2;H318:1;H315:1
69675,"2,3-Dimethyliodobenzene",608-648-1,31599-60-7,,Notified C&L,7,H319:7;H315:7;H335:6
69676,"1,3-dihydro-5-methyl-2H-benzimidazole-2-thione",248-350-5,27231-36-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43;H302:1
69677,"lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate",401-560-2,108624-00-6,Skin Sens. 1,Harmonised C&L,0,H317:0
69680,4-(Trifluoromethoxy)anisole,615-239-1,710-18-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:39;H312:39;H335:43;H315:45;H332:39;H319:45;H226:44
69681,"9-Octadecenoic acid (Z)-, reaction products with 2-[(2-aminoethyl)amino]ethanol",272-379-2,68815-51-0,Skin Sens. 1A;Repr. 1B,REACH registration C&L,89,H360:89;H317:89
69684,6-methyl-1H-pyrimidin-4-one,222-543-4,3524-87-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,40,H318:39;H302:39;H319:1;H315:1
69685,"β,5-dimethylfuran-2-propionaldehyde",250-771-4,31704-80-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1419,H319:1366;H315:1366;H335:1366;H226:131
69688,Cyclodecane,206-032-3,293-96-9,Asp. Tox. 1,Notified C&L,1,H304:1
69689,"2,16α,20,25-tetrahydroxy-9β-methyl-10α-19-norlanosta-1,5,23(E)-triene-3,11,22-trione",218-736-8,2222-07-3,Acute Tox. 3;Acute Tox. 3,Notified C&L,3,H301:2;H311:3;H300:1
69690,Pentacalcium hydroxide tris(orthophosphate),235-330-6,12167-74-7,Not Classified,REACH registration C&L,349,Not classified:341;H319:8;H315:8;H335:8
69691,4-nitrotoluene,202-808-0,99-99-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H331:0;H301:0;H311:0;H373:0
69692,"7-aminonaphthalene-1,3-disulphonic acid",201-689-2,86-65-7,Not Classified,Notified C&L,3,Not classified:1;H318:1;H314:1;H319:1
69694,"Soaps, stocks, palm kernel-oil, acidulated",283-099-5,84540-09-0,Not Classified,Notified C&L,3,Not classified:3
69696,Methyl L-serinate hydrochloride,227-140-7,5680-80-8,Not Classified,Notified C&L,7,Not classified:5;H319:2;H315:2;H335:2
69701,(2H2)phosphinic (2H)acid,260-831-1,57583-56-9,Skin Corr. 1B,Notified C&L,38,H314:38
69706,"4-fluorobenzene-1,2-diamine",206-691-7,367-31-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H335:47;H302:5;H311:4;H332:4
69708,[3-(dodecyloxy)-2-hydroxypropyl]bis(2-hydroxyethyl)methylammonium methyl sulphate,242-443-4,18602-17-0,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,14,H312:14;H318:14;H314:14;H410:14;H400:14
69710,3-iodobenzylamine hydrochloride,223-068-5,3718-88-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3;Repr. 2,Notified C&L,46,H317:40;H335:44;H315:45;H334:40;H319:45;H361:39;Not classified:1
69712,"Fatty acids, marine-oil, hydrogenated",270-305-3,68424-48-6,Not Classified,Notified C&L,20,Not classified:20
69716,"1,1-diethoxypropane",225-257-8,4744-08-5,Flam. Liq. 2,Notified C&L,133,H225:133;H302:1;H332:1;H312:1
69719,"Castor oil, sulfated",232-306-7,8002-33-3,Not Classified,REACH registration C&L,1026,Not classified:523;H319:379;H315:444;H318:124;H412:1
69720,Piperazine-1-ethylamine monoacetate,267-084-0,67786-00-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,60,H319:60;H315:60
69722,C.I. Acid Red 414,604-842-5,152287-09-7,Not Classified,Notified C&L,1,Not classified:1
69723,"3,3'-[biphenyl-4,4'-diylbis(oxy)]dianiline",700-102-1,105112-76-3,Aquatic Chronic 4,Notified C&L,1,H413:1
69724,tert-butylxylenol,253-226-9,36812-13-2,Not Classified,Notified C&L,82,Not classified:82
69731,"(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide",414-600-9,149182-72-9,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H302:0;H412:0
69735,"4,4'-[methylenebis[(2,6-dimethyl-4,1-phenylene)imino]]bis[1-amino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic]acid, sodium salt",306-845-4,97416-96-1,Not Classified,Notified C&L,1,Not classified:1
69738,2-butoxyethyl 4-(dimethylamino)benzoate,266-668-2,67362-76-9,Not Classified,Notified C&L,2,Not classified:1;H302:1;H332:1;H312:1
69739,p-tolyl acetate,205-413-1,140-39-6,Acute Tox. 4,REACH registration C&L,1750,H302:1750;H319:38;H315:38;H335:38
69741,DL-aminomethyl-3-hydroxybenzyl alcohol hydrochloride,239-351-1,15308-34-6,Acute Tox. 4,Notified C&L,2,H302:2
69742,"Acetic acid, cobalt(2+) salt, tetrahydrate",612-153-6,6147-53-1,Skin Sens. 1;Resp. Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2113,H317:2113;H341:2084;H360:2088;H410:2088;H400:2088;H334:2113;H350:2088;H302:63;H315:38
69748,"N,N-diethylpyridine-2-ethylamine",247-309-9,25877-30-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H302:38;H315:38;H335:38
69750,1-butyldihydroxyborane,224-607-7,4426-47-5,,Notified C&L,8,H319:8;H315:8;H335:7
69751,"2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol",408-020-5,109678-33-3,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
69752,3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinic acid,201-440-8,82-82-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H302:1
69753,Bis[3-(trimethoxysilyl)propyl] fumarate,222-150-8,3371-62-8,Not Classified,Notified C&L,31,Not classified:27;H319:4;H315:3;H335:3
69755,Ammonium dithiocarbamate,208-166-8,513-74-6,Flam. Liq. 2,Notified C&L,1,H225:1
69756,5-bromo-7-nitroindoline,279-411-4,80166-90-1,,Notified C&L,5,H302:5;H312:5;H335:5;H315:5;H319:5;H332:5
69757,"Scutellaria baicalensis, ext.",304-845-9,94279-99-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:3;H315:3;H335:3;Not classified:1
69760,Propiophenone,202-257-6,93-55-0,Eye Irrit. 2,REACH registration C&L,99,H319:8;Not classified:91;H315:2;H335:2
69761,p-butylbenzaldehyde,214-851-2,1200-14-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H315:38;H335:38
69762,"Fatty acids, tall-oil, reaction products with diethylenetriamine, tetraethylenepentamine and triethylenetetramine, hydrochlorides",273-602-6,68990-48-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,21,H318:20;H315:20;Not classified:1
69763,"Tris(pentane-2,4-dionato-O,O')cobalt",244-527-6,21679-46-9,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,81,H334:77;H302:26;H317:59;H312:1;H315:1;H351:1;H319:1;H332:1;H413:1;H318:1
69764,"Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, salts with montmorillonite",272-790-7,68911-87-5,Not Classified,Notified C&L,171,Not classified:168;H372:3;H373:3
69765,Mexenone,216-688-2,1641-17-4,Skin Sens. 1,Notified C&L,38,H317:38
69766,"pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate",414-930-3,159518-91-9,Aquatic Chronic 2,Harmonised C&L,0,H411:0
69769,Hexyl valerate,214-248-4,1117-59-5,Not Classified,Notified C&L,234,Not classified:234
69773,"Benzenemethanethiol, 2,4,6-trimethyl-",606-760-5,21411-42-7,,Notified C&L,4,H302:4;H312:4;H335:4;H315:4;H319:4;H332:4
69775,Methoxyfenozide,605-245-2,161050-58-4,Aquatic Chronic 2,Notified C&L,230,H411:157;H400:72;H410:72;H412:1
69777,"Trihydrogen tris[P-butyl P-methyl diphosphato(2-)-O'',O''''](propan-2-olato)titanate(3-), compound with dioctyl phosphonate, branched and linear (1:1)",271-581-8,68585-73-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H335:1
69780,Ethyl 5-oxo-L-prolinate,230-480-9,7149-65-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
69782,4-(4-isopropoxyphenylsulfonyl)phenol,405-520-5,95235-30-6,Aquatic Chronic 2,Harmonised C&L,0,H411:0
69787,4-ethyl-o-xylene,213-293-7,934-80-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,66,H318:38;H302:38;H304:20;H335:20;H315:20;H372:20;H319:20;H226:21;H225:4;Not classified:3
69789,Disodium trisilicon heptaoxide,237-626-0,13870-30-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,84,H302:83;H312:83;H335:83;H315:83;H319:83;H332:83;Not classified:1
69794,"reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane",406-490-6,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
69798,"2-[(3-mercapto-1-oxopropoxy)methyl]-2-methylpropane-1,3-diyl bis[3-mercaptopropionate]",233-691-4,10312-58-0,Acute Tox. 4,Notified C&L,38,H302:38
69802,Methyl 2-amino-5-iodobenzoate,616-450-1,77317-55-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;H302:1;H332:1;H312:1;H335:1
69805,"Isoascorbic acid, sodium salt",230-938-8,7378-23-6,Eye Irrit. 2,Notified C&L,1,H319:1
69810,Phenformin hydrochloride,212-637-3,834-28-6,Acute Tox. 4,Notified C&L,39,H302:39
69811,"1,1,1,2,3,3-hexafluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)pentane",484-290-8,,Aquatic Chronic 2,Notified C&L,1,H411:1
69812,"Benzoic acid, 4-fluoro-2-hydroxy-, methyl ester",609-620-1,392-04-1,,Notified C&L,5,H319:5;H315:5;H335:5
69815,"Fatty acids, C16-18, 2-butyloctyl esters",309-831-6,101227-08-1,Not Classified,REACH registration C&L,5,Not classified:5
69819,[No public or meaningful name is available],453-560-7,651325-27-8,Skin Sens. 1B;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,25,H317:25;H331:25;H332:25;H412:25
69822,Mepivacaine hydrochloride,217-023-9,1722-62-9,Acute Tox. 3,Notified C&L,60,H301:39;H302:21;H412:13;H319:1;H332:2;H312:1;H315:1
69824,"2-((6,6-diméthylbicyclo[3.1.1]hept-2-yl)éthoxy)éthyl morpholine",609-541-2,38284-47-8,Not Classified,REACH registration C&L,2,Not classified:2
69832,"Amides, palm kernel-oil, N-(hydroxyethyl)",295-958-1,92201-29-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;Not classified:1
69833,"3-acetamido-2,4,6-triiodobenzoic acid",201-600-7,85-36-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
69835,Methyl 1-naphthylacetate,220-720-0,2876-78-0,Acute Tox. 4,Notified C&L,43,H302:43
69839,"(diethyldithiocarbamato-S,S')silver",216-003-7,1470-61-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H315:45;H335:44;H302:2;Not classified:1
69840,Water,231-791-2,7732-18-5,Not Classified,Notified C&L,1825,Not classified:1819;H318:2;H302:2;H226:1;H314:2;H301:1;H330:1;H411:1
69841,"2,6-dibromo-4-(chloroimino)cyclohexa-2,5-dienone",208-667-1,537-45-1,Self-react. A;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H312:40;H335:44;H315:45;H240:38;H319:45;H332:2;H302:1;H242:1
69843,"Hexanamide, 3-amino-N-cyclopropyl-2-hydroxy-, hydrochloride (1:1), (3S)-",617-658-5,850252-34-5,Not Classified,Notified C&L,1,Not classified:1
69851,4-nitrobenzylammonium hydrochloride,242-441-3,18600-42-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
69852,"2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane;reaction products with ethylene oxide (alkyl is C",430-580-4,,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H315:0;H411:0
69854,"Imidazolium compounds, 1-[2-(2-carboxyethoxy)ethyl]-1(or 3)-(2-carboxyethyl)-4,5-dihydro-2-norcoco alkyl, hydroxides, disodium salts",271-704-5,68604-71-7,Eye Dam. 1,Notified C&L,106,H318:71;H319:27;H412:13;H331:8;H301:8;H320:8;H316:8;H311:8;H226:8;H302:1;H315:2
69857,Iodine pentafluoride,232-019-7,7783-66-6,Ox. Liq. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Acute Tox. 2,Notified C&L,14,H271:7;H314:14;H301:13;H311:13;H330:14;H335:6;H410:7;H336:6;H372:1;H310:1;H318:1;H300:1;H400:1;H272:1
69859,Thiophene-2-carbaldehyde,202-629-8,98-03-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,147,H302:147;H317:94;H335:43;H315:141;H319:147;H312:2;H332:1;H227:1
69863,"2-ethylhexyl 5-butyl-12-ethyl-5-[[3-[(2-ethylhexyl)oxy]-3-oxopropyl]thio]-9-oxo-10-oxa-4,6-dithia-5-stannahexadecanoate",262-672-3,61241-05-2,Aquatic Chronic 4,Notified C&L,1,H413:1
69865,"Aminopeptidase, cytosol",232-618-3,9001-61-0,Resp. Sens. 1,Notified C&L,49,H334:48;H319:21;H315:21;H335:21;Not classified:1
69872,"Formaldehyde, polymer with nonylphenol and oxirane, hydrogen 2-sulfobutanedioate, sodium salt",614-903-8,69029-29-4,Not Classified,Notified C&L,209,Not classified:209
69874,"(Z)-2,2'-(octadec-9-enylimino)bisethanol",236-062-2,13127-82-7,Not Classified,Notified C&L,144,Not classified:134;H400:8;H302:10;H314:10;H410:6
69875,4'-Chloro-2-phenylacetophenone,606-161-9,1889-71-0,Skin Sens. 1;Eye Dam. 1,Notified C&L,42,H318:40;H317:40;H319:1;H315:1;H335:1;Not classified:1
69880,2-bromo-6-(trifluoromethyl)aniline,261-262-1,58458-13-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
69882,"3-(2,3-dihydroxypropoxy)-2-hydroxypropyl decanoate",605-046-0,156153-06-9,Not Classified,Notified C&L,15,Not classified:14;H319:1;H317:1;H315:1
69883,Magnesium diethyl dicarbonate,240-926-4,16891-37-5,Flam. Sol. 1;Self-heat. 1;Eye Irrit. 2,REACH registration C&L,1,H319:1;H228:1;H251:1
69889,"2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione",404-230-6,164578-11-4,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
69890,"Aralia canadensis, ext.",296-469-6,92704-37-5,Flam. Liq. 3,Notified C&L,77,H226:77
69892,"Disodium 7-[(4-amino-3-methoxyphenyl)azo]naphthalene-1,3-disulphonate",265-529-3,65151-26-0,Acute Tox. 4,REACH registration C&L,43,H302:43
69893,"(2S)-1,3,4,5,6,7-hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalene",214-494-2,1135-66-6,Flam. Liq. 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1599,H400:4;H410:4;H226:42;H304:1524;H319:33;H317:32;H411:32;H412:31;H302:1;H335:1;H351:1;Not classified:1
69894,"Sodium 4-[4-[[3-(anilinosulphonyl)-p-tolyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-2,5-dichlorobenzenesulphonate",228-820-6,6359-99-5,Not Classified,Notified C&L,41,Not classified:41
69896,"1,9-diphenylnona-1,3,6,8-tetraen-5-one",210-724-0,622-21-9,,Notified C&L,4,H319:4;H315:4;H335:4
69898,"Guar gum, depolymd.",270-155-9,68411-94-9,Not Classified,Notified C&L,1,Not classified:1
69899,"(3-methyl-1,4-dioxo-2-naphthyl) 4-nitrobenzoate",604-586-4,14748-93-7,Aquatic Acute 1,REACH registration C&L,1,H400:1
69902,(+/-)-trans-methyl[2-(methylamino)cyclohexyl]amine,614-082-6,67579-81-1,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,24,H302:5;H314:21;H319:2;H315:2;H335:2;H332:1;H312:1;H318:3;H226:1
69903,Spectinomycin,216-911-3,1695-77-8,Not Classified,Notified C&L,1,Not classified:1
69905,"Dibenzo[b,f]cyclohepten-1-one",218-737-3,2222-33-5,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,46,H400:6;H411:17;H319:2;H315:2;Not classified:26;H410:1
69906,"Fatty acids, C5-20, Me esters",305-591-1,94733-11-6,Not Classified,Notified C&L,2,Not classified:2
69908,3-cyanopropyldimethoxymethylsilan,418-740-1,153723-40-1,Skin Irrit. 2,Notified C&L,1,H315:1;Not classified:1
69913,"2-(2-iodoethyl)-1,3-propanediol diacetate",411-780-0,127047-77-2,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H411:0
69915,Magnesium sulphate,242-691-3,18939-43-0,Not Classified,Notified C&L,1,Not classified:1
69920,Dexamphetamine,200-112-1,51-64-9,Flam. Liq. 3;Acute Tox. 2;Skin Corr. 1C,REACH registration C&L,41,H300:40;H314:41;H226:41;H301:1;H311:1;H330:1
69921,2-decenol,244-784-4,22104-80-9,Not Classified,Notified C&L,88,Not classified:88
69923,"trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate",410-130-3,136248-03-8,Skin Sens. 1,Harmonised C&L,0,H317:0
69929,"(3β,5β)-3,5,14-trihydroxy-19-oxocard-20(22)-enolide",200-626-6,66-28-4,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,38,H300:38;H330:38;H310:38
69933,"Sorbitan monolaurate, ethoxylated",500-018-3,9005-64-5,Not Classified,REACH registration C&L,1962,Not classified:1813;H317:122;H319:25;H315:5;H335:5;H412:2
69934,"2,5-diaminobenzenesulphonic acid",201-832-9,88-45-9,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,147,H318:66;H314:106;Not classified:37;H319:4;H315:4;H335:4;H302:1
69935,"[iminobis(ethyleneiminomethylene)]bis(phosphonic) acid, N,N-bis(phosphonomethyl) derivative, sodium salt",269-979-1,68399-68-8,Aquatic Chronic 4,Notified C&L,1,H413:1
69936,Chlorosuccinic acid,240-188-3,16045-92-4,Skin Corr. 1B,Notified C&L,38,H314:38
69940,Myrrh,232-543-6,9000-45-7,Acute Tox. 4,Notified C&L,1462,H302:1415;H304:38;H226:36;H315:26;Not classified:21;H225:1;H317:1;H411:1
69944,"2-(4-OXOPENTYL)-1H-ISOINDOLE-1,3 (2H)-DIONE",608-687-4,3197-25-9,Aquatic Chronic 3,Notified C&L,1,H412:1
69947,"1,1'-dimethylferrocene",215-067-3,1291-47-0,Not Classified,Notified C&L,9,Not classified:9
69949,Isopropyl benzoate,213-361-6,939-48-0,Not Classified,Notified C&L,553,Not classified:532;H317:21
69952,Hydrogen bis[2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxo-N-phenylbutyramidato(2-)]cobaltate(1-),235-861-3,13011-62-6,Aquatic Chronic 2,Notified C&L,9,H411:4;Not classified:4;H319:1;H315:1;H335:1
69957,"Reaction products of tetrakis(hydroxymethyl)phosphonium chloride, urea and tetradecan-1-amine",436-230-7,,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Carc. 1B;Repr. 2;STOT RE 1;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,3,H302:3;H317:3;H318:3;H314:3;H411:3;H372:3;H350:2;H361:3;H401:1
69958,4-(dimethylamino)butan-1-ol,236-380-1,13330-96-6,Skin Corr. 1B,Notified C&L,40,H314:40;H318:1
69959,N-ethyl-L-glutamine,221-379-0,3081-61-6,Not Classified,Notified C&L,96,Not classified:52;H317:44
69962,D-Alanine tert-butyl ester hydrochloride,611-847-6,59531-86-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
69968,[No public or meaningful name is available],458-590-4,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1286,H304:1286;H412:1286;H315:1286;H319:1286;H226:1286
69969,1-(tert-dodecylthio)propan-2-ol,266-582-5,67124-09-8,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,475,H400:475;H317:475;H410:475
69971,"Poly(oxy-1,2-ethanediyl), α-[(1,1,3,3-tetramethylbutyl)phenyl]-ω-hydroxy-, phosphate",610-876-1,52623-95-7,Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,418,H314:358;H412:317;H318:185;H315:55;Not classified:5
69974,"reaction mass of: (1'α,3'α,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);(1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane)",416-930-9,,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H315:0;H411:0
69977,"Quaternary ammonium compounds, C16-18-alkyl(2-ethylhexyl)dimethyl, Me sulfates",619-118-4,952500-60-6,Not Classified,Notified C&L,44,Not classified:36;H318:8;H400:7;H410:8;H315:8
69978,"Phosphoric acid, reaction products with diethanolamine",286-710-3,85338-35-8,Not Classified,Notified C&L,1,Not classified:1
69979,Ricinoleyl monomaleate triglyceride,432-500-3,,Skin Sens. 1,Notified C&L,2,H317:2
69982,(3R)-(-)-3-Hydroxytetrahydrofuran,617-796-6,86087-24-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
69983,5α-androst-16-en-3α-ol,214-573-1,1153-51-1,Not Classified,Notified C&L,88,Not classified:88
69987,"Disodium 4,4'-[methylenebis(4,1-phenyleneimino)]bis[1-amino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate]",247-287-0,25826-34-0,Not Classified,Notified C&L,43,Not classified:42;H412:1
69989,1-(6-methylpyridin-3-yl)ethan-1-one,252-995-8,36357-38-7,,Notified C&L,7,H319:7;H302:7;H315:7;H335:7
69991,1-phenylcyclohexanecarbonitrile,218-608-1,2201-23-2,Acute Tox. 3,Notified C&L,40,H301:39;H302:1;H312:1;H335:1;H315:2;H319:2;H332:1;H331:1;H311:1
69994,N'1-(4-methylthiazol-2-yl)sulphanilamide,208-203-8,515-59-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
69998,"3,9-dibromo-7H-benz[de]anthracen-7-one",201-391-2,81-98-1,,Notified C&L,39,Not classified:38;H319:1;H315:1;H335:1
70000,"Benzene, 1-butoxy-4-[2-(4-fluorophenyl)ethynyl]-",603-432-3,130746-61-1,Not Classified,Notified C&L,1,Not classified:1
70003,Sodium C-octadecyl 2-sulphosuccinate,276-215-0,71963-20-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:2;H315:2;Not classified:1
70004,"3-chloro-6-methyl-dibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide",247-865-2,26638-53-9,Not Classified,REACH registration C&L,2,Not classified:1;H302:1
70005,"Betaines, (C10-20 and C10-20-unsatd. alkyl)dimethyl",292-725-6,90989-68-7,Not Classified,Notified C&L,1,Not classified:1
70006,"Acid chlorides, coco",269-133-1,68187-89-3,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,99,H317:88;H315:88;H314:11;H302:5;H290:7
70011,"4-(4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)-1-butynyl)-.alpha.,.alpha.-dimethylbenzeneacetic acid",462-560-6,,STOT RE 2;Aquatic Chronic 2,REACH registration C&L,2,H372:2;H411:2
70013,"2-ethyl-2-(hydroxymethyl)propane-1,3-diol, propoxylated, reaction product with methyl 3-oxobutanoate",923-108-8,,Not Classified,Notified C&L,1,Not classified:1
70014,beryllium oxide,215-133-1,1304-56-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 2;STOT SE 3;STOT RE 1;Carc. 1B,Harmonised C&L,0,H317:0;H335:0;H315:0;H301:0;H350:0;H372:0;H330:0;H319:0
70015,"4,4-dimethyloxolan-2-one",604-088-7,13861-97-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
70017,Disodium 4-[2-[(12-hydroxy-1-oxooctadec-9-enyl)amino]ethyl] 2-sulphonatosuccinate,267-617-7,67893-42-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,47,H319:46;H315:46;H318:1;H302:1
70018,"diethyl{}{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}}ammonium butyltriphenylborate",418-070-1,141714-54-7,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0
70023,"Urea, reaction products with formaldehyde, furfuryl alc. and phenol",286-722-9,85338-46-1,Skin Sens. 1B,Notified C&L,5,H317:5
70024,Bismuth vanadium oxide,258-786-8,53801-77-7,Not Classified,Notified C&L,33,Not classified:33
70025,"Bambusa arundinacea, ext.",294-922-2,91771-32-3,Not Classified,Notified C&L,1,Not classified:1
70026,4-chloro-α-ethylbenzyl alcohol,237-591-1,13856-85-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H302:38;H315:39;H335:39
70027,"Carpinus betulus, ext.",294-763-9,91745-92-5,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
70029,Chloroethylmagnesium,219-206-9,2386-64-3,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,80,H318:2;H260:80;H314:80;H225:37;H302:4;H224:4;H336:4
70034,"β,2,2,3-tetramethylcyclopent-3-ene-1-butanol",276-333-2,72089-08-8,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,131,H317:2;H315:4;H411:2;Not classified:127;H319:2;H335:1
70040,"3,3'-[(2-methyl-1,3-phenylene)diimino]bis[4,5,6,7-tetrachloro-1H-isoindol-1-one]",225-744-5,5045-40-9,Not Classified,Notified C&L,126,Not classified:112;H413:14
70041,7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;[containing < 0.5 % formamide (EC No 200-842-0)];[containing ≥ 0.5 % formamide (EC No 200-842-0) ],429-400-7,199327-61-2,,,0,H412:0
70052,Apomorphine hydrochloride,206-243-0,314-19-2,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,2,H302:1;H317:2;H312:2;H334:2;H332:2;H301:1
70054,2-bromo-1-(3-nitro-4-phenylmethoxyphenyl)ethanone,610-115-3,43229-01-2,Not Classified,Notified C&L,4,Not classified:1;H370:1;H412:2;H319:1;H315:1
70055,"Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",270-806-7,68478-26-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
70060,"Benzenepropanamine, N-methyl-γ-(2-methylphenoxy)-, (γR)-",617-427-9,83015-26-3,Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;Repr. 2;Aquatic Chronic 2,Notified C&L,1,H318:1;H411:1;H331:1;H301:1;H361:1
70064,4-hydrazinobenzoic acid,210-609-5,619-67-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,89,H319:89;H315:89;H335:88;H302:33;H312:33;H332:33;H412:1;H341:1;H351:1
70065,"4-[[5-[[4-chloro-6-[(4-sulphophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulphophenyl]azo]-4,5-dihydro-5-oxo-1-(4-sulphophenyl)-1H-pyrazole-3-carboxylic acid, sodium salt",301-360-4,94006-24-3,,Notified C&L,1,Not classified:1
70067,METHYL 5-IODOVALERATE,604-306-0,14273-88-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H335:38
70068,"3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide",442-560-2,105043-55-8,Aquatic Chronic 4,Harmonised C&L,0,H413:0
70072,"Octanoic acid, compound with dibutylamine (1:1)",249-071-1,28537-85-1,Not Classified,Notified C&L,54,Not classified:52;H318:2;H302:2;H315:2
70075,Sulfinpyrazone,200-357-4,57-96-5,Acute Tox. 4,Notified C&L,103,H302:103
70076,4-chloro-7-(trifluoromethyl)quinoline,206-471-0,346-55-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:41
70081,4-CHLOROTETRAHYDROPYRAN,605-785-9,1768-64-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H315:40;H226:42;H335:39
70084,N4-Acetylcytosine,619-683-7,14631-20-0,,Notified C&L,6,H319:6;H315:6;H335:5
70086,"3,5-dihydroxy-2-naphthoic acid",201-900-8,89-35-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
70089,"4-methyl-1,3,2-dioxathiane 2-oxide",224-608-2,4426-51-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
70091,3-bromobenz[de]anthracen-7-one,201-390-7,81-96-9,Acute Tox. 4;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1,Notified C&L,2081,H334:2039;H302:2081;H317:2039;H331:2039
70093,Dibismuth trioxide,215-134-7,1304-76-3,Not Classified,REACH registration C&L,431,Not classified:390;H360:20;H319:21;H315:21;H335:21
70095,Nifurpirinol,236-503-9,13411-16-0,Eye Irrit. 2,Notified C&L,39,H319:39
70097,Diethylcarbamazine,202-023-3,90-89-1,Acute Tox. 4,Notified C&L,40,H302:40;H319:1;H315:1;H335:1
70098,"Sodium bis[3-[4-[[5-tert-butyl-2-hydroxy-3-nitrophenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzene-1-sulphonamidato(2-)]chromate(1-)",276-064-0,71839-77-5,Not Classified,Notified C&L,101,Not classified:83;H302:18
70099,"N,N'-diethylbut-2-enylenediamine",203-946-4,112-21-0,Skin Corr. 1B,Notified C&L,38,H314:38
70100,Lithium acetate dihydrate,612-081-5,6108-17-4,,Notified C&L,8,H302:5;Not classified:2;H332:1;H312:1;H319:1
70103,"Fatty acids, coco, light fractions",273-097-2,68937-86-0,,Notified C&L,34,Not classified:34
70108,(3S)-3-Hydroxytetrahydrofuran,617-795-0,86087-23-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:54;H315:54;H335:53;Not classified:1
70111,"Thiocyanic acid, compound with 4,4'-(propane-1,3-diyl)bis[piperidine] (2:1)",274-717-4,70644-48-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,38,H302:38;H332:38;H312:38;H412:38
70115,"Trisodium 7-[[2-[(aminocarbonyl)amino]-4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]phenyl]azo]naphthalene-1,3,5-trisulphonate",274-349-4,70161-14-7,Skin Sens. 1B,REACH registration C&L,111,H317:76;Not classified:35;H334:7
70116,2-methoxyphenyl benzoate,208-507-0,531-37-3,Skin Sens. 1;Aquatic Acute 1,Notified C&L,38,H400:38;H317:38
70119,methylene dithiocyanate,228-652-3,6317-18-6,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Aquatic Acute 1,Harmonised C&L,0,H317:0;H314:0;H400:0;H301:0;H330:0
70120,"Tetrasodium 3-[[4-[[4-[(6-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo]-6-sulphonato-1-naphthyl]azo]-1-naphthyl]azo]naphthalene-1,5-disulphonate",224-531-4,4399-55-7,Not Classified,Notified C&L,123,Not classified:121;H319:2
70121,Propyl methanesulphonate,217-619-9,1912-31-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Muta. 1B;Carc. 2,Notified C&L,40,H302:40;H335:38;H318:38;H315:38;H340:38;H351:39;H341:1;H314:1
70122,"Sulfuric acid, mono-C12-16-alkyl esters, ammonium salts",292-210-6,90583-12-3,Not Classified,Notified C&L,61,Not classified:36;H318:25;H315:25
70123,2-benzylideneheptanal,204-541-5,122-40-7,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,2006,H317:1987;H411:1965;H413:28;H319:27;H315:27;H400:14;H410:4;H335:5;Not classified:2;H371:1;H412:1
70124,Titanium tetra(methanolate),213-596-4,992-92-7,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H302:43;H312:43;H335:40;H318:40;H228:45;H315:40;H319:5;H332:4;H224:1
70126,"Citric acid, sodium titanium salt",273-399-4,68959-15-9,Not Classified,REACH registration C&L,216,Not classified:4;H319:178;H315:178;H318:34
70129,"Dimethyl 2-[[2-[(2-methoxyphenyl)amino]-2-oxo-1-(1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazin-2-yl)ethyl]azo]terephthalate",267-700-8,67906-31-4,Not Classified,Notified C&L,5,Not classified:5
70130,"2,2,6,6,7,8,8-HEPTAMETHYL-4,5,6,7,8,8B-HEXAHYDRO-3AH-INDENO[4,5-D][1,3]DIOXOLE",457-070-4,,Aquatic Chronic 2,REACH registration C&L,38,H411:1;Not classified:37
70133,"Butanoic acid, 4,5-dihydro-2,5-dimethyl-4-oxo-3-furanyl ester",601-298-0,114099-96-6,Not Classified,Notified C&L,89,Not classified:89
70140,"2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole",412-420-5,133909-99-6,Aquatic Chronic 4,Harmonised C&L,0,H413:0
70141,Ammonium sodium hydrogenorthophosphate,235-860-8,13011-54-6,Not Classified,Notified C&L,5,Not classified:5
70142,Methyl 3-Bromo-4-methylbenzoate,600-619-1,104901-43-1,,Notified C&L,5,H319:5;H315:5;H335:4
70143,Dodecanenitrile,219-440-1,2437-25-4,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1731,H400:1617;H410:1683;H315:1494;H411:4;H302:45;H332:40;H312:40
70144,"3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid",259-768-2,55701-05-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
70148,"Trihydrogen (2S-trans)-[18-carboxy-20-(carboxymethyl)-13-ethyl-2,3-dihydro-3,7,12,17-tetramethyl-8-vinyl-21H,23H-porphine-2-propionato(5-)-N21,N22,N23,N24]cuprate(3-)",247-608-4,26317-27-1,Not Classified,Notified C&L,1,Not classified:1
70150,Cyclododecane,206-033-9,294-62-2,Not Classified,REACH registration C&L,4,Not classified:3;H413:1
70156,Choline bromide,217-660-2,1927-06-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38;H302:1;H312:1;H332:1
70162,2-Iodopyridine,610-520-5,5029-67-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
70163,Trifluoro(trifluoromethyl)oxirane,207-050-4,428-59-1,Press. Gas (Liq.);Acute Tox. 3;STOT SE 3;STOT RE 2,REACH registration C&L,60,H331:5;H373:5;H280:45;H335:46;H319:41;H315:41;Not classified:14
70165,"Amines, C12-14-branched alkyl, dodecylbenzenesulfonates (1:1)",271-668-0,68603-62-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,4,H319:4;H317:4;H315:4;H411:4
70166,Butyl(1-methylpropyl)magnesium,254-671-1,39881-32-8,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,65,H250:65;H318:1;H260:65;H314:65
70167,Sodium 4-aminobenzoate,209-080-3,555-06-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:41;H317:2
70169,N-(5-chloro-2-methoxyphenyl)-3-hydroxy-4-[[2-methoxy-5-[(phenylamino)carbonyl]phenyl]azo]naphthalene-2-carboxamide,268-028-8,67990-05-0,Not Classified,REACH registration C&L,386,Not classified:315;H317:9;H341:62;H312:62;H412:62
70175,"3,5-dichloroanisole",251-655-6,33719-74-3,Not Classified,Notified C&L,2,Not classified:1;H319:1;H302:1;H315:1;H335:1
70176,Papaverine hydrochloride,200-502-1,61-25-6,Acute Tox. 3,Notified C&L,258,H301:216;H302:42;H372:1
70179,4-methyl hydrogen 2-methylenesuccinate,230-853-6,7338-27-4,Eye Dam. 1,Notified C&L,42,H318:39;H319:3;H315:3;H335:1
70185,PPG-2 Hydroxyethyl cocamide,432-290-3,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1290,H400:1290;H319:1290;H315:1290;H411:4;H410:1286
70188,Diethyl diallylmalonate,221-696-4,3195-24-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
70191,Isopropylsulphamoyl chloride,247-472-6,26118-67-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H318:2;H314:2;H302:1;H332:1
70194,1-chloro-2-phenylethane,210-725-6,622-24-2,Aquatic Chronic 4,REACH registration C&L,2,H413:1;H319:1;H315:1;H412:1
70195,2-oxocyclohexanepropiononitrile,224-991-6,4594-78-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,42,H302:38;H332:42;H312:42;H335:4;H315:4;H301:4;H319:4
70197,Bromocyclopentylmagnesium,251-420-8,33240-34-5,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,65,H318:1;H314:65;H225:26;H250:38;H260:38
70202,"Tetraisopropoxy titanate, reaction products with triethanolamine",616-125-4,74665-17-1,Flam. Liq. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,59,H318:38;H315:59;H225:38;H335:39;H319:21
70203,4-fluorophenethylamine hydrochloride,207-285-2,459-19-8,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H301:39;H332:38;H312:38
70205,"Bis(benzyl) 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate",252-883-9,36138-79-1,Not Classified,Notified C&L,1,Not classified:1
70207,"Antimony, methylated 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]benzenamine tannin complexes",273-548-3,68989-19-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,33,H400:25;H410:25;Not classified:8
70210,"Cumene, monosulpho derivative, sodium salt",250-913-5,32073-22-6,Eye Irrit. 2;STOT SE 3,Notified C&L,154,H319:83;H315:83;H335:83;Not classified:71
70213,(Z)-(octadec-9-enoato-O)oxoaluminium,235-629-1,12393-01-0,Not Classified,Notified C&L,1,Not classified:1
70215,methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate,443-120-2,393509-79-0,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
70219,"Acetic acid, oxo-, potassium salt, reaction products with ethylenediamine and para-hydroxybenzenesulfonic acid potassium salt, iron potassium salts",462-490-6,,Not Classified,REACH registration C&L,3,Not classified:3
70220,2-[(hydroxyimino)methyl]-1-methylpyridinium methyl sulphate,214-852-8,1200-55-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:38;H315:38;H335:38;H302:2;Not classified:1
70221,3-cyclopentylpropene,222-542-9,3524-75-2,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:39;H225:43;H332:39;H312:38
70224,"Oils, wheat",616-901-2,8006-95-9,Not Classified,Notified C&L,38,Not classified:38
70225,"6-(1-phenylethyl)-1,2,3,4-tetrahydronaphthalene",400-370-7,,Aquatic Chronic 1,Notified C&L,111,H410:56;Not classified:55
70226,Butane-2-thiol,208-165-2,513-53-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,222,H319:149;H315:149;H225:222;H335:148;H400:41;H410:41;H317:41
70230,"Phenylethane-1,2-diol",202-258-1,93-56-1,Not Classified,Notified C&L,11,Not classified:9;H332:1;H302:1
70234,Tetraphenyl m-phenylene bis(phosphate),260-830-6,57583-54-7,Aquatic Chronic 3,Notified C&L,164,H412:69;Not classified:61;H411:34
70235,4-oxopent-2-en-2-oic acid,225-256-2,4743-82-2,,Notified C&L,4,H319:4;H315:4;H335:4
70236,"2,5-difluoroaniline",206-690-1,367-30-6,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Notified C&L,46,H302:44;H317:39;H332:40;H312:40;H315:7;H331:5;H311:5;H319:7;H373:4;H335:2;H301:1
70237,Tar oils,232-305-1,8002-29-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,2,H319:1;H317:1;H315:1;Not classified:1
70242,dicyclohexylammonium nitrite,221-515-9,3129-91-7,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H332:0
70243,Zinc p-tert-butylbenzoate,225-628-4,4980-54-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,53,H302:51;H312:40;H411:48;H361:40;H332:45;H373:40;H360:11;H400:8;H372:11;H410:4;Not classified:2
70244,Tyrothricin,215-771-0,1404-88-2,Not Classified,Notified C&L,2,Not classified:2
70245,"Humic acids, potassium salts",271-030-1,68514-28-3,Not Classified,REACH registration C&L,93,Not classified:86;H318:7;H319:7;H315:7
70250,(2S)-[[(benzyloxy)carbonyl]amino](cyclohexyl)acetic acid,478-210-0,69901-75-3,STOT RE 2,Notified C&L,12,H373:12
70251,1-(phenylamino)anthraquinone,220-945-4,2944-28-7,Not Classified,Notified C&L,15,Not classified:15
70253,"Phenol, 4-(9H-carbazol-3-ylamino)-, reaction products with sodium sulfide (Na2(Sx)) and sulfur, leuco deriv.",288-914-8,85940-25-6,Not Classified,REACH registration C&L,39,Not classified:39
70256,1-bicyclo[2.2.1]hept-5-en-2-ylethan-1-one oxime,265-761-5,65416-21-9,Not Classified,Notified C&L,88,Not classified:88
70261,6-phenyl-2-thiouracil,253-227-4,36822-11-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
70262,Copper(II) trifluoromethanesulphonate,252-300-8,34946-82-2,Skin Corr. 1B,Notified C&L,58,H314:58;H318:2
70263,"methyl ({[(1Z)-1-(2-amino-1,3-thiazol-4-yl)-2-(1,3-benzothiazol-2-ylsulfanyl)-2-oxoethylidene]amino}oxy)acetate",700-101-6,246035-38-1,Not Classified,Notified C&L,1,Not classified:1
70266,Hydrogen sodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulphonato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-),267-824-2,67939-06-4,Eye Irrit. 2,Notified C&L,12,H319:11;Not classified:1
70267,Aminitrozole,205-414-7,140-40-9,Acute Tox. 4,Notified C&L,46,H302:46;H332:1;H312:1
70268,"[1,1'-Biphenyl]-2-carbonitrile, 4'-(trifluoromethyl)-",618-786-4,91748-21-9,,Notified C&L,33,Not classified:33
70270,"2-amino-1,7-dihydro-6H-purin-6-one monohydrochloride",211-235-5,635-39-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H335:47
70271,4-chloro-2-fluorobenzonitrile,260-712-4,57381-51-8,,Notified C&L,8,H302:5;H315:6;H311:5;H319:6;H332:5;H301:3;H331:1;H312:1;H335:1
70273,"Disodium 8-hydroxynaphthalene-1,6-disulphonate",280-631-8,83732-80-3,Not Classified,REACH registration C&L,3,Not classified:3
70275,1-(cyclohexylamino)-4-[(4-ethoxyphenyl)amino]anthraquinone,278-799-2,77946-99-7,Aquatic Chronic 2,Notified C&L,31,H411:31
70278,Bis[(3-pyridyl)methyl]amine,216-753-5,1656-94-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,90,H319:90;H315:90
70280,"Fatty acids, C16-18, 2-hexyldecyl esters",309-832-1,101227-09-2,Not Classified,REACH registration C&L,101,Not classified:101
70281,"2-chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide",239-350-6,15308-01-7,,Notified C&L,2,H302:2
70282,5-chloropent-1-yne,238-159-5,14267-92-6,Flam. Liq. 2;Skin Irrit. 2,Notified C&L,45,H315:45;H225:45;H319:7;H335:6
70285,1-chloro-4-nitrobenzene,202-809-6,100-00-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 2;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H341:0;H331:0;H411:0;H301:0;H351:0;H311:0;H373:0
70288,1-(1-phenylethyl)piperazine,274-057-7,69628-75-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
70289,Potassium Cocoyl Hydrolyzed Collagen (Marine),614-812-3,68920-65-0,Skin Sens. 1,Notified C&L,38,H317:37;Not classified:1
70290,"Titanate(2-), [P,P-dibutyl diphosphato(2-)-O'',O''''][P,P-dioctyl diphosphato(2-)-O'',O''''][hydroxyacetato(2-)-O1,O2]-, dihydrogen, branched and linear, compds. with branched and linear dioctyl phosphonate (1:2)",271-580-2,68585-72-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H335:1
70291,Chromium(III) 4-oxopent-2-ene-2-olate,244-526-0,21679-31-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,63,H319:60;H315:60;H335:52;Not classified:3
70292,Methyl 4-hydroxy-3-methoxyphenylacetate,240-101-9,15964-80-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
70294,"O,O-diethyl O-[3-methyl-4-(methylthio)phenyl] thiophosphate",216-999-3,1716-09-2,Acute Tox. 2;Acute Tox. 3;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H300:38;H410:38;H400:38;H311:38;H330:38
70295,Miconazole nitrate,245-256-6,22832-87-7,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,156,H302:156;H410:13;H317:141;H319:18;H400:10;H341:1;H361:1;H332:1;H312:1;H373:1;H411:1
70298,"N,N-dimethylformamide, compound with sulphur trioxide",249-701-5,29584-42-7,Skin Corr. 1B,Notified C&L,40,H314:40;H319:1;H302:1;H335:1
70304,dinickel diphosphate,238-426-6,14448-18-1,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H317:0;H410:0;H400:0;H372:0;H334:0;H350:0
70306,β-methylcinnamyl alcohol,216-128-7,1504-55-8,Skin Irrit. 2,Notified C&L,157,H315:134;H319:49;H335:38;Not classified:22
70308,"Fatty acids, linseed-oil",270-304-8,68424-45-3,Not Classified,Notified C&L,155,Not classified:131;H317:24
70309,"Furan-2,5-diyldimethanol",217-544-1,1883-75-6,Not Classified,Notified C&L,2,Not classified:1;H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
70314,6-methylpyridine-2-ethanol,213-292-1,934-78-1,Eye Dam. 1,Notified C&L,38,H318:38
70315,Phenylsuccinic acid,211-238-1,635-51-8,Eye Irrit. 2,REACH registration C&L,5,H319:4;H315:2;Not classified:1;H335:1
70316,Dimethylmalonic acid,209-867-1,595-46-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
70318,4-methoxybenzyl 3-chloromethyl-5-oxo-6-phenylacetamido-(2H)5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,403-040-0,,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
70323,sodium chlorate,231-887-4,7775-09-9,Ox. Sol. 1;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H271:0;H302:0;H411:0
70326,"N,N-dimethyl-p-toluidine",202-805-4,99-97-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H331:0;H301:0;H311:0;H373:0
70329,4-nitro-m-phenylenediamine,225-876-3,5131-58-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,47,H302:7;H317:2;H315:8;H334:39;H319:5;H341:4;H312:1;H412:1
70331,"[3-(2,3-epoxypropoxy)propyl]ethoxydimethylsilane",241-889-7,17963-04-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,13,H318:13;H315:13
70333,"Addition reaction of M-tolylidene diisocyanate, 2-hydroxyethyl methacrylate, Dibutylamine and 2-(2-aminoethylamino)ethanol",921-214-9,,Not Classified,Notified C&L,71,Not classified:71
70340,Sodium tungsten hydroxide oxide phosphate,257-132-9,51312-42-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H302:42;H315:42;H335:42
70341,Butyl nonan-1-oate,256-661-2,50623-57-9,Not Classified,Notified C&L,88,Not classified:88
70344,2-furylmethanethiol,202-628-2,98-02-2,Flam. Liq. 3,Notified C&L,1697,H226:1697;H302:4;H312:4;H335:5;H319:5;H332:4;H301:2;H311:2;H331:2;H315:1
70349,Pentaaminechlorocobalt dichloride,237-594-8,13859-51-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:38;H315:38;H335:38;H317:5;H351:5
70354,(2H6)phenol,236-063-8,13127-88-3,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Notified C&L,6,H301:5;H314:5;H311:5;H341:2;H331:2;Not classified:2;H373:2
70356,"Oxirane, methyl-, polymer with oxirane, ether with (1,2-ethanediyldinitrilo)tetrakis[propanol] (4:1)",601-047-5,11111-34-5,Not Classified,Notified C&L,240,Not classified:184;H302:56
70357,"1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-2-oxonicotinonitrile",248-865-5,28141-13-1,Skin Sens. 1,Notified C&L,122,H317:83;H302:38;H312:38;H335:38;H315:39;H319:39;H332:38;H331:1;H301:1;H311:1
70358,1-(3-sulphonatopropyl)-2-vinylpyridinium,229-565-3,6613-64-5,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,4,H302:3;H317:2;H412:2;H312:1;H315:1;H319:1;H332:1;Not classified:1
70363,5-methylhex-1-ene,222-541-3,3524-73-0,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,43,H225:43;H304:39
70364,"Glycine, N-methyl-, N-coco acyl derivs.",270-156-4,68411-97-2,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,71,H318:62;H314:6;H315:39;Not classified:9
70366,"9 alpha-Bromo-6 alpha-fluoro-11 beta-hydroxy-16 alpha-methyl-21-valeryloxy-1,4-pregnadiene-3,20-dione",611-173-2,54605-02-6,Repr. 1A;STOT RE 1;Aquatic Chronic 4,Notified C&L,1,H372:1;H360:1;H413:1
70369,"2,4,4'-trihydroxybenzophenone",216-004-2,1470-79-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
70370,Bis-tert-pentyl dicarbonate,272-436-1,68835-89-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H312:1;H315:1;H319:1;H332:1
70379,"4-bromo-3,3,4,4-tetrafluorobut-1-ene",242-440-8,18599-22-9,,Notified C&L,87,Not classified:81;H319:6;H335:5;H315:2;H225:1
70380,"1,3,4-Thiadiazolidine-2,5-dithione, reaction products with hydrogen peroxide and tert-nonanethiol",293-927-7,91648-65-6,Aquatic Chronic 3,REACH registration C&L,648,H412:448;Not classified:151;H318:49
70383,"Ethene, 1,1,2,2-tetrafluoro-, homopolymer",618-337-2,9002-84-0,Not Classified,Notified C&L,713,Not classified:684;H319:27;H315:3;H335:3;H332:1;H372:1
70386,"1,3,3,5-tetramethyl-1,1,5,5-tetraphenyltrisiloxane",223-620-5,3982-82-9,Not Classified,REACH registration C&L,65,Not classified:25;H319:40
70387,Methamphetamine,208-668-7,537-46-2,Acute Tox. 3,REACH registration C&L,40,H301:40
70389,6-chloromethyl-2-methylpyridinium chloride,221-451-1,3099-30-7,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H318:1;H314:2;H290:1
70390,"Lipase, triacylglycerol",232-619-9,9001-62-1,Resp. Sens. 1,REACH registration C&L,1745,H334:1647;Not classified:97;H319:51;H315:26;H335:51;H302:16;H317:17;H332:16
70392,"4-(1-((3-((2-(tert-butoxycarbonyl(methyl)amino)acetoxy)methyl)pyridin-2-yl)(methyl)carbamoyloxy)ethyl)-1-((2R,3S)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-1H-1,2,4-triazol-4-ium)hemisulphate",926-418-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT SE 3;Repr. 2;Aquatic Chronic 3,Notified C&L,1,H302:1;H312:1;H335:1;H412:1;H319:1;H332:1;H361:1
70393,17β-hydroxyandrost-4-en-3-one hexanoate,233-690-9,10312-45-5,,Notified C&L,1,H302:1;H361:1
70394,Ytterbium(3+) acetate,244-137-6,20981-49-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
70395,Diazepam,207-122-5,439-14-5,Acute Tox. 3;Acute Tox. 3,Notified C&L,237,H301:234;H311:220;H411:7;H341:1;H413:1;H312:5;H361:2;H332:4;H302:3;H335:1;H315:1;H319:1;H336:1;H362:2;H360:1;H351:1
70396,"Juniper, Juniperus oxycedrus, ext.",289-969-0,90046-02-9,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,1622,H317:1292;H412:6;H315:16;H402:5;H319:5;H226:5;H400:1361;H410:1364;H304:1507;Not classified:62;H204:13;H318:12;H314:1
70401,Levomenol,245-423-3,23089-26-1,Aquatic Chronic 3,REACH registration C&L,228,H412:63;H411:153;H317:75;Not classified:12
70402,3-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]propiononitrile,269-728-6,68310-68-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,2,H314:2;H317:2;H312:2;H412:2
70403,"2,4-dinitrobenzoic acid",210-219-5,610-30-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:43;H302:1
70409,"(S)-3,4-Epoxy-1-butene",612-971-3,62249-80-3,Flam. Liq. 2,Notified C&L,38,H225:38
70411,"Octahydro-5-vinyl-4,7-methano-1H-inden-5-ol",236-456-4,13380-90-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,10,H318:10;H315:10
70413,"Antimony, compound with cobalt (1:1)",234-993-9,12052-42-5,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Notified C&L,38,H302:38;H335:38;H315:38;H411:38;H311:38;H319:38;H332:38
70414,Triethylamine--borane,217-022-3,1722-26-5,Flam. Liq. 2;Skin Corr. 1C;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,152,H335:2;H314:152;H411:85;H225:69;H319:2;H318:84;H331:83;H301:83;H311:83;H226:83;H302:66;H312:66;H332:66
70415,"Fatty acids, C16-18 and C18-unsatd., esters with 2,2'-(methylimino)bis[ethanol]",605-322-0,163292-61-3,Skin Irrit. 2,REACH registration C&L,1,H315:1
70419,"Disodium 2,2'-[(9,10-dihydro-9,10-dioxo-1,4-anthrylene)diimino]bis[3-bromo-5-butyltoluene-4-sulphonate]",277-429-7,73398-29-5,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,4,H318:3;H411:2;H319:1;H412:1
70421,"17-hydroxypregn-4-ene-3,20-dione 17-heptanoate",224-995-8,4596-16-1,Carc. 2;Repr. 1A;Lact.,Notified C&L,24,H360:24;H362:24;H351:24
70422,"2,5-Furandione, dihydro-3-(tetrapropenyl)-, reaction products with triethanolamine",272-547-5,68877-10-1,,Notified C&L,1,Not classified:1
70428,"hexaflumuron (ISO);1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea",401-400-1,86479-06-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
70432,"2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with methyl 2-methyl-2-propenoate and tetradecyl 2-methyl-2-propenoate",614-349-7,68171-50-6,Not Classified,Notified C&L,6,Not classified:6
70433,N-[3-(phenylamino)allylidene]aniline hydrochloride,256-545-1,50328-50-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
70435,"Lubricating oils (petroleum), C",305-594-8,94733-15-0,Carc. 1B,Harmonised C&L,0,H350:0
70437,"N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-(diethylamino)-4-methoxyphenyl]acetamide",279-131-2,79295-99-1,Skin Sens. 1B,REACH registration C&L,19,H317:10;Not classified:9
70438,Carboxymethylcellulose,618-326-2,9000-11-7,Not Classified,Notified C&L,37,Not classified:37
70440,"Diethyl 4-ethyl-1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate",214-574-7,1153-66-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
70444,"lithium sodium 3-(4-(5-Amino-4-sulfonato-2-(3-(2-sulfatoethanesulfonyl)-phenylazo)-phenylamino)-6-cyanoamino-(1,3,5)triazin-2-ylamino)-benzenesulfonate (1:?:?)",413-090-5,,Eye Irrit. 2,REACH registration C&L,1,H319:1
70446,"3,4-dimethylpyridine",209-511-5,583-58-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,46,H302:45;H335:43;H315:44;H331:43;H301:39;H311:41;H319:44;H226:45;H310:5;H332:2
70449,Disodium disilicate,237-623-4,13870-28-5,Eye Dam. 1,REACH registration C&L,137,H318:135;H319:2;H315:2;H335:2
70451,"Phosphonium, triphenyl(3,7,11-trimethyl-2,4,6,10-dodecatetraenyl)-",603-493-6,131560-11-7,Acute Tox. 3;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H301:2;H314:2;H410:2
70452,"Trichloro(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane",278-947-6,78560-45-9,Skin Corr. 1A,REACH registration C&L,74,H314:74;H335:26;H226:1;H318:1;H290:1
70453,Dioctadecyl maleate,231-372-4,7516-70-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
70454,"3,11-dichloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepine 5,5-dioxide",247-866-8,26638-66-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
70456,"1,1'-ferrocenedicarboxylic acid",215-068-9,1293-87-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
70457,Khellin,201-392-8,82-02-0,Acute Tox. 3;Skin Irrit. 2,Notified C&L,46,H301:46;H315:43;H370:2;H372:2;H319:1;H331:1;H311:1
70460,"Octadecan-1-ol, ethoxylated",500-017-8,9005-00-9,Aquatic Chronic 2,REACH registration C&L,1114,H411:354;H318:712;H400:228;Not classified:182;H315:265;H302:192;H410:59;H319:50;H412:41
70463,"(+)-10,11-dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5,10-diyldiammonium maleate",278-614-5,77086-22-7,Acute Tox. 3;Eye Irrit. 2;Repr. 2;STOT SE 1;STOT RE 1,Notified C&L,36,H370:35;H301:35;H372:35;H319:35;H361:36
70464,4-(diphenylmethyl)piperidine,243-365-3,19841-73-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H302:1;H315:1;H335:1
70465,"1,1-diethoxyisononane",267-787-2,67923-83-5,Not Classified,Notified C&L,89,Not classified:89
70466,"[1,1'-biphenyl]-2-ol, compound with 2-aminoethanol (1:1)",282-227-7,84145-04-0,Not Classified,Notified C&L,3,Not classified:3
70467,Tetrafluorostannane,232-016-0,7783-62-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:38;H332:38;H312:38;H301:4;H314:5
70468,3-methyl-1H-pyrazole-1-carboxamide,212-840-7,873-50-7,Acute Tox. 4,Notified C&L,43,H302:43
70472,2-chloro-6-fluorobenzaldehyde,206-860-5,387-45-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45;H412:1
70473,Disodium 5-((4-acetylamino-2-sulphophenyl)azo)-6-amino-4-hydroxynaphthalene-2-disulphonate,228-823-2,6360-07-2,Not Classified,Notified C&L,9,Not classified:5;H412:2;H319:2;H315:2;H335:2
70479,"Amides, from C16-18 and C18-unsatd. fatty acids and diethylenetriamine, reaction products with urea",295-955-5,92201-25-7,Skin Corr. 1B,Notified C&L,2,H314:1;Not classified:1
70481,"tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane",411-240-4,143683-23-2,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
70483,Phthalimide,201-603-3,85-41-6,Not Classified,REACH registration C&L,7,Not classified:7
70485,[No public or meaningful name is available],472-150-9,,Not Classified,Notified C&L,24,Not classified:24
70487,"Fatty acids, vegetable-oil, compds. with diethanolamine",271-982-8,68648-22-6,Not Classified,Notified C&L,449,Not classified:448;H318:1;H315:1
70490,2-nitrophenylarsonic acid,226-485-0,5410-29-7,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H400:39;H301:39;H410:39;H331:39;H350:1
70491,"Rhamnus frangula, ext.",283-418-8,84625-48-9,Acute Tox. 4,Notified C&L,2,H302:2
70493,Thulium triiodide,237-472-4,13813-43-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,45,H360:38;H319:45;H315:45;H335:45
70494,"Estra-1,3,5(10)-triene-3,17β-diol 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate)",225-512-3,4891-15-0,Carc. 2;Repr. 1B,Notified C&L,30,H360:29;H351:29;H361:1;H373:1
70495,Trietazine,217-618-3,1912-26-1,Acute Tox. 4;Aquatic Acute 1,Notified C&L,41,H400:38;H302:41
70499,"6,8-disulfanyloctanoic acid",610-288-5,462-20-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,40,H302:2;H317:1;H318:1;H315:40;H411:1;H319:39;H335:38
70500,Strychnidin-10-one mononitrate,200-627-1,66-32-0,Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H300:40;H330:39;H410:39;H400:39;H310:1;H301:1;H370:1
70501,"endothal (ISO);7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid",205-660-5,145-73-3,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H312:0;H335:0;H315:0;H301:0;H319:0
70502,4-tert-butylphthalic anhydride,251-165-2,32703-79-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
70506,"5-Benzofuranacetic acid, 2,3-dihydro-, methyl ester",605-029-8,155852-41-8,Aquatic Chronic 3,REACH registration C&L,1,H412:1
70507,2-(4-Fluorphenyl)-5-pentylpyrimidine,619-132-0,95495-03-7,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
70512,5-BROMO-2-FLUOROBENZOIC ACID,604-519-9,146328-85-0,Acute Tox. 3,Notified C&L,42,H301:39;H319:4;H315:3;H335:2
70515,Lithium octanoate,240-637-3,16577-52-9,Not Classified,Notified C&L,10,Not classified:6;H319:4;H302:4;H315:4;H335:4
70516,2-[[4-(dimethylamino)phenyl]azo]-6-methoxy-3-methylbenzothiazolium acetate,281-562-6,83968-82-5,Eye Irrit. 2,Notified C&L,2,H319:2
70519,C.I. Direct Red 227,602-236-5,12222-51-4,Not Classified,Notified C&L,17,Not classified:17
70521,"2,2-bis(bromomethyl) propane-1,3-diol",221-967-7,3296-90-0,Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0
70524,3-Bromobenzaldehyde oxime,610-748-5,51873-95-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
70528,"Urea, reaction products with formaldehyde and furfuryl alc.",286-721-3,85338-45-0,Not Classified,Notified C&L,1,Not classified:1
70530,"flumetralin (ISO);N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine",613-108-3,62924-70-3,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H315:0;H410:0;H400:0;H319:0
70538,"2-methoxy-4-(4-methyl-1,3-dioxolan-2-yl)phenol",271-279-6,68527-74-2,Not Classified,Notified C&L,90,Not classified:88;H317:2
70539,Bis(tripropyltin) oxide,213-927-2,1067-29-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H331:38;H400:38;H301:38;H311:38
70543,"N,N-diethylbenzamide",216-912-9,1696-17-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H302:43;H312:43;H335:38;H318:38;H315:39;H319:1
70548,Benzyl but-2-enoate,265-764-1,65416-24-2,Not Classified,Notified C&L,1,Not classified:1
70549,"Tetrasodium 6,6'-((3,3'-dimethyl-(1,1'-biphenyl-4,4'diyl)bis(azo)bis(4-amino-5-hydroxy-1,3-naphthalenedisulphonate)",206-242-5,314-13-6,Carc. 1B,Notified C&L,63,H350:59;H351:4;H302:1;H312:1;H360:1;H332:1;H361:1
70551,"(±)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid",266-580-4,67123-97-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
70553,Bromocyclobutane,224-530-9,4399-47-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H225:46;H335:45
70554,"4H-1-Benzopyran-4-one, 7-(β-D-glucopyranosyloxy)-5-hydroxy-3-(4-hydroxyphenyl)-",610-921-5,529-59-9,Not Classified,Notified C&L,3,Not classified:3
70555,"1,2,5,6,9,10-hexabromocyclododecane",221-695-9,3194-55-6,Repr. 2;Lact.,Harmonised C&L,0,H361:0;H362:0
70560,"2-[2,4-bis(1,1-dimethylpropyl)phenoxy]butyryl chloride",254-978-0,40567-16-6,Not Classified,Notified C&L,1,Not classified:1
70561,Trilithium nitride,247-475-2,26134-62-3,Pyr. Sol. 1;Water-react. 1;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,239,H250:2;H260:214;H412:2;H318:40;H314:239;H228:4
70564,2-(1H-benzimidazol-2-yl)aniline,227-361-9,5805-39-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H318:39;H302:43;H315:43;H335:43;H312:4;H319:5;H332:4
70565,Dibutyltin di(acetate),213-928-8,1067-33-0,Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;STOT SE 1;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,619,H317:441;H318:392;H314:526;H410:489;H370:409;H372:511;H341:452;H360:452;H400:353;H301:80;H300:73;H302:49;H371:16;H319:27;Not classified:11;H315:11;H335:4;H373:4;H310:2;H411:1
70568,"Fatty acids, tall-oil, esters with ethylene glycol",269-130-5,68187-85-9,Not Classified,REACH registration C&L,6,Not classified:3;H413:2;H412:1
70571,"Tail gas (petroleum), catalytic reformed naphtha separator;Refinery gas;[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",270-807-2,68478-27-3,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
70580,3-oxo-N-2-pyridylbutyramide,216-756-1,1657-28-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
70581,"2-(dimethoxymethyl)quinoxaline 1,4-dioxide",250-910-9,32065-66-0,Acute Tox. 4,REACH registration C&L,1,H302:1
70585,Decacarbonyldimanganese,233-445-6,10170-69-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,43,H301:43;H331:43;H311:38
70588,Zirconium di(acetate) oxide,225-924-3,5153-24-2,Eye Dam. 1,Notified C&L,320,H318:260;Not classified:60
70589,"4,10-dioxa-1,7-diazacyclododecane",206-034-4,294-92-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
70590,"Glycerides, tallow sesqui-, hydrogenated, propoxylated",614-598-1,68553-12-8,Not Classified,REACH registration C&L,2,Not classified:2
70591,"1,1,1,2,2,3,3-heptafluoro-4-iodobutane",206-779-5,374-98-1,,Notified C&L,4,H319:4;H315:4;H335:4
70592,"Ethyl 3,3-[bis(tert-butyl)dioxy]butyrate",259-820-4,55794-20-2,Org. Perox. C,Notified C&L,1,H242:1
70593,Sodium C-(2-ethylhexyl) 2-sulphosuccinate,254-672-7,39881-83-9,Not Classified,Notified C&L,3,Not classified:3
70596,Calcium dihydroxide,215-137-3,1305-62-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,6590,H318:5059;H315:2964;H335:2560;H314:1489;H370:86;H373:75;H319:81;Not classified:28;H412:1;H302:1;H312:1;H290:1;H317:1
70599,Ethyl p-aminocinnamate,225-747-1,5048-82-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
70603,"4-amino-3,5,6-trichloropyridine-2-carbonitrile",237-992-1,14143-60-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H301:38;H319:38;H315:38;H335:38
70605,7-(5-amino-5-carboxyvaleramido)cephalosporanic acid,200-501-6,61-24-5,Repr. 2,Notified C&L,1,H361:1
70606,"5-[[4-[benzylmethylamino]phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium methyl sulphate",260-833-2,57583-72-9,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H318:2;H412:2
70607,4-bromobenzophenone,202-024-9,90-90-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
70609,6-oxoheptanoic acid,221-512-2,3128-07-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42,H318:38;H314:42
70610,"Tricarbonyl[(1,2,3,4,5,6-η)-m-toluidine]chromium",252-991-6,36352-77-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H302:38;H312:38;H335:38;H315:38;H319:38
70611,Nonylamine,203-945-9,112-20-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Aquatic Acute 1,Notified C&L,47,H302:40;H312:40;H314:47;H400:40;H332:40;H411:5;H318:2;H410:2
70614,"Tropaeolum majus, ext.",283-419-3,84625-49-0,Acute Tox. 2;Aquatic Chronic 4,Notified C&L,25,H330:25;H413:25
70616,"Sodium bis[3-[[1-(3-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-4-hydroxy-N-methylbenzene-1-sulphonamidato(2-)]chromate(1-)",276-067-7,71839-81-1,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2048,H400:2;H410:2;Not classified:2046
70617,Flavoxate hydrochloride,223-066-4,3717-88-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,95,H319:94;H302:95;H315:92;H335:93;H312:1;H332:1
70618,Vancomycin,215-772-6,1404-90-6,Resp. Sens. 1,Notified C&L,42,H334:38;H319:3;H317:3;H315:3;H335:3;Not classified:1
70619,"castor oil, polymer with 1,1'-methylenebis[[]4-isocyanatobenzene]",614-468-4,68424-09-9,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,21,H335:17;H315:17;H334:17;H319:17;H332:17;Not classified:4;H317:1;H351:1;H373:1
70624,"reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide",417-540-1,,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H318:0;H411:0
70630,"2-Chlormethyl-8-(1,1-dimethylethyl)-1,4-dioxaspiro[4.5]decan",601-507-5,118135-28-7,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,34,H315:34;H411:34
70631,N-butylbenzamide,220-485-4,2782-40-3,Eye Dam. 1,Notified C&L,38,H318:38
70632,hydrogen sodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-),604-840-4,152287-07-5,Aquatic Chronic 2,Notified C&L,34,H411:34
70635,Methyl benzimidate hydrochloride,227-537-5,5873-90-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
70638,Hexadecyl hydrogen maleate,220-942-8,2944-06-1,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,2,H319:1;H317:1;H413:1;Not classified:1
70640,"Reaction mass of iron chelate of sodium salt N-[1,2 dicarboxyethyl] D,L aspartic acid and sodium chloride",476-670-7,,Skin Sens. 1B,Notified C&L,1,H317:1
70641,"1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-b,d-dihydroxy-2,6-dimethyl-, monoammonium salt,(bR,dR,1S,2S,6R,8S,8aR)- (9CI);",604-165-5,139893-43-9,Carc. 2;Repr. 1A;Lact.;Aquatic Chronic 3,REACH registration C&L,76,H360:40;H362:1;H351:40;H412:75;H318:35;H315:36;H372:35;H319:1;H335:1
70644,"1-iodo-2,2-dimethylpropane",239-533-0,15501-33-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H226:39;H335:39;H302:1;H332:1
70646,"2-[4'-[difluoro(3,4,5-trifluorophenoxy)methyl]-3',5'-difluoro[1,1'-biphenyl]-4-yl]-5-ethyltetrahydro-2H-pyran",616-651-4,787582-75-6,Not Classified,REACH registration C&L,1,Not classified:1
70650,(S)-(β-D-glucopyranosyloxy)(4-hydroxyphenyl)acetonitrile,207-878-6,499-20-7,Acute Tox. 4,Notified C&L,40,H302:40
70651,"Butanoic acid, 4,4,4-trifluoro-3-hydroxy-, ethyl ester",609-363-5,372-30-5,,Notified C&L,5,H319:5;H315:5;H335:5;H225:1
70655,Methylammonium nitrate,244-787-0,22113-87-7,Not Classified,REACH registration C&L,8,Not classified:5;H318:3;H205:3;H314:3
70657,2-Chloro-isonicotinic acid,613-143-4,6313-54-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H335:47;H302:1;H312:1;H332:1
70658,"Amines, N-(hydrogenated tallow alkyl)trimethylenedi-",271-669-6,68603-64-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,9,H318:9;H400:5;H315:9;H410:4
70659,"Fatty acids, C16-22, reaction products with diethanolamine",288-310-4,85711-51-9,Not Classified,Notified C&L,2,Not classified:2
70662,"Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl methacrylate",231-403-1,7534-94-3,Aquatic Chronic 3,REACH registration C&L,1252,H412:305;H319:1020;H315:1034;H335:1023;H411:517;H317:25;Not classified:8
70663,o-nitrobenzenethiol,225-483-7,4875-10-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,Notified C&L,1,H301:1;H311:1;H330:1
70664,"pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid",442-030-0,321912-47-4,Eye Dam. 1,Harmonised C&L,0,H318:0
70666,Manganese dipropionate,244-229-6,21129-18-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,22,H302:18;H332:18;H319:2;H315:4
70667,4-pentylbenzoic acid,247-607-9,26311-45-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,70,H319:69;H315:69;H335:68;Not classified:1
70668,Pentadecylamine,219-912-7,2570-26-5,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 3;Aquatic Acute 1,Notified C&L,39,H400:38;H302:39;H314:39;H331:39;H318:1
70669,Lithium trifluoroacetate,220-878-0,2923-17-3,Acute Tox. 2;Aquatic Acute 1,Notified C&L,44,H300:42;H400:42;H319:2;H315:2;H335:2
70670,O-2-naphthyl chlorothioformate,234-037-0,10506-37-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,52,H318:2;H315:3;H335:3;H228:48;H314:48;H411:48;H302:1;H319:1
70675,"1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione",248-597-9,27676-62-6,Not Classified,REACH registration C&L,255,Not classified:255
70676,"17-α-hydroxypregn-4-ene-3,11,20-trione",217-541-5,1882-82-2,Eye Dam. 1,REACH registration C&L,2,H318:2
70677,"2,6-Difluorobenzaldehyde",610-142-0,437-81-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H335:47;H302:1
70678,"Tetrasodium [29H,31H-phthalocyaninetetrasulphonato(6-)-N29,N30,N31,N32]cuprate(4-)",248-427-3,27360-85-6,Not Classified,REACH registration C&L,1379,Not classified:23;H319:1356;H315:1356;H335:1356
70681,Dicobalt phosphide,235-212-4,12134-02-0,,Notified C&L,4,H341:4;H302:4;H317:4
70682,Disodium 3-methyl-5-[[4-[(4-sulphonatophenyl)azo]phenyl]azo]salicylate,229-028-3,6406-37-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
70683,"(dimethyl)[3-thieno[2,3-c][2]benzothiepin-4(9H)-ylidenepropyl]ammonium chloride",214-575-2,1154-12-7,Acute Tox. 4,Notified C&L,1,H302:1
70693,Fusanus Spicatus Wood Oil,617-026-9,8024-35-9,Flam. Liq. 3;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,31,H317:31;H226:30;H412:30;H319:1;H315:1
70697,"Aromatic hydrocarbons, C",309-956-6,101794-74-5,Carc. 1B,Harmonised C&L,0,H350:0
70698,5-bromo-8-naphtholactam,413-480-5,24856-00-6,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H317:0;H410:0
70703,Potassium deuteroxide,246-324-8,24572-01-8,Acute Tox. 4;Skin Corr. 1A,Notified C&L,39,H302:39;H314:39
70705,2-bromo-5-fluorobenzonitrile,260-711-9,57381-39-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,46,H302:45;H332:45;H312:45;H335:6;H315:7;H319:7;H301:1
70709,[No public or meaningful name is available],475-070-2,,Not Classified,Notified C&L,6,Not classified:6
70711,"Fatty acids, C16-18 and C18-unsatd., compds. with diethanolamine",268-096-9,68002-82-4,Not Classified,Notified C&L,26,Not classified:17;H319:9;H315:8
70724,6-tert-butyl-o-cresol,218-734-7,2219-82-1,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,131,H302:4;H318:41;H314:131;H411:4;H311:4;H335:10
70727,4-diethylaminobenzaldehyde,204-377-4,120-21-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:47;H315:47;H311:45;H335:45;H301:3;H410:1;H332:2;H302:1
70729,"Fatty acids, lanolin, calcium salts",270-303-2,68424-44-2,Not Classified,Notified C&L,48,Not classified:48
70732,"N,N'-phenylene-1,4-bis[4-[(2,5-dichlorophenyl)azo]-3-hydroxynaphthalene-2-carboxamide]",223-460-6,3905-19-9,Not Classified,REACH registration C&L,276,Not classified:276
70735,"6-chloro-4H-3,1-benzoxazine-2,4(1H)-dione",225-255-7,4743-17-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
70753,3-Bromo-5-fluorobenzonitrile,605-876-3,179898-34-1,,Notified C&L,9,H302:5;H312:5;H335:6;H315:7;H319:7;H332:5;H331:4;H301:4;H311:4
70755,"Phosphorodithioic acid, mixed O,O-bis(2-ethylhexyl and iso-Bu and iso-Pr) esters, zinc salts",288-917-4,85940-28-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,62,H318:8;H315:60;H411:62;H319:54
70756,Cerium triiodide,232-228-3,7790-87-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45,H319:42;H315:42;H335:4;H360:3;H317:3
70760,4-[4-(4-aminophenyl)piperazin-1-yl]phenol,616-147-4,74853-08-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H319:3;H315:3;H335:1
70761,N-(3-chloro-4-methylphenyl)acetamide,230-483-5,7149-79-3,Acute Tox. 1,Notified C&L,42,H300:38;H319:4;H315:4;H335:4
70764,2-Hydroxypropyl-.beta.-cyclodextrine ethers,420-920-1,,Not Classified,REACH registration C&L,71,Not classified:71
70774,"2,4,7,9-Tetramethyl-4,7-decanediol",451-160-7,17913-76-7,Eye Irrit. 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,120,H402:11;H319:120;H412:120
70775,"N,N'-bis(2-ethoxyethyl)-p-xylene-α,α'-diamine",296-859-6,93144-07-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H315:2;H335:2
70776,(S)-sec-butylamine;(S)-2-aminobutane,208-164-7,513-49-5,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H302:0;H314:0;H400:0;H225:0;H332:0
70778,2-isopropenyl-5-methylhex-4-en-1-ol,261-264-2,58461-27-1,Not Classified,Notified C&L,88,Not classified:88
70781,Pyren-1-ylamine,216-521-3,1606-67-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H302:44;H312:38;H341:4;H351:1;H311:1
70784,"Rosin, maleated, polymer with pentaerythritol",614-421-8,68333-69-7,Not Classified,Notified C&L,217,Not classified:165;H317:52;H319:19;H413:5;H318:1;H411:1
70785,"Benzene, ethenyl-, polymer with 2-methyl-1,3-butadiene, hydrogenated",614-693-8,68648-89-5,Not Classified,Notified C&L,561,Not classified:479;H413:73;H226:9
70786,o-isononylphenol,248-741-0,27938-31-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,6,H400:6;H410:6
70791,Methyl [(dimethoxyphosphinothioyl)thio]acetate,212-058-6,757-86-8,Not Classified,REACH registration C&L,1,Not classified:1
70792,Methyl benzoate,202-259-7,93-58-3,Acute Tox. 4,REACH registration C&L,2188,H302:2181;H319:161;H315:161;Not classified:8;H371:4;H412:1;H312:1;H304:1
70794,Ethylcyclopentane,216-686-1,1640-89-7,Flam. Liq. 2,Notified C&L,69,H225:69
70795,"Distillates (petroleum), heavy paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-052-0,64741-51-1,Carc. 1A,Harmonised C&L,0,H350:0
70806,Diethylenetriaminepentaacetic acid dianhydride,607-286-1,23911-26-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:43;H335:42;H361:1
70808,4-[(4-methoxyphenyl)amino]benzenediazonium,251-047-0,32445-13-9,Not Classified,Notified C&L,1,Not classified:1
70811,2-hydroxy-2-methylpropanedioic acid,209-868-7,595-48-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
70812,"6-ethyl-1,3,5-triazine-2,4-diamine",213-291-6,934-75-8,Not Classified,Notified C&L,1,Not classified:1
70814,"Disodium (5or8)-[[2,4-diamino-5-[(4-sulphonatophenyl)azo]phenyl]azo]-(8or5)-(phenylazo)naphthalene-2-sulphonate",281-712-0,84025-06-9,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,6,H319:4;H411:4;Not classified:1;H315:1
70815,"Fumes, silica",273-761-1,69012-64-2,Not Classified,REACH registration C&L,335,Not classified:301;H373:34
70818,p-methoxybenzyl phenyl carbonate,250-699-3,31558-46-0,Skin Sens. 1;Eye Dam. 1,Notified C&L,38,H318:38;H317:38
70820,"ditalimfos (ISO);O,O-diethyl phthalimidophosphonothioate",225-875-8,5131-24-8,Skin Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H317:0;H315:0
70822,S-METHYL 4-METHYLPENTANETHIOATE,612-089-9,61122-71-2,Flam. Liq. 3,Notified C&L,1,H226:1
70823,1-(trimethylsilyl)methylamine,242-049-2,18166-02-4,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,38,H314:38;H225:38
70824,Trifluoperazine dihydrochloride,207-123-0,440-17-5,Acute Tox. 4,Notified C&L,41,H302:41;H361:1
70826,"2,3-dinitrophenol",200-628-7,66-56-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H331:0;H301:0;H311:0;H373:0
70827,2-ethoxy-3-isopropylpyrazine,276-847-7,72797-16-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H302:38;H315:39;H335:38;H319:1
70830,Cerium trichloride,232-227-8,7790-86-5,Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,225,H318:87;H400:85;H314:2;H410:85;H315:222;H319:137;H335:136;H411:2;Not classified:2;H290:1
70834,"4-(1,1-dimethylethyl)benzene-1,2-dicarbonitrile",251-166-8,32703-80-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
70838,"N,N'-(p-phenylene)di(acetamide)",205-417-3,140-50-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
70841,Undecyl methacrylate,240-558-4,16493-35-9,,Notified C&L,4,H319:4;H315:4;H335:4
70842,"2,4-dichloro-5-fluorobenzoylchloride",428-390-1,86393-34-2,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;STOT SE 3;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0;H318:0;H335:0;H315:0
70843,"2,4,6-Trichlorobenzoyl Chloride",609-916-0,4136-95-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,48,H318:41;H314:48;H290:1
70848,"2,2'-dihydroxybenzophenone",212-639-4,835-11-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
70849,Aniline Blue diammonium salt,613-976-3,66687-07-8,Not Classified,Notified C&L,2077,Not classified:2038;H319:39;H315:39;H335:39
70851,Lithium p-toluenesulphonate,216-005-8,1470-83-3,Not Classified,Notified C&L,25,Not classified:25
70852,Hydrogen bis[1-[(5-chloro-2-hydroxyphenyl)azo]-2-naphtholato(2-)]chromate(1-),250-774-0,31714-55-3,Not Classified,REACH registration C&L,97,Not classified:96;H320:1
70855,pentaerythritol triacrylate,222-540-8,3524-68-3,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0;H315:0
70857,2-iodobutane,208-163-1,513-48-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H226:38;H335:42;H225:5
70860,"Distillates (petroleum), light paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-051-5,64741-50-0,Carc. 1A,Harmonised C&L,0,H350:0
70861,2-chlorobenzylmethylamine,202-350-1,94-64-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:39;H302:39;H315:39;H335:39
70862,Pyrimidine-5-carboxylic acid,224-994-2,4595-61-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
70864,Ethyl 5-methylisoxazole-3-carboxylate,221-720-3,3209-72-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
70868,"N-butyl-1,3,5-triazine-2,4,6-triamine",227-025-1,5606-24-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
70869,"1,2,3,4-tetrahydroquinoline",211-237-6,635-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,66,H319:47;H315:48;H335:43;Not classified:11;H350:8;H302:5;H312:5;H332:5;H318:2;H314:1
70872,o-dichloro(2H4)benzene,218-606-0,2199-69-1,,Notified C&L,12,H302:11;H335:11;H315:11;H410:11;H400:11;H319:11;Not classified:2
70876,"Fatty acids, C6-12, potassium salts",271-706-6,68604-78-4,Skin Irrit. 2,Notified C&L,4,H315:3;H319:2
70878,4-phenylsemicarbazide,208-669-2,537-47-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H312:1;H335:1;H315:1;H319:1;H332:1
70879,"Ethene, 1-chloro-1,2,2-trifluoro-, homopolymer",618-336-7,9002-83-9,Not Classified,Notified C&L,6,Not classified:6
70880,Titanium tetrafluoride,232-017-6,7783-63-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,45,H302:40;H312:40;H318:39;H314:45;H332:40;H300:4;H330:4;H310:4
70884,p-[o-[4-(5-methylbenzoxazol-2-yl)phenyl]vinyl]benzoic acid,262-674-4,61257-43-0,Not Classified,REACH registration C&L,33,Not classified:33
70885,Magnesium dodecylsulfate,221-450-6,3097-08-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
70888,Carbon fluoride,257-131-3,51311-17-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:44
70889,reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile;5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile,429-760-5,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
70894,2-furaldehyde,202-627-7,98-01-1,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 2,Harmonised C&L,0,H312:0;H335:0;H315:0;H331:0;H301:0;H351:0;H319:0
70898,"(2S)-1,3,4,5,6,7-hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalene-8-methyl formate",263-250-1,61826-52-6,Not Classified,Notified C&L,88,Not classified:88
70902,"Alcohols, C8-18, ethoxylated",500-349-3,157707-43-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,13,H319:2;H315:3;Not classified:10
70903,4-diisopropylaminobutyronitrile,237-593-2,13858-50-9,Acute Tox. 4,Notified C&L,38,H302:38
70906,(R)-2-Vinyloxirane,612-972-9,62249-81-4,Flam. Liq. 2,Notified C&L,38,H225:38
70907,"Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1)",273-545-7,68989-01-5,,Notified C&L,35,H318:31;H315:31;Not classified:3;H400:1;H302:1;H314:1;H312:1
70911,reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C,410-820-4,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
70913,4-benzoylbenzonitrile,216-126-6,1503-49-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H302:42;H312:42;H335:38;H315:38;H319:38;H332:42
70916,"Octahydro-4,7-methano-1H-inden-5-ol",236-455-9,13380-89-7,Eye Irrit. 2,Notified C&L,233,H319:233
70917,"Ethanone, 1-(1-oxido-4-pyridinyl)-",607-306-9,2402-96-2,Not Classified,Notified C&L,20,Not classified:20
70919,"Pitch, coal tar, low-temp;Pitch Residue;[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 °C to 180 °C (104 °F to 356 °F). Composed primarily of a complex mixture of hydrocarbons.]",292-651-4,90669-57-1,Carc. 1B,Harmonised C&L,0,H350:0
70924,2-Hydroxy-4-(trifluoromethyl)pyridine,610-554-0,50650-59-4,Acute Tox. 4,REACH registration C&L,205,H302:197;H318:195;H319:8;H315:8;H335:7
70928,3-cyclohexylaminopropane-1-sulphonic acid,214-492-1,1135-40-6,Not Classified,REACH registration C&L,78,Not classified:67;H319:9;H315:9;H335:8;H302:2;H312:1;H300:1
70929,Disodium 5-[(5-acetamido-2-sulphonatophenyl)azo]-6-amino-4-hydroxynaphthalene-2-sulphonate,228-822-7,6360-05-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
70930,"Meat extracts, pork",307-888-1,97766-27-3,Not Classified,Notified C&L,10,Not classified:10
70932,"Ethanol, 2-[(2-aminoethyl)amino]-, polymer with 2-methyloxirane",608-639-2,31568-06-6,Skin Sens. 1,Notified C&L,162,H317:162;H319:78;H315:1
70935,hydroxo(2-(benzenesulfonamido)benzoato)zinc(II),403-750-0,113036-91-2,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H332:0
70939,"Fatty acids, tallow, 2-ethylhexyl ester",271-981-2,68648-21-5,Not Classified,Notified C&L,13,Not classified:13
70941,o-phenethylbenzoic acid,225-511-8,4890-85-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,65,H319:64;H315:64;H335:64;Not classified:1
70943,Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride,248-595-8,27668-52-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,125,H400:72;H319:44;H410:64;H315:79;H318:74;H331:51;H411:35;H301:51;H225:51;H351:35;H311:51;H226:35;Not classified:7;H401:7;H350:15;H371:1
70948,"Cobaltate(3-), bis[2-[[[4-(hydroxy-κO)-3-[2-[2-(oxo-κO)-1-[(phenylamino)carbonyl]propyl]diazenyl-κN1]phenyl]sulfonyl]amino]benzoato(3-)]-, ammonium sodium",603-059-6,125352-02-5,Not Classified,Notified C&L,31,Not classified:31
70949,Eleutheroside B,601-519-0,118-34-3,Acute Tox. 4,Notified C&L,3,H302:3
70951,(Z)-9-Octadecen-1-ol ethoxylated,500-016-2,9004-98-2,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,3003,H315:294;H411:104;H319:1500;H318:918;H302:778;Not classified:431;H400:152;H335:20;H412:14;H410:26;H312:3
70952,"tris(η5-cyclopenta-2,4-dien-1-yl)yttrium",215-069-4,1294-07-1,Flam. Sol. 2;Water-react. 2,Notified C&L,42,H228:42;H261:38;H319:4;H315:4;H335:4
70953,"trans-DL-cyclopentane-1,2-dicarboxylic acid",215-962-9,1461-97-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
70956,"1,4-bis(2,3-dihydroxypropylamino)anthraquinone",421-470-7,99788-75-7,Aquatic Chronic 2,Harmonised C&L,0,H411:0
70959,"Molybdenum, bis[[]O,O-bis(2-ethylhexyl) phosphorodithioato-[?]S,[?]S']dioxodi-µ-thioxodi-, (Mo-Mo)",615-708-0,72030-25-2,Not Classified,Notified C&L,74,Not classified:73;H350:1;H315:1;H411:1
70961,1-(methylamino)-4-[(4-methylphenyl)amino]anthraquinone,204-912-1,128-85-8,Not Classified,Notified C&L,15,Not classified:15
70962,Carob gum,232-541-5,9000-40-2,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,1516,H304:1295;H226:1295;Not classified:221
70964,"Hexasodium 2,2'-[vinylenebis[(3-sulphonato-4,1-phenylene)imino[6-[bis(2-hydroxyethyl)amino]-1,3,5-triazine-4,2-diyl]imino]]bis(benzene-1,4-disulphonate)",273-468-9,68971-49-3,Not Classified,REACH registration C&L,27,Not classified:27
70967,"Benzene, 1-fluoro-4-[[4-(hexyloxy)phenyl]ethynyl]-",604-476-6,145532-21-4,Not Classified,Notified C&L,1,Not classified:1
70968,"Resin acids and Rosin acids, zinc salts, polymers with linseed oil",614-650-3,68607-34-1,Not Classified,Notified C&L,6,Not classified:6
70969,1-chloro-4-iodobenzene,211-305-5,637-87-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,46,H302:41;H332:41;H312:41;H319:5;H315:5;H335:5
70970,"4(3H)-Pyrimidinone, 5-amino-6-hydroxy-",614-950-4,69340-97-2,Not Classified,Notified C&L,1,Not classified:1
70971,"Tetraammonium [μ-[[5,5'-[carbonylbis[imino(2-hydroxy-5-sulpho-p-phenylene)azo]]bis[6-hydroxynaphthalene-2-sulphonato]](8-)]]dicuprate(4-)",235-863-4,13011-70-6,Not Classified,Notified C&L,10,Not classified:10
70977,Cobalt diiron tetraoxide,234-992-3,12052-28-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,67,H319:41;H317:61;H315:41;H335:41;H334:16;Not classified:5;H302:4;H301:1
70980,"2,3-dihydro-5-hydroxyindol-2-one",222-309-1,3416-18-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
70983,3-(methylaminomethyl)pyridine,243-561-9,20173-04-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,45,H318:38;H302:38;H315:44;H335:43;H319:6;H314:1
70985,Orciprenaline sulphate,227-539-6,5874-97-5,Acute Tox. 4,Notified C&L,45,H332:42;H412:3
70994,"1,2,3,6-tetrahydrophthalimide",201-602-8,85-40-5,Not Classified,Notified C&L,1,Not classified:1
70997,Triisopropyl phosphite,204-130-0,116-17-6,Acute Tox. 3;Skin Irrit. 2,REACH registration C&L,170,H301:166;H315:170;H335:4;H341:5;H319:5;H226:4
71001,"Butter, Et esters",308-239-5,97926-23-3,Flam. Liq. 2,Notified C&L,1398,H225:1286;H226:112
71006,Trimethylsilyl bromoacetate,242-165-3,18291-80-0,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,44,H314:44;H226:44;Not classified:1;H318:1
71009,Erbium triiodide,237-471-9,13813-42-8,Repr. 1B,Notified C&L,38,H360:38
71010,"atrazine (ISO);2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine",217-617-8,1912-24-9,Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0;H373:0
71015,"1,4-Dioxa-8-azaspiro[4.5]dec-8-yloxy, 7,7,9,9-tetramethyl-",604-764-1,150980-92-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,1,H302:1;H314:1;H312:1;H412:1
71016,"Cellulose, 2-hydroxyethyl ether, polymer with N,N-dimethyl-N-2-propenyl-2-propen-1-aminium chloride, graft",601-121-7,111774-28-8,Aquatic Chronic 2,Notified C&L,371,H411:371
71021,Bromopentamethylbenzene,225-926-4,5153-40-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,39,H319:39;H315:39;H413:38;H335:38
71027,Benz[de]anthracen-7-one,201-393-3,82-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:42;H335:42
71030,"Glycerides, C16-18 mono- and di-, ethoxylated",601-536-3,118577-94-9,Not Classified,Notified C&L,1,Not classified:1
71035,"Hydroxylamine, O-ethyl-",613-044-6,624-86-2,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;STOT RE 1;Aquatic Acute 1,Notified C&L,156,H317:156;H331:156;H400:156;H301:156;H225:156;H311:156;H372:156;H319:156
71036,"Sulfurous acid, monosodium salt, reaction products with formaldehyde and phenol, sodium salts",286-720-8,85338-44-9,Not Classified,Notified C&L,1,Not classified:1
71038,N-[3-(dimethylamino)propyl]stearamide monohydrochloride,280-508-9,83607-13-0,Not Classified,Notified C&L,3,Not classified:3
71039,4-[[(1-methylheptyl)oxy]carbonyl]phenyl 4-(hexyloxy)benzoate,264-746-0,64240-64-8,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
71043,"Methyl (2E,6E)-(±)-9-(3,3-dimethyloxiranyl)-3,7-dimethylnona-2,6-dienoate",246-072-9,24198-95-6,Aquatic Chronic 4,Notified C&L,38,H413:38
71045,"Oxidation products of (esterification of tall oil, alcohols, C8-22, distn. residues and alcohols, C16-18)",923-683-5,,Not Classified,Notified C&L,36,Not classified:36
71051,4-acetylmorpholine,216-913-4,1696-20-4,Skin Sens. 1B;Repr. 2,REACH registration C&L,396,H361:390;H317:390;H319:183;H315:182;H335:4
71055,"Fatty acids, C5-9, esters with triethylene glycol",284-870-9,84988-81-8,Not Classified,Notified C&L,18,Not classified:18
71056,"2,6-Dioxo-3-phenyl-7-(4-n-propoxy-phenyl)-2,6-dihydrobenzo-(1,2-b;4,5-b')difuran",400-750-2,,Not Classified,REACH registration C&L,10,Not classified:10
71059,Hexahydro-1H-azepine-1-butyronitrile,221-694-3,3194-43-2,Acute Tox. 3,Notified C&L,38,H301:38
71061,"Tail gas (petroleum), catalytic reformed naphtha stabilizer;Refinery gas;[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]",270-808-8,68478-28-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
71063,Disodium oxobis[sulphato(2-)-O]zirconate(2-),246-441-4,24735-35-1,Eye Irrit. 2;STOT SE 3,Notified C&L,36,H319:36;H335:36
71064,Tetrabutylgermanium,213-929-3,1067-42-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H302:39;H332:38;H312:38;H319:5;H315:5;H335:4
71069,6-methyloct-5-en-2-one,246-073-4,24199-46-0,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,86,H317:85;H412:2;Not classified:1
71073,"7,12-dimethylbenz[a]anthracene",200-359-5,57-97-6,Acute Tox. 4;Carc. 1B,Notified C&L,43,H302:43;H350:40
71074,"α,α-difluoroanisole",207-283-1,458-92-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H226:1
71076,tert-butyl peroxypivalate,213-147-2,927-07-1,Org. Perox. C;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,105,H317:105;H304:10;H335:105;H315:105;H411:10;H242:57;H412:95
71080,Hexadecenylsuccinic anhydride,250-911-4,32072-96-1,Skin Sens. 1;Eye Irrit. 2,Notified C&L,569,H319:447;H317:469;Not classified:98;H413:21;H315:2;H318:1;H335:1
71083,Dodec-2-en-1-ol,244-786-5,22104-81-0,Not Classified,Notified C&L,88,Not classified:88
71087,"2,4-Diamino-6-pyrrolidinopyrimidine-3-oxide",611-333-1,55921-65-8,Acute Tox. 4,Notified C&L,35,H302:35
71088,Bismuth hydroxide nitrate oxide,215-136-8,1304-85-4,Not Classified,REACH registration C&L,181,Not classified:98;H272:48;H319:46;H315:46;H335:46;H372:35
71089,2-ethylhexyl 4-hydroxybenzoate,225-925-9,5153-25-3,Not Classified,Notified C&L,6,Not classified:4;H319:2;H315:2
71094,4-methylbenzyl acetate,218-689-3,2216-45-7,Not Classified,Notified C&L,236,Not classified:236
71095,"Agathosma betulina, ext.",291-047-8,90320-23-3,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1289,H302:1289;H317:1289;H315:1287;H410:1286;H400:1286;H226:1286;H304:3;H411:3
71097,Potassium trifluoroacetate,220-877-5,2923-16-2,Aquatic Chronic 3,REACH registration C&L,51,H412:6;H300:40;H400:40;H319:7;H315:7;H335:7;H302:3;H312:1;H332:1
71099,Isopropyl isothiocyanate,218-851-3,2253-73-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:39;H315:39;H226:42;H335:38;H302:4;H312:4;H314:5;H332:4;H301:2;H225:1;H311:1;H330:1
71101,Lecithins,232-307-2,8002-43-5,Not Classified,Notified C&L,2103,Not classified:2100;H319:1;H315:1;H335:3
71102,Butyl 2-pyridyl ether,248-428-9,27361-16-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
71103,"Cuprate(4-), [4-hydroxy-7-[[4-[(2-hydroxyethyl)amino]-6-[[5-hydroxy-6-[(2-hydroxy-5-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-3-[(4-methoxy-2-sulfophenyl)azo]-2-naphthalenesulfonato(6-)]-, tetrasodium",258-271-8,52953-36-3,Not Classified,Notified C&L,56,Not classified:55;H334:1;H319:1;H317:1;H412:1
71104,"Trisodium 5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(1-sulphonato-2-naphthyl)azo]naphthalene-2,7-disulphonate",260-832-7,57583-69-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,6,H334:6;H317:6
71105,"1-(2-chloroethoxy)-4-(1,2-diphenylvinyl)benzene",600-478-6,1037197-98-0,Not Classified,Notified C&L,2,Not classified:1;H302:1
71106,4-Hydroxy-3-nitropyridine,611-127-1,5435-54-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H302:4
71108,5-isopropyl-2-methylanisole,228-959-2,6379-73-3,Not Classified,Notified C&L,162,Not classified:122;H302:39;H319:2;H315:2;H335:2;H227:1
71109,"Fatty acids, C12-18, Me esters",273-095-1,68937-84-8,Aquatic Acute 1,Notified C&L,9,H400:7;Not classified:2
71110,Ethyl benzenesulphonate,208-200-1,515-46-8,Acute Tox. 4,Notified C&L,38,H302:38
71111,"Neomycin, sulfate (salt)",215-773-1,1405-10-3,,Notified C&L,355,H317:352;H335:120;H334:197;H361:132;H412:91;H410:35;H400:35;H373:36;H315:5;H319:7;H372:1;H411:1;H332:2;H302:2;H362:1;H301:1;H311:1;H360:1;H312:1
71114,Sodium bis[4-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-N-(3-methoxypropyl)benzene-1-sulphonamidato(2-)]chromate(1-),276-066-1,71839-80-0,,Notified C&L,2045,H412:2045
71115,Undec-10-enyl acetate,203-944-3,112-19-6,Not Classified,Notified C&L,88,Not classified:88
71118,"4,4'-bis(diethylamino)benzophenone",202-025-4,90-93-7,Not Classified,REACH registration C&L,148,Not classified:22;H413:53;H400:43;H319:80;H315:66;H335:65;H411:15;H410:2;H351:1
71120,Butyltris[(2-ethyl-1-oxohexyl)oxy]stannane,245-912-1,23850-94-4,Skin Corr. 1;Eye Irrit. 2,REACH registration C&L,437,H319:248;H314:10;H400:2;H410:2;H315:367;H412:327;Not classified:60;H335:38;H331:38;H301:38;H311:38;H413:2;H302:1;H312:1;H373:1
71121,"Disodium 3,3'-((3,3'-dimethyl(1,1'-biphenyl)-4,4'-diyl)bis(azo)bis(4-aminonaphthalene-1-sulphonate)",213-594-3,992-59-6,Carc. 1B,Notified C&L,38,H350:38
71123,3-(dimethylamino)-1-phenylpropan-1-ol,611-283-0,5554-64-3,,Notified C&L,2,H302:2;H312:1;H335:1;H315:1;H319:1;H332:1
71127,"1,3,5-triphenylformazan",208-509-1,531-52-2,Acute Tox. 4;Aquatic Acute 1,Notified C&L,39,H400:39;H302:39
71128,"3,4,5,6-tetrahydropyrimidine-2-thiol",218-152-3,2055-46-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
71129,Butyl phenylacetate,204-543-6,122-43-0,Not Classified,Notified C&L,128,Not classified:89;H319:39;H315:39;H332:39;H335:39;H302:1;H312:1
71134,"Octadecane-1,2-diol",243-711-3,20294-76-2,Not Classified,Notified C&L,2,Not classified:2
71136,"Bis(diethyldithiocarbamato-S,S')nickel",238-157-4,14267-17-5,Skin Sens. 1;Resp. Sens. 1;Carc. 1A,Notified C&L,1,H334:1;H350:1;H317:1
71137,Benodanil,239-352-7,15310-01-7,Not Classified,Notified C&L,3,Not classified:3
71138,"Ethyl bis(2,4-dinitrophenyl)acetate",227-415-1,5833-18-1,Acute Tox. 3,Notified C&L,40,H301:38;H228:1;H302:1;H413:1
71139,"Aluminum, hydrobis(2-methylpropyl)-, reaction products with isoprene",274-261-6,70024-64-5,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B;Muta. 2;Carc. 1B,REACH registration C&L,2,H250:2;H260:2;H341:1;H314:2;H350:1
71140,5-chloro-2-fluorobenzonitrile,260-710-3,57381-34-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,46,H302:44;H332:45;H312:40;H315:8;H311:6;H319:8;H304:1;H335:4;H301:2;H331:1
71142,Ethyl chlorofluoroacetate,206-930-5,401-56-9,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,44,H314:44;H226:44;H302:6;H312:6;H332:6;H318:1
71143,6-O-α-D-glucopyranosyl-D-glucose,207-879-1,499-40-1,Not Classified,Notified C&L,36,Not classified:36
71146,"Alcohols, C9-16, ethoxylated",619-252-3,97043-91-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,53,H318:53;H302:53
71148,"4-tert-butyl-3-hydroxy-2,6-xylylacetonitrile",259-766-1,55699-10-0,Aquatic Chronic 2,REACH registration C&L,85,H411:84;H302:1
71149,"Indan-1,3-dione",210-109-7,606-23-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H315:4;H335:4;H302:2
71157,4-aminobutan-2-ol,254-673-2,39884-48-5,Skin Corr. 1B,Notified C&L,40,H314:40;H318:1;H227:1
71169,"Tetradecane-1,2-diol",244-228-0,21129-09-9,Not Classified,Notified C&L,24,Not classified:24
71172,"Waxes and Waxy substances, jojoba, iso-Pr esters",605-924-3,181314-46-5,Not Classified,REACH registration C&L,1,Not classified:1
71173,3-Bromo-2-chlorobenzoic acid,611-434-0,56961-27-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H302:2;H332:1;H312:1;H319:1;H315:1;H335:1
71174,Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate,229-029-9,6406-56-0,Not Classified,REACH registration C&L,29,Not classified:15;H412:12;H413:2
71175,Adenosine phosphate,200-500-0,61-19-8,Not Classified,REACH registration C&L,24,Not classified:23;H319:1;H315:1;H335:1
71176,"2,6-Difluoroanisole",610-144-1,437-82-1,,Notified C&L,7,H319:6;H315:6;H226:5;H335:6;H225:1
71181,"Fatty acids, lanolin",270-302-7,68424-43-1,Not Classified,REACH registration C&L,139,Not classified:129;H413:10
71184,"L-2,4-diaminobutyric acid dihydrochloride",217-542-0,1883-09-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:39;H315:39;H335:39
71185,"5,8-dihydro-1-naphthol",248-596-3,27673-48-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,44,H319:6;H302:40;H411:40;H315:4;H335:4
71186,Alumichelate AW,606-204-1,19022-77-6,Flam. Liq. 2,REACH registration C&L,2,H225:2
71187,o-chlorobenzaldehyde oxime,223-065-9,3717-28-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H302:1;H332:1;H312:1
71191,Propyl cyanoacetate,238-424-5,14447-15-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H312:1;H315:1;H319:1;H332:1
71193,C.I. Disperse Orange 47,602-617-6,12236-03-2,Not Classified,Notified C&L,21,Not classified:21
71194,Piperidine-4-ethanol,210-727-7,622-26-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,61,H319:55;H315:55;H335:54;H314:6
71196,"Polymer with 2-Butyne-1,4-Diol and (Chloromethyl-)Oxirane, Brominated, Dehydrochlorinated, Methoxylated",617-903-6,86675-46-9,Acute Tox. 4,Notified C&L,1,H302:1
71204,"(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(furan-2-carbonylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrochloride",600-507-2,103980-44-5,Skin Sens. 1B;Resp. Sens. 1,REACH registration C&L,56,H334:55;H317:55;Not classified:1
71205,3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride,421-310-6,87691-88-1,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H302:0;H317:0;H410:0;H400:0;H319:0;H361:0
71207,"Fatty acids, vegetable-oil, compds. with triethanolamine",272-200-8,68783-57-3,Not Classified,Notified C&L,33,Not classified:33
71208,"Oils, vegetable, interesterified",307-351-1,97593-46-9,Not Classified,Notified C&L,4,Not classified:4
71209,"Octahydro-4,7-methano-1H-indene-2-methyl acetate",264-991-3,64644-34-4,Not Classified,Notified C&L,36,Not classified:36
71210,Pancuronium bromide,239-532-5,15500-66-0,Acute Tox. 3,Notified C&L,58,H301:58;H331:18;H311:18;H312:1;H335:1;H315:1;H319:1;H373:1;H332:1;H361:2
71214,"3-phenylfuran-2,5-dione",252-881-8,36122-35-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,52,H302:47;H332:47;H312:46;H319:6;H315:6;H335:5
71217,Bis[(2-ethyl-1-oxohexyl)oxy]dioctylstannane,246-325-3,24577-34-2,STOT SE 2,REACH registration C&L,75,H371:2;H413:71;H373:71;H372:2;H361:3;H412:2
71224,"N,N-diethylglycine",216-520-8,1606-01-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
71226,p-menth-1-en-4-ol,209-235-5,562-74-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2023,H302:2023;H317:136;H315:2019;H336:82;H319:1970;H335:125;H332:35;H312:2;H304:1;H411:1
71227,Acenaphthenequinone,201-441-3,82-86-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
71228,Octadecyl isothiocyanate,220-722-1,2877-26-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
71229,Cyanocyclobutane,224-606-1,4426-11-3,,Notified C&L,6,H302:5;H332:4;H226:6;H312:5;H301:1;H311:1;H331:2
71230,p-bromocinnamic acid,214-850-7,1200-07-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H302:38;H315:43;H335:42
71240,"2,4,5-trifluoroaniline",206-692-2,367-34-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H302:44;H312:44;H335:38;H315:44;H319:44;H332:44
71241,Imazaquin,617-220-3,81335-37-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,296,H400:239;H410:239;H312:41;H412:16
71242,"N,N'-bis(2-aminoethyl)propane-1,3-diamine",225-254-1,4741-99-5,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1
71243,3-methoxyphenylhydrazine hydrochloride,254-368-4,39232-91-2,,Notified C&L,4,H319:4;H302:4;H315:4;H335:4
71247,3-pyridylmethyl isothiocyanate,253-225-3,36810-90-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,3,H302:2;H312:2;H335:3;H318:2;H315:3;H334:2;H332:2;H319:1
71250,"Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.'-(iminodi-2,1-ethanediyl)bis[.omega.-hydroxy-, N-[3-(C10-16-alkyloxy)propyl] derivs., di-Et sulfate-quaternized",615-231-8,70983-58-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,24,H302:2;H318:24;H410:2;H315:24;H400:2
71251,"Benzoic acid, compound with 2,2'-iminobisethanol (1:1)",258-867-8,53926-87-7,Not Classified,Notified C&L,46,Not classified:46
71252,"Resin acids and Rosin acids, fumarated, ammonium salts",272-791-2,68911-88-6,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,2,H318:2;H317:2;H413:2
71253,Ethyl 3-methylpiperidine-1-propionate,274-719-5,70644-49-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
71260,"Speiss, copper",273-836-9,69029-97-6,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Carc. 1A;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H302:4;H317:4;H360:4;H410:4;H400:4;H362:4;H372:4;H350:4;H332:4
71261,"1,2,3-propanetriyl tris[acetoxyoctadecanoate]",248-351-0,27233-00-7,Not Classified,Notified C&L,57,Not classified:57
71262,Ruthenium trichloride hydrate,604-667-4,14898-67-0,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,140,H302:99;H290:88;H318:88;H314:140;H410:5;H400:5;H412:88;H332:4;H312:4
71264,"1,1'-Carbonyl-di-(1,2,4-triazole)",634-845-7,41864-22-6,Acute Tox. 4;Eye Dam. 1;Repr. 2,Notified C&L,53,H318:40;H302:53;H361:38;H412:13
71265,"2-(2-hydroxypropyl)-5-methoxy-1H-xantheno[2,1,9-def]isoquinoline-1,3(2H)-dione",252-466-1,35254-10-5,Not Classified,Notified C&L,5,Not classified:5
71266,N-[4-(chloroacetyl)phenyl]acetamide,205-416-8,140-49-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:39;H335:39;H318:1;H302:1
71269,3-butoxycyclohex-2-en-1-one,240-557-9,16493-04-2,Not Classified,REACH registration C&L,2,Not classified:1;H302:1;H317:1
71274,"Fatty acids, tall-oil, reaction products with diethylenetriamine, maleic anhydride, tetraethylenepentamine and triethylenetetramine",273-601-0,68990-47-6,Skin Sens. 1,REACH registration C&L,121,H317:97;H319:23;H315:23;H302:1;H314:1;H410:1
71278,Dimethylcyclohex-3-ene-1-carbaldehyde,248-742-6,27939-60-2,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,405,H319:384;H317:404;H315:404;H411:73;H412:331;H314:21;H312:22;Not classified:1
71280,"Adenosine 5'-(tetrahydrogen triphosphate), 2',3'-dideoxy-, trilithium salt",300-359-6,93939-70-9,Acute Tox. 4;Repr. 2,Notified C&L,38,H302:38;H361:38
71281,"1-Ethoxy-2,3-difluor-4-(trans-4-propylcyclohexyl)-benzene",605-718-3,174350-05-1,Not Classified,REACH registration C&L,1,Not classified:1
71282,Acetic [2H]acid,212-059-1,758-12-3,Flam. Liq. 3;Skin Corr. 1A,Notified C&L,42,H314:42;H226:42;Not classified:1;H318:1
71283,"4-(1,1,3,3-tetramethylbutyl)-o-cresol",218-735-2,2219-84-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H318:38;H315:38;H413:38;H335:38
71285,5-nitro-2-furaldehyde oxime,209-082-4,555-15-7,,Notified C&L,4,H319:4;H302:4;H315:4;H335:4
71286,"4-amino-N,N-dimethylaniline;3-amino-N,N'-dimethylaniline",202-807-5,99-98-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0,H301:0;H331:0;H311:0
71297,Thiophene-3-carbonitrile,216-687-7,1641-09-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:41;H312:45;H335:39;H315:43;H319:43;H332:45;H301:4
71299,tert-butylamine--borane,230-851-5,7337-45-3,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,140,H312:92;H315:140;H411:93;H301:140;H319:140;H335:46;H311:48;H228:11;Not classified:2
71300,"3,4-dimethoxyphenethylamine",204-376-9,120-20-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,176,H318:97;H302:175;H317:95;H315:162;H319:71;H335:71;H314:13;H332:1;H372:1
71304,Quinhydrone,203-387-6,106-34-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H301:48;H319:46;H315:46;H335:44;H400:8;Not classified:1
71306,4-Fluoro-2-methylanisole,609-758-2,399-54-2,,Notified C&L,5,H319:5;H315:5;H335:5
71307,Xanthene-9-carboxylic acid,201-394-9,82-07-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
71308,3-hexenyl 3-methylisocrotonate,265-766-2,65416-28-6,Not Classified,Notified C&L,1,Not classified:1
71309,2-Acetamido-5-chlorobenzoic Acid Methyl Ester,606-599-0,20676-54-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
71311,"silicic acid, nickel salt",253-461-7,37321-15-6,Skin Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H317:0;H410:0;H400:0;H372:0;H350:0
71312,"1-Butanaminium (R)-3-(fluorbenzenesulfonamido)-1,2,3,4-tetrahydro-9H-carbazole-9-propanoate",925-462-9,,Acute Tox. 4;Eye Dam. 1,Notified C&L,1,H318:1;H302:1
71314,"2,2-dimethylbutyric acid",209-865-0,595-37-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,193,H318:5;H302:9;H315:188;H319:184;H335:184;H314:5;H290:1
71319,MMTP,467-290-2,,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,1,H302:1;H317:1;H315:1;H226:1
71321,2-methylcyclohexanone,209-513-6,583-60-8,Flam. Liq. 3;Acute Tox. 4,Harmonised C&L,0,H332:0;H226:0
71327,"Pentasodium hydrogen 1,2,3,4,5,6-cyclohexanehexacarboxylate",256-547-2,50329-18-5,Not Classified,Notified C&L,22,Not classified:22
71330,"Disodium lead N,N'-ethylenebis[N-(carboxylatomethyl)aminoacetate]",245-314-0,22904-40-1,Acute Tox. 3;Acute Tox. 3;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H360:1;H410:1;H331:1;H400:1;H301:1
71348,4-chlorotoluene-2-sulphonyl chloride,252-306-0,34981-38-9,,Notified C&L,5,H314:5
71350,"Benzoic acid, 2-hydroxy-3-methyl-, reaction products with 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid, 6-amino-4-hydroxy-2-naphthalenesulfonic acid and 2,2'-(1,2-ethenediyl)bis[5-aminobenzenesulfonic acid]",619-077-2,94825-60-2,Not Classified,Notified C&L,83,Not classified:83
71351,"azothoate (ISO);O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate",227-419-3,5834-96-8,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H302:0;H332:0
71355,6-fluoro-2-methylindan-1-one,609-478-0,37794-19-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H319:1;H315:1;H335:1
71358,"Chloro[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]aluminium",237-998-4,14154-42-8,Not Classified,REACH registration C&L,98,Not classified:98
71361,"ametryn (ISO);N-ethyl-N'-isopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine",212-634-7,834-12-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H410:0
71364,"2,3,5,6-tetramethyl-p-phenylenediamine",221-457-4,3102-87-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
71366,5-chloro-p-xylene-2-sulphonyl chloride,201-835-5,88-49-3,,Notified C&L,6,H314:6
71367,cadmium fluoride,232-222-0,7790-79-6,Acute Tox. 3;Acute Tox. 2;Muta. 1B;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H360:0;H410:0;H340:0;H400:0;H301:0;H372:0;H330:0;H350:0
71368,"4,5-dimethylthiazol-2-amine monohydrobromide",230-523-1,7170-76-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,94,H319:93;H302:94;H315:93;H335:93
71369,"1,3-Isobenzofurandione, polymer with oxirane and 2,2'-oxybis[ethanol]",600-444-0,103513-05-9,Not Classified,REACH registration C&L,1,Not classified:1
71375,4-isobutylmorpholine,233-696-1,10315-98-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H226:39;H335:38
71376,3-methylpyridine-2-carbonitrile,244-131-3,20970-75-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H319:56;H315:52;H335:51;H302:6;H301:1;H312:2;H332:2
71377,"2,4-dihydroxybenzoic acid 2-hydroxybenzoic acid copper plumbane",614-455-3,68411-07-4,Skin Irrit. 2;Eye Irrit. 2;Repr. 1A;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,4,H360:4;H315:2;H410:4;H400:2;H319:2;H320:1;H373:3;H302:2;H228:2;Not classified:1;H361:1;H332:1
71380,"Cobaltate(2-), [2-[[[4-hydroxy-3-[[2-oxo-1-[(phenylamino) carbonyl]propyl]azo]phenyl]sulfonyl]amino]benzoato(3-)][2-[[2- hydroxy-5-[(phenylamino)sulfonyl]phenyl]azo]-3-oxo-N- phenylbutanamidato(2-)]-, ammonium sodium",603-060-1,125352-03-6,Aquatic Chronic 2,Notified C&L,31,H411:31
71381,"cinidon ethyl (ISO);ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate",604-318-6,142891-20-1,Skin Sens. 1;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H317:0;H410:0;H351:0
71384,Indan-1-carboxylic acid,238-355-0,14381-42-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1
71386,"1,3,5-Estratriene-3,17-alpha-diol",200-354-8,57-91-0,Carc. 2;Repr. 1A;Lact.,Notified C&L,153,H360:93;H362:86;H351:148;H361:68;H302:17;H312:16;H332:16;Not classified:3;H341:1;H350:1;H372:1
71390,"Fumaria officinalis, ext.",283-416-7,84625-41-2,Flam. Liq. 3,Notified C&L,4,H226:3;H319:1;H301:1
71394,Palladium dihydroxide,235-219-2,12135-22-7,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,122,H318:4;H302:4;H317:4;H413:115;H319:2;H315:2;H335:1;Not classified:1
71399,2-(methylamino)pyridine,224-997-9,4597-87-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H302:42;H312:42;H335:42;H315:45;H319:45;H332:42
71401,"Dibenzo[b,e]thiepin-11(6H)-one",216-241-1,1531-77-7,Not Classified,REACH registration C&L,11,Not classified:4;H319:6;H315:6;H335:5;H302:1
71403,"Glycerides, C14-18 and C18-unsatd., branched and linear",288-316-7,85711-56-4,Not Classified,Notified C&L,6,Not classified:6
71411,bis(2-ethylhexyl) dithiodiacetate,404-510-8,62268-47-7,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H317:0;H411:0
71418,"Cyclohexane-1,4-dione",211-306-0,637-88-7,Not Classified,Notified C&L,6,Not classified:5;H319:1;H315:1;H335:1
71420,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononyl methacrylate",217-419-1,1841-46-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
71424,(-)-Methadone,603-081-6,125-58-6,Acute Tox. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,40,H300:2;H336:2;H412:2;H317:38;H335:38;H315:38;H301:38;H334:38;H319:38
71425,1-methyl-4-(2-methyloxiranyl)-7-oxabicyclo[4.1.0]heptane,202-475-1,96-08-2,Acute Tox. 4,Notified C&L,83,H312:79;H319:17;Not classified:4;H317:1;H315:1;H302:1
71426,"2-(3,4-dichlorophenyl)-5-phenyloxazole",282-654-9,84282-08-6,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H413:38;H335:38;H318:38;H315:38;H301:38
71428,"Ethylene glycol, propylene glycol, isophthalic acid, tall oil fattyacids, pentaerythritol, glycerol polymer",614-420-2,68333-62-0,Flam. Liq. 3;Skin Irrit. 2,Notified C&L,1,H315:1;H226:1
71431,Trisodium 4-[[6-[[[[6-[(o-anisyl)azo]-5-hydroxy-7-sulphonato-2-naphthyl]amino]carbonyl]amino]-1-hydroxy-3-sulphonato-2-naphthyl]azo]naphthalene-1-sulphonate,222-984-2,3687-80-7,Not Classified,Notified C&L,2,Not classified:2
71434,furfuryl alcohol,202-626-1,98-00-0,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 2;STOT RE 2,Harmonised C&L,0,H302:0;H312:0;H335:0;H331:0;H351:0;H319:0;H373:0
71437,4-(2-Hydroxyethyl)indolin-2-one,925-636-4,,Not Classified,Notified C&L,1,Not classified:1
71439,3-[tris(acetoxy)silyl]propyl methacrylate,257-407-3,51772-85-1,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,22,H318:5;H314:18;H335:5;H332:13;H312:13;Not classified:4
71441,(4-methylphenyl) 2-pyridyl ketone,278-941-3,78539-88-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
71442,"2,3,6,7-tetrahydro-11-oxo-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinolizine-10-carbonitrile",259-827-2,55804-68-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H302:1;H312:1;H315:1;H319:1;H332:1
71445,"N,N-dimethyl-m-toluidine",204-495-6,121-72-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H331:0;H301:0;H311:0;H373:0
71446,p-toluic acid,202-803-3,99-94-5,Skin Sens. 1,REACH registration C&L,69,H317:14;H302:48;H319:21;H315:19;Not classified:7;H335:8
71447,N-cyclohexyl-1H-indole-3-methylamine,258-864-1,53924-03-1,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H302:38;H413:38
71448,"Oils, fish, sulfated, compds. with triethanolamine",269-136-8,68187-94-0,Not Classified,Notified C&L,2,Not classified:2
71450,Methyleneaminoacetonitrile,203-709-5,109-82-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,98,H302:94;H312:94;H335:97;H315:98;H319:98;H332:94
71452,"3-[10,10-dimethyl-9(10H)-anthrylidene]-N,N-dimethylpropylamine hydrochloride",234-150-5,10563-70-9,Acute Tox. 3,Notified C&L,2,H301:2
71453,Titanium,231-142-3,7440-32-6,Not Classified,REACH registration C&L,633,Not classified:435;H319:62;H315:62;H335:62;H228:63;H250:44;H260:27;H252:4;H251:7;H413:1
71454,Aminoacridine,201-995-6,90-45-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38;H302:1
71455,"Amines, N-tallow alkyltrimethylenedi-",263-189-0,61791-55-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT RE 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,779,H302:734;H312:447;H318:677;H314:763;H410:642;H400:762;H372:457;H373:66;H411:33;Not classified:12;H335:1;H315:1
71456,"N,N-dimethyl-1H-indole-3-ethylamine",200-508-4,61-50-7,Not Classified,Notified C&L,56,Not classified:55;H301:1
71457,Benzyl 2-methylbutyrate,260-169-3,56423-40-6,Not Classified,Notified C&L,90,Not classified:90
71458,4-methylpentan-2-ol;methyl isobutyl carbinol,203-551-7,108-11-2,Flam. Liq. 3;STOT SE 3,Harmonised C&L,0,H226:0;H335:0
71459,2-methylbutyl hydrogen 5(or 6)-carboxylato-4-hexylcyclohex-2-ene-1-octanoate,281-713-6,84025-07-0,Not Classified,Notified C&L,3,Not classified:3
71460,"[[(acetoxy)methyl]octahydro-4,7-methano-1H-indenyl]methyl acrylate",299-602-6,93893-14-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H317:1;H315:1;H335:1
71462,4-fluorocinnamic acid,207-288-9,459-32-5,,Notified C&L,6,H319:6;H315:6;H335:5
71463,"2,6-Dichloroisonicotinic Acid",611-076-5,5398-44-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
71467,2-amino-5-chlorobenzonitrile,227-651-5,5922-60-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,49,H302:40;H312:40;H335:48;H315:49;H319:49;H332:45;H301:7;H311:6;H331:1
71472,1-diethylaminopropan-2-ol,224-537-7,4402-32-8,Flam. Liq. 3;Skin Corr. 1,REACH registration C&L,46,H314:4;H226:46;H319:42;H315:42;H335:38;H318:1;H302:1
71479,"Quaternary ammonium compounds, benzyl-C10-16-alkyldimethyl, chlorides",273-544-1,68989-00-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,46,H318:38;H302:46;H315:38;H400:7;H314:8;H312:1
71480,Diphenyl[μ-[(tetrapropenyl)succinato(2-)-O:O']]dimercury,248-355-2,27236-65-3,Not Classified,Notified C&L,7,Not classified:5;H310:2;H300:2;H410:2;H400:2;H330:2;H373:2
71481,"Estr-5-ene-3,17-dione, 11-hydroxy-, Cyclic Bis(1,2-ethanediyl Acetal), (11beta)-",611-772-9,59017-03-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H302:1;H332:1;H312:1
71483,Sodium methanesulphonate,219-203-2,2386-57-4,Not Classified,REACH registration C&L,358,Not classified:17;H319:340;H315:340;H335:253;H302:1;H317:1
71485,4-chloro-α-(chloromethyl)benzyl alcohol,228-954-5,6378-66-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
71486,"Glycerides, C12-18 di- and tri-",294-590-9,91744-28-4,Not Classified,REACH registration C&L,2,Not classified:2
71489,"2,4,4,6,6-pentamethylhept-1-ene",237-869-2,14031-86-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,441,H319:441;H315:441;H226:441
71492,"Quino[2,3-b]acridine-6,7,13,14(5H,12H)-tetrone",216-125-0,1503-48-6,Skin Sens. 1B,REACH registration C&L,84,H317:84
71493,Valeric anhydride,218-212-9,2082-59-9,Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,42,H319:2;H317:2;H314:40;H318:1;H290:1
71497,Reaction mass of 2–hydroxyethyl-3-Imidazol-1-yl-propanoate and 2-(3-imidazol-1-yl-propanoyloxy)ethyl 3-Imidazol-1-yl-propanoate,926-135-3,,Not Classified,REACH registration C&L,87,Not classified:87
71498,"Wine, ext.",293-806-9,91082-91-6,Not Classified,Notified C&L,264,Not classified:210;H224:25;H226:25;H318:4;H315:4;H336:4;H225:4;H351:4
71500,esterification products of castor oil and polyphosphoric acids,614-406-6,68308-61-2,Skin Sens. 1;Eye Irrit. 2,Notified C&L,3,H319:2;H317:2;H318:1;H314:1
71502,1-{[4-(4-trans-Propylcyclohexyl)-phenyl]-ethinyl}- 4-trifluormethoxy-benzene,603-433-9,130746-64-4,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
71508,4-ethylaniline,209-637-0,589-16-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,46,H301:44;H331:41;H311:42;H373:45;H332:4;H312:4;H302:2;H319:1;H315:1
71511,"Birch, Betula pendula, ext.",288-919-5,85940-29-0,Aquatic Chronic 3,Notified C&L,537,H412:389;Not classified:144;H304:2;H226:2;H319:1
71513,"Gases (petroleum), catalytic cracking;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]",272-203-4,68783-64-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H350:0;H340:0;Not classified:0
71516,Ammonium diethyl phosphate,246-502-5,24856-80-2,Skin Corr. 1B,Notified C&L,1,H314:1
71517,phenthoate (ISO);ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate,219-997-0,2597-03-7,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H410:0;H312:0
71519,"2,2-dimethylpropionyl bromide",248-590-0,27644-18-4,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1C,Notified C&L,1,H302:1;H314:1;H226:1
71521,4-(bromoacetyl)benzonitrile,606-435-8,20099-89-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,REACH registration C&L,47,H302:46;H314:47;H332:46;H312:46;H318:2;H331:1;H301:1;H311:1
71522,"4-bromo-3,5-dimethoxybenzaldehyde",250-698-8,31558-40-4,Not Classified,Notified C&L,1,Not classified:1
71532,Dibromomalononitrile,217-548-3,1885-23-0,Acute Tox. 3,Notified C&L,38,H301:38
71534,"5-tert-butyl-1,3,4-thiadiazol-2-amine",254-364-2,39222-73-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:39;H332:39
71540,Diisopropyl oxalate,210-448-0,615-81-6,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H227:1;H335:1
71541,2-Chloro-2-propen-1-ol,611-879-0,5976-47-6,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H302:39;H332:39;H226:39;H312:39
71542,Hexobendine dihydrochloride,200-054-7,50-62-4,Aquatic Chronic 3,Notified C&L,1,H412:1
71543,methyl 3-methyl-4-oxo-4-(3-nitro-4-aminophenyl)butanoate,922-399-9,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H315:2;H335:2
71544,"N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide",431-530-4,,Skin Corr. 1A;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H314:0;H317:0
71548,5-ethyl-m-xylene,213-290-0,934-74-7,Acute Tox. 4;Skin Sens. 1,Notified C&L,46,H302:38;H317:38;H225:4;Not classified:3;H226:1
71551,tert-butyldimethylsilyl trifluoromethanesulphonate,274-102-0,69739-34-0,Flam. Liq. 3;Skin Corr. 1B;STOT SE 3,REACH registration C&L,56,H314:56;H226:56;H335:48;H318:2;H331:1;H332:1
71552,1-(1H-indol-3-yl)acetone,214-855-4,1201-26-9,,Notified C&L,1,H319:1;H302:1;H332:1;H312:1
71557,RB68,415-650-4,153965-54-9,Not Classified,REACH registration C&L,6,Not classified:6
71558,Methenamine hydrochloride,246-206-6,24360-05-2,,Notified C&L,1,H318:1;H228:1
71559,Methyl tetrahydro-5-methyl-4-oxo-3-furoate,221-721-9,3210-57-9,Flam. Liq. 3,Notified C&L,1,H226:1
71561,"Disodium 2,2'-([1,1'-biphenyl]-4,4'-diyldivinylene)bis(benzenesulphonate)",248-421-0,27344-41-8,Eye Irrit. 2,REACH registration C&L,551,H319:404;H318:141;H332:38;H412:36;Not classified:7;H315:2;H335:2;H302:1;H312:1;H413:1
71563,"4-hydroxy[1,1'-biphenyl]-3-carboxylic acid",206-301-5,323-87-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
71564,"2-(2,4-Dimethylcyclohex-3-ene-1-yl)-5-methyl-(1-methylpropyl)-1,3-dioxane",601-499-3,117933-89-8,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,161,H400:155;H410:161;H373:122;H411:8;H317:1
71568,"Tricyclo[5.2.1.02,6]decane-8-one",236-458-5,13380-94-4,Not Classified,Notified C&L,237,Not classified:205;H319:29;H302:31;H315:28;H312:31
71570,2-(benzylamino)acetamide,609-744-6,39796-49-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
71573,2-(N-ethylanilino)ethyl carbanilate,251-727-7,33898-93-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H400:38;H319:38;H315:38;H335:38
71574,"3,3'-[(dibutylstannylene)bis(thio)]bis(propane-1,2-diol)",269-561-9,68298-38-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Repr. 1B;STOT RE 1,Notified C&L,1,H302:1;H317:1;H360:1;H315:1;H372:1;H319:1
71575,"2,6-dimethylheptane-3,5-dione",242-234-8,18362-64-6,,Notified C&L,14,H319:13;H315:13;H226:13;H335:13
71576,"Potassium 2',4'-difluoro-4-hydroxy[1,1'-biphenyl]-3-carboxylate",288-176-7,85665-84-5,Not Classified,REACH registration C&L,2,Not classified:2
71578,Tetrakis(trifluorophosphine)nickel,237-597-4,13859-65-9,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Notified C&L,38,H334:38;H314:38;H317:38
71580,"Bis(tetraphenylphosphonium) tetrahydrogen tris(4,4'-sulfonyldiphenolate)",484-440-2,502157-74-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,2,H318:2;H302:2
71581,"Chromate(2-), [2-[[[4-hydroxy-3-[[(2-hydroxyphenyl)methylene]amino]phenyl]sulfonyl]amino]benzoato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-, potassium sodium",286-948-8,85407-92-7,Skin Sens. 1,Notified C&L,1,H317:1
71582,Isopropyl valerate,242-235-3,18362-97-5,Flam. Liq. 3,Notified C&L,2,H226:2
71586,o-tolylhydrazinium(1+) chloride,211-232-9,635-26-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H302:44;H312:39;H335:42;H315:43;H319:43;H332:39
71587,"3,3'-oxydipropiononitrile",216-750-9,1656-48-0,Eye Irrit. 2,Notified C&L,43,H319:43;H315:4;H335:4
71591,"Benzene, 1,2-dibromo-5-chloro-3-fluoro-",606-641-8,208186-78-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
71592,Phenyl-pyridin-2-yl-methanol,604-239-7,14159-57-0,Acute Tox. 4,Notified C&L,38,H302:38
71596,"2',3'-dideoxyadenosine",223-853-2,4097-22-7,Muta. 2,Notified C&L,2,H341:1;H319:1;H315:1;H335:1
71603,3-butoxypropan-2-ol;propylene glycol monobutyl ether,225-878-4,5131-66-8,Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0,H319:0;H315:0
71604,N-2-naphthylacetamide,209-476-6,581-97-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
71606,"hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate",428-140-1,210706-50-6,Aquatic Chronic 4,Harmonised C&L,0,H413:0
71608,"Oxirane, 2-phenyl-, polymer with oxirane, mono(dihydrogen phosphate), octyl ether",620-260-4,308336-62-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,29,H318:29;H315:29
71610,Phentolamine,200-053-1,50-60-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
71611,"(3aS,9aS,9bS)-3-hydroxy-3a-methyl-6-(3-oxobutyl)-1,2,3,3a,4,5,8,9,9a,9b-decahydro-7H-cyclopenta[a]naphthalen-7-one",609-999-3,4222-76-8,Not Classified,REACH registration C&L,2,Not classified:2
71612,turmeric extract,617-027-4,8024-37-1,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,54,H317:54;H304:54;H412:54
71613,"Diethyl sulphate, compound with 2-(heptadec-8-enyl)-4,5-dihydro-1H-imidazole-1-ethanol (1:1)",271-272-8,68527-63-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H302:1;H317:1;H318:1;H315:1;H410:1;H400:1
71619,Diethyl 4-chlorobenzylphosphonate,254-365-8,39225-17-7,,Notified C&L,5,H319:5;H315:5
71622,"2,3-Difluoro-4-[trans-4-(trans-4-propylcyclohexyl)-cyclohexyl]-toluene",605-719-9,174350-06-2,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
71624,Dodecyldimethylamine,203-943-8,112-18-5,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,REACH registration C&L,995,H400:953;H302:980;H314:969;H410:604;H318:691;H319:48;H411:15;H315:12;Not classified:12;H361:1
71628,Calcium peroxide,215-139-4,1305-79-9,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,200,H272:196;H319:192;H315:192;H335:192;H314:4;H271:4
71630,Indan-5-ol,216-006-3,1470-94-6,Acute Tox. 3,Notified C&L,44,H311:44;H319:5;H315:5;H335:4
71632,Diethyl-2-mercaptoethylammonium chloride,217-731-8,1942-52-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
71633,"Slags, ferrovanadium-manufg., aluminothermic",282-220-9,84144-98-9,Not Classified,REACH registration C&L,6,Not classified:6
71636,"Oils, macadamia",603-361-8,129811-19-4,Not Classified,Notified C&L,37,Not classified:37
71638,"(2E,6Z)-1,1-diethoxynona-2,6-diene",266-874-2,67674-36-6,Not Classified,Notified C&L,114,Not classified:78;H317:35;H315:35;H319:10;H413:1
71641,Nonadecylbenzene,249-467-4,29136-19-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H304:1
71642,"2,2'-[[4-[(4-nitrophenyl)azo]phenyl]imino]bisethyl diacetate",266-254-1,66214-54-8,Not Classified,Notified C&L,3,Not classified:3
71643,Potassium tridecan-1-yl hydrogen phosphate,271-495-0,68568-53-6,Not Classified,Notified C&L,32,Not classified:32
71644,Chromium iron oxide,235-790-8,12737-27-8,Not Classified,REACH registration C&L,346,Not classified:346
71645,3-Dimethylamino-1-(pyrid-3-yl)-2-propen-1-one,434-770-8,,,Notified C&L,1,Not classified:1
71648,5-sulphamoyl-o-anisic acid,244-789-1,22117-85-7,,Notified C&L,7,H319:6;H315:6;H335:6;H302:1
71650,"2-Imidazolidinone, 4,5-dihydroxy-1,3-bis(hydroxymethyl)-, methylated",270-150-1,68411-81-4,Not Classified,Notified C&L,2,Not classified:2
71654,5-tert-Butyl-2-methylbenzenethiol,438-520-9,7340-90-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H319:2;H315:2;H411:1;H317:1;H304:1;H410:1;H400:1;H336:1;H373:1;H226:1;H361:1
71655,"Pitch, coal tar, low-temp., heat-treated;Pitch Residue, oxidised;Pitch Residue, heat-treated;[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 °C to 140 °C (122 °F to 284 °F). Composed primarily of a complex mixture of aromatic compounds.]",292-653-5,90669-58-2,Carc. 1B,Harmonised C&L,0,H350:0
71658,Estrone sodium sulphate,207-120-4,438-67-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B;Repr. 1A,Notified C&L,99,H335:43;H360:61;H315:44;H350:82;H319:44;H351:17;H362:1;H373:1
71659,Thallium formate,213-599-0,992-98-3,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,39,H300:39;H330:39;H411:39;H373:39
71661,4-fluoro-α-propylbenzyl alcohol,211-881-8,704-83-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
71664,2-[[4-[(2-cyanoethyl)ethylamino]phenyl]azo]-5-nitrobenzonitrile,240-923-8,16889-10-4,Not Classified,REACH registration C&L,134,Not classified:81;H319:39;H315:40;H335:38;H412:13
71668,"1,2-dihydro-2-oxoquinoline-4-carboxylic acid",239-827-9,15733-89-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50,H319:47;H315:8;H335:7;H302:40;Not classified:2
71669,"Fatty acids, C16-22, calcium salts",271-700-3,68604-59-1,Not Classified,Notified C&L,50,Not classified:50
71670,Camphene,201-234-8,79-92-5,Flam. Sol. 2;Eye Irrit. 2;Aquatic Chronic 1,REACH registration C&L,2118,H319:2041;H228:1950;H410:2040;H304:1304;H400:1764;H226:54;Not classified:75;H225:37;H411:2;H318:1;H315:2;H335:1
71672,Zinc isodecyl phosphorodithioate,246-618-6,25103-54-2,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H410:2
71673,"Reaction mass of 2-HEPTANOL, 3,4,5,6,6-PENTAMETHYL and 2-HEPTANOL, 3,4,5,5,6-PENTAMETHYL and 2-Heptanol,4-Methylene-3,5,6,6-Tetramethyl- and 2-Heptanol,4-Methylene-3,5,5,6-Tetramethyl-",401-030-0,,Aquatic Chronic 2,Notified C&L,1573,H411:1573
71674,"L-Cysteine, hydrochloride, hydrate",615-117-8,7048-04-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,438,H319:399;H315:318;H335:317;Not classified:39
71683,4-methylpentan-2-one;isobutyl methyl ketone,203-550-1,108-10-1,Flam. Liq. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H319:0;H225:0;H332:0;H335:0
71685,Anthrone,201-994-0,90-44-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:46;H315:46;H335:45;Not classified:2
71688,"1-Propene, homopolymer, chlorinated",614-508-0,68442-33-1,Not Classified,Notified C&L,25,Not classified:25
71693,Diethyl [2-(triethoxysilyl)ethyl]phosphonate,212-056-5,757-44-8,,Notified C&L,2,H319:1;H315:1;H335:1;H318:1;H314:1
71694,"Distillates (petroleum), heavy naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-054-1,64741-53-3,Carc. 1A,Harmonised C&L,0,H350:0
71696,1-chloro-3-nitrobenzene,204-496-1,121-73-3,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,81,H319:2;H302:48;H400:38;H317:33;H331:33;H411:38;H301:33;H351:33;H311:38;H372:34;H373:7;H200:3;H310:3;H330:3;H370:1
71701,4-nitrophenylacetonitrile,209-085-0,555-21-5,,Notified C&L,9,H302:5;H332:5;H311:5;Not classified:2;H301:2;H319:1;H315:1;H312:1;H331:1
71708,Chloride 2-chloropyridinium 1-oxide,243-712-9,20295-64-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
71711,"reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid",418-230-9,163879-69-4,Expl. 1.3;Skin Sens. 1;STOT RE 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H203:0;H317:0;H411:0;H361:0;H373:0
71713,p-mercaptophenol,211-307-6,637-89-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:40;H315:40;H335:39;H302:5;H314:5;H312:1;H332:1
71720,"4-bromo-1,2-dichlorobenzene",242-160-6,18282-59-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,85,H302:37;H317:4;H315:52;H411:4;H319:48;H335:46
71722,"2,6-dinitroaniline",210-108-1,606-22-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,47,H301:43;H331:39;H311:43;H373:43;H330:5;H372:3;H302:3;H332:3;H312:3;H310:1;H300:1;H315:1;H319:1
71723,(2-hydroxyethyl)(3-hydroxypropyl)dimethylammonium chloride,278-860-3,78182-00-0,Not Classified,Notified C&L,83,Not classified:83
71728,"2-[4-[[1-[[(2-methoxy-5-sulphophenyl)amino]carbonyl]-2-oxopropyl]azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid, sodium salt",280-758-9,83763-70-6,Not Classified,Notified C&L,1,Not classified:1
71732,4-[[p-(phenylazo)phenyl]azo]-o-cresol,228-587-0,6300-37-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
71733,1-(2-furyl)propan-1-one,221-693-8,3194-15-8,Acute Tox. 4,Notified C&L,44,H302:44;H319:6;H315:2;H335:2
71735,m-aminobenzohydrazide,237-907-8,14062-34-1,,Notified C&L,5,H319:5;H315:5;H335:5
71739,"Quinazoline, 6-chloro-2-(chloromethyl)-4-phenyl-, 3-oxide",620-225-3,5958-24-7,Not Classified,Notified C&L,2,Not classified:1;H302:1
71744,"Fatty acids, coco, zinc salts",270-301-1,68424-42-0,Not Classified,Notified C&L,1,Not classified:1
71745,"Fatty acids, palm-oil, hydrogenated, sodium salts",297-840-5,93763-22-5,Not Classified,Notified C&L,51,Not classified:51
